
<html lang="en"     class="pb-page"  data-request-id="4cca0095-bfb3-43ef-b971-d7196a2aad5c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-4;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01760;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles" /></meta><meta name="dc.Creator" content="Dominik  Dolles" /></meta><meta name="dc.Creator" content="Matthias  Hoffmann" /></meta><meta name="dc.Creator" content="Sandra  Gunesch" /></meta><meta name="dc.Creator" content="Oliviero  Marinelli" /></meta><meta name="dc.Creator" content="Jan  Möller" /></meta><meta name="dc.Creator" content="Giorgio  Santoni" /></meta><meta name="dc.Creator" content="Arnaud  Chatonnet" /></meta><meta name="dc.Creator" content="Martin J.  Lohse" /></meta><meta name="dc.Creator" content="Hans-Joachim  Wittmann" /></meta><meta name="dc.Creator" content="Andrea  Strasser" /></meta><meta name="dc.Creator" content="Massimo  Nabissi" /></meta><meta name="dc.Creator" content="Tangui  Maurice" /></meta><meta name="dc.Creator" content="Michael  Decker" /></meta><meta name="dc.Description" content="The enzyme butyrylcholinesterase (BChE) and the human cannabinoid receptor 2 (hCB2R) represent promising targets for pharmacotherapy in the later stages of Alzheimer’s disease. We merged pharmacoph..." /></meta><meta name="Description" content="The enzyme butyrylcholinesterase (BChE) and the human cannabinoid receptor 2 (hCB2R) represent promising targets for pharmacotherapy in the later stages of Alzheimer’s disease. We merged pharmacoph..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 5, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01760" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01760" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01760" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01760" /></link>
        
    
    

<title>Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01760" /></meta><meta property="og:title" content="Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0021.jpeg" /></meta><meta property="og:description" content="The enzyme butyrylcholinesterase (BChE) and the human cannabinoid receptor 2 (hCB2R) represent promising targets for pharmacotherapy in the later stages of Alzheimer’s disease. We merged pharmacophores for both targets into small benzimidazole-based molecules, investigated SARs, and identified several dual-acting ligands with a balanced affinity/inhibitory activity and an excellent selectivity over both hCB1R and hAChE. A homology model for the hCB2R was developed based on the hCB1R crystal structure and used for molecular dynamics studies to investigate binding modes. In vitro studies proved hCB2R agonism. Unwanted μ-opioid receptor affinity could be designed out. One well-balanced dual-acting and selective hBChE inhibitor/hCB2R agonist showed superior in vivo activity over the lead CB2 agonist with regards to cognition improvement. The data shows the possibility to combine a small molecule with selective and balanced GPCR-activity/enzyme inhibition and in vivo activity for the therapy of AD and may help to rationalize the development of other dual-acting ligands." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01760"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01760">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01760&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01760&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01760&amp;href=/doi/10.1021/acs.jmedchem.7b01760" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1646-1663</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01746" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01765" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dominik++Dolles">Dominik Dolles</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Hoffmann">Matthias Hoffmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Gunesch">Sandra Gunesch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oliviero++Marinelli">Oliviero Marinelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++M%C3%B6ller">Jan Möller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giorgio++Santoni">Giorgio Santoni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arnaud++Chatonnet">Arnaud Chatonnet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+J.++Lohse">Martin J. Lohse</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hans-Joachim++Wittmann">Hans-Joachim Wittmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Strasser">Andrea Strasser</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Massimo++Nabissi">Massimo Nabissi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tangui++Maurice">Tangui Maurice</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Decker">Michael Decker</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6773-6245" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, D-97074 Würzburg, Germany</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">School of Pharmacy, Department of Experimental Medicine, University of Camerino, I-62032 Camerino, Italy</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Institute of Pharmacology and Toxicology, Julius Maximilian University of Würzburg, Versbacher Strabe 9, D-97078 Würzburg, Germany</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">INRA UMR866, University of Montpellier, F-34060 Montpellier, France</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Pharmaceutical and Medicinal Chemistry II, Institute of Pharmacy, University of Regensburg, D-95053 Regensburg, Germany</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">INSERM UMR-S1198, University of Montpellier, EPHE, F-34095 Montpellier, France</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#9ef3f7fdf6fffbf2b0fafbfdf5fbecdeebf0f7b3e9ebfbece4fcebecf9b0fafb"><span class="__cf_email__" data-cfemail="563b3f353e37333a783233353d33241623383f7b212333242c34232431783233">[email protected]</span></a>. Tel: 0049-931-31-89676.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01760&amp;href=/doi/10.1021%2Facs.jmedchem.7b01760" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1646–1663</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 5, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 November 2017</li><li><span class="item_label"><b>Published</b> online</span>5 February 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 February 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01760" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01760</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1646%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDominik%2BDolles%252C%2BMatthias%2BHoffmann%252C%2BSandra%2BGunesch%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D4%26contentID%3Dacs.jmedchem.7b01760%26title%3DStructure%25E2%2580%2593Activity%2BRelationships%2Band%2BComputational%2BInvestigations%2Binto%2Bthe%2BDevelopment%2Bof%2BPotent%2Band%2BBalanced%2BDual-Acting%2BButyrylcholinesterase%2BInhibitors%2Band%2BHuman%2BCannabinoid%2BReceptor%2B2%2BLigands%2Bwith%2BPro-Cognitive%2Bin%2BVivo%2BProfiles%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1663%26publicationDate%3DFebruary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01760"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1576</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01760" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dominik&quot;,&quot;last_name&quot;:&quot;Dolles&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Hoffmann&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Gunesch&quot;},{&quot;first_name&quot;:&quot;Oliviero&quot;,&quot;last_name&quot;:&quot;Marinelli&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Möller&quot;},{&quot;first_name&quot;:&quot;Giorgio&quot;,&quot;last_name&quot;:&quot;Santoni&quot;},{&quot;first_name&quot;:&quot;Arnaud&quot;,&quot;last_name&quot;:&quot;Chatonnet&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;J. Lohse&quot;},{&quot;first_name&quot;:&quot;Hans-Joachim&quot;,&quot;last_name&quot;:&quot;Wittmann&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Strasser&quot;},{&quot;first_name&quot;:&quot;Massimo&quot;,&quot;last_name&quot;:&quot;Nabissi&quot;},{&quot;first_name&quot;:&quot;Tangui&quot;,&quot;last_name&quot;:&quot;Maurice&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Decker&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;1646-1663&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01760&quot;},&quot;abstract&quot;:&quot;The enzyme butyrylcholinesterase (BChE) and the human cannabinoid receptor 2 (hCB2R) represent promising targets for pharmacotherapy in the later stages of Alzheimer’s disease. We merged pharmacophores for both targets into small benzimidazole-based molecules, investigated SARs, and identified several dual-acting ligands with a balanced affinity/inhibitory activity and an excellent selectivity over both hCB1R and hAChE. A homology model for the hCB2R was developed based on the hCB1R crystal structure and used for molecular dynamics studies to investigate binding modes. In vitro studies proved hCB2R agonism. Unwanted μ-opioid receptor affinity could be designed out. One well-balanced dual-acting and selective hBChE inhibitor/hCB2R agonist showed superior in vivo activity over the lead CB2 agonist with regards to cognition improvement. The data shows the possibility to combine a small molecule with selective and balanced GPCR-activity/enzyme inhibition and in vivo activity for the therapy of AD and may help to &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01760&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01760" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01760&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01760" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01760&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01760" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01760&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01760&amp;href=/doi/10.1021/acs.jmedchem.7b01760" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01760" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01760" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01760%26sid%3Dliteratum%253Aachs%26pmid%3D29400965%26genre%3Darticle%26aulast%3DDolles%26date%3D2018%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationships%2Band%2BComputational%2BInvestigations%2Binto%2Bthe%2BDevelopment%2Bof%2BPotent%2Band%2BBalanced%2BDual-Acting%2BButyrylcholinesterase%2BInhibitors%2Band%2BHuman%2BCannabinoid%2BReceptor%2B2%2BLigands%2Bwith%2BPro-Cognitive%2Bin%2BVivo%2BProfiles%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D4%26spage%3D1646%26epage%3D1663%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/jmcmar.2018.61.issue-4/20180222/jmcmar.2018.61.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The enzyme butyrylcholinesterase (BChE) and the human cannabinoid receptor 2 (<i>h</i>CB<sub>2</sub>R) represent promising targets for pharmacotherapy in the later stages of Alzheimer’s disease. We merged pharmacophores for both targets into small benzimidazole-based molecules, investigated SARs, and identified several dual-acting ligands with a balanced affinity/inhibitory activity and an excellent selectivity over both <i>h</i>CB<sub>1</sub>R and <i>h</i>AChE. A homology model for the <i>h</i>CB<sub>2</sub>R was developed based on the <i>h</i>CB<sub>1</sub>R crystal structure and used for molecular dynamics studies to investigate binding modes. In vitro studies proved <i>h</i>CB<sub>2</sub>R agonism. Unwanted μ-opioid receptor affinity could be designed out. One well-balanced dual-acting and selective <i>h</i>BChE inhibitor/<i>h</i>CB<sub>2</sub>R agonist showed superior in vivo activity over the lead CB<sub>2</sub> agonist with regards to cognition improvement. The data shows the possibility to combine a small molecule with selective and balanced GPCR-activity/enzyme inhibition and in vivo activity for the therapy of AD and may help to rationalize the development of other dual-acting ligands.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15680" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15680" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common form of dementia. According to the annual Word Alzheimer Report, there are more than 47 million people suffering from AD. By 2050, researchers expect this number to climb up to even more than 130 million.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Currently, a cure is pending and pharmacotherapy is very limited. Three acetylcholinesterase (AChE) inhibitors (rivastigmine, donepezil, and galantamine) and one <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor (NMDA) antagonist (memantine) are currently available as drugs. Unfortunately, these drugs are only effective in early stages of AD, and they only act symptomatically but do not slow down progression or even cure AD.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">The reasons for an outbreak of this complex disease still remain unknown. AD is pathobiologically characterized by the presence of senile plaques, which consist of β-amyloid (Aβ). Aβ is an insoluble peptide and is formed by β/γ-secretase-induced cleavage of the amyloid precursor protein (APP). Another hallmark is the formation of neurofibrillary tangles, which consist of hyper-phosphorylated τ-protein aggregates. Once formed, both Aβ and τ-proteins trigger the progressive loss of muscarinergic neurons in the brain and lead to memory deficits and cognitive dysfunction.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> Moreover, Aβ induces activation of neuroinflammatory pathways characterized by activated microglia and astrocytes as observed in the brains of AD patients.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Neuroinflammation then leads to the production of pro-inflammatory chemokines, cytokines, and neurotoxins, which speed up AD progression by themselves.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The exact sequence of these cascade processes is still under discussion.</div><div class="NLM_p">In the past years, the human cannabinoid receptors (<i>h</i>CBRs) were identified as targets for drug development concerning neurodegenerative disorders. Currently, there are two known subtypes: the human cannabinoid receptors 1 (<i>h</i>CB<sub>1</sub>R) and 2 (<i>h</i>CB<sub>2</sub>R). <i>h</i>CB<sub>1</sub>Rs are mainly expressed in the brain;<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a><i>h</i>CB<sub>2</sub>Rs were first described in the peripheral immune system<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and then described to occur to a lower extent in the central nervous system (CNS), especially microglia.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> In the course of AD, expression levels of <i>h</i>CB<sub>1</sub>R do not change, but overexpression of <i>h</i>CB<sub>2</sub>R is observed in certain brain regions (especially in the hippocampus) of AD patients.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Furthermore, CB<sub>2</sub>R expression is associated with microglia and astrocytes that are surrounded by neuritic plaques.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The theory that up-regulation of CB<sub>2</sub>R signaling leads to reduction of associated inflammatory processes<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> was substantiated in several in vitro studies: <i>h</i>CB<sub>2</sub>R agonists reduce the production of neurotoxic factors, such as reactive oxygen species (ROS) and pro-inflammatory mediators (TNF-α and cytokines).<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> Furthermore, in vivo studies support the therapeutic potential of <i>h</i>CB<sub>2</sub>R agonists: Wu et al. injected Aβ<sub>1–40</sub> intracerebrally into rat brains and then treated the animals with MDA7, a known <i>h</i>CB<sub>2</sub>R agonist. After 14 days, behavioral tests were performed (place learning in the Morris water maze) and the rat brains slices were then examined. MDA7 was found to promote Aβ clearance, to decrease secretion of proinflammatory mediators and ultimately led to restored synaptic plasticity, cognition, and memory.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In another study, transgenic Tg2576 mice that overexpress APP were continuously treated with JWH-133, another known <i>h</i>CB<sub>2</sub>R agonist, at different stages of AD. As a result, Aβ production was lowered, reactive microglia cells were reduced, and a positive cognitive performance was observed.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The importance of CB<sub>2</sub>R in Aβ formation was shown in J20APP mice (overexpression of APP in neocortex and hippocampus). Deletion of CB<sub>2</sub>R led to an increased formation and deposition of Aβ, which supports CB<sub>2</sub>R’s role as a reducing agent of Aβ.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In summary, activation of <i>h</i>CB<sub>2</sub>R leads to various beneficial effects concerning AD and additionally seems to play a central role in other neurodegenerative diseases such as Parkinson’s and Huntington’s disease.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">The oldest theory regarding AD pathophysiology is the “cholinergic hypothesis”, which describes the massive loss of cholinergic neurons in AD.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The amount of acetylcholinesterase (AChE), the metabolizing enzyme of the neurotransmitter acetylcholine (ACh), decreases in the course of AD. However, the concentration of its isoenzyme butyrylcholinesterase (BChE) stays unchanged or even increases and is able to compensate for the loss of AChE, since BChE can also hydrolyze ACh into choline and acetate.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Besides that, it was shown that BChE (over-) expression is associated with senile plaques and the transformation of nonfibrillar to fibrillary Aβ plaques.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Inhibition of BChE is therefore a promising approach when it comes to combat AD’s cognitive deficits, especially in later stages when AChE diminishes.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In a very recent in vivo study, BChE knockout mice showed enhanced learning abilities in memory tests as compared to wildtype littermates, and after intercerebroventricular injections of Aβ<sub>25–35</sub> oligomers, BChE knockout mice appeared less sensitive to the learning and memory deficits, oxidative stress, and decrease in hippocampal ACh, as induced by the amyloid peptide in wildtype animals.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In another study, a sulfonamide-based nanomolar BChE inhibitor was investigated. In one of the very few in vivo studies that applied BChE-selective inhibitors, mice treated with this inhibitor showed improved memory and learning abilities in passive avoidance and Morris water maze tests without producing acute cholinergic adverse effects.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">Furthermore, it is remarkable that there’s a colocalization of BChE and <i>h</i>CB<sub>2</sub>Rs in microglia cells of the pathophysiologically altered branch. Glia cells play an important role in production of BChE and can be specifically targeted by CB<sub>2</sub>R agonists.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a></div><div class="NLM_p">The multifactorial character of AD makes it difficult if not impossible to apply the classical “one target–one disease” for successful drug development.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> It is therefore advantageous to develop multitarget drugs, which address different targets simultaneously. These drugs consist of two drug entities either as a hybrid linked by a spacer<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> or merged into one single entity;<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a><sup>,</sup><a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34-36)</a> for the latter case, only a few successful examples have been described. (For a review, see ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">35</a>.) Hybrids addressing CBRs as one of the targets have been developed successfully.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37-39)</a> In a remarkable recent work, Rampa et al. have achieved inhibiting both <i>h</i>BChE and fatty acid amide hydrolase (FAAH) and therefore target both the endocannabinoid and cholinergic system.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The main disadvantage of hybrid molecules is their (often) high molecular weight, which goes along with a violation of Lipinski’s rule of five.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In contrast, merged ligands are still “small molecules” and their molar mass remains often at the same level as the “single compound”.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> In return, their development is more laborious. Both drug moieties have to be “fused” into one entity. The problem is that, if affinity is increased at one target, it is very likely decreased at the other one.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> There are three common approaches to obtain such merged/dual-acting compounds: “designing in”, “designing out”, and “balancing”. The most common approach is “designing in”, where structural elements of two highly selective ligands are combined in one molecule, and the resulting compound then incorporates activity at the two desired targets. In a second approach, a merged compound not only possesses activity for two desired targets but also shows undesirable activity at a third target. In this case, “designing out” aims for excluding activity at the third, undesired target but keeping activity at the other two desired ones. In the third approach, a compound shows a very high affinity for one target but only moderate activity for the other target. Here, the aim is to balance the affinity at both desired targets.<a onclick="showRef(event, 'ref32 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref35">(32, 35)</a> Despite these difficulties, there are already several successful examples for merged ligands in the recent literature, such as adenosine A<sub>2A</sub> receptor/monoamine oxidase B ligands and human histamine H<sub>3</sub> receptor antagonists/AChE inhibitors developed in our group; the latter proved successful even in vivo.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a></div><div class="NLM_p">In our previous work,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> we applied a novel pharmacophore model for BChE inhibitors to several benzimidazole-based selective <i>h</i>CB<sub>2</sub>R agonists initially developed by AstraZeneca <b>A</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> in a “designing in” approach. A related merged structure based on indazole had been described before.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> After the synthesis of various heterocyclic templates and applying various substitution patterns, we had obtained a first substance library and some compounds showed activity in the (sub)micromolar range at both targets and an excellent selectivity over both <i>h</i>CB<sub>1</sub>R and AChE (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Furthermore, we conducted molecular dynamics (MD) simulations in both <i>h</i>CB<sub>2</sub>R and BChE, which gave the first insights into the binding mode of our lead compounds <b>A</b> and <b>B</b> and helped the understanding of structure–activity relationships (SARs) at both targets.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Development of the second generation lead structures <b>B</b>, <b>C</b>, and <b>D</b> starting from AstraZeneca’s selective <i>h</i>CB<sub>2</sub>R agonist <b>A</b>, the first generation lead.<a onclick="showRef(event, 'ref36 ref44'); return false;" href="javascript:void(0);" class="ref ref36 ref44">(36, 44)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the present study, we developed our compound portfolio further by balancing activities at <i>h</i>CB<sub>2</sub>R and BChE and by investigating and designing out unwanted interactions with the μ opioid receptor (MOP). We synthesized and characterized in a portfolio of in vitro assays 13 novel dual-acting <i>h</i>CB<sub>2</sub>R ligands and BChE inhibitors. We furthermore investigated for the first time intrinsic activities at the <i>h</i>CB<sub>2</sub>R for second and third generation compounds. Finally, we evaluated the ability of our second generation lead compound <b>B</b> to fight cognition deficits induced by intracerebroventricular (ICV) Aβ<sub>25–35</sub> injections in mice, as an in vivo pharmacological model for AD.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The difficulty in designing a multitarget compound is to “fuse” drug entities and at the same time to keep or even improve the activity at both targets. The starting point for advanced synthetic approaches are Astra Zeneca’s benzimidazole <b>A</b> as well as our second generation lead compounds <b>B</b>, <b>C</b>, and <b>D</b> described very recently (<a class="ref internalNav" href="#fig1" aria-label="Figures 1">Figures 1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref36 ref44'); return false;" href="javascript:void(0);" class="ref ref36 ref44">(36, 44)</a> These compounds already showed either a high affinity at one of the two targets or even a balanced micromolar activity profile. From these results, we followed several design approaches (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>): the introduction of different amides (green) and substituents (yellow) at position 5 of the benzimidazole core, alternation of the chain length (red), and a combination of the most promising substitution patterns (blue). Before, we also had synthesized other heterocyclic templates such as amino-indazoles, but the compounds lost affinity at all targets.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Therefore, we returned to the initial structural template.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural compound design approaches carried out starting from lead compounds <b>A</b>–<b>D</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The necessity of a (diethyl)amide for a high <i>h</i>CB<sub>2</sub>R affinity had been previously demonstrated,<a onclick="showRef(event, 'ref36 ref44'); return false;" href="javascript:void(0);" class="ref ref36 ref44">(36, 44)</a> but data for inhibition of either AChE or BChE of several amides was not available. The electron-withdrawing character of amides led us using substituents with different electronic effects (e.g., nitro and amino) at position 5 of the benzimidazole core. Ethylenepiperidinyl substitution at the <i>N</i><sup>1</sup> of the benzimidazole core already caused (sub)micromolar activity at both <i>h</i>CB<sub>2</sub>R and BChE. The aim was to extend the alkylene chain and to increase lipophilicity and interaction between the side chain and the oxyanion hole of the BChE.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Lastly, we combined the most promising substituents in order to increase dual-activity.</div><div class="NLM_p">Specifically, the synthesis of benzimidazoles and 2-amino benzimidazoles was carried out as previously reported starting from 4-fluoro-3-nitrobenzoic acid <b>1</b>.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> To introduce the different amide moieties in the last step, esterification was performed to obtain ester <b>2</b>. For the synthesis of target compounds <b>23</b>, <b>24</b>, and <b>30</b>–<b>32</b>, the diethylamide moiety <b>3</b> was formed using HBTU as the coupling agent. In the next step, nucleophilic substitution with various amines afforded compounds <b>4</b>–<b>8</b>. Reduction of the nitro group was achieved using tin(II) to obtain <i>o</i>-phenylenediamines <b>9</b>–<b>13</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>o</i>-Phenylene Diamine Precursors <b>9</b>–<b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (i) H<sub>2</sub>SO<sub>4</sub>, EtOH, reflux, 24 h; (ii) HNEt<sub>2</sub>, (COCl)<sub>2</sub>, NEt<sub>3</sub>, DMF, 0 °C to rt, 5 h; (iii) NHR<sup>2</sup>, NEt<sub>3</sub>, EtOH, rt, 3 h; (iv) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, reflux, 6 h.</p></p></figure><div class="NLM_p">To obtain benzimidazoles with various amide moieties and spacer lengths, diamines <b>9</b>, <b>12</b>, and <b>13</b> were coupled with 2-(4-ethoxyphenyl)acetic acid to afford compounds <b>14</b>–<b>16</b>. Cyclization was achieved in glacial acetic acid, and benzimidazoles <b>17</b>–<b>19</b> were obtained in quantitative yields. Ester <b>17</b> was hydrolyzed under basic conditions and then coupled with various amines using HBTU as a coupling agent. After purification, amides <b>20a</b>–<b>e</b> were obtained in high yields. For various spacer lengths, hydroxy compounds <b>18</b> and <b>19</b> were treated in an Appel-like reaction with phosphorus tribromide to obtain the bromo compounds <b>21</b> and <b>22</b>. In the last step, bromine was substituted with piperidine under basic conditions to afford compounds <b>23</b> and <b>24</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Benzimidazoles with Different Amide Moieties or Spacer Lengths<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (v) <i>o</i>-phenylene diamine <b>9</b>, <b>12</b>, or <b>13</b>, HBTU, NEt<sub>3</sub>, DMF, rt, 24 h; (vi) AcOH, reflux, 2 h; (vii) LiOH, THF/H<sub>2</sub>O, rt, 24 h; (viii) primary and secondary amines <b>a</b>–<b>e</b>, HBTU, NEt<sub>3</sub>, DMF, rt, 24 h; (ix) PBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 12 h; (x) piperidine, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, 12 h.</p></p></figure><div class="NLM_p">The synthesis of 2-amino benzimidazoles was performed as previously reported.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Upon reaction of benzylic and anilinic amines <b>25a</b>–<b>c</b> with carbon disulfide, isothiocyanates <b>26a</b>–<b>c</b> were obtained.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Thiourea derivatives <b>27</b>–<b>29</b> were afforded by reacting the respective isothiocyanates with <i>o</i>-phenylenediamine <b>10</b> or <b>11</b>. Cyclization was carried out using EDCI as a coupling reagent, and 2-amino benzimidazoles <b>30</b>–<b>32</b> were obtained (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2-Amino Benzimidazoles<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (i) CS<sub>2</sub>, NEt<sub>3</sub>, Boc<sub>2</sub>O, THF, 0 °C to rt, 12 h; (ii) <i>o</i>-phenylene diamine <b>10</b> or <b>11</b>, THF, rt, 6 h; (iii) EDCI·HCl, NEt<sub>3</sub>, THF, reflux, 5 h.</p></p></figure><div class="NLM_p">For the introduction of electron-withdrawing/donating functions at position 5 of the benzimidazole core, a different synthetic approach was applied. Starting from 1-chloro-2,4-dinitro benzene <b>33</b>, nucleophilic substitution with isopentylamine led to compound <b>34</b> in quantitative yields. Selective reduction of the 2-nitro moiety to obtain <i>o</i>-phenylenediamine <b>35</b> was carried out according to Freitag et al.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> using sodium sulfide as a reducing agent. Amide coupling and cyclization were carried out as described above. 5-Nitro benzimidazole <b>37</b> was reduced by tin(II) to afford 5-amino benzimidazole <b>38</b>. In the final step, HBTU-mediated amide coupling with benzoic acid afforded compound <b>39</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Benzimidazoles with Electron-Withdrawing/Donating Substituents at Position 5<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (i) isopentylamine, NEt<sub>3</sub>, EtOH, rt, 24 h; (ii) Na<sub>2</sub>S·H<sub>2</sub>O, NaHCO<sub>3</sub>, MeOH/H<sub>2</sub>O, reflux, 4 h; (iii) 2-(4-ethoxyphenyl)acetic, HBTU, NEt<sub>3</sub>, DMF, rt, 12 h; (iv) AcOH, reflux, 6 h; (v) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, reflux, 6 h; (vi) benzoic acid, HBTU, NEt<sub>3</sub>, DMF, rt, 6 h.</p></p></figure></div><div id="sec2-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Pharmacological Profile of Dual-Acting Compounds</h3><div class="NLM_p">All target compounds were tested for affinity to <i>h</i>CB<sub>1</sub>R and <i>h</i>CB<sub>2</sub>R in radioligand binding studies (HEK cells stably expressing <i>h</i>CB<sub>2</sub>R; CHO cells stably expressing <i>h</i>CB<sub>1</sub>R). Inhibition of AChE (<i>ee</i>AChE, E.C.3.1.1.7, from electric eels and <i>h</i>AChE, E.C.3.1.1.7, from humans) and BChE (<i>h</i>BChE, E.C.3.1.1.8, from humans) was evaluated in the colorimetric Ellman’s assay (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Sequence alignment had shown that the isoform <i>ee</i>AChE exhibits a very high sequence homology to the human enzyme (88% sequence identity)<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Results of the Biological Evaluation of the Inhibitory Effect of AChE/BChE and Radioligand Binding Studies at <i>h</i>CB<sub>1</sub>R/<i>h</i>CB<sub>2</sub>R</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0019.gif" alt="" id="gr6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0020.gif" alt="" id="GRAPHIC-d153e1222-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Screened on membranes of HEK cells stably expressing <i>h</i>CB<sub>2</sub>R using 10 μM of the compound; values are mean values from at least 2 independent experiments performed in triplicates. <i>K</i><sub>i</sub> value was determined when displacement of [<sup>3</sup>H] CP 55,940 was >50%, mean values of at least 2 independent experiments performed in triplicates.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Screened on membranes of CHO cells stably expressing <i>h</i>CB<sub>1</sub>R using 10 μM of the compound; values are mean values from at least 2 independent experiments performed in triplicates. <i>K</i><sub>i</sub> value was determined when displacement of [<sup>3</sup>H] CP 55,940 was >50%, mean values of at least 2 independent experiments.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Values are means of at least three determinations. AChE from human erythrocytes. n.d. = not determined</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Values are means of at least three determinations. AChE from electric eel. Also included in this table, see references <a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">36</a>, <a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">49</a>, and <a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">50</a>.</p></div></div><div></div></div><div class="NLM_p">In the first set of compounds, we kept the benzimidazole scaffold of lead compound <b>A</b> and introduced different amide moieties at position 5 of the benzimidazole core (<b>20a</b>–<b>d</b>). While <b>20c</b>, with a straight <i>N</i>-alkyl chain, shows a low micromolar affinity toward <i>h</i>CB<sub>2</sub>R and a micromolar inhibition of BChE, compound <b>20a</b>, with a branched <i>N</i>-alkyl chain, shows a micromolar inhibition of BChE as well as a submicromolar affinity toward <i>h</i>CB<sub>2</sub>R (<b>20a</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 763.3 nM and IC<sub>50</sub>(<i>h</i>BChE) = 1.6 μM; <b>20c</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 1.9 μM and IC<sub>50</sub>(<i>h</i>BChE) = 5.2 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). When we replaced the straight/branched <i>N</i>-alkyl chains with a 1-piperidinyl amide (<b>20d</b>), the activity at BChE did not change, but the affinity for <i>h</i>CB<sub>2</sub>R could be increased (<b>20d</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 384.5 nM and IC<sub>50</sub>(<i>h</i>BChE) = 5.7 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). It is furthermore remarkable that the introduction of a 1-piperidinyl amide (<b>20d</b>), which is similar to AstraZeneca’s benzimidazole <b>A</b>, resulted in some, albeit moderate, regain in affinity toward <i>h</i>CB<sub>1</sub>R (<i>K</i><sub>i</sub>(<i>h</i>CB<sub>1</sub>R) = 17.0 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The introduction of a sterically demanding 1-adamantyl amide scaffold (<b>20e</b>), a typical CB pharmacophore, resulted in a complete loss of activity at both ChEs. The affinity at <i>h</i>CB<sub>2</sub>R still was in the micromolar range (<b>20e</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 4.7 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), which suggests a tolerance of <i>h</i>CB<sub>2</sub>R concerning bulky and nonpolar substituents at position 5 of the benzimidazole core. Lastly, we introduced an aniline amide (<b>20b</b>), which kept micromolar activity at BChE but led to an approximately 10-fold decreased affinity at <i>h</i>CB<sub>2</sub>R compared to other investigated amides (<b>20a</b>–<b>e</b>) (<b>20b</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 14.4 μM and IC<sub>50</sub>(<i>h</i>BChE) = 1.2 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). We also introduced a “flipped” amide, where the amine moiety is directly attached to the benzimidazole (<b>39</b>). Compound <b>39</b> is a structural isomer of <b>20b</b> and surprisingly shows a different pharmacological profile. While <b>20b</b> shows a one-digit micromolar activity at BChE and two-digit affinity at <i>h</i>CB<sub>2</sub>R (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), <b>39</b> completely lost inhibitory activity at BChE, but the affinity toward <i>h</i>CB<sub>2</sub>R is increased compared to compound <b>20b</b> (<b>39</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 4.3 μM; <b>20b</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 14.4 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">With another set of compounds, we investigated the influence of electron-withdrawing/donating substituents at position 5 of the benzimidazole core, which was otherwise not altered (<b>37</b> and <b>38</b>). Our assumption was based on our previous results from computational studies<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> that an electron-withdrawing substituent is crucial for any affinity/activity at both <i>h</i>CB<sub>2</sub>R and BChE. We could confirm this by completely losing activity at BChE and dramatically decreasing affinity at <i>h</i>CB<sub>2</sub>R when we introduced an amino moiety (<b>38</b>). Moreover, an electron-withdrawing nitro substituent (<b>37</b>) achieved a submicromolar affinity at <i>h</i>CB<sub>2</sub>R, but again it completely lost the ability to inhibit BChE (<b>37</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 961.8 nM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">For a third set, we synthesized a set of “combination” compounds using scaffolds from our lead compounds <b>B</b>, <b>C</b>, and <b>D</b> and combining them in several 2-amino benzimidazoles (<b>31</b> and <b>32</b>). With this, we obtained <b>32</b>, a combination of the <i>para</i>-phenoxy phenyl moiety from <b>C</b> and ethylene piperidinyl from <b>D</b>, and <b>31</b>, which combine the <i>para</i>-ethoxy phenyl moiety of <b>B</b> with the ethylene piperidinyl moiety of <b>D</b>. Both compounds failed to show the desired pharmacological profile though. While affinity at <i>h</i>CB<sub>2</sub>R decreased compared to the lead compounds <b>B</b>–<b>D</b> (<b>31</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 10.4 μM; <b>32</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 8.9 μM), both compounds completely lost inhibitory activity at BChE. Nevertheless, both compounds are still selective <i>h</i>CB<sub>2</sub>R ligands. Compound <b>30</b> was developed by using the 2-amino benzimidazole scaffold from lead compound <b>B</b> and changing the <i>para</i>-ethoxy phenyl to a <i>para</i>-ethoxy benzyl moiety. With the additional methylene group, a higher degree of freedom is achieved and the conjugated system is interrupted, which may increase basicity and thereby interaction with BChE. Compared to lead compound <b>B</b>, affinity toward <i>h</i>CB<sub>2</sub>R increased; selectivity was kept (<b>30</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 353.4 nM), but again inhibition of both ChEs was lost.</div><div class="NLM_p">On the basis of our previous computational studies, which indicated a binding cavity in the oxyanion hole of the BChE and the <i>N</i><sup>1</sup>-alkyl chain pointing toward it,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> we changed the length of the ethylene piperidinyl moiety of our lead structure <b>D</b>. We synthesized <i>N</i><sup>1</sup>-substituted benzimidazoles with a butylene (<b>23</b>) and a hexylene spacer (<b>24</b>) with the aim to increase lipophilicity and interactions between the side chain and the oxyanion hole of the BChE. Compared to the structurally similar lead compound <b>D</b> with an ethylene spacer, both compounds <b>23</b> and <b>24</b> show an approximately 10-fold decreased affinity toward <i>h</i>CB<sub>2</sub>R (<b>23</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 4.8 μM; <b>24</b>, <i>K</i><sub>i</sub>(<i>h</i>CB<sub>2</sub>R) = 1.0 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), with an improved selectivity over <i>h</i>CB<sub>1</sub>R. Regarding BChE, both compounds indeed showed a low micromolar activity at BChE (<b>23</b>, IC<sub>50</sub>(<i>h</i>BChE) = 2.7 μM; <b>24</b>, IC<sub>50</sub>(<i>h</i>BChE) = 8.2 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) but lose selectivity over AChE with longer alkylene spacers (<b>23</b>, IC<sub>50</sub>(<i>ee</i>AChE) = 20.5 μM; <b>24</b>, IC<sub>50</sub>(<i>ee</i>AChE) = 11.9 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). When tested at the <i>h</i>AChE, both compounds showed a similar inhibitory activity (<b>23</b>, IC<sub>50</sub>(<i>h</i>AChE) = 60.1 μM; <b>24</b>, IC<sub>50</sub>(<i>h</i>AChE) = 20.0 μM; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">Since lead compounds <b>A</b>–<b>D</b> were previously only tested at the <i>eq</i>BChE and <i>ee</i>AChE (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), we also investigated activity at both human enzymes, <i>h</i>BChE and <i>h</i>AChE. Surprisingly, lead compounds <b>A</b>–<b>D</b>, which showed a (sub)micromolar activity at <i>eq</i>BChE, completely lost significant activity at <i>h</i>BChE. In contrast, values for <i>h</i>AChE were very similar to the <i>ee</i>AChE (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). We recommend using the human enzyme whenever possible, which is in the literature rarely done in the development of BChE inhibitors, probably due to its high price.<a onclick="showRef(event, 'cit27b'); return false;" href="javascript:void(0);" class="ref cit27b">(27b)</a> Some heterocyclic templates can show pronounced differences in inhibitory activities between species, so for each template, we recommend at least to test representative compounds at <i>h</i>BChE to check whether interspecies-dependent BChE inhibition occurs.<a onclick="showRef(event, 'cit27c'); return false;" href="javascript:void(0);" class="ref cit27c">(27c)</a></div><div class="NLM_p">We were able to successfully develop a set of second-generation benzimidazole/2-aminobenzimidazole compounds, which nearly all show good selectivity for both <i>h</i>CB<sub>2</sub>R and <i>h</i>BChE with affinity/activity in the micromolar to submicromolar range. Furthermore, our best compounds show a well-balanced activity profile at both targets. A balanced profile is one of the main difficulties in designing merged dual-active compounds.</div><div class="NLM_p">For a better comparison of all compounds and investigating/describing SARs, we correlated p<i>K</i><sub>i</sub> values from <i>h</i>CB<sub>2</sub>R and pIC<sub>50</sub> values from <i>h</i>BChE in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. Interpretation is greatly simplified by the fact that the majority of compounds still show a high selectivity over both <i>h</i>CB<sub>1</sub>R and AChE.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of IC<sub>50</sub> values for <i>h</i>BChE inhibition against p<i>K</i><sub>i</sub> values of <i>h</i>CB<sub>2</sub>R affinity. Compounds with no significant affinity for one of the targets are placed on the black lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Computational Studies, Construction of the Active-State Model of the <i>h</i>CB<sub>2</sub>R, and Docking of Compounds <b>20a</b> and <b>20d</b></h3><div class="NLM_p">Computationally driven multitarget drug discovery has emerged recently as a subfield of computational drug design, and it uses fragment-based approaches to identify multitarget hits in silico or deals with optimizing multitarget hits, e.g., by application of molecular dynamics (MD) [ref <a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">51</a> and references cited herein].</div><div class="NLM_p">Within a previous study, an active state model of the <i>h</i>CB<sub>2</sub>R was constructed based on the crystal structure of the active human β<sub>2</sub>R adrenergic receptor (<i>h</i>β<sub>2</sub>R).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Since a crystal structure of the <i>h</i>CB<sub>1</sub>R in complex with the agonist AM11542 ((6a<i>R</i>,10a<i>R</i>)-3-(8-bromanyl-2-methyl-octan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[<i>c</i>]chromen-1-ol) was published (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XRA">5XRA</a>),<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> a new homology model of the <i>h</i>CB<sub>2</sub>R based on this crystal structure was constructed because the homology between the <i>h</i>CB<sub>2</sub>R and the <i>h</i>CB<sub>1</sub>R is considerably higher than between the <i>h</i>CB<sub>2</sub>R and the <i>h</i>β<sub>2</sub>R. For the alignment of the amino acid sequences between the <i>h</i>CB<sub>1</sub>R and the <i>h</i>CB<sub>2</sub>R (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), the most conserved amino acid of each transmembrane (TM) domain according to Ballesteros and Weinstein<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (marked by an asterisk) was used as reference.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Amino acid sequence alignment of the <i>h</i>CB<sub>1</sub>R (UniProtKB accession code: P21554) and the <i>h</i>CB<sub>2</sub>R (UniProtKB accession code: P34972). Asterisk: highly conserved amino acids, according to the Ballesteros and Weinstein nomenclature. Yellow boxes: amino acids, different between <i>h</i>CB<sub>1</sub>R and <i>h</i>CB<sub>2</sub>R. Gray boxes: amino acids of the <i>h</i>CB<sub>2</sub>R, not included in the homology model within the present work. Cyan boxes: part of the E2-loop, deleted in the <i>h</i>CB<sub>1</sub>R template and inserted by “LoopSearch” according to the amino acid sequence of the <i>h</i>CB<sub>2</sub>R. Green boxes: part of the I3-loop of the <i>h</i>CB<sub>2</sub>R, inserted by “LoopSearch”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For homology modeling of the <i>h</i>CB<sub>2</sub>R, the software package SYBYL 7.0 (Tripos Inc.) was used. The flavodoxin of the <i>h</i>CB<sub>1</sub>R crystal was deleted. The first 18 amino acids of the N-terminus and the last 44 amino acids of the C-terminus were not included in the <i>h</i>CB<sub>2</sub>R homology model because these parts are not solved in the crystal structure of the <i>h</i>CB<sub>1</sub>R. All amino acids that were different between the sequence of the <i>h</i>CB<sub>1</sub>R (inclusive mutations in the X-ray structure) and the <i>h</i>CB<sub>2</sub>R were mutated into the corresponding amino acid of the <i>h</i>CB<sub>2</sub>R, except these parts of the extracellular loop E2 and the intracellular loop I3, marked in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>: To model the E2-loop, the amino acids Glu258 (<i>h</i>CB<sub>1</sub>R) to Val263 (<i>h</i>CB<sub>1</sub>R) were deleted and the missing amino acids of the <i>h</i>CB<sub>2</sub>R Cys175 to Pro178 were inserted, using the “LoopSearch” module of SYBYL 7.0 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, cyan boxes). Furthermore, to model the I3-loop, the amino acids Ser222 to Met237 of the <i>h</i>CB<sub>2</sub>R were inserted, using the “LoopSearch” module of SYBYL 7.0 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, green boxes). Compounds <b>20a</b> and <b>20d</b> were docked manually in two different poses (mode 1 and mode 2), inspired by the AM11542-<i>h</i>CB<sub>1</sub>R-crystal structure (5XRA), into the binding pocket of the <i>h</i>CB<sub>2</sub>R (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking poses (mode 1 and mode 2) of <b>20a</b> compared to the pose of compound AM11542 in the <i>h</i>CB<sub>1</sub>R-crystal structure (5XRA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Molecular Dynamics Simulations at the <i>h</i>CB<sub>2</sub>R</h3><div class="NLM_p last">The ligand–receptor complex, constructed with SYBYL 7.0, as described above was embedded in a POPC lipid bilayer. The parametrization for the ligands <b>20a</b> and <b>20d</b> was obtained from the PRODRG server (davapc1.bioch.dundee.ac.uk/prodrg/). For the generation of the complete simulation box (6.9  nm × 6.9 nm × 9.2 nm) and subsequent molecular dynamics simulations, the software package GROMACS 4.0.2 (<a href="http://www.gromacs.org" class="extLink">www.gromacs.org</a>) was used. Intracellular and extracellular water molecules were added using the command “genbox”. To achieve electroneutrality, 5 sodium and 17 chloride ions were added using the command “genion”. After minimization of the simulation box, MD simulations (10 ns equilibration phase and 10 ns productive phase) were performed for the ligand-free <i>h</i>CB<sub>2</sub>R and the ligand–<i>h</i>CB<sub>2</sub>R complexes, as described previously.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a></div></div><div id="sec2-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Binding Mode of Compounds <b>20a</b> and <b>20d</b> at the <i>h</i>CB<sub>2</sub>R</h3><div class="NLM_p">For compounds <b>20a</b> and <b>20d</b>, MD simulations for both binding modes 1 and 2 were performed. For <b>20a</b>, the short-range Coulomb and Lennard-Jones interactions amounted to ca. −19 kJ/mol and ca. −277 kJ/mol for mode 1 and ca. −44 kJ/mol and ca. −290 kJ/mol for mode 2. Similarly, for <b>20d</b>, the short-range Coulomb and Lennard-Jones interactions amounted to ca. −25 kJ/mol and ca. −246 kJ/mol for mode 1 and ca. −63 kJ/mol and ca. −260 kJ/mol for mode 2. Because mode 2 is the more stable one in both cases, subsequent data analysis was performed only on this mode. Since the orthosteric binding pocket of the <i>h</i>CB<sub>2</sub>R is mainly formed by the aromatic amino acids Phe<sup>3.36</sup>, Phe183 (E2-loop), Trp<sup>5.43</sup>, and Trp<sup>6.48</sup>, an aromatic moiety of the ligand in this region of the binding site should be preferred with respect to a more aliphatic one. Thus, for ligands containing an aromatic moiety in side chain R<sup>1</sup> and in side chain R<sup>3</sup>, e.g., <b>20b</b>, both modes should be considered.</div><div class="NLM_p">The ligands <b>20a</b> and <b>20d</b> are stably embedded (mode 2) in the orthosteric binding pocket of the <i>h</i>CB<sub>2</sub>R (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0006.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Orthosteric binding pocket of the <i>h</i>CB<sub>2</sub>R with compound <b>20a</b> as well as internal water molecules and the allosteric binding site, as obtained by MD simulations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For compound <b>20a</b>, the benzimidazole core interacts with Phe<sup>2.57</sup>, Phe183 (E2-loop), and Phe<sup>7.35</sup> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>a). The aliphatic side chain R<sup>1</sup> is embedded in a subpocket at the extracellular domains of the <i>h</i>CB<sub>2</sub>R. The isopentyl moiety (R<sup>2</sup>) is well-embedded in a hydrophobic pocket, formed by the amino acids Ile<sup>3.29</sup>, Val<sup>3.32</sup>, Thr<sup>3.33</sup> (methyl group), Phe<sup>3.36</sup>, Phe183 (E2-loop), Ile186 (E2-loop), Leu<sup>5.40</sup>, Trp<sup>5.43</sup>, Leu<sup>5.44</sup>, Val<sup>6.51</sup>, and Met<sup>6.55</sup> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>b). The 4-ethoxybenzyl moiety (R<sup>3</sup>) is embedded in a hydrophobic pocket, mainly formed by the amino acids Phe<sup>3.36</sup>, Trp<sup>6.48</sup>, Val<sup>6.51</sup>, Met<sup>6.55</sup>, and Leu<sup>7.41</sup> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>c). During ∼33% of the whole productive phase, a direct H-bond between the carbonyl oxygen of <b>20a</b> and the OH moiety of Ser<sup>7.39</sup> was observed. Alternatively, the interaction between <b>20a</b> and the <i>h</i>CB<sub>2</sub>R was stabilized by a water-mediated H-bond interaction between the CO moiety of <b>20a</b> and Ser<sup>7.39</sup> or His<sup>2.65</sup> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>d).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Interaction sites of the <i>h</i>CB<sub>2</sub>R with (a) the benzimidazole core, (b) the isopentyl side chain (R<sup>2</sup>), (c) the 4-ethoxy phenyl moiety (R<sup>3</sup>), and (d) the carbonyl moiety (mediated by water molecules) of compound <b>20a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, the MD simulations of the <b>20a</b>–<i>h</i>CB<sub>2</sub>R complex revealed a well-established interaction network between the highly conserved Asn<sup>7.49</sup>, Asn<sup>7.45</sup>, Trp<sup>6.48</sup>, Ser<sup>3.39</sup>, Asp<sup>2.50</sup>, and internal water molecules (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). A comparable water chain was also revealed by MD simulations for the histamine H<sub>3</sub> and H<sub>4</sub> receptor.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Thus, at the <i>h</i>CB<sub>2</sub>R, the allosteric Asp<sup>2.50</sup> binding site, which is described as the Na<sup>+</sup> binding site for several GPCRs<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> is well-connected with the orthosteric ligand binding site. Because the highly conserved amino acids of the allosteric binding site may be involved in receptor activation, it may be speculated that ligands (e.g., agonists), bound to the orthosteric binding site, may transfer information for activation of the receptor downstream not only by the highly conserved amino acids but also by the internal water molecules located in this region.</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Interaction network between the <i>h</i>CB<sub>2</sub>R and internal water molecules between the orthosteric (Val<sup>3.32</sup>) and allosteric (Asp<sup>2.50</sup>) binding site, obtained by MD simulations in the presence of <b>20a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compared to <b>20a</b>, the MD simulations revealed different binding modes for <b>20d</b> (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>): For compound <b>20d</b>, the benzimidazole core interacts with Phe<sup>2.57</sup>, Phe<sup>2.61</sup>, Phe183 (E2-loop), and Phe<sup>7.35</sup>. The piperidine moiety R<sup>1</sup> is embedded in a subpocket at the extracellular domains of the <i>h</i>CB<sub>2</sub>R, mainly formed by the amino acids Phe<sup>2.61</sup>, Leu182, Leu<sup>6.54</sup>, and Lys<sup>7.32</sup> (aliphatic part). The isopentyl moiety (R<sup>2</sup>) is well-embedded in a hydrophobic pocket, formed by the amino acids Val<sup>2.56</sup>, Phe<sup>3.25</sup>, Lys<sup>3.28</sup> (aliphatic part), and Ile<sup>3.29</sup>. The 4-ethoxybenzyl moiety (R<sup>3</sup>) is embedded in a hydrophobic pocket, mainly formed by the amino acids Ile<sup>3.29</sup>, Val<sup>3.32</sup>, Thr<sup>3.33</sup> (methyl group), Phe<sup>3.36</sup>, Phe183 (E2-loop), Ile186 (E2-loop), Leu<sup>5.40</sup>, Trp<sup>5.43</sup>, Leu<sup>5.44</sup>, Val<sup>6.51</sup>, and Met<sup>6.55</sup> (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>a). During ∼95% of the whole productive phase, a direct H-bond between the carbonyl oxygen and the OH moiety of Ser<sup>7.39</sup> was observed. However, in contrast to <b>20a</b>, the H-bond to His<sup>2.65</sup> was not observed and there was no water-mediated interaction between the ligand and the receptor (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>b). An overlay of <b>20a</b> and <b>20d</b> in the binding pocket of the <i>h</i>CB<sub>2</sub>R, obtained by MD simulations, is presented in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>: The moiety R<sup>1</sup> points for both ligands toward the extracellular region of the receptor. The isopentyl moiety (R<sup>2</sup>) is located in pocket 1 in the case of <b>20a</b> and in pocket 3 in the case of <b>20d</b>. The 4-ethoxy phenyl moiety (R<sup>3</sup>) is located in pocket 2 in the case of <b>20a</b> and in pocket 1 in the case of <b>20d</b>. Consequently, the benzimidazole core of <b>20d</b> is twisted about 45° with respect to <b>20a</b>.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (a) Overlay of <b>20a</b> and <b>20d</b> in the binding pocket of the <i>h</i>CB<sub>2</sub>R, obtained by MD simulations. (b) Differences in H-bond interactions between the <i>h</i>CB<sub>2</sub>R and <b>20a</b> or <b>20d</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Since pocket 1 (Ile<sup>3.29</sup>, Val<sup>3.32</sup>, Thr<sup>3.33</sup>, Phe<sup>3.36</sup>, Phe183, Ile186, Leu<sup>5.40</sup>, Trp<sup>5.43</sup>, Leu<sup>5.44</sup>, Val<sup>6.51</sup> and Met<sup>6.55</sup>) is formed by aromatic and aliphatic side chains, ligands comprising of one or more of these moieties may be able to establish more than one binding pose. In this context two orientations of ligand <b>20a</b> (R<sup>2</sup> aliphatic) as well as <b>20d</b> (R<sup>3</sup> aromatic/aliphatic) are to be considered. Furthermore, it can be speculated that an equilibrium between different binding poses may be established depending on the chemical nature of the moieties R<sup>1</sup>, R<sup>2</sup> and R<sup>3</sup>. Since the two ligands differ in R<sup>1</sup>, which points into the extracellular domain, this group may influence the equilibrium of different binding poses.</div></div><div id="sec2-6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Determination of Efficacy at <i>h</i>CB<sub>2</sub>R</h3><div class="NLM_p">CB<sub>2</sub>Rs are coupled through G<sub>i/o</sub> proteins and negatively regulate adenylate cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> One of the notable CB<sub>2</sub>R biological responses is the regulation of intracellular cAMP levels. CB<sub>2</sub>R agonists decrease cAMP levels and revert forskolin-stimulated cAMP production, while CB<sub>2</sub>R antagonists/reverse agonists increase cAMP levels and enhance forskolin-stimulated cAMP production in cell lines.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> So the detection of the cAMP concentration, for example, by ELISA, is a common method for the identification of CB<sub>2</sub>R ligand activity. In addition, receptor-mediated changes in the intracellular cAMP concentration can be detected via changes in the expression level of particular genes, which are regulated by the transcription factor cAMP response-element binding (CREB) protein binding to upstream cAMP response elements (CREs).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Between potential cAMP-target genes, macrophage migration inhibitory factor (MIF), which is highly expressed in multiple myeloma, is under cAMP-induced expression, since a functional cAMP-responsive element (CRE) in the proximal region of the MIF promoter is detected.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61, 62)</a> Signal transducer and activators of transcription (STAT-3) is another gene highly expressed in multiple myeloma cells, and its expression is also under CRE promoter control.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a></div><div class="NLM_p">Before evaluating the CB<sub>2</sub>R activity of the compounds, the nontoxic concentration of each compound was evaluated by an MTT assay, and the IC<sub>50</sub> values were determined. U266 myeloma cells were treated with different concentrations of each compound (up to 100 μM) for 48 h, and the cell viability was calculated. As shown in Figure S1 of the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_001.pdf" class="ext-link">Supporting Information</a>, the compounds show different cytotoxic activity in U266 cells, with each IC<sub>50</sub> value over 40 μM, calculated at 48 h post-treatment.</div><div class="NLM_p">To evaluate the biological activity of the compounds (as agonist or antagonist/reverse agonist), a cAMP assay was applied. U266 cell lines were treated for 2 h with forskolin (10 μM) as the cAMP-inducer, AM630 (25 μM) as the CB<sub>2</sub>R antagonist/reverse agonist or with test compounds (50 μM) alone, and in combination with AM630, respectively. In combination treatment, U266 cells were pretreated with AM630 for 30 min and then treated with the single test compounds. In the cAMP assay, we found that forskolin increased the cAMP levels (as expected) and so did AM630 (by inhibiting CB<sub>2</sub>R basal activity), compared to vehicle-treated cells (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_001.pdf" class="ext-link">Figure S2</a> of the Supporting Information).</div><div class="NLM_p">All of the test compounds decreased cAMP levels compared to vehicle, indicating that they are CB<sub>2</sub>R agonists. To further confirm this data, test compounds were incubated in competition with AM630, and the results revealed that the compounds were able to revert AM630-increased cAMP levels (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_001.pdf" class="ext-link">Figure S2</a> of the Supporting Information). By summarizing these results, we confirmed that test compounds <b>A</b>–<b>D</b> act, with different potency, as CB<sub>2</sub>R agonists.</div><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Test compounds (<b>A</b>–<b>D</b>, <b>20a</b>–<b>c</b>, <b>20e</b>, and <b>23</b>) reduce MIF and STAT-3 gene expression. U266 cells were treated with test compounds (50 μM), forskolin (10 μM), or AM630 (25 μM) for 2 h. In combination experiment (AM630 plus test compounds), U266 cells were preincubated with AM630 for 30 min before adding the test compounds. MIF and STAT-3 mRNA levels were determined by qRT-PCR. GAPDH was used for normalization. Data are expressed as relative fold with respect to vehicle-treated cells used as the control. Data are expressed as mean ± SD *<i>p</i> < 0.01 vs untreated; # vs AM630.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since changes in the cAMP concentration can be detected via changes in expression level of specific genes regulated by the CREB binding to upstream cAMP response elements (CREs), we selected two genes that are under cAMP-regulated transcription, the macrophage migration inhibitory factor (MIF) and the signal transducer and activator of transcription 3 (STAT-3). First, U266 cells were treated with forskolin to confirm that MIF and STAT-3 are under cAMP-induced transcription. As shown, both gene levels increase compared with vehicle-treated cells (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>), confirming that this assay can show changes in the cAMP levels. Then, U266 cells were treated with test compounds <b>A</b>–<b>D</b> alone and in combination with AM630. The results show that AM630 increases the expression of MIF and STAT-3, confirming that AM630 increases the cAMP levels (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>), as previously evidenced by cAMP ELISA, while all of our test compounds reduced MIF and STAT-3 expression levels compared with vehicle-treated cells and reduced AM630-induced MIF and STAT-3 when coincubating our test compounds and AM630 (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>).</div><div class="NLM_p last">Herein, we confirmed that AM630 was able to increase cAMP production in U266 cells and that all compounds tested were able to reduce basal cAMP levels and to reverse the AM630-induced increase of cAMP concentration. An additional sensitive tool for evaluating variation in intracellular cAMP levels is the detection of CREB-induced gene expression.<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65, 66)</a> In this context, the transcription of two genes highly expressed in U266 cells, MIF and STAT-3, were found to be under CREB regulation.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> So, we applied a RT/PCR methodology to evaluate the MIF and STAT-3 gene expression levels in U266 cells. This experimental approach confirmed that AM630 as well as forskolin, by increasing the cAMP levels, induced MIF and STAT-3 expression, while test compounds reduced MIF and STAT-3 gene expression levels both when used alone or when combined with AM630. Since all of this data was strongly evidenced by cAMP ELISA and RT/PCR, we were able to characterize the agonist activity of test compounds and this data provides evidence that the entire set of test compounds acts as CB<sub>2</sub>R agonists, further confirming the data obtained by the cAMP ELISA assay.</div></div><div id="sec2-7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> μ-Opioid Receptor Binding</h3><div class="NLM_p">As already described above, dual-acting compounds have been developed to be applied for a variety of different targets in various diseases. One example is merged/dual-acting μ-opioid (MOP) receptor agonists/neuronal nitric oxide synthase (<i>n</i>NOS) inhibitors for the treatment of pain. Such a set of compounds was designed by Renton et al. on the basis of several NOS inhibitors and etonitazene, a well-known MOP receptor agonist developed in the 1960s.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a> During the development of our own dual-acting compounds, we came across etonitazene, which shows strong structural similarities: an electron-withdrawing substituent at position 5 of the benzimidazole core (red), a 4-ethoxybenzyl moiety at position 2 (green), and a basic amine linked with an ethylene bridge to <i>N</i><sup>1</sup> (blue), with the latter structural feature only shown by some of our compounds (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). On the basis of these observations, we tested our lead compounds <b>A</b>, <b>B</b>, and <b>D</b> in a radioligand binding assay at the MOP receptor (HEK cells transient transfected with the <i>h</i>MOP receptor) to evaluate unwanted interactions with the MOP receptor and to avoid them in further compound development (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><figure id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structural similarities between etonitazene<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and (exemplary) lead compound <b>D</b>: an electron-withdrawing substituent at position 5 of the benzimidazole (red), a 4-ethoxybenzyl moiety at position 2 (green), and a basic amine linked with an ethylene bridge to <i>N</i><sup>1</sup> (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biological Evaluation of Radioligand Binding Studies at the <i>h</i>MOP Receptor</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0024.gif" alt="" id="GRAPHIC-d153e3132-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Screened on membranes of HEK cells transiently transfected with the <i>h</i>MOP receptor; values are mean values from at least 2 independent experiments performed in triplicates.</p></div></div><div></div></div><div class="NLM_p last">Radioligand binding studies confirmed our assumptions. While compound <b>D</b>, with the highest structural analogy, shows a significant, albeit moderate, three-digit nanomolar binding to the MOP receptor (<b>D</b>, <i>K</i><sub>i</sub>(MOP) = 556.0 nM; <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), lead compound <b>A</b> only shows a one-digit micromolar affinity (<b>A</b>, <i>K</i><sub>i</sub>(MOP) = 6.7 μM; <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). This is probably due to the lack of a basic amine. Compound <b>B</b>, which does lack not only the basic amine but also the methylene unit between the benzimidazole core and the 4-ethoxy phenyl moiety, shows the lowest affinity at the MOP receptor (<b>B</b>, <i>K</i><sub>i</sub>(MOP) = 53.6 μM; <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Based on these observations for “designing out” the MOP affinity, a basic amine attached over an alkylene linker to <i>N</i><sup>1</sup> should advantageously be avoided and the methylene unit should be substituted by a 2-amino moiety. Substitution/removal of the electron-withdrawing amide function at position 5 should be avoided to keep affinity/activity at <i>h</i>CB<sub>2</sub>R and BChE as discussed above (cf. <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and ref <a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">36</a>).</div></div><div id="sec2-8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo Studies</h3><div class="NLM_p">Lead compounds <b>A</b> and <b>B</b> and compound <b>20a</b> were tested for their neuroprotectant and pro-cognitive effects in the in vivo mouse model of AD, in which neuroinflammation and cognitive deficits are induced by the intracerebroventricular injection of the oligomerized Aβ<sub>25–35</sub> peptide into the mouse brains.<a onclick="showRef(event, 'ref28 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref28 ref69 ref70">(28, 69, 70)</a></div><div class="NLM_p">Each compound was solubilized in DMSO/saline or DMSO/Tween-80/saline vehicle solutions (cf. <a href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_001.pdf" class="ext-link">Supporting Information</a> for detailed description). Compounds were fully dissolved, and no precipitation was observed. Extended (in vitro) pharmacokinetic studies were not conducted since they are beyond the scope of this work.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p">The prepared compounds were injected intraperitoneally between day 1 and 7. Animal status and weight were checked daily during the treatments. Vehicle solutions, compounds <b>A</b> and <b>B</b>, did not affect weight gains (+0.3 g/day on average). Compound <b>20a</b> decreased weight gain (+0.2 g/day at 0.3 mg/kg, +0.1 g/day at 1 mg/kg, and 0 g/day at 3 mg/kg) but did not provoke weight loss. No treatment induced behavioral alteration, prostration, signs of abdominal pain, or changes in the fur aspect, suggesting that high DMSO concentrations applied in some groups were well-tolerated. Moreover, since the injection period was limited and animals were used for behavioral observation 24 h after the last injection, vehicle-treated animals showed the performances expected for Sc.Aβ- or Aβ<sub>25–35</sub>-treated groups.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69, 70)</a> The amyloid peptide was injected on day 1 and the behavioral examination performed between day 8 and 10. All animals were then sacrificed on day 11 and their brains stored at −80 °C (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>).</div><figure id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Protocol followed. Abbreviations key: Cpd, compound; ICV, intracerebroventricular injection; YMT, spontaneous alternation test in the Y-maze; ST-PA, step-through passive avoidance test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The spontaneous alternation performance, an index of spatial working memory, was tested on day 8 in the Y-maze test. Long-term memory response was measured on days 9 and 10 in a step-through passive avoidance test.</div></div><div id="sec2-9" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Repeated Treatment with Compounds <b>A</b>, <b>B</b>, and <b>20a</b></h3><div class="NLM_p last">As described above, none of the treatments (ip for the compounds solubilized in DMSO/water or DMSO/Tween-80/water and ICV for peptides solubilized in water) affected the mouse body weight, suggesting a good tolerability. Animals gained about 2.1 g during the 7 day treatment period.</div></div><div id="sec2-10" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Spontaneous Alternation Performances</h3><div class="NLM_p">CB<sub>2</sub> agonist <b>A</b> attenuated, significantly but partially, the Aβ<sub>25–35</sub>-induced alternation deficit at the highest dose tested, 3 mg/kg (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>a). Dual-acting compounds <b>B</b> and <b>20a</b> showed significant preventions at 1 and 3 mg/kg (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>b,c). Note that the Aβ<sub>25–35</sub> treatment slightly, but significantly for compounds <b>A</b> and <b>B</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>c,d), increased locomotion, measured in terms of number of arms entered during the session, in these experiments. This is not routinely observed but remains pertinent considering the model. Slight variations with compounds <b>A</b> and <b>B</b> were noted (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>c,d).</div><figure id="fig13" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Effect of test compounds <b>A</b>, <b>B</b>, and <b>20a</b> on Aβ<sub>25–35</sub>-induced spontaneous alternation deficits in mice. Animals received Aβ<sub>25–35</sub> or Sc.Aβ peptide (9 nmol ICV) on day 1 and the test compounds (0.3 mg/kg ip) or vehicle solution (V, DMSO 20% in saline or DMSO 20%, Tween-80 2% in saline) od between days 1–7. Alternation performance was tested on day 8. Data shown mean ± SEM. ANOVA: F<sub>(4,54)</sub> = 6.55, <i>p</i> < 0.001, <i>n</i> = 9–14 per group in part a; F<sub>(4,54)</sub> = 5.43, <i>p</i> < 0.001, <i>n</i> = 8–14 per group in part b; F<sub>(4,57)</sub> = 4.05, <i>p</i> < 0.01, <i>n</i> = 9–14 per group in part c; F<sub>(4,54)</sub> = 2.72, <i>p</i> < 0.05 in part d; F<sub>(4,54)</sub> = 4.70, <i>p</i> < 0.01 in part e; F<sub>(4,57)</sub> = 0.59, <i>p</i> > 0.05 in part f. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 vs (Sc.Aβ+V)-treated group; ## <i>p</i> < 0.01, ### <i>p</i> < 0.001 vs (Aβ<sub>25–35</sub>+V)-treated group; Dunnett’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-11" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Passive Avoidance Test</h3><div class="NLM_p">For the long-term memory response, CB<sub>2</sub> agonist <b>A</b> failed to show any prevention of the step-through latency deficit induced by Aβ<sub>25–35</sub>, at all doses tested (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>a). Dual-acting compound <b>B</b> showed significant prevention of the latency diminution at the highest dose tested, 3 mg/kg (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>b). Compound <b>20a</b> dose-dependently attenuated the step-through latency deficit induced by Aβ<sub>25–35</sub> with significant effects at 1 and 3 mg/kg (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>c).</div><figure id="fig14" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Effect of test compounds <b>A</b>, <b>B</b>, and <b>20a</b> on Aβ<sub>25–35</sub>-induced passive avoidance deficits in mice. Animals received Aβ<sub>25–35</sub> or Sc.Aβ peptide (9 nmol ICV) on day 1 and the test compounds (0.3 mg/kg ip) or vehicle solution (V, DMSO 20% in saline or DMSO 20%, Tween-80 2% in saline) od between days 1–7. Training was performed on day 9 and retention measured on day 10. Data show median and interquartile range. Kruskal–Wallis ANOVA: H = 19.0, <i>p</i> < 0.001, <i>n</i> = 9–14 per group in part a; H = 15.0, <i>p</i> < 0.01, <i>n</i> = 8–14 per group in part b; H = 21.1, <i>p</i> < 0.001, <i>n</i> = 11–14 in part c; H = 6.89, <i>p</i> > 0.05 in part d; H = 6.34, <i>p</i> > 0.05 in part e; H = 19.7, <i>p</i> < 0.001 in part f. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 vs (Sc.Aβ+V)-treated group; # <i>p</i> < 0.05, ## <i>p</i> < 0.01 vs (Aβ<sub>25–35</sub>+V)-treated group; Dunn’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Escape latency was also measured. For compounds <b>A</b> and <b>B</b>, the Kruskal–Wallis ANOVA did not lead to significant effects (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>d,e), but tendencies could be noted. The Aβ<sub>25–35</sub> treatment led to an increase in escape latency, and several groups treated with the compounds, particularly at the highest doses, showed a trend of a reduction of the latency close to the (Sc.Aβ/V) control group data (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>d,e). For compound <b>20a</b>, the ANOVA was significant and the Aβ<sub>25–35</sub>-induced increase was highly significant, while the two highest doses of <b>20a</b> significantly prevented the Aβ<sub>25–35</sub>-induced increase (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>f).</div><div class="NLM_p last">A protective activity for dual-acting compounds <b>B</b> and <b>20a</b> on the two behavioral responses analyzed at doses of 1–3 mg/kg was shown, and compound <b>20a</b> appeared as the most active with sustained prevention of Aβ<sub>25–35</sub>-induced learning deficits in both tests at 1 mg/kg. Since compound <b>A</b> is a potent <i>h</i>CB<sub>2</sub>R agonist, but weakly potent BChE inhibitor and compounds <b>B</b> and <b>20a</b> show balanced low micromolar activities at both targets, the in vivo studies prove cognition enhancement for such dual-acting compounds and, of course, also prove penetration of the blood–brain barrier. Obviously, the solubilization conditions were not optimized, and the vehicle solutions used here remain first-attempt choices and will be improved in future studies. However, a correct bioavailability was expected for a small dual-acting compound with a much lower molecular weight compared to conventional covalently connected hybrid molecules. The compounds described herein are “true” hybrids in a way that these molecules merge the respective pharmacophores for two targets, whereas compounds termed “hybrid molecules” in the literature in the vast majority of cases covalently connect two distinct molecules that act at two different targets and therefore have a high molecular weight.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Taken together, a compound library based on benzimidazoles and 2-aminobenzimidazoles was synthesized and SARs were investigated with respect to the <i>h</i>CB<sub>1</sub>R and <i>h</i>CB<sub>2</sub>R affinity and the AChE and <i>h</i>BChE inhibition, respectively. Generally, the compounds show excellent selectivity over both <i>h</i>CB<sub>1</sub>R and AChE, and several compounds show well-balanced affinities at the two desired targets in the low micromolar range. Molecular docking and dynamics studies were performed applying for the first time a homology model of the <i>h</i>CB<sub>2</sub> based on the recently published crystal structure of the <i>h</i>CB<sub>1</sub> receptor bound to an agonist in the orthosteric binding site. While compound <b>20a</b> binds, as expected, to the orthosteric binding site, a stable amino acid and water interaction network was observed which extends into the allosteric binding site. Nitro-benzimidazoles can show a significant potency at the MOP receptor, and MOP affinities of dual-acting compounds could be designed out, e.g., by removing the basic nitrogen atom in the alkyl chain. Furthermore, it was proven for the first time by a cAMP assay as well as by two cAMP response elements (MIF and STAT-3) that the compounds act as agonists at the <i>h</i>CB<sub>2</sub>R and might therefore exhibit antineuroinflammatory effects in vivo also. In an in vivo study with mice showing neuroinflammation and cognition deficits after Aβ<sub>25–35</sub> ICV administration, the ability and superiority of a well-balanced dual-acting compound compared to a high-affinity <i>h</i>CB<sub>2</sub>R agonist with moderate BChE inhibition in improving cognition at dosages from 1 to 3 mg/kg were demonstrated. This shows that it is possible to design small molecules that act specifically at two very different targets like a GPCR and an enzyme with a high selectivity and a good potency in the same concentration range to yield compounds with a pronounced in vivo activity. The development methods like compound design and application of computational methods shown in this work will hopefully provide support in related drug development efforts for dual-acting compounds.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Information</h3><div class="NLM_p last">All reagents were used without further purification and bought from common commercial suppliers. For anhydrous reaction conditions, THF was dried prior to use by refluxing over sodium slices for at least 2 days under an argon atmosphere. Thin-layer chromatography was performed on silica gel 60 (alumina foils with fluorescent indicator 254 nm). For detection, iodine vapor and UV light (254 and 366 nm) were used. For column chromatography, silica gel 60 (particle size 0.040–0.063 mm) was used. Nuclear magnetic resonance spectra were recorded with a Bruker AV-400 NMR instrument (Bruker, Karlsruhe, Germany) in CDCl<sub>3</sub>, and chemical shifts are expressed in ppm relative to CDCl<sub>3</sub> (7.26 ppm for <sup>1</sup>H and 77.16 ppm for <sup>13</sup>C).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Purity was determined by HPLC (Shimadzu Products), containing a DGU-20A3R degassing unit, a LC20AB liquid chromatograph, and a SPD-20A UV/vis detector. UV detection was measured at 254 nm. Mass spectra were obtained by a LCMS 2020 (Shimadzu Products). As a stationary phase, a Synergi 4U fusion-RP (150 mm × 4.6 mm) column was used, and as a mobile phase, a gradient of MeOH/water with 0.1% formic acid was used. Parameters: A = water, B = MeOH, V(B)/(V(A) + V(B)) = from 5% to 90% over 10 min, V(B)/(V(A) + V(B)) = 90% for 5 min, V(B)/(V(A) + V(B)) = from 90% to 5% over 3 min. The method was performed with a flow rate of 1.0 mL/min. Compounds were only used for biological evaluation if the purity was ≥95%.</div></div><div id="sec4-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for the Synthesis of Target Compounds <b>20a</b>–<b>e</b></h3><div class="NLM_p">The respective ester compound <b>17</b> (1 equiv) was dissolved in a THF/water mixture (2:1), and LiOH (2 equiv) was added. The mixture was refluxed for 12 h. THF was evaporated, and the aqueous residue was acidified with 2 M aqueous HCl (pH = 4). The organic phase was separated with EtOAc and washed with water and brine. After the residue was dried over Na<sub>2</sub>SO<sub>4</sub>, the solvent was removed in vacuo and the product was used without further purification. The respective acid (1 equiv) was dissolved in DMF, and NEt<sub>3</sub> (1.5 equiv), HBTU (1.1 equiv), and the appropriate amine (1 equiv) were added in one portion. The mixture was stirred overnight at room temperature. Then, EtOAc and an aqueous saturated NaHCO<sub>3</sub> solution were added. The organic layer was washed several times with water and brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo, and the product was purified by column chromatography.</div><div id="sec4-2-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-(4-Ethoxybenzyl)-<i>N</i>,1-diisopentyl-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxamide (<b>20a</b>)</h4><div class="NLM_p last"><b>20a</b> was obtained as a light yellow solid (0.26 mmol, 0.11 g, 79%). <sup>1</sup>H NMR(400 MHz, CDCl<sub>3</sub>): δ = 8.08 (d, <i>J</i> = 1.2 Hz, 1H), 7.76 (dd, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.23 (d, <i>J</i> = 8.5 Hz, 1H), 7.10 (d, <i>J</i> = 8.4 Hz, 2H), 6.78 (d, <i>J</i> = 8.5 Hz, 2H), 6.41 (s, 1H), 4.21 (s, 2H), 3.99–3.90 (m, 4H), 3.46 (dd, <i>J</i> = 13.8, 6.5 Hz, 2H), 1.71–1.61 (m, 1H), 1.56–1.45 (m, 3H), 1.34 (t, <i>J</i> = 7.0 Hz, 5H), 0.92 (d, <i>J</i> = 6.6 Hz, 6H), 0.86 (d, <i>J</i> = 6.6 Hz, 6H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 167.96, 158.05, 154.83, 141.97, 137.29, 129.47, 129.05, 127.68, 122.05, 117.78, 114.86, 109.29, 63.46, 42.67, 38.56, 38.43, 38.05, 33.69, 26.11, 25.98, 22.49, 22.31, 14.75 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>37</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 436.29; found, 436.35. HPLC purity: 98% (retention time = 11.03 min).</div></div><div id="sec4-2-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-(4-Ethoxybenzyl)-1-isopentyl-<i>N</i>-phenyl-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxamide (<b>20b</b>)</h4><div class="NLM_p last"><b>20b</b> was obtained as a light yellow solid (0.21 mmol, 92.0 mg, 64%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.71–8.75 (m, 1H), 8.23 (s, 1H), 7.79–7.81 (m, 1H), 7.65–7.66 (d, <i>J</i> = 7.7 Hz, 2H), 7.18–7.25 (m, 3H), 6.97–7.03 (m, 3H), 6.68–6.70 (m, 2H), 4.12 (s, 2H), 3.84–3.90 (m, 4H), 1.18–1.30 (m, 6H), 0.79–0.81 (d, <i>J</i> = 6.6 Hz, 6H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 166.40, 158.20, 155.00, 141.04, 138.74, 137.33, 129.61, 129.01, 127.31, 124.18, 122.82, 120.36, 118.06, 114.96, 109.78, 63.57, 42.93, 38.06, 33.52, 26.24, 22.40, 14.86 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>31</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 442.24; found, 442.15. HPLC purity: 96% (retention time = 10.69 min).</div></div><div id="sec4-2-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-(4-Ethoxybenzyl)-<i>N</i>-hexyl-1-isopentyl-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxamide (<b>20c</b>)</h4><div class="NLM_p last"><b>20c</b> was obtained as a light yellow solid (0.15 mmol, 68.0 mg, 45%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.03 (s, 1H), 7.80–7.82 (m, 1H), 7.30–7.33 (d, <i>J</i> = 8.5 Hz, 1H), 7.08–7.10 (d, <i>J</i> = 8.6 Hz, 2H), 6.75–6.77 (m, 2H), 6.46 (m, 1H), 4.25 (s, 2H), 4.00–4.04 (m, 2H), 3.90–3.96 (q, <i>J</i> = 7.0 Hz, 2H), 3.41–3.46 (m, 2H), 1.36–1.61 (m, 14H), 0.89–0.91 (m, 9H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 167.91, 158.46, 154.92, 140.02, 136.83, 130.12, 129.85, 127.02, 122.99, 117.06, 115.18, 110.11, 63.72, 43.25, 40.51, 38.17, 33.40, 31.77, 29.85, 26.93, 26.39, 22.82, 22.54, 14.99, 14.26 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>39</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 450.30; found, 450.25. HPLC purity: 99% (retention time = 11.23 min).</div></div><div id="sec4-2-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (2-(4-Ethoxybenzyl)-1-isopentyl-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)(piperidin-1-yl)methanone (<b>20d</b>)</h4><div class="NLM_p last"><b>20d</b> was obtained as a light yellow solid (0.15 mmol, 68.0 mg, 45%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 7.72 (s, 1H), 7.27–7.30 (m, 1H), 7.20–7.23 (d, <i>J</i> = 9.2 Hz, 1H), 7.07–7.10 (d, <i>J</i> = 8.7, 2H), 6.74–6.76 (m, 2H), 5.95 (s, 1H), 4.22 (s, 2H), 3.91–3.92 (m, 2H), 3.41–3.58 (br, 2H), 1.44–1.61 (m, 7H), 1.29–1.32 (m, 5H), 0.82–0.83 (d, <i>J</i> = 6.6 Hz, 6H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 170.73, 158.22, 154.33, 135.65, 130.75, 129.63, 127.52, 122.29, 117.87, 115.02, 109.77, 63.58, 42.85, 38.12, 33.58, 26.21, 24.75, 22.42, 14.87 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>35</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 434.27; found, 434.15. HPLC purity: 98% (retention time = 10.35 min).</div></div><div id="sec4-2-5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-((3s,5s,7s)-Adamantan-1-yl)-2-(4-ethoxybenzyl)-1-isopentyl-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxamide (<b>20e</b>)</h4><div class="NLM_p last"><b>20e</b> was obtained as a light yellow solid (0.23 mmol, 113.0 mg, 70%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 7.98 (s, 1H), 7.74–7.76 (d, <i>J</i> = 8.7 Hz, 1H), 7.30–7.33 (d, <i>J</i> = 8.7 Hz, 1H), 7.10–7.12 (m, 2H), 6.77–6.80 (m, 2H), 5.95 (s, 1H), 4.25 (s, 2H), 4.02–4.06 (m, 2H), 3.92–3.98 (d, <i>J</i> = 7.0 Hz, 2H), 2.14 (m, 9H), 1.72 (m, 6H), 1.54–1.61 (m, 1H), 1.35–1.39 (t, <i>J</i> = 7.0 Hz, 3H), 0.89–0.91 (d, <i>J</i> = 7.1 Hz, 6H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 167.19, 158.34, 154.87, 140.19, 131.68, 129.76, 127.10, 122.52, 117.11, 115.10, 109.92, 63.64, 52.53, 43.13, 41.83, 38.12, 36.57, 33.37, 29.70, 26.29, 22.48, 14.93 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>41</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 500.32; found, 500.25. HPLC purity: 99% (retention time = 11.77 min).</div></div></div><div id="sec4-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure for the Synthesis of Target Compounds <b>23</b> and <b>24</b></h3><div class="NLM_p">The respective bromine compound <b>21</b> or <b>22</b> (1 equiv) was dissolved in DMF, and piperidine (2.5 equiv), Na<sub>2</sub>CO<sub>3</sub> (3 equiv), and a catalytic amount of NaI were added. The mixture was stirred at 70 °C for 12 h. After the reaction has finished, water was added and the organics were extracted with dichloromethane. The organic phase was washed several times with water and afterward dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo, and the crude product was afterward purified by column chromatography using dichloromethane/methanol/NH<sub>3</sub>, aq 25% (15:1:0.1), as the eluent system.</div><div id="sec4-3-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-(4-Ethoxybenzyl)-<i>N</i>,<i>N</i>-diethyl-1-(4-(piperidin-1-yl)butyl)-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxamide (<b>23</b>)</h4><div class="NLM_p last"><b>23</b> was obtained as a light yellow oil (0.12 mmol, 58.0 mg, 46%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.00 (s, 1H), 7.74 (t, <i>J</i> = 0.8 Hz, 1H), 7.29 (d, <i>J</i> = 0.8 Hz, 1H), 7.15 (m, 2H), 6.82 (m, 2H), 4.25 (s, 2H), 3.96–4.03 (m, 4H), 3.30–3.61 (m, 4H), 2.52 (s, 3H), 2.36 (t, <i>J</i> = 7.2 Hz, 2H), 1.67–1.73 (m, 2H), 1.48–1.54 (m, 4H), 1.37 (t, <i>J</i> = 7.2 Hz, 3H), 1.13–1.27 (m, 10H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 171.90, 158.16, 154.57, 142.17, 135.89, 131.29, 129.66, 128.08, 121.50, 117.70, 115.01, 109.72, 63.62, 57.74, 54.00, 43.88, 33.87, 27.28, 24.62, 23.58, 22.93, 14.94 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>42</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 491.34; found, 491.25. HPLC purity: 97% (retention time = 6.78 min).</div></div><div id="sec4-3-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(4-Ethoxybenzyl)-<i>N</i>,<i>N</i>-diethyl-1-(6-(piperidin-1-yl)hexyl)-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxamide (<b>24</b>)</h4><div class="NLM_p last"><b>24</b> was obtained as a light yellow oil (0.26 mmol, 0.13 g, 70%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 7.98 (s, 1 H), 7.72 (m, 1 H), 7.25–7.26 (m, 1 H), 7.11 (m, 2 H), 6.79 (m, 2 H), 4.22 (s, 4 H), 3.93–3.99 (m, 4 H), 3.27–3.59 (m, 4 H), 2.41 (s, 3 H), 2.28 (t, <i>J</i> = 8 Hz, 2 H), 1.58–1.65 (m, 4 H), 1.50–1.53 (m, 2 H), 1.39–1.47 (m, 3 H), 1.35 (t, <i>J</i> = 7.2 Hz, 3 H), 1.20 (m, 9 H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 171.88, 158.09, 154.55, 142.18, 135.98, 131.09, 129.52, 128.05, 121.34, 117.63, 114.91, 109.64, 63.54, 59.02, 54.44, 44.16, 33.87, 29.50, 27.25, 26.83, 26.26, 25.48, 24.15, 14.88 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>46</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 519.37; found, 519.13. HPLC purity: 96% (retention time = 7.06 min).</div></div></div><div id="sec4-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for the Synthesis of Target Compounds <b>30</b>–<b>32</b></h3><div class="NLM_p">The respective thiourea compound <b>27</b>, <b>28</b>, or <b>29</b> (1 equiv) was dissolved in anhydrous THF, and NEt<sub>3</sub> (1.5 equiv) and EDCI·HCl (2.5 equiv) were added. The mixture was refluxed for 3–5 h. Afterward, EtOAc was added, and the organic layer was washed with brine. The crude product was purified by column chromatography.</div><div id="sec4-4-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-((4-Ethoxybenzyl)amino)-<i>N</i>,<i>N</i>-diethyl-1-isopentyl-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxamide (<b>30</b>)</h4><div class="NLM_p last">The crude product was purified by column chromatography using petroleum ether and EtOAc (1:10) as eluent system. <b>30</b> was obtained as a light brown solid (0.71 mmol, 0.31 g, 38%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 7.42 (d, <i>J</i> = 1.0 Hz, 1H), 7.33–7.28 (m, 2H), 7.04 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 6.97 (d, <i>J</i> = 8.0 Hz, 1H), 6.87–6.82 (m, 2H), 4.61 (d, <i>J</i> = 5.3 Hz, 2H), 4.00 (q, <i>J</i> = 7.0 Hz, 2H), 3.79 (dd, <i>J</i> = 16.4, 9.0 Hz, 1H), 3.43 (d, <i>J</i> = 3.8 Hz, 4H), 1.61–1.49 (m, 3H), 1.39 (t, <i>J</i> = 7.0 Hz, 3H), 1.21–1.09 (m, 6H), 0.91 (d, <i>J</i> = 6.2 Hz, 6H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 13.79, 15.10, 23.00, 25.79, 37.93, 42.33, 47.91, 64.02, 114.72, 115.46, 119.32, 121.03, 129.99, 133.41, 134.45, 141.67, 151.22, 155.09, 172.78 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>36</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 437.28; found, 437.25. HPLC purity: 97% (retention time = 8.53 min).</div></div><div id="sec4-4-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-((4-Ethoxyphenyl)amino)-<i>N</i>,<i>N</i>-diethyl-1-(2-(piperidin-1-yl)ethyl)-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxamide (<b>31</b>)</h4><div class="NLM_p last">The crude product was purified by column chromatography using dichloromethane/methanol/NH<sub>3</sub>, aq 25% (50:1:0.1), as the eluent system. <b>31</b> was obtained as a light yellow solid (0.56 mmol, 0.26 g, 85%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 7.52–7.43 (m, 3H), 7.05 (dt, <i>J</i> = 5.9, 3.0 Hz, 1H), 6.96 (d, <i>J</i> = 8.1 Hz, 1H), 6.88–6.81 (m, 2H), 3.97 (dt, <i>J</i> = 14.0, 4.9 Hz, 4H), 3.51–3.32 (m, 4H), 2.67 (dd, <i>J</i> = 5.4, 3.0 Hz, 2H), 2.51 (s, 4H), 1.68–1.59 (m, 4H), 1.54–1.42 (m, 2H), 1.38–1.32 (m, 3H), 1.23–1.02 (m, 6H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 172.23, 154.35, 153.75, 142.04, 134.81, 133.71, 130.28, 120.74, 118.80, 115.22, 114.89, 106.63, 63.77, 55.27, 53.48, 43.24, 41.56, 25.84, 23.75, 14.91, 13.85 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 464.29; found, 464.15. HPLC purity: 96% (retention time = 6.18 min).</div></div><div id="sec4-4-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>,<i>N</i>-Diethyl-2-((4-phenoxyphenyl)amino)-1-(2-(piperidin-1-yl)ethyl)-1<i>H</i>-benzo[<i>d</i>] imidazole-5-carboxamide (<b>32</b>)</h4><div class="NLM_p last">The crude product was purified by column chromatography using dichloromethane/methanol/NH<sub>3</sub>, aq 25% (50:1:0.1), as the eluent system. <b>32</b> was obtained as a light brown solid (0.82 mmol, 0.42 g, 61%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 7.59–7.51 (m, 2H), 7.43 (d, <i>J</i> = 1.1 Hz, 1H), 7.25–7.16 (m, 2H), 7.03 (dt, <i>J</i> = 8.7, 4.3 Hz, 1H), 6.99–6.86 (m, 6H), 3.98–3.90 (m, 2H), 3.46–3.22 (m, 4H), 2.67–2.61 (m, 2H), 2.49 (s, 4H), 1.65–1.55 (m, 4H), 1.50–1.41 (m, 2H), 1.14–0.98 (m, 6H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 172.22, 158.17, 153.12, 151.41, 141.87, 136.50, 134.66, 130.44, 129.60, 122.61, 120.29, 120.24, 119.07, 118.02, 115.06, 106.84, 59.92, 55.35, 41.60, 31.62, 25.84, 23.73, 13.88 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 512.29; found, 512.20. HPLC purity: 97% (retention time = 7.79 min).</div></div><div id="sec4-4-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(2-(4-Ethoxybenzyl)-1-isopentyl-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)benzamide (<b>39</b>)</h4><div class="NLM_p last">Benzoic acid (1 equiv) was dissolved in DMF, and NEt<sub>3</sub> (1.5 equiv), HBTU (1.1 equiv), and amine <b>38</b> (1 equiv) were added in one portion. The mixture was stirred overnight at room temperature. EtOAc and a saturated aqueous NaHCO<sub>3</sub> solution were added. The organic layer was washed several times with water and brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo, and the product was purified by column chromatography using petroleum ether and EtOAc (1:2) as the eluent system. <b>39</b> was obtained as a colorless solid (0.42 mmol, 0.19 g, 64%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.08–7.95 (m, 4H), 7.56–7.42 (m, 3H), 7.29 (d, <i>J</i> = 9.3 Hz, 1H), 7.22–7.15 (m, 2H), 6.82 (dd, <i>J</i> = 8.6, 4.4 Hz, 2H), 4.43 (s, 2H), 4.08–4.01 (m, 2H), 4.01–3.93 (m, 2H), 1.62–1.50 (m, 1H), 1.41–1.32 (m, 5H), 0.89 (d, <i>J</i> = 6.6 Hz, 6H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 165.98, 158.21, 150.89, 134.89, 131.75, 129.82, 129.61, 128.70, 127.33, 123.31, 114.98, 110.59, 109.88, 63.51, 42.97, 37.93, 33.09, 26.15, 22.33, 14.77 ppm. ESI: <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>31</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 442.24; found, 442.10. HPLC purity: 99% (retention time = 9.27 min).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01760">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01760" class="ext-link">10.1021/acs.jmedchem.7b01760</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental and spectral data of compounds, detailed information about the measurement of inhibition of AChE and BChE, radioligand binding studies on the <i>h</i>CB<sub>1</sub>R, <i>h</i>CB<sub>2</sub>R, and <i>h</i>MOP receptors, efficacy on <i>h</i>CB<sub>2</sub>R, information on cell culture and cell lines, statistics, animals, biochemical and histological procedures, and statistics of behavioral studies (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Crystal structure of the human CB1 receptor (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_003.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_001.pdf">jm7b01760_si_001.pdf (723.49 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_002.csv">jm7b01760_si_002.csv (2.53 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_003.pdb">jm7b01760_si_003.pdb (376.6 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code for the crystal structure of the human CB1 receptor in complex with agonist AM11542 is 5XRA.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> This crystal structure was used for the generation of the homology model for computational studies of the human CB2 receptor in complex with compound <b>20a</b> or <b>20d</b>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01760" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Decker</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy
and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, D-97074 Würzburg, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6773-6245" title="Orcid link">http://orcid.org/0000-0002-6773-6245</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fe93979d969f9b92d09a9b9d959b8cbe8b9097d3898b9b8c849c8b8c99d09a9b"><span class="__cf_email__" data-cfemail="523f3b313a33373e7c36373139372012273c3b7f2527372028302720357c3637">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dominik Dolles</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy
and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, D-97074 Würzburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Hoffmann</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy
and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, D-97074 Würzburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Gunesch</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy
and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, D-97074 Würzburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliviero Marinelli</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Department of Experimental Medicine, University of Camerino, I-62032 Camerino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Möller</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacology and Toxicology, Julius Maximilian University of Würzburg, Versbacher Strabe 9, D-97078 Würzburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giorgio Santoni</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Department of Experimental Medicine, University of Camerino, I-62032 Camerino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arnaud Chatonnet</span> - <span class="hlFld-Affiliation affiliation">INRA
UMR866, University of Montpellier, F-34060 Montpellier, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin J. Lohse</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacology and Toxicology, Julius Maximilian University of Würzburg, Versbacher Strabe 9, D-97078 Würzburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans-Joachim Wittmann</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry II, Institute of
Pharmacy, University of Regensburg, D-95053 Regensburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Strasser</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry II, Institute of
Pharmacy, University of Regensburg, D-95053 Regensburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Massimo Nabissi</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Department of Experimental Medicine, University of Camerino, I-62032 Camerino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tangui Maurice</span> - <span class="hlFld-Affiliation affiliation">INSERM
UMR-S1198, University of Montpellier, EPHE, F-34095 Montpellier, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>M. Decker gratefully acknowledges the German Science Foundation (Deutsche Forschungsgemeinschaft) for financial support (DFG DE1546/6-3). M. Decker and T. Maurice acknowledge support from Campus France (PHC Procope), and the German Academic Exchange Service (DAAD), the latter providing funds from the Federal Ministry of Education and Research (BMBF). The Elite Network of Bavaria (Elitenetzwerk Bayern) awarded M. Hoffmann and J. Möller  PhD positions within the International Doctoral Program “Receptor Dynamics”. A travel grant by the Alzheimer Forschung Initiative e.V. for D. Dolles to present this work at the ACS spring meeting in San Francisco 2017 is gratefully acknowledged.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank O. Lockridge (University of Nebraska Medcial Center) for providing human BChE. Cell lines stably expressing <i>h</i>CB<sub>1</sub>R and <i>h</i>CB<sub>2</sub>R were kindly provided by AbbVie (Chicago, IL, USA). We thank S. Kachler and Professor K.-N. Klotz (Institute of Pharmacology and Toxicology, University of Würzburg) for the technical support and workspace for radioligand binding studies.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> Abbreviations Used</h2><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ANOVA</td><td class="NLM_def"><p class="first last">analysis of variance</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">Cpd</td><td class="NLM_def"><p class="first last">compound</p></td></tr><tr><td class="NLM_term">CRE</td><td class="NLM_def"><p class="first last">cAMP response element</p></td></tr><tr><td class="NLM_term">CREB</td><td class="NLM_def"><p class="first last">cAMP response-element binding protein</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">GAPDH</td><td class="NLM_def"><p class="first last">glyceraldehyde 3-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein coupled receptor</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term"><i>h</i>C<i>B</i><sub>1/2</sub>R</td><td class="NLM_def"><p class="first last">human cannabinoid receptor subtype 1/2</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryotic kidney</p></td></tr><tr><td class="NLM_term"><i>h</i>β<sub>2</sub>R</td><td class="NLM_def"><p class="first last">human β<sub>2</sub>R adrenergic receptor</p></td></tr><tr><td class="NLM_term">ICV</td><td class="NLM_def"><p class="first last">intracerebroventricular</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">MIF</td><td class="NLM_def"><p class="first last">macrophage migration inhibitory factor</p></td></tr><tr><td class="NLM_term">MOP</td><td class="NLM_def"><p class="first last">μ-opioid</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">n.d.</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor</p></td></tr><tr><td class="NLM_term">nNOS</td><td class="NLM_def"><p class="first last">neuronal nitric oxide synthase</p></td></tr><tr><td class="NLM_term">od</td><td class="NLM_def"><p class="first last">oculus dextrus</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">(q)RT/PCR</td><td class="NLM_def"><p class="first last">(quantitative) reverse transcription polymerase chain reaction</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">Sc.Aβ</td><td class="NLM_def"><p class="first last">scrambled amyloid β</p></td></tr><tr><td class="NLM_term">STAT-3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription</p></td></tr><tr><td class="NLM_term">ST-PA</td><td class="NLM_def"><p class="first last">step-through passive avoidance</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane</p></td></tr><tr><td class="NLM_term">V or VEI</td><td class="NLM_def"><p class="first last">vehicle</p></td></tr><tr><td class="NLM_term">YMT</td><td class="NLM_def"><p class="first last">Y-maze test.</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 72 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Prince, M.; Comas-Herrera, A.; Knapp, M.; Guerchet, M., Karagiannidou, M.</span> <span class="citation_source-book">World Alzheimer Report 2016; Improving healthcare for people living with dementia; Coverage, quality and costs now and in the future</span>; <span class="NLM_publisher-name">Alzheimer’s Disease International (ADI)</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+Prince&author=A.+Comas-Herrera&author=M.+Knapp&author=M.+Guerchet&author=M.+Karagiannidou&title=World+Alzheimer+Report+2016%3B+Improving+healthcare+for+people+living+with+dementia%3B+Coverage%2C+quality+and+costs+now+and+in+the+future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26btitle%3DWorld%2520Alzheimer%2520Report%25202016%253B%2520Improving%2520healthcare%2520for%2520people%2520living%2520with%2520dementia%253B%2520Coverage%252C%2520quality%2520and%2520costs%2520now%2520and%2520in%2520the%2520future%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%2520%2528ADI%2529%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Zemek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drtinova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepsova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span> </span><span class="NLM_article-title">Outcomes of Alzheimer’s disease therapy with acetylcholinesterase inhibitors and memantine</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=759-774&author=F.+Zemekauthor=L.+Drtinovaauthor=E.+Nepovimovaauthor=V.+Sepsovaauthor=J.+Korabecnyauthor=J.+Klimesauthor=K.+Kuca&title=Outcomes+of+Alzheimer%E2%80%99s+disease+therapy+with+acetylcholinesterase+inhibitors+and+memantine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZemek%26aufirst%3DF.%26aulast%3DDrtinova%26aufirst%3DL.%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DKlimes%26aufirst%3DJ.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DOutcomes%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%2520with%2520acetylcholinesterase%2520inhibitors%2520and%2520memantine%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2014%26volume%3D6%26spage%3D759%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ballard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aarsland, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span><span class="refDoi"> DOI: 10.1016/S0140-6736(10)61349-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS0140-6736%2810%2961349-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=21371747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADC%252BC3M3otlCqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=1019-1031&author=C.+Ballardauthor=S.+Gauthierauthor=A.+Corbettauthor=C.+Brayneauthor=D.+Aarslandauthor=E.+Jones&title=Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2810%2961349-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Ballard Clive; Gauthier Serge; Corbett Anne; Brayne Carol; Aarsland Dag; Jones Emma</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">9770</span>),
    <span class="NLM_cas:pages">1019-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">An estimated 24 million people worldwide have dementia, the majority of whom are thought to have Alzheimer's disease.  Thus, Alzheimer's disease represents a major public health concern and has been identified as a research priority.  Although there are licensed treatments that can alleviate symptoms of Alzheimer's disease, there is a pressing need to improve our understanding of pathogenesis to enable development of disease-modifying treatments.  Methods for improving diagnosis are also moving forward, but a better consensus is needed for development of a panel of biological and neuroimaging biomarkers that support clinical diagnosis.  There is now strong evidence of potential risk and protective factors for Alzheimer's disease, dementia, and cognitive decline, but further work is needed to understand these better and to establish whether interventions can substantially lower these risks.  In this Seminar, we provide an overview of recent evidence regarding the epidemiology, pathogenesis, diagnosis, and treatment of Alzheimer's disease, and discuss potential ways to reduce the risk of developing the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPHrxmEUcI2DdblLE_E9PWfW6udTcc2eZmr6qw4z3bwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3otlCqtQ%253D%253D&md5=e37ee3fb78a85dfc774b372d0a9af0c5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2961349-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252961349-9%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DC.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DCorbett%26aufirst%3DA.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DAarsland%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DE.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26spage%3D1019%26epage%3D1031%26doi%3D10.1016%2FS0140-6736%2810%2961349-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Duyckaerts, C.; Dickson, D.</span><span> </span><span class="NLM_article-title">Neuropathology of Alzheimer’s disease and its variants</span>. In  <span class="citation_source-book">Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders</span>; <span class="NLM_contrib-group">Dickson, D.; Weller, R.</span>, Eds.; <span class="NLM_publisher-name">Wiley-Blackwell</span>: <span class="NLM_publisher-loc">Oxford</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">2</span>, pp  <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2F9781444341256.ch10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=62-91&author=C.+Duyckaerts&author=D.+Dicksonauthor=D.+Dickson&author=R.+Weller&title=Neurodegeneration%3A+The+Molecular+Pathology+of+Dementia+and+Movement+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2F9781444341256.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781444341256.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DDuyckaerts%26aufirst%3DC.%26atitle%3DNeuropathology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520its%2520variants%26btitle%3DNeurodegeneration%253A%2520The%2520Molecular%2520Pathology%2520of%2520Dementia%2520and%2520Movement%2520Disorders%26aulast%3DDickson%26aufirst%3DD.%26pub%3DWiley-Blackwell%26date%3D2011%26volume%3D2%26spage%3D62%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ferrer, I.</span><span> </span><span class="NLM_article-title">Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2012.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.pneurobio.2012.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=22459297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADC%252BC38rgs1GgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2012&pages=38-51&author=I.+Ferrer&title=Defining+Alzheimer+as+a+common+age-related+neurodegenerative+process+not+inevitably+leading+to+dementia&doi=10.1016%2Fj.pneurobio.2012.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia</span></div><div class="casAuthors">Ferrer Isidro</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since the description by Alois Alzheimer, more than 50 years have passed during which senile dementia and pre-senile dementia have been considered Alzheimer disease (AD) on the basis of their common neuropathological and clinical manifestations.  AD now covers pre-senile dementia, senile dementia, mild cognitive impairment and pre-clinical AD, all of them within the context of AD-related pathology.  However, there is still a gray area between normal aging with AD-related pathology and AD.  Here it is proposed that Alzheimer (or alzheimer) is an age-related neurodegenerative process distinguished from normal aging by the presence of senile plaques and neurofibrillary tangles.  Alzheimer affects about 80% of individuals aged 65 years but dementia only occurs in a small percentage of individuals at this age; prevalence of dementia in Alzheimer increases to 25% in individuals aged 80 years.  The concepts derived from the β-amyloid hypothesis support β-amyloid as a conductor in the pathogenesis of familial AD and as a prodding factor in sporadic AD.  Moreover, seeding of β-amyloid and truncated tau explains incorporation, enhancement and perpetuation of AD-related changes.  Therefore, the earliest Alzheimer changes confined to selected regions are the first grounds and the main risk factor for developing dementia.  The term Alzheimer embraces this assumption and likens its meaning to other degenerative biological processes, such as atherosclerosis, that may eventually progress to disease.  In this context, the first stages of Alzheimer should be considered as primary targets of therapeutic intervention in order to prevent progression to diseased states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8RZSMq5h6HMAKB7Fa-xrUfW6udTcc2eZmr6qw4z3bwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rgs1GgtA%253D%253D&md5=60276ba23f11747b14a35ea1e18c45bf</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2012.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2012.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DFerrer%26aufirst%3DI.%26atitle%3DDefining%2520Alzheimer%2520as%2520a%2520common%2520age-related%2520neurodegenerative%2520process%2520not%2520inevitably%2520leading%2520to%2520dementia%26jtitle%3DProg.%2520Neurobiol.%26date%3D2012%26volume%3D97%26spage%3D38%26epage%3D51%26doi%3D10.1016%2Fj.pneurobio.2012.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wyss-Coray, T.</span><span> </span><span class="NLM_article-title">Inflammation in Alzheimer disease: driving force, bystander or beneficial response?</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=16960575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1005-1015&author=T.+Wyss-Coray&title=Inflammation+in+Alzheimer+disease%3A+driving+force%2C+bystander+or+beneficial+response%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation in Alzheimer disease: driving force, bystander or beneficial response?</span></div><div class="casAuthors">Wyss-Coray, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1005-1015</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease is a progressive dementia with unknown etiol. that affects a growing no. of the aging population.  Increased expression of inflammatory mediators in postmortem brains of people with Alzheimer disease has been reported, and epidemiol. studies link the use of anti-inflammatory drugs with reduced risk for the disorder.  On the initial basis of this kind of evidence, inflammation has been proposed as a possible cause or driving force of Alzheimer disease.  If true, this could have important implications for the development of new treatments.  Alternatively, inflammation could simply be a byproduct of the disease process and may not substantially alter its course.  Or components of the inflammatory response might even be beneficial and slow the disease.  To address these possibilities, we need to det. whether inflammation in Alzheimer disease is an early event, whether it is genetically linked with the disease and whether manipulation of inflammatory pathways changes the course of the pathol.  Although there is still little evidence that inflammation triggers or promotes Alzheimer disease, increasing evidence from mouse models suggests that certain inflammatory mediators are potent drivers of the disease.  Related factors, on the other hand, elicit beneficial responses and can reduce disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYCLID8AGyfLVg90H21EOLACvtfcHk0lhpUwQPsDdvlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFClurs%253D&md5=5d9aace20aebc0af42f7d7cafe877e19</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyss-Coray%26aufirst%3DT.%26atitle%3DInflammation%2520in%2520Alzheimer%2520disease%253A%2520driving%2520force%252C%2520bystander%2520or%2520beneficial%2520response%253F%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D1005%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Perry, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, J. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, C.</span><span> </span><span class="NLM_article-title">Microglia in neurodegenerative disease</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1038/nrneurol.2010.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnrneurol.2010.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=20234358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADC%252BC3c3kslyntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=193-201&author=V.+H.+Perryauthor=J.+A.+R.+Nicollauthor=C.+Holmes&title=Microglia+in+neurodegenerative+disease&doi=10.1038%2Fnrneurol.2010.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia in neurodegenerative disease</span></div><div class="casAuthors">Perry V Hugh; Nicoll James A R; Holmes Clive</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">193-201</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Microglia, the resident macrophages of the CNS, are exquisitely sensitive to brain injury and disease, altering their morphology and phenotype to adopt a so-called activated state in response to pathophysiological brain insults.  Morphologically activated microglia, like other tissue macrophages, exist as many different phenotypes, depending on the nature of the tissue injury.  Microglial responsiveness to injury suggests that these cells have the potential to act as diagnostic markers of disease onset or progression, and could contribute to the outcome of neurodegenerative diseases.  The persistence of activated microglia long after acute injury and in chronic disease suggests that these cells have an innate immune memory of tissue injury and degeneration.  Microglial phenotype is also modified by systemic infection or inflammation.  Evidence from some preclinical models shows that systemic manipulations can ameliorate disease progression, although data from other models indicates that systemic inflammation exacerbates disease progression.  Systemic inflammation is associated with a decline in function in patients with chronic neurodegenerative disease, both acutely and in the long term.  The fact that diseases with a chronic systemic inflammatory component are risk factors for Alzheimer disease implies that crosstalk occurs between systemic inflammation and microglia in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQICI_RTJIiGzC850By6mxpfW6udTcc2ebSoIDJU36GU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3kslyntw%253D%253D&md5=efb215a8a737c924905e7aa04a5b6706</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2010.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2010.17%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DV.%2BH.%26aulast%3DNicoll%26aufirst%3DJ.%2BA.%2BR.%26aulast%3DHolmes%26aufirst%3DC.%26atitle%3DMicroglia%2520in%2520neurodegenerative%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D193%26epage%3D201%26doi%3D10.1038%2Fnrneurol.2010.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Matsuda, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lolait, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownstein, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, T. I.</span><span> </span><span class="NLM_article-title">Structure of cannabinoid receptor and functional expression of the cloned cDNA</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1038/346561a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2F346561a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=561-564&author=L.+A.+Matsudaauthor=S.+J.+Lolaitauthor=M.+J.+Brownsteinauthor=A.+C.+Youngauthor=T.+I.+Bonner&title=Structure+of+cannabinoid+receptor+and+functional+expression+of+the+cloned+cDNA&doi=10.1038%2F346561a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F346561a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F346561a0%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DL.%2BA.%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DBrownstein%26aufirst%3DM.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BC.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26atitle%3DStructure%2520of%2520cannabinoid%2520receptor%2520and%2520functional%2520expression%2520of%2520the%2520cloned%2520cDNA%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D561%26epage%3D564%26doi%3D10.1038%2F346561a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chiurchiù, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span> </span><span class="NLM_article-title">Endocannabinoid signaling in innate and adaptive immunity</span> <span class="citation_source-journal">Immunology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1111/imm.12441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1111%2Fimm.12441" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2015&pages=352-364&author=V.+Chiurchi%C3%B9author=L.+Battistiniauthor=M.+Maccarrone&title=Endocannabinoid+signaling+in+innate+and+adaptive+immunity&doi=10.1111%2Fimm.12441"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fimm.12441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimm.12441%26sid%3Dliteratum%253Aachs%26aulast%3DChiurchi%25C3%25B9%26aufirst%3DV.%26aulast%3DBattistini%26aufirst%3DL.%26aulast%3DMaccarrone%26aufirst%3DM.%26atitle%3DEndocannabinoid%2520signaling%2520in%2520innate%2520and%2520adaptive%2520immunity%26jtitle%3DImmunology%26date%3D2015%26volume%3D144%26spage%3D352%26epage%3D364%26doi%3D10.1111%2Fimm.12441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Van Sickle, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouihate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittmann, Q. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharkey, K. A.</span><span> </span><span class="NLM_article-title">Identification and functional characterization of brainstem cannabinoid CB2 receptors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1126/science.1115740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1126%2Fscience.1115740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=16224028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2hurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=329-332&author=M.+D.+Van+Sickleauthor=M.+Duncanauthor=P.+J.+Kingsleyauthor=A.+Mouihateauthor=P.+Urbaniauthor=K.+Mackieauthor=N.+Stellaauthor=A.+Makriyannisauthor=D.+Piomelliauthor=J.+S.+Davisonauthor=L.+J.+Marnettauthor=V.+Di+Marzoauthor=Q.+J.+Pittmannauthor=K.+D.+Patelauthor=K.+A.+Sharkey&title=Identification+and+functional+characterization+of+brainstem+cannabinoid+CB2+receptors&doi=10.1126%2Fscience.1115740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and functional characterization of brainstem cannabinoid CB2 receptors</span></div><div class="casAuthors">Van Sickle, Marja D.; Duncan, Marnie; Kingsley, Philip J.; Mouihate, Abdeslam; Urbani, Paolo; Mackie, Ken; Stella, Nephi; Makriyannis, Alexandros; Piomelli, Daniele; Davison, Joseph S.; Marnett, Lawrence J.; Di Marzo, Vincenzo; Pittman, Quentin J.; Patel, Kamala D.; Sharkey, Keith A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">5746</span>),
    <span class="NLM_cas:pages">329-332</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The presence and function of CB2 receptors in central nervous system (CNS) neurons are controversial.  The authors report the expression of CB2 receptor mRNA and protein localization on brainstem neurons.  These functional CB2 receptors in the brainstem were activated by a CB2 receptor agonist, 2-arachidonoylglycerol, and by elevated endogenous levels of endocannabinoids, which also act at CB1 receptors.  CB2 receptors represent an alternative site of action of endocannabinoids that opens the possibility of nonpsychotropic therapeutic interventions using enhanced endocannabinoid levels in localized brain areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriWgg6LDIT0bVg90H21EOLACvtfcHk0liSAREnkU3D-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2hurvL&md5=ab457ab0bd1b8e30ea927a1e61366323</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.1115740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1115740%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BSickle%26aufirst%3DM.%2BD.%26aulast%3DDuncan%26aufirst%3DM.%26aulast%3DKingsley%26aufirst%3DP.%2BJ.%26aulast%3DMouihate%26aufirst%3DA.%26aulast%3DUrbani%26aufirst%3DP.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DStella%26aufirst%3DN.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DDavison%26aufirst%3DJ.%2BS.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DPittmann%26aufirst%3DQ.%2BJ.%26aulast%3DPatel%26aufirst%3DK.%2BD.%26aulast%3DSharkey%26aufirst%3DK.%2BA.%26atitle%3DIdentification%2520and%2520functional%2520characterization%2520of%2520brainstem%2520cannabinoid%2520CB2%2520receptors%26jtitle%3DScience%26date%3D2005%26volume%3D310%26spage%3D329%26epage%3D332%26doi%3D10.1126%2Fscience.1115740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Núnez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazos, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbachano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fajardo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolón, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span> </span><span class="NLM_article-title">Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1002/syn.20050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fsyn.20050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=208-213&author=E.+N%C3%BAnezauthor=C.+Benitoauthor=M.+R.+Pazosauthor=A.+Barbachanoauthor=O.+Fajardoauthor=S.+Gonz%C3%A1lezauthor=R.+M.+Tol%C3%B3nauthor=J.+Romero&title=Cannabinoid+CB2+receptors+are+expressed+by+perivascular+microglial+cells+in+the+human+brain%3A+an+immunohistochemical+study&doi=10.1002%2Fsyn.20050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20050%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25BAnez%26aufirst%3DE.%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DPazos%26aufirst%3DM.%2BR.%26aulast%3DBarbachano%26aufirst%3DA.%26aulast%3DFajardo%26aufirst%3DO.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DS.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB2%2520receptors%2520are%2520expressed%2520by%2520perivascular%2520microglial%2520cells%2520in%2520the%2520human%2520brain%253A%2520an%2520immunohistochemical%2520study%26jtitle%3DSynapse%26date%3D2004%26volume%3D53%26spage%3D208%26epage%3D213%26doi%3D10.1002%2Fsyn.20050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Grünblatt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zander, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monoranu, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arzberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roggendorf, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span> </span><span class="NLM_article-title">Comparison analysis of gene expression patterns between sporadic Alzheimer’s and Parkinson’s disease</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span><span class="refDoi"> DOI: 10.3233/JAD-2007-12402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.3233%2FJAD-2007-12402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=18198416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFKjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=291-311&author=E.+Gr%C3%BCnblattauthor=N.+Zanderauthor=J.+Bartlauthor=L.+Jieauthor=C.+M.+Monoranuauthor=T.+Arzbergerauthor=R.+Ravidauthor=W.+Roggendorfauthor=M.+Gerlachauthor=P.+Riederer&title=Comparison+analysis+of+gene+expression+patterns+between+sporadic+Alzheimer%E2%80%99s+and+Parkinson%E2%80%99s+disease&doi=10.3233%2FJAD-2007-12402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison Analysis of Gene Expression Patterns between Sporadic Alzheimer's and Parkinson's Disease</span></div><div class="casAuthors">Gruenblatt, Edna; Zander, Nicole; Bartl, Jasmin; Jie, Li; Monoranu, Camelia-Maria; Arzberger, Thomas; Ravid, Rivka; Roggendorf, Wolfgang; Gerlach, Manfred; Riederer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">291-311</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Sporadic Alzheimer's (AD) and Parkinson's disease (PD) are late-onset neurodegenerative diseases with tremendous impact on lives of affected individuals.  There is a great probability of developing concurrent Parkinsonism in AD and vice-versa than would be predicted by independent prevalence of each disease.  We hypothesize that in sporadic AD as well as PD a combination of environmental effects and gene expression may affect specific brain areas leading to neurodegeneration.  We profiled gene expression of AD compared to PD and age matched controls post-mortem in the hippocampus, the gyrus-frontalis-medius (Gfm) and the cerebellum using Gene-Chip microarray (Affymetrix) and quant.-real-time-RT-PCR.  Twelve genes altered in similar manner in AD and PD, while four genes showed differential expression profiles between AD and PD in different brain regions (cannabinoid-receptor-2, Histone-cluster-1-H3e, nicotinic-cholinergic-receptor-α6 and β-site-APP-cleaving enzyme-1).  Knowledge of selective gene expression profile can lead to better understanding of disease pathol. and development of specific diagnosis and effective therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt2Fj086--37Vg90H21EOLACvtfcHk0lhOOASgG0ZYfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFKjtA%253D%253D&md5=ca706394d8bc3649b7d316e42abd33f1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3233%2FJAD-2007-12402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2007-12402%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnblatt%26aufirst%3DE.%26aulast%3DZander%26aufirst%3DN.%26aulast%3DBartl%26aufirst%3DJ.%26aulast%3DJie%26aufirst%3DL.%26aulast%3DMonoranu%26aufirst%3DC.%2BM.%26aulast%3DArzberger%26aufirst%3DT.%26aulast%3DRavid%26aufirst%3DR.%26aulast%3DRoggendorf%26aufirst%3DW.%26aulast%3DGerlach%26aufirst%3DM.%26aulast%3DRiederer%26aufirst%3DP.%26atitle%3DComparison%2520analysis%2520of%2520gene%2520expression%2520patterns%2520between%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2007%26volume%3D12%26spage%3D291%26epage%3D311%26doi%3D10.3233%2FJAD-2007-12402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Solas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, M. J.</span><span> </span><span class="NLM_article-title">CB<sub>2</sub> receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span><span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2012.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.neurobiolaging.2012.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=22763024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSgtb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=805-808&author=M.+Solasauthor=P.+T.+Francisauthor=R.+Francoauthor=M.+J.+Ramirez&title=CB2+receptor+and+amyloid+pathology+in+frontal+cortex+of+Alzheimer%E2%80%99s+disease+patients&doi=10.1016%2Fj.neurobiolaging.2012.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients</span></div><div class="casAuthors">Solas, Maite; Francis, Paul T.; Franco, Rafael; Ramirez, Maria J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">805-808</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The cannabinoid system seems to play an important role in various neurodegenerative diseases including Alzheimer's disease (AD).  The relationship of cannabinoid receptors (CB1R and CB2R) to cognitive function and neuropathol. markers in AD remains unclear.  In the present study, postmortem cortical brain tissues (Brodmann area 10) from a cohort of neuropathol. confirmed AD patients and age-matched controls were used to measure CB1R and CB2R by immunoblotting.  Correlational analyses were performed for the neurochem. and cognitive data.  CB1R expression was significantly decreased in AD.  Levels of CB1R correlated with hypophagia, but not with any AD mol. marker or cognitive status (Mini Mental State Examn. score).  The level of CB2R was significantly higher (40%) in AD.  Increases in the expression of the glial marker glial fibrillar acidic protein were also found.  CB2R expression did not correlate with cognitive status.  Interestingly, expression levels of CB2R correlated with two relevant AD mol. markers, Aβ42 levels and senile plaque score.  These results may constitute the basis of CB2R-based therapies and/or diagnostic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK3Am3IXxWvbVg90H21EOLACvtfcHk0lhOOASgG0ZYfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSgtb3M&md5=e7605adc118eb1782772c686a49efebc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DSolas%26aufirst%3DM.%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DRamirez%26aufirst%3DM.%2BJ.%26atitle%3DCB2%2520receptor%2520and%2520amyloid%2520pathology%2520in%2520frontal%2520cortex%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D805%26epage%3D808%26doi%3D10.1016%2Fj.neurobiolaging.2012.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Fernández-Ruiz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolón, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzmán, M.</span><span> </span><span class="NLM_article-title">Cannabinoid CB<sub>2</sub> receptor: a new target for controlling neural cell survival?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1016/j.tips.2006.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.tips.2006.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=17141334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlOmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=39-45&author=J.+Fern%C3%A1ndez-Ruizauthor=J.+Romeroauthor=G.+Velascoauthor=R.+M.+Tol%C3%B3nauthor=J.+A.+Ramosauthor=M.+Guzm%C3%A1n&title=Cannabinoid+CB2+receptor%3A+a+new+target+for+controlling+neural+cell+survival%3F&doi=10.1016%2Fj.tips.2006.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptor: a new target for controlling neural cell survival?</span></div><div class="casAuthors">Fernandez-Ruiz, Javier; Romero, Julian; Velasco, Guillermo; Tolon, Rosa M.; Ramos, Jose A.; Guzman, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-45</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Two types of cannabinoid receptor have been cloned and characterized.  Whereas CB1 receptors are ubiquitously expressed in neurons of the CNS, CB2 receptors have been thought to be absent from the CNS.  Recent data now question this notion and support the expression of CB2 receptors in microglial cells, astrocytes and even some neuron subpopulations.  This discrete distribution makes CB2 receptors interesting targets for treating neurol. disorders because CB2-selective agonists lack psychoactivity.  Here, we review evidence supporting the idea that CB2 receptors are implicated in the control of fundamental neural cell processes, such as proliferation and survival, and that their pharmacol. manipulation might be useful for both delaying the progression of neurodegenerative disorders and inhibiting the growth of glial tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpNrWrT5XU9bVg90H21EOLACvtfcHk0lhOOASgG0ZYfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlOmsw%253D%253D&md5=8f809e0332df14885c66df7e891294f2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Ruiz%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DVelasco%26aufirst%3DG.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DRamos%26aufirst%3DJ.%2BA.%26aulast%3DGuzm%25C3%25A1n%26aufirst%3DM.%26atitle%3DCannabinoid%2520CB2%2520receptor%253A%2520a%2520new%2520target%2520for%2520controlling%2520neural%2520cell%2520survival%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D39%26epage%3D45%26doi%3D10.1016%2Fj.tips.2006.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Molina-Holgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina-Holgado, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guaza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothwell, N. J.</span><span> </span><span class="NLM_article-title">Role of CB<sub>1</sub> and CB<sub>2</sub> receptors in the inhibitory effects of cannabinoids on liposaccharide-induced nitric oxide release in astrocyte cultures</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span><span class="refDoi"> DOI: 10.1002/jnr.10165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fjnr.10165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=11891798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFCgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=829-836&author=F.+Molina-Holgadoauthor=E.+Molina-Holgadoauthor=C.+Guazaauthor=N.+J.+Rothwell&title=Role+of+CB1+and+CB2+receptors+in+the+inhibitory+effects+of+cannabinoids+on+liposaccharide-induced+nitric+oxide+release+in+astrocyte+cultures&doi=10.1002%2Fjnr.10165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures</span></div><div class="casAuthors">Molina-Holgado, Francisco; Molina-Holgado, Eduardo; Guaza, Carmen; Rothwell, Nancy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">829-836</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate the role of the central cannabinoid receptor (CB1) in mediating the actions of the endogenous cannabinoid agonist anandamide and the synthetic cannabinoid CP-55940.  Activation of primary mouse astrocyte cultures by exposure to bacterial lipopolysaccharide (LPS) caused a marked (approx. tenfold) increase in nitric oxide (NO) release.  Coincubation with the cannabinoid agonists anandamide or CP-55940 markedly inhibited release of NO (-12% to -55%).  This effect was abolished by SR-141716A (1 μM), a CB1 receptor antagonist.  SR-141716A alone also significantly increased NO release in response to LPS, suggesting that endogenous cannabinoids modify inflammatory responses.  In contrast, coincubation with the CB2 receptor antagonist SR-144528 (1 μM) abolished the inhibitory effects of the endogenous cannabinoid anandamide on LPS-induced NO release, although this may reflect nonspecific effects of this ligand or cannabinoid actions through atypical receptors of anandamide.  We also showed that endogenous or synthetic cannabinoids inhibit LPS-induced inducible NO synthase expression (mRNA and protein) in astrocyte cultures.  These results indicate that CB1 receptors may promote antiinflammatory responses in astrocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob_NRvXnWJg7Vg90H21EOLACvtfcHk0ljpBRdaeDbEbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFCgtLo%253D&md5=4a2e3e4f6d36a78359f79549e6ee4214</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjnr.10165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.10165%26sid%3Dliteratum%253Aachs%26aulast%3DMolina-Holgado%26aufirst%3DF.%26aulast%3DMolina-Holgado%26aufirst%3DE.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DRothwell%26aufirst%3DN.%2BJ.%26atitle%3DRole%2520of%2520CB1%2520and%2520CB2%2520receptors%2520in%2520the%2520inhibitory%2520effects%2520of%2520cannabinoids%2520on%2520liposaccharide-induced%2520nitric%2520oxide%2520release%2520in%2520astrocyte%2520cultures%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2002%26volume%3D67%26spage%3D829%26epage%3D836%26doi%3D10.1002%2Fjnr.10165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sheng, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabral, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokensgard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, P. K.</span><span> </span><span class="NLM_article-title">Synthetic cannabinoid WIN55,212–2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1002/glia.20108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fglia.20108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=211-219&author=W.+S.+Shengauthor=S.+Huauthor=X.+Minauthor=G.+A.+Cabralauthor=J.+R.+Lokensgardauthor=P.+K.+Peterson&title=Synthetic+cannabinoid+WIN55%2C212%E2%80%932+inhibits+generation+of+inflammatory+mediators+by+IL-1beta-stimulated+human+astrocytes&doi=10.1002%2Fglia.20108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fglia.20108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20108%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DW.%2BS.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DCabral%26aufirst%3DG.%2BA.%26aulast%3DLokensgard%26aufirst%3DJ.%2BR.%26aulast%3DPeterson%26aufirst%3DP.%2BK.%26atitle%3DSynthetic%2520cannabinoid%2520WIN55%252C212%25E2%2580%25932%2520inhibits%2520generation%2520of%2520inflammatory%2520mediators%2520by%2520IL-1beta-stimulated%2520human%2520astrocytes%26jtitle%3DGlia%26date%3D2005%26volume%3D49%26spage%3D211%26epage%3D219%26doi%3D10.1002%2Fglia.20108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ehrhart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obregon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shytle, R. D.</span><span> </span><span class="NLM_article-title">Stimulation of cannabinoid receptor 2 (CB<sub>2</sub>) suppresses microglial activation</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="refDoi"> DOI: 10.1186/1742-2094-2-29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1186%2F1742-2094-2-29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=16343349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FlvFWnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=29&author=J.+Ehrhartauthor=D.+Obregonauthor=T.+Moriauthor=H.+Houauthor=N.+Sunauthor=Y.+Baiauthor=T.+Kleinauthor=F.+Fernandezauthor=J.+Tanauthor=R.+D.+Shytle&title=Stimulation+of+cannabinoid+receptor+2+%28CB2%29+suppresses+microglial+activation&doi=10.1186%2F1742-2094-2-29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation</span></div><div class="casAuthors">Ehrhart Jared; Obregon Demian; Mori Takashi; Hou Huayan; Sun Nan; Bai Yun; Klein Thomas; Fernandez Francisco; Tan Jun; Shytle R Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Activated microglial cells have been implicated in a number of neurodegenerative disorders, including Alzheimer's disease (AD), multiple sclerosis (MS), and HIV dementia.  It is well known that inflammatory mediators such as nitric oxide (NO), cytokines, and chemokines play an important role in microglial cell-associated neuron cell damage.  Our previous studies have shown that CD40 signaling is involved in pathological activation of microglial cells.  Many data reveal that cannabinoids mediate suppression of inflammation in vitro and in vivo through stimulation of cannabinoid receptor 2 (CB2).  METHODS:  In this study, we investigated the effects of a cannabinoid agonist on CD40 expression and function by cultured microglial cells activated by IFN-gamma using RT-PCR, Western immunoblotting, flow cytometry, and anti-CB2 small interfering RNA (siRNA) analyses.  Furthermore, we examined if the stimulation of CB2 could modulate the capacity of microglial cells to phagocytise Abeta1-42 peptide using a phagocytosis assay.  RESULTS:  We found that the selective stimulation of cannabinoid receptor CB2 by JWH-015 suppressed IFN-gamma-induced CD40 expression.  In addition, this CB2 agonist markedly inhibited IFN-gamma-induced phosphorylation of JAK/STAT1.  Further, this stimulation was also able to suppress microglial TNF-alpha and nitric oxide production induced either by IFN-gamma or Abeta peptide challenge in the presence of CD40 ligation.  Finally, we showed that CB2 activation by JWH-015 markedly attenuated CD40-mediated inhibition of microglial phagocytosis of Abeta1-42 peptide.  Taken together, these results provide mechanistic insight into beneficial effects provided by cannabinoid receptor CB2 modulation in neurodegenerative diseases, particularly AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwpZCNS5cmhmhHGZei4OW9fW6udTcc2eYepIbmhep1uLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FlvFWnsA%253D%253D&md5=516f5264a60d5aa11675107dbd0e8879</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-2-29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-2-29%26sid%3Dliteratum%253Aachs%26aulast%3DEhrhart%26aufirst%3DJ.%26aulast%3DObregon%26aufirst%3DD.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DN.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DKlein%26aufirst%3DT.%26aulast%3DFernandez%26aufirst%3DF.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DShytle%26aufirst%3DR.%2BD.%26atitle%3DStimulation%2520of%2520cannabinoid%2520receptor%25202%2520%2528CB2%2529%2520suppresses%2520microglial%2520activation%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2005%26volume%3D2%26spage%3D29%26doi%3D10.1186%2F1742-2094-2-29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naguib, M.</span><span> </span><span class="NLM_article-title">Activation of the CB<sub>2</sub> receptor system reverses amyloid-induced memory deficiency</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span><span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2012.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.neurobiolaging.2012.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=22795792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVektLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=791-804&author=J.+Wuauthor=B.+Bieauthor=H.+Yangauthor=J.+J.+Xuauthor=D.+L.+Brownauthor=M.+Naguib&title=Activation+of+the+CB2+receptor+system+reverses+amyloid-induced+memory+deficiency&doi=10.1016%2Fj.neurobiolaging.2012.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the CB2 receptor system reverses amyloid-induced memory deficiency</span></div><div class="casAuthors">Wu, Jiang; Bie, Bihua; Yang, Hui; Xu, Jijun J.; Brown, David L.; Naguib, Mohamed</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">791-804</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Cannabinoid type 2 (CB2) agonists are neuroprotective and appear to play modulatory roles in neurodegenerative processes in Alzheimer's disease.  We have studied the effect of 1-((3-benzyl-3-methyl-2,3-dihydro-1-benzofuran-6-yl) carbonyl) piperidine (MDA7)-a novel selective CB2 agonist that lacks psychoactivity-on ameliorating the neuroinflammatory process, synaptic dysfunction, and cognitive impairment induced by bilateral microinjection of amyloid-β (Aβ)1-40 fibrils into the hippocampal CA1 area of rats.  In rats injected with Aβ1-40 fibrils, compared with the administration of i.p. saline for 14 days, treatment with 15 mg/kg of i.p. MDA7 daily for 14 days (1) ameliorated the expression of CD11b (microglia marker) and glial fibrillary acidic protein (astrocyte marker), (2) decreased the secretion of interleukin-1β, (3) decreased the upsurge of CB2 receptors, (4) promoted Aβ clearance, and (5) restored synaptic plasticity, cognition, and memory.  Our findings suggest that MDA7 is an innovative therapeutic approach for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqekBBhIM0ej7Vg90H21EOLACvtfcHk0ljpBRdaeDbEbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVektLnO&md5=ee0c45a830bc6f4d2236ccfcee75b2ad</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DBie%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DJ.%2BJ.%26aulast%3DBrown%26aufirst%3DD.%2BL.%26aulast%3DNaguib%26aufirst%3DM.%26atitle%3DActivation%2520of%2520the%2520CB2%2520receptor%2520system%2520reverses%2520amyloid-induced%2520memory%2520deficiency%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D791%26epage%3D804%26doi%3D10.1016%2Fj.neurobiolaging.2012.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Martin-Moreno, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brera, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spuch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Garcia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innamorato, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuadrado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Ceballos, M. L.</span><span> </span><span class="NLM_article-title">Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1186/1742-2094-9-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1186%2F1742-2094-9-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=22248049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC38XksFGnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=8-12&author=A.+M.+Martin-Morenoauthor=B.+Breraauthor=C.+Spuchauthor=E.+Carroauthor=L.+Garcia-Garciaauthor=M.+Delgadoauthor=M.+A.+Pozoauthor=N.+G.+Innamoratoauthor=A.+Cuadradoauthor=M.+L.+de+Ceballos&title=Prolonged+oral+cannabinoid+administration+prevents+neuroinflammation%2C+lowers+%CE%B2-amyloid+levels+and+improves+cognitive+performance+in+Tg+APP+2576+mice&doi=10.1186%2F1742-2094-9-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice</span></div><div class="casAuthors">Martin-Moreno, Ana Maria; Brera, Begona; Spuch, Carlos; Carro, Eva; Garcia-Garcia, Luis; Delgado, Mercedes; Pozo, Miguel A.; Innamorato, Nadia G.; Cuadrado, Antonio; de Ceballos, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease (AD) brain shows an ongoing inflammatory condition and non-steroidal anti-inflammatories diminish the risk of suffering the neurol. disease.  Cannabinoids are neuroprotective and anti-inflammatory agents with therapeutic potential.  Methods: We have studied the effects of prolonged oral administration of transgenic amyloid precursor protein (APP) mice with two pharmacol. different cannabinoids (WIN 55,212-2 and JWH-133, 0.2 mg/kg/day in the drinking water during 4 mo) on inflammatory and cognitive parameters, and on 18F-fluoro-deoxyglucose (18FDG) uptake by positron emission tomog. (PET).  Results: Novel object recognition was significantly reduced in 11 mo old Tg APP mice and 4 mo administration of JWH was able to normalize this cognitive deficit, although WIN was ineffective.  Wild type mice cognitive performance was unaltered by cannabinoid administration.  Tg APP mice showed decreased 18FDG uptake in hippocampus and cortical regions, which was counteracted by oral JWH treatment.  Hippocampal GFAP immunoreactivity and cortical protein expression was unaffected by genotype or treatment.  In contrast, the d. of Iba1 pos. microglia was increased in Tg APP mice, and normalized following JWH chronic treatment.  Both cannabinoids were effective at reducing the enhancement of COX-2 protein levels and TNF-α mRNA expression found in the AD model.  Increased cortical β-amyloid (Aβ) levels were significantly reduced in the mouse model by both cannabinoids.  Noteworthy both cannabinoids enhanced Aβ transport across choroid plexus cells in vitro.  Conclusions: In summary we have shown that chronically administered cannabinoid showed marked beneficial effects concomitant with inflammation redn. and increased Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovz80RwKqgHbVg90H21EOLACvtfcHk0ljen9r18qVlhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksFGnt7k%253D&md5=f180a238cf921e7e18b87a9804219be1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-9-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-9-8%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Moreno%26aufirst%3DA.%2BM.%26aulast%3DBrera%26aufirst%3DB.%26aulast%3DSpuch%26aufirst%3DC.%26aulast%3DCarro%26aufirst%3DE.%26aulast%3DGarcia-Garcia%26aufirst%3DL.%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DPozo%26aufirst%3DM.%2BA.%26aulast%3DInnamorato%26aufirst%3DN.%2BG.%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3Dde%2BCeballos%26aufirst%3DM.%2BL.%26atitle%3DProlonged%2520oral%2520cannabinoid%2520administration%2520prevents%2520neuroinflammation%252C%2520lowers%2520%25CE%25B2-amyloid%2520levels%2520and%2520improves%2520cognitive%2520performance%2520in%2520Tg%2520APP%25202576%2520mice%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2012%26volume%3D9%26spage%3D8%26epage%3D12%26doi%3D10.1186%2F1742-2094-9-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Koppel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vingtdeux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marambaud, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">d’Abramo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span> </span><span class="NLM_article-title">CB<sub>2</sub> receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=357-364&author=J.+Koppelauthor=V.+Vingtdeuxauthor=P.+Marambaudauthor=C.+d%E2%80%99Abramoauthor=H.+Jimenezauthor=M.+Stauberauthor=R.+Friedmanauthor=P.+Davies&title=CB2+receptor+deficiency+increases+amyloid+pathology+and+alters+tau+processing+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoppel%26aufirst%3DJ.%26aulast%3DVingtdeux%26aufirst%3DV.%26aulast%3DMarambaud%26aufirst%3DP.%26aulast%3Dd%25E2%2580%2599Abramo%26aufirst%3DC.%26aulast%3DJimenez%26aufirst%3DH.%26aulast%3DStauber%26aufirst%3DM.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DDavies%26aufirst%3DP.%26atitle%3DCB2%2520receptor%2520deficiency%2520increases%2520amyloid%2520pathology%2520and%2520alters%2520tau%2520processing%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Med.%26date%3D2014%26volume%3D19%26spage%3D357%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span> </span><span class="NLM_article-title">Type-2 cannabinoid receptors in neurodegeneration</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1016/j.phrs.2016.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.phrs.2016.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=27450295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWnsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=721-730&author=T.+Bisognoauthor=S.+Oddiauthor=A.+Piccoliauthor=D.+Fazioauthor=M.+Maccarrone&title=Type-2+cannabinoid+receptors+in+neurodegeneration&doi=10.1016%2Fj.phrs.2016.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Type-2 cannabinoid receptors in neurodegeneration</span></div><div class="casAuthors">Bisogno, Tiziana; Oddi, Sergio; Piccoli, Alessandra; Fazio, Domenico; Maccarrone, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">721-730</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Based on its wide expression in immune cells, type-2 cannabinoid (CB2) receptors were traditionally thought to act as "peripheral receptors" with an almost exclusively immunomodulatory function.  However, their recent identification in mammalian brain areas, as well as in distinct neuronal cells, has opened the way to a re-consideration of CB2 signaling in the context of brain pathophysiol., synaptic plasticity and neuroprotection.  To date, accumulated evidence from several independent preclin. studies has offered new perspectives on the possible involvement of CB2 signaling in brain and spinal cord traumatic injury, as well as in the most relevant neurodegenerative disorders like Alzheimer's disease, Parkinson's disease and Huntington's chorea.  Here, we will review available information on CB2 in these disease conditions, along with data that support also its therapeutic potential to treat them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDLv1Yh2dX27Vg90H21EOLACvtfcHk0ljen9r18qVlhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWnsr7F&md5=b880502073163ef08a7af918544a7dd1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2016.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2016.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DOddi%26aufirst%3DS.%26aulast%3DPiccoli%26aufirst%3DA.%26aulast%3DFazio%26aufirst%3DD.%26aulast%3DMaccarrone%26aufirst%3DM.%26atitle%3DType-2%2520cannabinoid%2520receptors%2520in%2520neurodegeneration%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D111%26spage%3D721%26epage%3D730%26doi%3D10.1016%2Fj.phrs.2016.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A. J.</span><span> </span><span class="NLM_article-title">Selective loss of central cholinergic neurons in Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span><span class="refDoi"> DOI: 10.1016/S0140-6736(76)91936-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS0140-6736%2876%2991936-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=1976&pages=1403&author=P.+Daviesauthor=A.+J.+Maloney&title=Selective+loss+of+central+cholinergic+neurons+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2876%2991936-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2876%2991936-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252876%252991936-X%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMaloney%26aufirst%3DA.%2BJ.%26atitle%3DSelective%2520loss%2520of%2520central%2520cholinergic%2520neurons%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D1976%26volume%3D308%26spage%3D1403%26doi%3D10.1016%2FS0140-6736%2876%2991936-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Nordberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darreh-Shori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somogyi, M.</span><span> </span><span class="NLM_article-title">A Review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Prim. Care Companion CNS Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="refDoi"> DOI: 10.4088/PCC.12r01412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.4088%2FPCC.12r01412" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=2&author=A.+Nordbergauthor=C.+Ballardauthor=R.+Bullockauthor=T.+Darreh-Shoriauthor=M.+Somogyi&title=A+Review+of+butyrylcholinesterase+as+a+therapeutic+target+in+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.4088%2FPCC.12r01412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4088%2FPCC.12r01412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FPCC.12r01412%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26aulast%3DBallard%26aufirst%3DC.%26aulast%3DBullock%26aufirst%3DR.%26aulast%3DDarreh-Shori%26aufirst%3DT.%26aulast%3DSomogyi%26aufirst%3DM.%26atitle%3DA%2520Review%2520of%2520butyrylcholinesterase%2520as%2520a%2520therapeutic%2520target%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPrim.%2520Care%2520Companion%2520CNS%2520Disord.%26date%3D2013%26volume%3D15%26spage%3D2%26doi%3D10.4088%2FPCC.12r01412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Darvesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span> </span><span class="NLM_article-title">Neurobiology of butyrylcholinesterase</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1038/nrn1035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnrn1035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=12563284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=131-138&author=S.+Darveshauthor=D.+A.+Hopkinsauthor=C.+Geula&title=Neurobiology+of+butyrylcholinesterase&doi=10.1038%2Fnrn1035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Neurobiology of butyrylcholinesterase</span></div><div class="casAuthors">Darvesh, Sultan; Hopkins, David A.; Geula, Changiz</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-138</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Butyrylcholinesterase is a serine hydrolase related to acetylcholinesterase that catalyzes the hydrolysis of esters of choline, including acetylcholine.  Butyrylcholinesterase has unique enzymic properties and is widely distributed in the nervous system, pointing to its possible involvement in neural function.  Here, we summarize the biochem. properties of butyrylcholinesterase and review the evidence that this enzyme has important roles in cholinergic neurotransmission and could be involved in other nervous system functions and in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf8WbhaQUqP7Vg90H21EOLACvtfcHk0lgV2vxq3egLlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12hsg%253D%253D&md5=aeb5008a2c61e5feb48506f835899519</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrn1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1035%26sid%3Dliteratum%253Aachs%26aulast%3DDarvesh%26aufirst%3DS.%26aulast%3DHopkins%26aufirst%3DD.%2BA.%26aulast%3DGeula%26aufirst%3DC.%26atitle%3DNeurobiology%2520of%2520butyrylcholinesterase%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D4%26spage%3D131%26epage%3D138%26doi%3D10.1038%2Fnrn1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Mesulam, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span> </span><span class="NLM_article-title">Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">722</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.1002/ana.410360506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fana.410360506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=7979218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADyaK2M%252FmvF2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1994&pages=722-727&author=M.+M.+Mesulamauthor=C.+Geula&title=Butyrylcholinesterase+reactivity+differentiates+the+amyloid+plaques+of+aging+from+those+of+dementia&doi=10.1002%2Fana.410360506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia</span></div><div class="casAuthors">Mesulam M M; Geula C</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">722-7</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">In a sample of consecutively received, 4 demented and 4 age-matched nondemented brains, the total cortical area covered by plaque-like A beta amyloid and butyrylcholinesterase deposits was measured at two regions of the temporal cortex with the help of computed densitometry.  Demented as well as age-matched nondemented brains contained A beta and butyrylcholinesterase-positive plaques.  The total cortical area covered by the A beta precipitates was higher in demented individuals but there was overlap with the values seen in the specimens from nondemented individuals.  The proportional plaque area displaying butyrylcholinesterase reactivity was very significantly and five fold to sixfold higher in the demented than in the nondemented group and there was no overlap between the two populations.  Diffuse A beta deposits in nondemented elderly brains may represent a benign or preclinical stage of plaque deposition with relatively little pathological effect on brain tissue and mental function.  Our results suggest that the progressively more extensive butyrylcholinesterase reactivity of plaques may participate in their transformation from a relatively benign form to pathogenic structures associated with neuritic degeneration and dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIhMoEIAbG5O-MdeMhXAHkfW6udTcc2eYsRtMs39RW_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FmvF2gug%253D%253D&md5=85364c013028b9b0ccf028555d62c305</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fana.410360506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410360506%26sid%3Dliteratum%253Aachs%26aulast%3DMesulam%26aufirst%3DM.%2BM.%26aulast%3DGeula%26aufirst%3DC.%26atitle%3DButyrylcholinesterase%2520reactivity%2520differentiates%2520the%2520amyloid%2520plaques%2520of%2520aging%2520from%2520those%2520of%2520dementia%26jtitle%3DAnn.%2520Neurol.%26date%3D1994%26volume%3D36%26spage%3D722%26epage%3D727%26doi%3D10.1002%2Fana.410360506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Guillozet, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiley, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mash, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesulam, M. M.</span><span> </span><span class="NLM_article-title">Butyrylcholinesterase in the life cycle of amyloid plaques</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span><span class="refDoi"> DOI: 10.1002/ana.410420613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fana.410420613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=9403484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADyaK1c%252FmsFOnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1997&pages=909-918&author=A.+L.+Guillozetauthor=J.+F.+Smileyauthor=D.+C.+Mashauthor=M.+M.+Mesulam&title=Butyrylcholinesterase+in+the+life+cycle+of+amyloid+plaques&doi=10.1002%2Fana.410420613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase in the life cycle of amyloid plaques</span></div><div class="casAuthors">Guillozet A L; Smiley J F; Mash D C; Mesulam M M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">909-18</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">Deposits of diffuse beta-amyloid (Abeta) may exist in the brain for many years before leading to neuritic degeneration and dementia.  The factors that contribute to the putative transformation of the Abeta amyloid from a relatively inert to a pathogenic state remain unknown and may involve interactions with additional plaque constituents.  Matching brain sections from 2 demented and 4 nondemented subjects were processed for the demonstration of Abeta immunoreactivity, butyrylcholinesterase (BChE) enzyme activity, and thioflavine S binding.  Additional sections were processed for the concurrent demonstration of two or three of these markers.  A comparative analysis of multiple cytoarchitectonic areas processed with each of these markers indicated that Abeta plaque deposits are likely to undergo three stages of maturation, ie, a "diffuse" thioflavine S-negative stage, a thioflavine S-positive (ie, compact) but nonneuritic stage, and a compact neuritic stage.  A multiregional analysis showed that BChE-positive plaques were not found in cytoarchitectonic areas or cortical layers that contained only the thioflavine S-negative, diffuse type of Abeta plaques.  The BChE-positive plaques were found only in areas containing thioflavine S-positive compact plaques, both neuritic and nonneuritic.  Within such areas, almost all (>98%) BChE-containing plaques bound thioflavine S, and almost all (93%) thioflavine S plaques contained BChE.  These results suggest that BChE becomes associated with amyloid plaques at approximately the same time that the Abeta deposit assumes a compact beta-pleated conformation.  BChE may therefore participate in the transformation of Abeta from an initially benign form to an eventually malignant form associated with neuritic tissue degeneration and clinical dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2szOfqK4uRcvLc4ARHEmzfW6udTcc2eYsRtMs39RW_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c%252FmsFOnsA%253D%253D&md5=fc12e41d78b02a2fc06a65bd612aa13f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fana.410420613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410420613%26sid%3Dliteratum%253Aachs%26aulast%3DGuillozet%26aufirst%3DA.%2BL.%26aulast%3DSmiley%26aufirst%3DJ.%2BF.%26aulast%3DMash%26aufirst%3DD.%2BC.%26aulast%3DMesulam%26aufirst%3DM.%2BM.%26atitle%3DButyrylcholinesterase%2520in%2520the%2520life%2520cycle%2520of%2520amyloid%2520plaques%26jtitle%3DAnn.%2520Neurol.%26date%3D1997%26volume%3D42%26spage%3D909%26epage%3D918%26doi%3D10.1002%2Fana.410420613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Greig, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepeu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamczarz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambamurti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, D. K.</span><span> </span><span class="NLM_article-title">Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">17213</span><span class="NLM_x">–</span> <span class="NLM_lpage">17218</span><span class="refDoi"> DOI: 10.1073/pnas.0508575102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1073%2Fpnas.0508575102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=16275899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yksLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17213-17218&author=N.+H.+Greigauthor=T.+Utsukiauthor=D.+K.+Ingramauthor=Y.+Wangauthor=G.+Pepeuauthor=C.+Scaliauthor=Q.-S.+Yuauthor=J.+Mamczarzauthor=H.+W.+Hollowayauthor=T.+Giordanoauthor=D.+Chenauthor=K.+Furukawaauthor=K.+Sambamurtiauthor=A.+Brossiauthor=D.+K.+Lahiri&title=Selective+butyrylcholinesterase+inhibition+elevates+brain+acetylcholine%2C+augments+learning+and+lowers+Alzheimer+%CE%B2-amyloid+peptide+in+rodent&doi=10.1073%2Fpnas.0508575102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent</span></div><div class="casAuthors">Greig, Nigel H.; Utsuki, Tadanobu; Ingram, Donald K.; Wang, Yue; Pepeu, Giancarlo; Scali, Carla; Yu, Qian-Sheng; Mamczarz, Jacek; Holloway, Harold W.; Giordano, Tony; Chen, DeMao; Furukawa, Katsutoshi; Sambamurti, Kumar; Brossi, Arnold; Lahiri, Debomoy K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">17213-17218</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Like acetylcholinesterase, butyrylcholinesterase (BChE) inactivates the neurotransmitter acetylcholine (ACh) and is hence a viable therapeutic target in Alzheimer's disease, which is characterized by a cholinergic deficit.  Potent, reversible, and brain-targeted BChE inhibitors (cymserine analogs) were developed based on binding domain structures to help elucidate the role of this enzyme in the central nervous system.  In rats, cymserine analogs caused long-term inhibition of brain BChE and elevated extracellular ACh levels, without inhibitory effects on acetylcholinesterase.  In rat brain slices, selective BChE inhibition augmented long-term potentiation.  These compds. also improved the cognitive performance (maze navigation) of aged rats.  In cultured human SK-N-SH neuroblastoma cells, intra- and extracellular β-amyloid precursor protein, and secreted β-amyloid peptide levels were reduced without affecting cell viability.  Treatment of transgenic mice that overexpressed human mutant amyloid precursor protein also resulted in lower β-amyloid peptide brain levels than controls.  Selective, reversible inhibition of brain BChE may represent a treatment for Alzheimer's disease, improving cognition and modulating neuropathol. markers of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI6ACIUUc5wrVg90H21EOLACvtfcHk0lgcecvhbQ0AwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yksLfE&md5=a4ac89f6186f77125545c667f9efbe21</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0508575102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0508575102%26sid%3Dliteratum%253Aachs%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DUtsuki%26aufirst%3DT.%26aulast%3DIngram%26aufirst%3DD.%2BK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DQ.-S.%26aulast%3DMamczarz%26aufirst%3DJ.%26aulast%3DHolloway%26aufirst%3DH.%2BW.%26aulast%3DGiordano%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DSambamurti%26aufirst%3DK.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DLahiri%26aufirst%3DD.%2BK.%26atitle%3DSelective%2520butyrylcholinesterase%2520inhibition%2520elevates%2520brain%2520acetylcholine%252C%2520augments%2520learning%2520and%2520lowers%2520Alzheimer%2520%25CE%25B2-amyloid%2520peptide%2520in%2520rodent%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D17213%26epage%3D17218%26doi%3D10.1073%2Fpnas.0508575102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span> </span><span class="NLM_article-title">Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.ejmech.2017.03.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=28371641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1Kgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2017&pages=294-309&author=Q.+Liauthor=H.+Yangauthor=Y.+Chenauthor=H.+Sun&title=Recent+progress+in+the+identification+of+selective+butyrylcholinesterase+inhibitors+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2017.03.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Li, Qi; Yang, Hongyu; Chen, Yao; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">294-309</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders with notable factor of dysfunction in cholinergic system.  Low ACh level can be obsd. in the pathogenesis of AD.  Several AChE inhibitors have already been used for clin. treatments.  However, other than normal conditions, ACh is mostly hydrolyzed by BuChE in progressed AD.  Account for an increased level of BuChE and decreased level of AChE in the late stage of AD, development of selective BuChE inhibitor is of vital importance.  Up till now, compds. with various scaffolds have been discovered to selectively inhibit BuChE.  Different effective anti-BuChE mols. are concluded in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDt6Tt3Xrt4rVg90H21EOLACvtfcHk0lgcecvhbQ0AwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1Kgs78%253D&md5=75d8199f06da3d1b2b27d43510067720</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.062%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DRecent%2520progress%2520in%2520the%2520identification%2520of%2520selective%2520butyrylcholinesterase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D132%26spage%3D294%26epage%3D309%26doi%3D10.1016%2Fj.ejmech.2017.03.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sawatzky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bringmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Discovery of highly selective and nanomolar carbamate-based butyrylcholinesterase inhibitors by rational investigation into their inhibition mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2067</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01674</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01674" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis1Gks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2067-2082&author=E.+Sawatzkyauthor=S.+Wehleauthor=B.+Klingauthor=J.+Wendrichauthor=G.+Bringmannauthor=C.+A.+Sotrifferauthor=J.+Heilmannauthor=M.+Decker&title=Discovery+of+highly+selective+and+nanomolar+carbamate-based+butyrylcholinesterase+inhibitors+by+rational+investigation+into+their+inhibition+mode&doi=10.1021%2Facs.jmedchem.5b01674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27cR"><div class="casContent"><span class="casTitleNuber">27c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode</span></div><div class="casAuthors">Sawatzky, Edgar; Wehle, Sarah; Kling, Beata; Wendrich, Jan; Bringmann, Gerhard; Sotriffer, Christoph A.; Heilmann, Joerg; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2067-2082</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Butyrylcholinesterase (BChE) is a promising target for the treatment of later stage cognitive decline in Alzheimer's disease.  A set of pseudo-irreversible BChE inhibitors with high selectivity over hAChE was synthesized based on carbamates attached to tetrahydroquinazoline scaffolds with the 2-thiophenyl compd. I (R = n-heptyl) as the most potent inhibitor of eqBChE (KC = 14.3 nM) and also of hBChE (KC = 19.7 nM).  The inhibitors transfer the carbamate moiety onto the active site under release of the phenolic tetrahydroquinazoline scaffolds that themselves act as neuroprotectants.  By combination of kinetic data with mol. docking studies, a plausible binding model was probed describing how the tetrahydroquinazoline scaffold guides the carbamate into a close position to the active site.  The model explains the influence of the carrier scaffold onto the affinity of an inhibitor just before carbamate transfer.  This strategy can be used to utilize the binding mode of other carbamate-based inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrU8IRPStxUbVg90H21EOLACvtfcHk0lgAqU8g2cgPrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis1Gks7Y%253D&md5=3498d21d7e134df2ad55505fdc22c313</span></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01674%26sid%3Dliteratum%253Aachs%26aulast%3DSawatzky%26aufirst%3DE.%26aulast%3DWehle%26aufirst%3DS.%26aulast%3DKling%26aufirst%3DB.%26aulast%3DWendrich%26aufirst%3DJ.%26aulast%3DBringmann%26aufirst%3DG.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DHeilmann%26aufirst%3DJ.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520highly%2520selective%2520and%2520nanomolar%2520carbamate-based%2520butyrylcholinesterase%2520inhibitors%2520by%2520rational%2520investigation%2520into%2520their%2520inhibition%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2067%26epage%3D2082%26doi%3D10.1021%2Facs.jmedchem.5b01674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strehaiano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siméon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatonnet, A.</span><span> </span><span class="NLM_article-title">Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/j.bbr.2015.08.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bbr.2015.08.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=26306824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVOqt7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2016&pages=351-360&author=T.+Mauriceauthor=M.+Strehaianoauthor=N.+Sim%C3%A9onauthor=C.+Bertrandauthor=A.+Chatonnet&title=Learning+performances+and+vulnerability+to+amyloid+toxicity+in+the+butyrylcholinesterase+knockout+mouse&doi=10.1016%2Fj.bbr.2015.08.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse</span></div><div class="casAuthors">Maurice, Tangui; Strehaiano, Manon; Simeon, Nathalie; Bertrand, Christelle; Chatonnet, Arnaud</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">351-360</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Butyrylcholinesterase (BChE) is an important enzyme for detoxication and metab. of ester compds.  It also hydrolyzes the neurotransmitter acetylcholine (ACh) in pathol. conditions and may play a role in Alzheimer's disease (AD).  We here compared the learning ability and vulnerability to Aβ toxicity in male and female BChE knockout (KO) mice and their 129 Sv wild-type (Wt) controls.  Animals tested for place learning in the water-maze showed increased acquisition slopes and presence in the training quadrant during the probe test.  An increased passive avoidance response was also obsd. for males.  BChE KO mice therefore showed enhanced learning ability in spatial and non-spatial memory tests.  Intracerebroventricular (ICV) injection of increasing doses of amyloid-β[25-35] (Aβ25-35) peptide oligomers resulted, in Wt mice, in learning and memory deficits, oxidative stress and decrease in ACh hippocampal content.  In BChE KO mice, the Aβ25-35-induced deficit in place learning was attenuated in males and blocked in females.  No change in lipid peroxidn. or ACh levels was obsd. after Aβ25-35 treatment in male or female BChE KO mice.  These data showed that the genetic invalidation of BChE in mice augmented learning capacities and lowered the vulnerability to Aβ toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV3M4M6LenzrVg90H21EOLACvtfcHk0lgAqU8g2cgPrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOqt7bP&md5=1b8f7885ee358acacce167f61ea2599c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2015.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2015.08.026%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DStrehaiano%26aufirst%3DM.%26aulast%3DSim%25C3%25A9on%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DC.%26aulast%3DChatonnet%26aufirst%3DA.%26atitle%3DLearning%2520performances%2520and%2520vulnerability%2520to%2520amyloid%2520toxicity%2520in%2520the%2520butyrylcholinesterase%2520knockout%2520mouse%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D296%26spage%3D351%26epage%3D360%26doi%3D10.1016%2Fj.bbr.2015.08.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kosak, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakelj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trontelj, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pislar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slenc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zivin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tratnjek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podkowa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nachon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazzolotto, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieckowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malawska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mlinaric Rascan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coquelle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletier, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span> </span><span class="NLM_article-title">Development of an <i>in-vivo</i> active reversible butyrylcholinesterase inhibitor</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">39495</span><span class="NLM_x">–</span> <span class="NLM_lpage">39510</span><span class="refDoi"> DOI: 10.1038/srep39495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fsrep39495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=28000737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGju7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=39495-39510&author=U.+Kosakauthor=B.+Brusauthor=D.+Knezauthor=R.+Sinkauthor=S.+Zakeljauthor=J.+Tronteljauthor=A.+Pislarauthor=J.+Slencauthor=M.+Gobecauthor=M.+Zivinauthor=L.+Tratnjekauthor=M.+Perseauthor=K.+Salatauthor=A.+Podkowaauthor=B.+Filipekauthor=F.+Nachonauthor=X.+Brazzolottoauthor=A.+Wieckowskaauthor=B.+Malawskaauthor=J.+Stojanauthor=I.+Mlinaric+Rascanauthor=J.+Kosauthor=N.+Coquelleauthor=J.-P.+Colletierauthor=S.+Gobec&title=Development+of+an+in-vivo+active+reversible+butyrylcholinesterase+inhibitor&doi=10.1038%2Fsrep39495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Development of an in-vivo active reversible butyrylcholinesterase inhibitor</span></div><div class="casAuthors">Kosak, Urban; Brus, Boris; Knez, Damijan; Sink, Roman; Zakelj, Simon; Trontelj, Jurij; Pislar, Anja; Slenc, Jasna; Gobec, Martina; Zivin, Marko; Tratnjek, Larisa; Perse, Martina; Salat, Kinga; Podkowa, Adrian; Filipek, Barbara; Nachon, Florian; Brazzolotto, Xavier; Wieckowska, Anna; Malawska, Barbara; Stojan, Jure; Rascan, Irena Mlinaric; Kos, Janko; Coquelle, Nicolas; Colletier, Jacques-Philippe; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39495</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by severe basal forebrain cholinergic deficit, which results in progressive and chronic deterioration of memory and cognitive functions.  Similar to acetylcholinesterase, butyrylcholinesterase (BChE) contributes to the termination of cholinergic neurotransmission.  Its enzymic activity increases with the disease progression, thus classifying BChE as a viable therapeutic target in advanced AD.  Potent, selective and reversible human BChE inhibitors were developed.  The solved crystal structure of human BChE in complex with the most potent inhibitor reveals its binding mode and provides the mol. basis of its low nanomolar potency.  Addnl., this compd. is noncytotoxic and has neuroprotective properties.  Furthermore, this inhibitor moderately crosses the blood-brain barrier and improves memory, cognitive functions and learning abilities of mice in a model of the cholinergic deficit that characterizes AD, without producing acute cholinergic adverse effects.  Our study provides an advanced lead compd. for developing drugs for alleviating symptoms caused by cholinergic hypofunction in advanced AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0VM7BEyEMGbVg90H21EOLACvtfcHk0lgAqU8g2cgPrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGju7nJ&md5=fdec90109df9052d9b7340e45c7e7feb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep39495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep39495%26sid%3Dliteratum%253Aachs%26aulast%3DKosak%26aufirst%3DU.%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DKnez%26aufirst%3DD.%26aulast%3DSink%26aufirst%3DR.%26aulast%3DZakelj%26aufirst%3DS.%26aulast%3DTrontelj%26aufirst%3DJ.%26aulast%3DPislar%26aufirst%3DA.%26aulast%3DSlenc%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DZivin%26aufirst%3DM.%26aulast%3DTratnjek%26aufirst%3DL.%26aulast%3DPerse%26aufirst%3DM.%26aulast%3DSalat%26aufirst%3DK.%26aulast%3DPodkowa%26aufirst%3DA.%26aulast%3DFilipek%26aufirst%3DB.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DBrazzolotto%26aufirst%3DX.%26aulast%3DWieckowska%26aufirst%3DA.%26aulast%3DMalawska%26aufirst%3DB.%26aulast%3DStojan%26aufirst%3DJ.%26aulast%3DMlinaric%2BRascan%26aufirst%3DI.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DCoquelle%26aufirst%3DN.%26aulast%3DColletier%26aufirst%3DJ.-P.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520an%2520in-vivo%2520active%2520reversible%2520butyrylcholinesterase%2520inhibitor%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D39495%26epage%3D39510%26doi%3D10.1038%2Fsrep39495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Darvesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span> </span><span class="NLM_article-title">Neurobiology of butyrylcholinesterase</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1038/nrn1035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnrn1035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=12563284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=131-138&author=S.+Darveshauthor=D.+A.+Hopkinsauthor=C.+Geula&title=Neurobiology+of+butyrylcholinesterase&doi=10.1038%2Fnrn1035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Neurobiology of butyrylcholinesterase</span></div><div class="casAuthors">Darvesh, Sultan; Hopkins, David A.; Geula, Changiz</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-138</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Butyrylcholinesterase is a serine hydrolase related to acetylcholinesterase that catalyzes the hydrolysis of esters of choline, including acetylcholine.  Butyrylcholinesterase has unique enzymic properties and is widely distributed in the nervous system, pointing to its possible involvement in neural function.  Here, we summarize the biochem. properties of butyrylcholinesterase and review the evidence that this enzyme has important roles in cholinergic neurotransmission and could be involved in other nervous system functions and in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf8WbhaQUqP7Vg90H21EOLACvtfcHk0lh7WeZ8oYSZyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12hsg%253D%253D&md5=aeb5008a2c61e5feb48506f835899519</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrn1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1035%26sid%3Dliteratum%253Aachs%26aulast%3DDarvesh%26aufirst%3DS.%26aulast%3DHopkins%26aufirst%3DD.%2BA.%26aulast%3DGeula%26aufirst%3DC.%26atitle%3DNeurobiology%2520of%2520butyrylcholinesterase%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D4%26spage%3D131%26epage%3D138%26doi%3D10.1038%2Fnrn1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Wright, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesulam, M.-M.</span><span> </span><span class="NLM_article-title">Neurological cholinesterases in the normal brain and in Alzheimer’s disease: relationship to plaques, tangles, and patterns of selective vulnerability</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span><span class="refDoi"> DOI: 10.1002/ana.410340312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fana.410340312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=8363355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADyaK3szntFSisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=373-384&author=C.+I.+Wrightauthor=C.+Geulaauthor=M.-M.+Mesulam&title=Neurological+cholinesterases+in+the+normal+brain+and+in+Alzheimer%E2%80%99s+disease%3A+relationship+to+plaques%2C+tangles%2C+and+patterns+of+selective+vulnerability&doi=10.1002%2Fana.410340312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability</span></div><div class="casAuthors">Wright C I; Geula C; Mesulam M M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-84</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">Butyrylcholinesterase (BChE) and an altered form of acetylcholinesterase (AChE) accumulate in the plaques and tangles of Alzheimer's disease (AD).  The sources for these plaque- and tangle-bound cholinesterases have not been identified.  We now report that AChE and BChE activities with pH preferences and inhibitor selectivities identical to those of plaque- and tangle-bound cholinesterases are found in the astrocytes and oligodendrocytes of control and AD brains.  These glial-type cholinesterases are selectively inhibited by indolamines and protease inhibitors.  In control brains glial-type cholinesterases appear confined to the intracellular space, whereas in patients with AD they decorate plaques and tangles as well.  In control and AD brains AChE-positive glia are distributed throughout the cortical layers and subcortical white matter, whereas BChE-positive glia reach high densities only in the deep cortical layers and white matter.  In non-AD control brains, the ratio of BChE to AChE glia was higher in entorhinal and inferotemporal cortex, two regions with a high susceptibility to the pathology of AD, than in primary somatosensory and visual cortex, two areas with a relatively lower susceptibility to the disease process.  There was no age-related differences in the density or distribution of cholinesterase-positive glia.  In comparison with age-matched control specimens, AD brains had a significantly higher density of BChE glia and a lower density of AChE glia in entorhinal and inferotemporal regions but not in the primary somatosensory or visual areas.  These results suggest that glia constitute a likely source for the cholinesterase activity of plaques and tangles and that a high ratio of BChE- to AChE-positive glia may play a permissive or causative role in the neuropathology of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPUmjxU3wJE02yPDyEFiigfW6udTcc2eZAP6D1Zt7nzLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szntFSisw%253D%253D&md5=024c8bf904699ff4a3002c4d0801ceb3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fana.410340312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410340312%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DC.%2BI.%26aulast%3DGeula%26aufirst%3DC.%26aulast%3DMesulam%26aufirst%3DM.-M.%26atitle%3DNeurological%2520cholinesterases%2520in%2520the%2520normal%2520brain%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520relationship%2520to%2520plaques%252C%2520tangles%252C%2520and%2520patterns%2520of%2520selective%2520vulnerability%26jtitle%3DAnn.%2520Neurol.%26date%3D1993%26volume%3D34%26spage%3D373%26epage%3D384%26doi%3D10.1002%2Fana.410340312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span><span class="refDoi"> DOI: 10.1021/jm058225d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm&doi=10.1021%2Fjm058225d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lh7WeZ8oYSZyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543%26doi%3D10.1021%2Fjm058225d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uliassi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena-Altamira, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesaresi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Multitarget drug design strategy: quinone–tacrine hybrids designed To block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8576</span><span class="NLM_x">–</span> <span class="NLM_lpage">8589</span><span class="refDoi"> DOI: 10.1021/jm5010804</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010804" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8576-8589&author=E.+Nepovimovaauthor=E.+Uliassiauthor=J.+Korabecnyauthor=L.+E.+Pena-Altamiraauthor=S.+Samezauthor=A.+Pesaresiauthor=G.+E.+Garciaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=C.+Bergaminiauthor=R.+Fatoauthor=D.+Lambaauthor=M.+Robertiauthor=K.+Kucaauthor=B.+Montiauthor=M.+L.+Bolognesi&title=Multitarget+drug+design+strategy%3A+quinone%E2%80%93tacrine+hybrids+designed+To+block+amyloid-%CE%B2+aggregation+and+to+exert+anticholinesterase+and+antioxidant+effects&doi=10.1021%2Fjm5010804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1021%2Fjm5010804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010804%26sid%3Dliteratum%253Aachs%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DPena-Altamira%26aufirst%3DL.%2BE.%26aulast%3DSamez%26aufirst%3DS.%26aulast%3DPesaresi%26aufirst%3DA.%26aulast%3DGarcia%26aufirst%3DG.%2BE.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBergamini%26aufirst%3DC.%26aulast%3DFato%26aufirst%3DR.%26aulast%3DLamba%26aufirst%3DD.%26aulast%3DRoberti%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DMultitarget%2520drug%2520design%2520strategy%253A%2520quinone%25E2%2580%2593tacrine%2520hybrids%2520designed%2520To%2520block%2520amyloid-%25CE%25B2%2520aggregation%2520and%2520to%2520exert%2520anticholinesterase%2520and%2520antioxidant%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8576%26epage%3D8589%26doi%3D10.1021%2Fjm5010804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolezal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babkova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondrejicek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepsova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrabinova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soukup, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muckova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span> </span><span class="NLM_article-title">Tacrine–Trolox Hybrids: A novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8985</span><span class="NLM_x">–</span> <span class="NLM_lpage">9003</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01325</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01325" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8985-9003&author=E.+Nepovimovaauthor=J.+Korabecnyauthor=R.+Dolezalauthor=K.+Babkovaauthor=A.+Ondrejicekauthor=D.+Junauthor=V.+Sepsovaauthor=A.+Horovaauthor=M.+Hrabinovaauthor=O.+Soukupauthor=N.+Bukumauthor=P.+Jostauthor=L.+Muckovaauthor=J.+Kassaauthor=D.+Malinakauthor=M.+Andrsauthor=K.+Kuca&title=Tacrine%E2%80%93Trolox+Hybrids%3A+A+novel+class+of+centrally+active%2C+nonhepatotoxic+multi-target-directed+ligands+exerting+anticholinesterase+and+antioxidant+activities+with+low+in+vivo+toxicity&doi=10.1021%2Facs.jmedchem.5b01325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span></div><div class="casAuthors">Nepovimova, Eugenie; Korabecny, Jan; Dolezal, Rafael; Babkova, Katerina; Ondrejicek, Ales; Jun, Daniel; Sepsova, Vendula; Horova, Anna; Hrabinova, Martina; Soukup, Ondrej; Bukum, Neslihan; Jost, Petr; Muckova, Lubica; Kassa, Jiri; Malinak, David; Andrs, Martin; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8985-9003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coupling of two distinct pharmacophores, tacrine and trolox, endowed with different biol. properties, afforded 21 hybrid compds. as novel multifunctional candidates against Alzheimer's disease.  Several of them showed improved inhibitory properties toward acetylcholinesterase (AChE) in relation to tacrine.  These hybrids also scavenged free radicals.  Mol. modeling studies in tandem with kinetic anal. exhibited that these hybrids target both catalytic active site as well as peripheral anionic site of AChE.  In addn., incorporation of the moiety bearing antioxidant abilities displayed negligible toxicity on human hepatic cells.  This striking effect was explained by formation of nontoxic metabolites after 1 h incubation in human liver microsomes system.  Finally, tacrine-trolox hybrids exhibited low in vivo toxicity after i.m. administration in rats and potential to penetrate across blood-brain barrier.  All of these outstanding in vitro results in combination with promising in vivo outcomes highlighted deriv. I as the lead structure worthy of further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWjX4tC8Sy17Vg90H21EOLACvtfcHk0lh2WzlyBs1y-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI&md5=550bddcd59b5bbb90d77e67faca28839</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01325%26sid%3Dliteratum%253Aachs%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DBabkova%26aufirst%3DK.%26aulast%3DOndrejicek%26aufirst%3DA.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DHorova%26aufirst%3DA.%26aulast%3DHrabinova%26aufirst%3DM.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DBukum%26aufirst%3DN.%26aulast%3DJost%26aufirst%3DP.%26aulast%3DMuckova%26aufirst%3DL.%26aulast%3DKassa%26aufirst%3DJ.%26aulast%3DMalinak%26aufirst%3DD.%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DTacrine%25E2%2580%2593Trolox%2520Hybrids%253A%2520A%2520novel%2520class%2520of%2520centrally%2520active%252C%2520nonhepatotoxic%2520multi-target-directed%2520ligands%2520exerting%2520anticholinesterase%2520and%2520antioxidant%2520activities%2520with%2520low%2520in%2520vivo%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8985%26epage%3D9003%26doi%3D10.1021%2Facs.jmedchem.5b01325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Spilovska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolezal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezeiova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soukup, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span> </span><span class="NLM_article-title">Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1006</span><span class="NLM_x">–</span> <span class="NLM_lpage">1026</span><span class="refDoi"> DOI: 10.2174/1568026605666160927152728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.2174%2F1568026605666160927152728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=27697055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVOrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=1006-1026&author=K.+Spilovskaauthor=J.+Korabecnyauthor=E.+Nepovimovaauthor=R.+Dolezalauthor=E.+Mezeiovaauthor=O.+Soukupauthor=K.+Kuca&title=Multitarget+tacrine+hybrids+with+neuroprotective+properties+to+confront+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1568026605666160927152728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease</span></div><div class="casAuthors">Spilovska, Katarina; Korabecny, Jan; Nepovimova, Eugenie; Dolezal, Rafael; Mezeiova, Eva; Soukup, Ondrej; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1006-1026</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder.  Several hallmarks such as β-amyloid (Aβ) aggregation underlying amyloid plaque formation, τ-hyperphosphorylation leading to prodn. of neurofibrillary tangles, and decline in the no. of cholinergic neurons appear to be fundamental in the pathophysiol. of the disease.  Other evidence points also to the involvement of oxidative stress, biometal dyshomeostasis, inflammation, and cell cycle regulatory failure.  Taking into account such premises, many attractive targets for the development of anti-AD drugs have emerged.  Specifically, the multifactorial nature of AD calls for multi-target-directed ligands (MTDLs) which can be beneficial by providing interactions with multiple targets.  Tacrine (THA), the first clin. effective acetylcholinesterase inhibitor, was approved for the treatment of mild to moderate AD.  Unfortunately, frequent adverse effects including peripheral cholinergic effects and hepatotoxicity limited its therapeutic potential.  Based on the numerous biol. systems involved in AD progression, this review covers THA-incorporated hybrids possessing a neuroprotective profile.  In particular, it focuses on THA hybrids capable of scavenging reactive oxygen species (ROS), and derivs. which reduce the formation of Aβ-plaques either directly by confronting the Aβ1-42 selfaggregation process or indirectly by inhibiting the BACE-1 enzyme or AChE-induced Aβ1-40 aggregation.  Particular interest is also addressed to THA hybrids with suppressed hepatotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp91WDdPABL1bVg90H21EOLACvtfcHk0lh2WzlyBs1y-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVOrurc%253D&md5=395db30019a8773fc2915161d2dae231</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.2174%2F1568026605666160927152728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026605666160927152728%26sid%3Dliteratum%253Aachs%26aulast%3DSpilovska%26aufirst%3DK.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DMezeiova%26aufirst%3DE.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DMultitarget%2520tacrine%2520hybrids%2520with%2520neuroprotective%2520properties%2520to%2520confront%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D1006%26epage%3D1026%26doi%3D10.2174%2F1568026605666160927152728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Nimczick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span><span class="refDoi"> DOI: 10.1002/cmdc.201500041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fcmdc.201500041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=25820617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlt1alu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=773-786&author=M.+Nimczickauthor=M.+Decker&title=New+approaches+in+the+design+and+development+of+cannabinoid+receptor+ligands%3A+multifunctional+and+bivalent+compounds&doi=10.1002%2Fcmdc.201500041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds</span></div><div class="casAuthors">Nimczick, Martin; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">773-786</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Since the identification of the endocannabinoid system, two G protein-coupled receptors (GPCRs) of this complex system were identified and characterized: cannabinoid receptors type 1 (CB1R) and type 2 (CB2R).  In addn. to orthosteric and subsequently allosteric ligands, new strategies have been used to target CBRs.  Bivalent ligands and multifunctional ligands acting at diverse biol. targets have been designed, synthesized, and characterized for both CBRs.  Due to their altered receptor binding and pharmacol. profiles, they are interesting tools to explore CBR functions and their interactions with other physiol. systems.  Moreover, this approach may bear therapeutic advantages in the therapy of CBR-related disorders, esp. multifactorial diseases.  Promising prospects include anorectics with fewer side effects, analgesics with decreased tolerance, and therapeutics with multiple pharmacol. activities for the treatment of cancer, inflammation, multiple sclerosis, Huntington's and Alzheimer's diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO0S1iWc8qP7Vg90H21EOLACvtfcHk0ljTE6FdjKCROw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlt1alu7s%253D&md5=48866ef33207c0dcb703225d1e2e577e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500041%26sid%3Dliteratum%253Aachs%26aulast%3DNimczick%26aufirst%3DM.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DNew%2520approaches%2520in%2520the%2520design%2520and%2520development%2520of%2520cannabinoid%2520receptor%2520ligands%253A%2520multifunctional%2520and%2520bivalent%2520compounds%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D773%26epage%3D786%26doi%3D10.1002%2Fcmdc.201500041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Dolles, D.; Decker, M.</span><span> </span><span class="NLM_article-title">Dual-acting compounds acting as receptor ligands and enzyme inhibitors</span>. In  <span class="citation_source-book">Design of Hybrid Molecules for Drug Development</span>; <span class="NLM_contrib-group">Decker, M.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FB978-0-08-101011-2.00005-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=137-165&author=D.+Dolles&author=M.+Deckerauthor=M.+Decker&title=Design+of+Hybrid+Molecules+for+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FB978-0-08-101011-2.00005-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-08-101011-2.00005-2%26sid%3Dliteratum%253Aachs%26aulast%3DDolles%26aufirst%3DD.%26atitle%3DDual-acting%2520compounds%2520acting%2520as%2520receptor%2520ligands%2520and%2520enzyme%2520inhibitors%26btitle%3DDesign%2520of%2520Hybrid%2520Molecules%2520for%2520Drug%2520Development%26aulast%3DDecker%26aufirst%3DM.%26pub%3DElsevier%26date%3D2017%26spage%3D137%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Dolles, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimczick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadtmüller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawatzky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Aminobenzimidazoles and structural isomers as templates for dual-acting butyrylcholinesterase inhibitors and <i>h</i>CB<sub>2</sub>R ligands to combat neurodegenerative disorders</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span><span class="refDoi"> DOI: 10.1002/cmdc.201500418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fcmdc.201500418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=26548365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyms7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1270-1283&author=D.+Dollesauthor=M.+Nimczickauthor=M.+Scheinerauthor=J.+Ramlerauthor=P.+Stadtm%C3%BCllerauthor=E.+Sawatzkyauthor=A.+Drakopoulosauthor=C.+Sotrifferauthor=H.-J.+Wittmannauthor=A.+Strasserauthor=M.+Decker&title=Aminobenzimidazoles+and+structural+isomers+as+templates+for+dual-acting+butyrylcholinesterase+inhibitors+and+hCB2R+ligands+to+combat+neurodegenerative+disorders&doi=10.1002%2Fcmdc.201500418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aminobenzimidazoles and Structural Isomers as Templates for Dual-Acting Butyrylcholinesterase Inhibitors and hCB2R Ligands To Combat Neurodegenerative Disorders</span></div><div class="casAuthors">Dolles, Dominik; Nimczick, Martin; Scheiner, Matthias; Ramler, Jacqueline; Stadtmueller, Patricia; Sawatzky, Edgar; Drakopoulos, Antonios; Sotriffer, Christoph; Wittmann, Hans-Joachim; Strasser, Andrea; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1270-1283</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A pharmacophore model for butyrylcholinesterase (BChE) inhibitors was applied to a human cannabinoid subtype 2 receptor (hCB2R) agonist and verified it as a first-generation lead for resp. dual-acting compds.  The design, synthesis, and pharmacol. evaluation of various derivs. led to the identification of aminobenzimidazoles as second-generation leads with micro- or sub-micromolar activities at both targets and excellent selectivity over hCB1 and AChE, resp.  Computational studies of the first- and second-generation lead structures by applying mol. dynamics (MD) on the active hCB2R model, along with docking and MD on hBChE, has enabled an explanation of their binding profiles at the protein levels and opened the way for further optimization.  Dual-acting compds. with "balanced" affinities and excellent selectivities could be obtained that represent leads for treatment of both cognitive and pathophysiol. impairment occurring in neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP2lcUsRAXJ7Vg90H21EOLACvtfcHk0ljTE6FdjKCROw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyms7%252FI&md5=dcd6f52f38134002413bd3d975ee9da3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500418%26sid%3Dliteratum%253Aachs%26aulast%3DDolles%26aufirst%3DD.%26aulast%3DNimczick%26aufirst%3DM.%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DRamler%26aufirst%3DJ.%26aulast%3DStadtm%25C3%25BCller%26aufirst%3DP.%26aulast%3DSawatzky%26aufirst%3DE.%26aulast%3DDrakopoulos%26aufirst%3DA.%26aulast%3DSotriffer%26aufirst%3DC.%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DAminobenzimidazoles%2520and%2520structural%2520isomers%2520as%2520templates%2520for%2520dual-acting%2520butyrylcholinesterase%2520inhibitors%2520and%2520hCB2R%2520ligands%2520to%2520combat%2520neurodegenerative%2520disorders%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1270%26epage%3D1283%26doi%3D10.1002%2Fcmdc.201500418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Le Naour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akgün, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yekkirala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunzer, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyuzhny, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portoghese, P. S.</span><span> </span><span class="NLM_article-title">Bivalent ligands that target μ opioid (MOP) and cannabinoid 1 (CB<sub>1</sub>) receptors are potent analgesics devoid of tolerance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5505</span><span class="NLM_x">–</span> <span class="NLM_lpage">5513</span><span class="refDoi"> DOI: 10.1021/jm4005219</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005219" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5505-5513&author=M.+Le+Naourauthor=E.+Akg%C3%BCnauthor=A.+Yekkiralaauthor=M.+M.+Lunzerauthor=M.+D.+Powersauthor=A.+E.+Kalyuzhnyauthor=P.+S.+Portoghese&title=Bivalent+ligands+that+target+%CE%BC+opioid+%28MOP%29+and+cannabinoid+1+%28CB1%29+receptors+are+potent+analgesics+devoid+of+tolerance&doi=10.1021%2Fjm4005219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm4005219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005219%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BNaour%26aufirst%3DM.%26aulast%3DAkg%25C3%25BCn%26aufirst%3DE.%26aulast%3DYekkirala%26aufirst%3DA.%26aulast%3DLunzer%26aufirst%3DM.%2BM.%26aulast%3DPowers%26aufirst%3DM.%2BD.%26aulast%3DKalyuzhny%26aufirst%3DA.%2BE.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DBivalent%2520ligands%2520that%2520target%2520%25CE%25BC%2520opioid%2520%2528MOP%2529%2520and%2520cannabinoid%25201%2520%2528CB1%2529%2520receptors%2520are%2520potent%2520analgesics%2520devoid%2520of%2520tolerance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5505%26epage%3D5513%26doi%3D10.1021%2Fjm4005219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Perrey, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Toward the development of bivalent ligand probes of cannabinoid CB1 and orexin OX1 receptor heterodimers</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">634</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span><span class="refDoi"> DOI: 10.1021/ml4004759</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4004759" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVCku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=634-638&author=D.+A.+Perreyauthor=B.+P.+Gilmourauthor=B.+F.+Thomasauthor=Y.+Zhang&title=Toward+the+development+of+bivalent+ligand+probes+of+cannabinoid+CB1+and+orexin+OX1+receptor+heterodimers&doi=10.1021%2Fml4004759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers</span></div><div class="casAuthors">Perrey, David A.; Gilmour, Brian P.; Thomas, Brian F.; Zhang, Yanan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">634-638</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cannabinoid CB1 and orexin OX1 receptors have been suggested to form heterodimers and oligomers.  Aimed at studying these complexes, a series of bivalent CB1 and OX1 ligands combining SR141716 and ACT-078573 pharmacophores were designed, synthesized, and tested for activity against CB1 and OX1 individually and in cell lines that coexpress both receptors.  Compd. I showed a robust enhancement in potency at both receptors when coexpressed as compared to individually expressed, suggesting possible interaction with CB1-OX1 dimers.  Bivalent ligands targeting CB1-OX1 receptor dimers could be potentially useful as a tool for further exploring the roles of such heterodimers in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBpUEo2iDgJLVg90H21EOLACvtfcHk0ljTE6FdjKCROw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVCku7c%253D&md5=6c863e7a9a205cbcb330853f37bdcbeb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fml4004759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4004759%26sid%3Dliteratum%253Aachs%26aulast%3DPerrey%26aufirst%3DD.%2BA.%26aulast%3DGilmour%26aufirst%3DB.%2BP.%26aulast%3DThomas%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DToward%2520the%2520development%2520of%2520bivalent%2520ligand%2520probes%2520of%2520cannabinoid%2520CB1%2520and%2520orexin%2520OX1%2520receptor%2520heterodimers%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D634%26epage%3D638%26doi%3D10.1021%2Fml4004759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Lange, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coolen, H. K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Neut, M. A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, A. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stork, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verveer, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span> </span><span class="NLM_article-title">Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1338</span><span class="NLM_x">–</span> <span class="NLM_lpage">1346</span><span class="refDoi"> DOI: 10.1021/jm901614b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901614b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1338-1346&author=J.+H.+M.+Langeauthor=H.+K.+A.+Coolenauthor=M.+A.+W.+Van+der+Neutauthor=A.+J.+M.+Borstauthor=B.+Storkauthor=P.+C.+Verveerauthor=C.+G.+Kruse&title=Design%2C+synthesis%2C+biological+properties%2C+and+molecular+modeling+investigations+of+novel+tacrine+derivatives+with+a+combination+of+acetylcholinesterase+inhibition+and+cannabinoid+CB1+receptor+antagonism&doi=10.1021%2Fjm901614b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm901614b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901614b%26sid%3Dliteratum%253Aachs%26aulast%3DLange%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DCoolen%26aufirst%3DH.%2BK.%2BA.%26aulast%3DVan%2Bder%2BNeut%26aufirst%3DM.%2BA.%2BW.%26aulast%3DBorst%26aufirst%3DA.%2BJ.%2BM.%26aulast%3DStork%26aufirst%3DB.%26aulast%3DVerveer%26aufirst%3DP.%2BC.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26atitle%3DDesign%252C%2520synthesis%252C%2520biological%2520properties%252C%2520and%2520molecular%2520modeling%2520investigations%2520of%2520novel%2520tacrine%2520derivatives%2520with%2520a%2520combination%2520of%2520acetylcholinesterase%2520inhibition%2520and%2520cannabinoid%2520CB1%2520receptor%2520antagonism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1338%26epage%3D1346%26doi%3D10.1021%2Fjm901614b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Montanari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalvini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Fatty acid amide hydrolase (FAAH), acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE): networked targets for the development of carbamates as potential anti-Alzheimer’s disease agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">6387</span><span class="NLM_x">–</span> <span class="NLM_lpage">6406</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00609</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFylsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6387-6406&author=S.+Montanariauthor=L.+Scalviniauthor=M.+Bartoliniauthor=F.+Bellutiauthor=S.+Gobbiauthor=V.+Andrisanoauthor=A.+Ligrestiauthor=V.+Di+Marzoauthor=S.+Rivaraauthor=M.+Morauthor=A.+Bisiauthor=A.+Rampa&title=Fatty+acid+amide+hydrolase+%28FAAH%29%2C+acetylcholinesterase+%28AChE%29%2C+and+butyrylcholinesterase+%28BuChE%29%3A+networked+targets+for+the+development+of+carbamates+as+potential+anti-Alzheimer%E2%80%99s+disease+agents&doi=10.1021%2Facs.jmedchem.6b00609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents</span></div><div class="casAuthors">Montanari, Serena; Scalvini, Laura; Bartolini, Manuela; Belluti, Federica; Gobbi, Silvia; Andrisano, Vincenza; Ligresti, Alessia; Di Marzo, Vincenzo; Rivara, Silvia; Mor, Marco; Bisi, Alessandra; Rampa, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6387-6406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The modulation of the endocannabinoid system is emerging as a viable avenue for the treatment of neurodegeneration, being involved in neuroprotective and anti-inflammatory processes.  In particular, indirectly enhancing endocannabinoid signaling to therapeutic levels through FAAH inhibition might be beneficial for neurodegenerative disorders such as Alzheimer's disease, effectively preventing or slowing the progression of the disease.  Hence, in the search for a more effective treatment for Alzheimer's disease, in this paper, the multitarget-directed ligand paradigm was applied to the design of carbamates able to simultaneously target the recently proposed endocannabinoid system and the classic cholinesterase system, and achieve effective dual FAAH/cholinesterase inhibitors.  Among the two series of synthesized compds., while some derivs. proved to be extremely potent on a single target, compds. 9 and 19 were identified as effective dual FAAH/ChE inhibitors, with well-balanced nanomolar activities.  Thus, 9 and 19 might be considered as new promising candidates for Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKiL1QuQosRrVg90H21EOLACvtfcHk0ljJ6so27iht1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFylsL4%253D&md5=b1dcd2958856cf5bfc9d77c451186b5b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00609%26sid%3Dliteratum%253Aachs%26aulast%3DMontanari%26aufirst%3DS.%26aulast%3DScalvini%26aufirst%3DL.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DFatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%252C%2520acetylcholinesterase%2520%2528AChE%2529%252C%2520and%2520butyrylcholinesterase%2520%2528BuChE%2529%253A%2520networked%2520targets%2520for%2520the%2520development%2520of%2520carbamates%2520as%2520potential%2520anti-Alzheimer%25E2%2580%2599s%2520disease%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6387%26epage%3D6406%26doi%3D10.1021%2Facs.jmedchem.6b00609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and compoutational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+compoutational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520compoutational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Stößel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlenk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Küppers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span> </span><span class="NLM_article-title">Dual Targeting of adenosine A<sub>2A</sub> receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4580</span><span class="NLM_x">–</span> <span class="NLM_lpage">4596</span><span class="refDoi"> DOI: 10.1021/jm400336x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400336x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4580-4596&author=A.+St%C3%B6%C3%9Felauthor=M.+Schlenkauthor=S.+Hinzauthor=P.+K%C3%BCppersauthor=J.+Heerauthor=M.+G%C3%BCtschowauthor=C.+E.+M%C3%BCller&title=Dual+Targeting+of+adenosine+A2A+receptors+and+monoamine+oxidase+B+by+4H-3%2C1-benzothiazin-4-ones&doi=10.1021%2Fjm400336x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm400336x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400336x%26sid%3Dliteratum%253Aachs%26aulast%3DSt%25C3%25B6%25C3%259Fel%26aufirst%3DA.%26aulast%3DSchlenk%26aufirst%3DM.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DK%25C3%25BCppers%26aufirst%3DP.%26aulast%3DHeer%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDual%2520Targeting%2520of%2520adenosine%2520A2A%2520receptors%2520and%2520monoamine%2520oxidase%2520B%2520by%25204H-3%252C1-benzothiazin-4-ones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4580%26epage%3D4596%26doi%3D10.1021%2Fjm400336x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Darras, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pockes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimczick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and computational studies of tri- and tetracyclic nitrogen-bridgehead compounds as potent dual-acting AChE inhibitors and <i>h</i>H<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1021/cn4002126</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn4002126" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVSntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=225-242&author=F.+H.+Darrasauthor=S.+Pockesauthor=G.+Huangauthor=S.+Wehleauthor=A.+Strasserauthor=H.-J.+Wittmannauthor=M.+Nimczickauthor=C.+A.+Sotrifferauthor=M.+Decker&title=Synthesis%2C+biological+evaluation%2C+and+computational+studies+of+tri-+and+tetracyclic+nitrogen-bridgehead+compounds+as+potent+dual-acting+AChE+inhibitors+and+hH3+receptor+antagonists&doi=10.1021%2Fcn4002126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43aR"><div class="casContent"><span class="casTitleNuber">43a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Biological Evaluation, and Computational Studies of Tri- and Tetracyclic Nitrogen-Bridgehead Compounds as Potent Dual-Acting AChE Inhibitors and hH3 Receptor Antagonists</span></div><div class="casAuthors">Darras, Fouad H.; Pockes, Steffen; Huang, Guozheng; Wehle, Sarah; Strasser, Andrea; Wittmann, Hans-Joachim; Nimczick, Martin; Sotriffer, Christoph A.; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-242</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Combination of AChE inhibiting and histamine H3 receptor antagonizing properties in a single mol. might show synergistic effects to improve cognitive deficits in Alzheimer's disease, since both pharmacol. actions are able to enhance cholinergic neurotransmission in the cortex.  However, whereas AChE inhibitors prevent hydrolysis of acetylcholine also peripherally, histamine H3 antagonists will raise acetylcholine levels mostly in the brain due to predominant occurrence of the receptor in the central nervous system.  In this work, we designed and synthesized two novel classes of tri- and tetracyclic nitrogen-bridgehead compds. acting as dual AChE inhibitors and histamine H3 antagonists by combining the nitrogen-bridgehead moiety of novel AChE inhibitors with a second N-basic fragment based on the piperidinylpropoxy pharmacophore with different spacer lengths.  Intensive structure-activity relationships (SARs) with regard to both biol. targets led to compd. (I) which showed balanced affinities as hAChE inhibitor with IC50 = 33.9 nM, and hH3R antagonism with Ki = 76.2 nM with greater than 200-fold selectivity over the other histamine receptor subtypes.  Mol. docking studies were performed to explain the potent AChE inhibition of the target compds. and mol. dynamics studies to explain high affinity at the hH3R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrUrSATqvWOLVg90H21EOLACvtfcHk0lhPrZqEWl7xDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVSntw%253D%253D&md5=c2853a155748d5748989b59e5c17b2e9</span></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=10.1021%2Fcn4002126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn4002126%26sid%3Dliteratum%253Aachs%26aulast%3DDarras%26aufirst%3DF.%2BH.%26aulast%3DPockes%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DWehle%26aufirst%3DS.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DNimczick%26aufirst%3DM.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520computational%2520studies%2520of%2520tri-%2520and%2520tetracyclic%2520nitrogen-bridgehead%2520compounds%2520as%2520potent%2520dual-acting%2520AChE%2520inhibitors%2520and%2520hH3%2520receptor%2520antagonists%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D225%26epage%3D242%26doi%3D10.1021%2Fcn4002126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurulain, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darras, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadek, B.</span><span> </span><span class="NLM_article-title">The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairments in Rats</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span><span class="refDoi"> DOI: 10.1016/j.bbr.2015.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bbr.2015.10.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2016&pages=155-164&author=N.+Khanauthor=A.+Saadauthor=S.+M.+Nurulainauthor=F.+H.+Darrasauthor=M.+Deckerauthor=B.+Sadek&title=The+dual-acting+H3+receptor+antagonist+and+AChE+inhibitor+UW-MD-71+dose-dependently+enhances+memory+retrieval+and+reverses+dizocilpine-induced+memory+impairments+in+Rats&doi=10.1016%2Fj.bbr.2015.10.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2015.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2015.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DSaad%26aufirst%3DA.%26aulast%3DNurulain%26aufirst%3DS.%2BM.%26aulast%3DDarras%26aufirst%3DF.%2BH.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DSadek%26aufirst%3DB.%26atitle%3DThe%2520dual-acting%2520H3%2520receptor%2520antagonist%2520and%2520AChE%2520inhibitor%2520UW-MD-71%2520dose-dependently%2520enhances%2520memory%2520retrieval%2520and%2520reverses%2520dizocilpine-induced%2520memory%2520impairments%2520in%2520Rats%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D297%26spage%3D155%26epage%3D164%26doi%3D10.1016%2Fj.bbr.2015.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit43c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sadek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darras, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pockes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">The dual-acting AChE inhibitor and H<sub>3</sub> receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats</span> <span class="citation_source-journal">Physiol. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1016/j.physbeh.2016.08.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.physbeh.2016.08.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=27568232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFaru7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2016&pages=383-391&author=B.+Sadekauthor=N.+Khanauthor=F.+H.+Darrasauthor=S.+Pockesauthor=M.+Decker&title=The+dual-acting+AChE+inhibitor+and+H3+receptor+antagonist+UW-MD-72+reverses+amnesia+induced+by+scopolamine+or+dizocilpine+in+passive+avoidance+paradigm+in+rats&doi=10.1016%2Fj.physbeh.2016.08.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43cR"><div class="casContent"><span class="casTitleNuber">43c</span><div class="casTitle"><span class="NLM_cas:atitle">The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats</span></div><div class="casAuthors">Sadek, Bassem; Khan, Nadia; Darras, Fouad H.; Pockes, Steffen; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Physiology & Behavior</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">383-391</span>CODEN:
                <span class="NLM_cas:coden">PHBHA4</span>;
        ISSN:<span class="NLM_cas:issn">0031-9384</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Both the acetylcholine esterase (AChE) and the histamine H3 receptor (H3R) are involved in the metab. and modulation of acetylcholine release and numerous other centrally acting neurotransmitters.  Hence, dual-active AChE inhibitors (AChEIs) and H3R antagonists hold potential to treat cognitive disorders like Alzheimer's disease (AD).  The novel dual-acting AChEI and H3R antagonist 7-(3-(piperidin-1-yl)propoxy)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one (UW-MD-72) shows excellent selectivity profiles over the AChE's isoenzyme butyrylcholinesterase (BChE) as well as high and balanced in-vitro affinities at both AChE and hH3R with IC50 of 5.4 μM on hAChE and hH3R antagonism with Ki of 2.54 μM, resp.  In the current study, the effects of UW-MD-72 (1.25, 2.5, and 5 mg/kg, i.p.) on memory deficits induced by the muscarinic cholinergic antagonist scopolamine (SCO) and the non-competitive N-methyl-D-aspartate (NMDA) antagonist dizocilpine (DIZ) were investigated in a step-through type passive avoidance paradigm in adult male rats applying donepezil (DOZ) and pitolisant (PIT) as ref. drugs.  The results obsd. show that SCO (2 mg/kg, i.p.) and DIZ (0.1 mg/kg, i.p.) significantly impaired learning and memory in rats.  However, acute systemic administration of UW-MD-72 significantly ameliorated the SCO- and DIZ-induced amnesic effects.  Furthermore, the ameliorating activity of UW-MD-72 (1.25 mg/kg, i.p.) in DIZ-induced amnesia was partly reversed when rats were pretreated with the centrally-acting H2R antagonist zolantidine (ZOL, 10 mg/kg, i.p.), but not with the CNS penetrant H1R antagonist pyrilamine (PYR, 10 mg/kg, i.p.).  Moreover, ameliorative effect of UW-MD-72 (1.25 mg/kg, i.p.) in DIZ-induced amnesia was strongly reversed when rats were pretreated with a combination of ZOL (10 mg/kg, i.p.) and SCO (1.0 mg/kg, i.p.), indicating that these memory enhancing effects were, in addn. to other neural circuits, obsd. through histaminergic H2R as well as muscarinic cholinergic neurotransmission.  These results demonstrate the ameliorative effects of UW-MD-72 in two in-vivo memory models and provide evidence for the potential of dual-acting AChEI and H3R antagonists to treat cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBRc7BhsE5YrVg90H21EOLACvtfcHk0lhPrZqEWl7xDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFaru7vJ&md5=59b884447a8de8426d8107282498bb30</span></div><a href="/servlet/linkout?suffix=cit43c&amp;dbid=16384&amp;doi=10.1016%2Fj.physbeh.2016.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.physbeh.2016.08.022%26sid%3Dliteratum%253Aachs%26aulast%3DSadek%26aufirst%3DB.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DDarras%26aufirst%3DF.%2BH.%26aulast%3DPockes%26aufirst%3DS.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DThe%2520dual-acting%2520AChE%2520inhibitor%2520and%2520H3%2520receptor%2520antagonist%2520UW-MD-72%2520reverses%2520amnesia%2520induced%2520by%2520scopolamine%2520or%2520dizocilpine%2520in%2520passive%2520avoidance%2520paradigm%2520in%2520rats%26jtitle%3DPhysiol.%2520Behav.%26date%3D2016%26volume%3D165%26spage%3D383%26epage%3D391%26doi%3D10.1016%2Fj.physbeh.2016.08.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pagé, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisvert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodzic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Onge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salois, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payza, K.</span><span> </span><span class="NLM_article-title">Novel benzimidazole derivatives as selective CB2 agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3695</span><span class="NLM_x">–</span> <span class="NLM_lpage">3700</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.05.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bmcl.2008.05.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=18522867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1Ohurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3695-3700&author=D.+Pag%C3%A9author=E.+Balauxauthor=L.+Boisvertauthor=Z.+Liuauthor=C.+Milburnauthor=M.+Tremblayauthor=Z.+Weiauthor=S.+Wooauthor=X.+Luoauthor=Y.-X.+Chengauthor=H.+Yangauthor=S.+Srivastavaauthor=F.+Zhouauthor=W.+Brownauthor=M.+Tomaszewskiauthor=C.+Walpoleauthor=L.+Hodzicauthor=S.+St-Ongeauthor=C.+Godboutauthor=D.+Saloisauthor=K.+Payza&title=Novel+benzimidazole+derivatives+as+selective+CB2+agonists&doi=10.1016%2Fj.bmcl.2008.05.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44aR"><div class="casContent"><span class="casTitleNuber">44a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel benzimidazole derivatives as selective CB2 agonists</span></div><div class="casAuthors">Page, Daniel; Balaux, Elise; Boisvert, Luc; Liu, Ziping; Milburn, Claire; Tremblay, Maxime; Wei, Zhongyong; Woo, Simon; Luo, Xuehong; Cheng, Yun-Xing; Yang, Hua; Srivastava, Sanjay; Zhou, Fei; Brown, William; Tomaszewski, Miroslaw; Walpole, Christopher; Hodzic, Leila; St-Onge, Stephane; Godbout, Claude; Salois, Dominic; Payza, Keymal</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3695-3700</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The prepn. and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety, e.g., I, are reported.  They showed binding affinities up to 1 nM towards the CB2 receptor with partial to full agonist potencies.  They also demonstrated good to excellent selectivity (>1000-fold) over the CB1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbeiXe1I0Yg7Vg90H21EOLACvtfcHk0lhPrZqEWl7xDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1Ohurs%253D&md5=fa9e0921054b0d9f26044a1feb82a604</span></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.073%26sid%3Dliteratum%253Aachs%26aulast%3DPag%25C3%25A9%26aufirst%3DD.%26aulast%3DBalaux%26aufirst%3DE.%26aulast%3DBoisvert%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMilburn%26aufirst%3DC.%26aulast%3DTremblay%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DWoo%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DY.-X.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DBrown%26aufirst%3DW.%26aulast%3DTomaszewski%26aufirst%3DM.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DHodzic%26aufirst%3DL.%26aulast%3DSt-Onge%26aufirst%3DS.%26aulast%3DGodbout%26aufirst%3DC.%26aulast%3DSalois%26aufirst%3DD.%26aulast%3DPayza%26aufirst%3DK.%26atitle%3DNovel%2520benzimidazole%2520derivatives%2520as%2520selective%2520CB2%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3695%26epage%3D3700%26doi%3D10.1016%2Fj.bmcl.2008.05.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cheng, Y.-X.; Tomaszewski, M.; Walpole, C.; Yang, H.</span><span> </span><span class="NLM_article-title">Novel Compounds</span>. WO 02/085866 A1, October 31,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=Y.-X.+Cheng&author=M.+Tomaszewski&author=C.+Walpole&author=H.+Yang&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-X.%26atitle%3DNovel%2520Compounds%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">González-Naranjo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Macias, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arán, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girón, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Robles, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Canas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Arencibia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Ruiz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Páez, J. A.</span><span> </span><span class="NLM_article-title">Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.ejmech.2013.11.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=56-72&author=P.+Gonz%C3%A1lez-Naranjoauthor=N.+P%C3%A9rez-Maciasauthor=N.+E.+Campilloauthor=C.+P%C3%A9rezauthor=V.+J.+Ar%C3%A1nauthor=R.+Gir%C3%B3nauthor=E.+S%C3%A1nchez-Roblesauthor=M.+I.+Mart%C3%ADnauthor=M.+G%C3%B3mez-Canasauthor=M.+Garc%C3%ADa-Arencibiaauthor=J.+Fern%C3%A1ndez-Ruizauthor=J.+A.+P%C3%A1ez&title=Cannabinoid+agonists+showing+BuChE+inhibition+as+potential+therapeutic+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2013.11.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DGonz%25C3%25A1lez-Naranjo%26aufirst%3DP.%26aulast%3DP%25C3%25A9rez-Macias%26aufirst%3DN.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DGir%25C3%25B3n%26aufirst%3DR.%26aulast%3DS%25C3%25A1nchez-Robles%26aufirst%3DE.%26aulast%3DMart%25C3%25ADn%26aufirst%3DM.%2BI.%26aulast%3DG%25C3%25B3mez-Canas%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Arencibia%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez-Ruiz%26aufirst%3DJ.%26aulast%3DP%25C3%25A1ez%26aufirst%3DJ.%2BA.%26atitle%3DCannabinoid%2520agonists%2520showing%2520BuChE%2520inhibition%2520as%2520potential%2520therapeutic%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D73%26spage%3D56%26epage%3D72%26doi%3D10.1016%2Fj.ejmech.2013.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Munch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittelkow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boas, U.</span><span> </span><span class="NLM_article-title">A new efficient synthesis of isothiocyanates from amines using di-<i>tert</i>-butyl dicarbonate</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3117</span><span class="NLM_x">–</span> <span class="NLM_lpage">3119</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2008.03.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.tetlet.2008.03.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=3117-3119&author=H.+Munchauthor=J.+S.+Hansenauthor=M.+Pittelkowauthor=J.+B.+Christensenauthor=U.+Boas&title=A+new+efficient+synthesis+of+isothiocyanates+from+amines+using+di-tert-butyl+dicarbonate&doi=10.1016%2Fj.tetlet.2008.03.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2008.03.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2008.03.045%26sid%3Dliteratum%253Aachs%26aulast%3DMunch%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DJ.%2BS.%26aulast%3DPittelkow%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DJ.%2BB.%26aulast%3DBoas%26aufirst%3DU.%26atitle%3DA%2520new%2520efficient%2520synthesis%2520of%2520isothiocyanates%2520from%2520amines%2520using%2520di-tert-butyl%2520dicarbonate%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D3117%26epage%3D3119%26doi%3D10.1016%2Fj.tetlet.2008.03.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Freitag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemies, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Gaghlab, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumpf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, A.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of splitomicin analogs targeted at human NAD<sup>+</sup>-dependent histone deacetylases (sirtuins)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3669</span><span class="NLM_x">–</span> <span class="NLM_lpage">3677</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.01.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bmc.2011.01.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3669-3677&author=M.+Freitagauthor=J.+Schemiesauthor=T.+Larsenauthor=K.+El+Gaghlabauthor=F.+Schulzauthor=T.+Rumpfauthor=M.+Jungauthor=A.+Link&title=Synthesis+and+biological+activity+of+splitomicin+analogs+targeted+at+human+NAD%2B-dependent+histone+deacetylases+%28sirtuins%29&doi=10.1016%2Fj.bmc.2011.01.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.01.026%26sid%3Dliteratum%253Aachs%26aulast%3DFreitag%26aufirst%3DM.%26aulast%3DSchemies%26aufirst%3DJ.%26aulast%3DLarsen%26aufirst%3DT.%26aulast%3DEl%2BGaghlab%26aufirst%3DK.%26aulast%3DSchulz%26aufirst%3DF.%26aulast%3DRumpf%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DLink%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520splitomicin%2520analogs%2520targeted%2520at%2520human%2520NAD%252B-dependent%2520histone%2520deacetylases%2520%2528sirtuins%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3669%26epage%3D3677%26doi%3D10.1016%2Fj.bmc.2011.01.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Darras, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with ’inverted’ binding mode</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4867</span><span class="NLM_x">–</span> <span class="NLM_lpage">4881</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.06.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bmc.2014.06.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4867-4881&author=F.+H.+Darrasauthor=S.+Wehleauthor=G.+Huangauthor=C.+A.+Sotrifferauthor=M.+Decker&title=Amine+substitution+of+quinazolinones+leads+to+selective+nanomolar+AChE+inhibitors+with+%E2%80%99inverted%E2%80%99+binding+mode&doi=10.1016%2Fj.bmc.2014.06.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.06.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.06.045%26sid%3Dliteratum%253Aachs%26aulast%3DDarras%26aufirst%3DF.%2BH.%26aulast%3DWehle%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DAmine%2520substitution%2520of%2520quinazolinones%2520leads%2520to%2520selective%2520nanomolar%2520AChE%2520inhibitors%2520with%2520%25E2%2580%2599inverted%25E2%2580%2599%2520binding%2520mode%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4867%26epage%3D4881%26doi%3D10.1016%2Fj.bmc.2014.06.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Lange, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Stuivenberg, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coolen, H. K. A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolfs, T. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCreary, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keizer, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wals, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veerman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, A. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Looff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verveer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span> </span><span class="NLM_article-title">Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1823</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span><span class="refDoi"> DOI: 10.1021/jm040843r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040843r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFSrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1823-1838&author=J.+H.+M.+Langeauthor=H.+H.+van+Stuivenbergauthor=H.+K.+A.+C.+Coolenauthor=T.+J.+P.+Adolfsauthor=A.+C.+McCrearyauthor=H.+G.+Keizerauthor=H.+C.+Walsauthor=W.+Veermanauthor=A.+J.+M.+Borstauthor=W.+de+Looffauthor=C.+Verveerauthor=C.+G.+Kruse&title=Bioisosteric+replacements+of+the+pyrazole+moiety+of+rimonabant%3A+synthesis%2C+biological+properties%2C+and+molecular+modeling+investigations+of+thiazoles%2C+triazoles%2C+and+imidazoles+as+potent+and+selective+CB1+cannabinoid+receptor+antagonists&doi=10.1021%2Fjm040843r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosteric Replacements of the Pyrazole Moiety of Rimonabant: Synthesis, Biological Properties, and Molecular Modeling Investigations of Thiazoles, Triazoles, and Imidazoles as Potent and Selective CB1 Cannabinoid Receptor Antagonists</span></div><div class="casAuthors">Lange, Jos H. M.; van Stuivenberg, Herman H.; Coolen, Hein K. A. C.; Adolfs, Tiny J. P.; McCreary, Andrew C.; Keizer, Hiskias G.; Wals, Henri C.; Veerman, Willem; Borst, Alice J. M.; de Looff, Wouter; Verveer, Peter C.; Kruse, Chris G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1823-1838</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Series of thiazoles, triazoles, and imidazoles were designed as bioisosteres, based on the 1,5-diarylpyrazole motif that is present in the potent CB1 receptor antagonist rimonabant.  A no. of target compds. were synthesized and evaluated in cannabinoid (hCB1 and hCB2) receptor assays.  The thiazoles, triazoles, and imidazoles elicited in vitro CB1 antagonistic activities and in general exhibited considerable CB1 vs CB2 receptor subtype selectivities, thereby demonstrating to be cannabinoid bioisosteres of the original diarylpyrazole class.  Some key representatives in the imidazole series showed potent pharmacol. in vivo activities after oral administration in both a CB agonist-induced hypotension model and a CB agonist-induced hypothermia model.  Mol. modeling studies showed a close three-dimensional structural overlap between the imidazole I and rimonabant.  A structure-activity relationship (SAR) study revealed a close correlation between the biol. results in the imidazole and pyrazole series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp16SsR1EEEVbVg90H21EOLACvtfcHk0lgPm3lzNCttEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFSrsLg%253D&md5=c3b80380a273d7f69a33c812a45e0154</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm040843r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040843r%26sid%3Dliteratum%253Aachs%26aulast%3DLange%26aufirst%3DJ.%2BH.%2BM.%26aulast%3Dvan%2BStuivenberg%26aufirst%3DH.%2BH.%26aulast%3DCoolen%26aufirst%3DH.%2BK.%2BA.%2BC.%26aulast%3DAdolfs%26aufirst%3DT.%2BJ.%2BP.%26aulast%3DMcCreary%26aufirst%3DA.%2BC.%26aulast%3DKeizer%26aufirst%3DH.%2BG.%26aulast%3DWals%26aufirst%3DH.%2BC.%26aulast%3DVeerman%26aufirst%3DW.%26aulast%3DBorst%26aufirst%3DA.%2BJ.%2BM.%26aulast%3Dde%2BLooff%26aufirst%3DW.%26aulast%3DVerveer%26aufirst%3DC.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26atitle%3DBioisosteric%2520replacements%2520of%2520the%2520pyrazole%2520moiety%2520of%2520rimonabant%253A%2520synthesis%252C%2520biological%2520properties%252C%2520and%2520molecular%2520modeling%2520investigations%2520of%2520thiazoles%252C%2520triazoles%252C%2520and%2520imidazoles%2520as%2520potent%2520and%2520selective%2520CB1%2520cannabinoid%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1823%26epage%3D1838%26doi%3D10.1021%2Fjm040843r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrison, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daza, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayson, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wensink, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> and in vivo characterization of A-796260: a selective cannabinoid CB<sub>2</sub> receptor agonist exhibiting analgesic activity in rodent pain models</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fsj.bjp.0707568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=17994110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlajsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=390-401&author=B.+B.+Yaoauthor=G.+C.+Hsiehauthor=J.+M.+Frostauthor=Y.+Fanauthor=T.+R.+Garrisonauthor=A.+V.+Dazaauthor=G.+K.+Graysonauthor=C.+Z.+Zhuauthor=M.+Paiauthor=P.+Chandranauthor=A.+K.+Salyersauthor=E.+J.+Wensinkauthor=P.+Honoreauthor=J.+P.+Sullivanauthor=M.+J.+Dartauthor=M.+D.+Meyer&title=In+vitro+and+in+vivo+characterization+of+A-796260%3A+a+selective+cannabinoid+CB2+receptor+agonist+exhibiting+analgesic+activity+in+rodent+pain+models&doi=10.1038%2Fsj.bjp.0707568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models</span></div><div class="casAuthors">Yao, B. B.; Hsieh, G. C.; Frost, J. M.; Fan, Y.; Garrison, T. R.; Daza, A. V.; Grayson, G. K.; Zhu, C. Z.; Pai, M.; Chandran, P.; Salyers, A. K.; Wensink, E. J.; Honore, P.; Sullivan, J. P.; Dart, M. J.; Meyer, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">390-401</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Selective cannabinoid CB2 receptor agonists have demonstrated analgesic activity across multiple preclin. pain models.  AM1241 is an indole deriv. that exhibits high affinity and selectivity for the CB2 binding site and broad spectrum analgesic activity in rodent models, but is not an antagonist of CB2 in vitro functional assays.  Addnl., its analgesic effects are -opioid receptor-dependent.  Herein, we describe the in vitro and in vivo pharmacol. properties of A-796260, a novel CB2 agonist.  Exptl. approach: A-796260 was characterized in radioligand binding and in vitro functional assays at rat and human CB1 and CB2 receptors.  The behavioral profile of A-796260 was assessed in models of inflammatory, post-operative, neuropathic, and osteoarthritic (OA) pain, as well as its effects on motor activity.  The receptor specificity was confirmed using selective CB1, CB2, and -opioid receptor antagonists.  A-796260 exhibited high affinity and agonist efficacy at human and rat CB2 receptors, and was selective for the CB2 vs CB1 subtype.  Efficacy in models of inflammatory, post-operative, neuropathic and OA pain was demonstrated, and these activities were selectively blocked by CB2, but not CB1, or -opioid receptor-selective antagonists.  Efficacy was achieved at doses that had no significant effects on motor activity.  These results further confirm the therapeutic potential of CB2 receptor-selective agonists for the treatment of pain.  In addn., they demonstrate that A-796260 may be a useful new pharmacol. compd. for further studying CB2 receptor pharmacol. and for evaluating its role in the modulation of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRpbBOoGZg27Vg90H21EOLACvtfcHk0lgPm3lzNCttEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlajsbs%253D&md5=c4d06d34da40f688a17aa15fffe03c64</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707568%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DDaza%26aufirst%3DA.%2BV.%26aulast%3DGrayson%26aufirst%3DG.%2BK.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DWensink%26aufirst%3DE.%2BJ.%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520characterization%2520of%2520A-796260%253A%2520a%2520selective%2520cannabinoid%2520CB2%2520receptor%2520agonist%2520exhibiting%2520analgesic%2520activity%2520in%2520rodent%2520pain%2520models%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D390%26epage%3D401%26doi%3D10.1038%2Fsj.bjp.0707568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Bottegoni, G.; Cavalli, A.</span><span> </span><span class="NLM_article-title">Computational Methods in Multitarget Drug Discovery</span>. In  <span class="citation_source-book">Design of Hybrid Molecules for Drug Development</span>; <span class="NLM_contrib-group">Decker, M.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FB978-0-08-101011-2.00009-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=239-258&author=G.+Bottegoni&author=A.+Cavalliauthor=M.+Decker&title=Design+of+Hybrid+Molecules+for+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FB978-0-08-101011-2.00009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-08-101011-2.00009-X%26sid%3Dliteratum%253Aachs%26aulast%3DBottegoni%26aufirst%3DG.%26atitle%3DComputational%2520Methods%2520in%2520Multitarget%2520Drug%2520Discovery%26btitle%3DDesign%2520of%2520Hybrid%2520Molecules%2520for%2520Drug%2520Development%26aulast%3DDecker%26aufirst%3DM.%26pub%3DElsevier%26date%3D2017%26spage%3D239%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Hua, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vemuri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikas, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laprairie, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z. J.</span><span> </span><span class="NLM_article-title">Crystal structures of agonist-bound human cannabinoid receptor CB1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">547</span><span class="NLM_x">, </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1038/nature23272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnature23272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=28678776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=547&publication_year=2017&pages=468-471&author=T.+Huaauthor=K.+Vemuriauthor=S.+P.+Nikasauthor=R.+B.+Laprairieauthor=Y.+Wuauthor=L.+Quauthor=M.+Puauthor=A.+Kordeauthor=S.+Jiangauthor=J.+H.+Hoauthor=G.+W.+Hanauthor=K.+Dingauthor=X.+Liauthor=H.+Liuauthor=M.+A.+Hansonauthor=S.+Zhaoauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=R.+C.+Stevensauthor=Z.+J.+Liu&title=Crystal+structures+of+agonist-bound+human+cannabinoid+receptor+CB1&doi=10.1038%2Fnature23272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of agonist-bound human cannabinoid receptor CB1</span></div><div class="casAuthors">Hua, Tian; Vemuri, Kiran; Nikas, Spyros P.; Laprairie, Robert B.; Wu, Yiran; Qu, Lu; Pu, Mengchen; Korde, Anisha; Jiang, Shan; Ho, Jo-Hao; Han, Gye Won; Ding, Kang; Li, Xuanxuan; Liu, Haiguang; Hanson, Michael A.; Zhao, Suwen; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">547</span>
        (<span class="NLM_cas:issue">7664</span>),
    <span class="NLM_cas:pages">468-471</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC).  Here the authors report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841) at 2.80 Å and 2.95 Å resoln., resp.  The two CB1-agonist complexes reveal important conformational changes in the overall structure, relative to the antagonist-bound state, including a 53% redn. in the vol. of the ligand-binding pocket and an increase in the surface area of the G-protein-binding region.  In addn., a 'twin toggle switch' of Phe 2003.36 and Trp 3566.48 (superscripts denote Ballesteros-Weinstein numbering) is exptl. obsd. and appears to be essential for receptor activation.  The structures reveal important insights into the activation mechanism of CB1 and provide a mol. basis for predicting the binding modes of Δ9-THC, and endogenous and synthetic cannabinoids.  The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G-protein-coupled receptors.  These findings should inspire the design of chem. diverse ligands with distinct pharmacol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw6XE4Hx5gDrVg90H21EOLACvtfcHk0lgPm3lzNCttEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73E&md5=f77fcc823e5856ece0bb5730ac00ea07</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnature23272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature23272%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DLaprairie%26aufirst%3DR.%2BB.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DKorde%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DJ.%2BH.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%2BJ.%26atitle%3DCrystal%2520structures%2520of%2520agonist-bound%2520human%2520cannabinoid%2520receptor%2520CB1%26jtitle%3DNature%26date%3D2017%26volume%3D547%26spage%3D468%26epage%3D471%26doi%3D10.1038%2Fnature23272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1016/S1043-9471(05)80049-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=366-428&author=J.+A.+Ballesterosauthor=H.+Weinstein&title=Integrated+methods+for+the+construction+of+three-dimensional+models+and+computational+probing+of+structure-function+relations+in+G+protein-coupled+receptors&doi=10.1016%2FS1043-9471%2805%2980049-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span></div><div class="casAuthors">Ballesteros, Juan A.; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">366-428</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review, with 135 refs., on approaches that can be used to resolve the apparent ambiguities that burden the pharmacol. testing of G protein-coupled receptor (GPCR) models, based on the integration of structural information about the receptor, about mutants, and about the changes induced by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfENoRspqa7LVg90H21EOLACvtfcHk0lgex-dY1gQjIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D&md5=d3f99e9d07cea245a770f3f099bc8cc7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three-dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure-function%2520relations%2520in%2520G%2520protein-coupled%2520receptors%26jtitle%3DMethods%2520Neurosci.%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428%26doi%3D10.1016%2FS1043-9471%2805%2980049-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Igel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dove, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschauer, A.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6297</span><span class="NLM_x">–</span> <span class="NLM_lpage">6313</span><span class="refDoi"> DOI: 10.1021/jm900526h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900526h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6297-6313&author=P.+Igelauthor=R.+Geyerauthor=A.+Strasserauthor=S.+Doveauthor=R.+Seifertauthor=A.+Buschauer&title=Synthesis+and+structure-activity+relationships+of+cyanoguanidine-type+and+structurally+related+histamine+H4+receptor+agonists&doi=10.1021%2Fjm900526h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of Cyanoguanidine-Type and Structurally Related Histamine H4 Receptor Agonists</span></div><div class="casAuthors">Igel, Patrick; Geyer, Roland; Strasser, Andrea; Dove, Stefan; Seifert, Roland; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6297-6313</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, we identified high-affinity human histamine H3 (hH3R) and H4 receptor (hH4R) ligands among a series of NG-acylated imidazolylpropylguanidines, which were originally designed as histamine H2 receptor (H2R) agonists.  Aiming at selectivity for hH4R, the acylguanidine group was replaced with related moieties.  Within a series of cyanoguanidines, 2-cyano-1-[4-(1H-imidazol-4-yl)butyl]-3-[(2-phenylthio)ethyl]guanidine (UR-PI376, I) was identified as the most potent hH4R agonist (pEC50 = 7.47, α = 0.93) showing negligible hH1R and hH2R activities and significant selectivity over the hH3R (pKB = 6.00, α = -0.28), as detd. in steady-state GTPase assays using membrane prepns. of hHxR-expressing Sf9 cells.  In contrast to previously described selective H4R agonists, this compd. and other 3-substituted derivs. are devoid of agonistic activity at the other HR subtypes.  Modeling of the binding mode of I suggests that the cyanoguanidine moiety forms charge-assisted hydrogen bonds not only with the conserved Asp-94 but also with the hH4R-specific Arg-341 residue.  2-Carbamoyl-1-[2-(1H-imidazol-4-yl)ethyl]-3-(3-phenylpropyl)guanidine (UR-PI97, II) was unexpectedly identified as a highly potent and selective hH3R inverse agonist (pKB = 8.42, >300-fold selectivity over the other HR subtypes).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8F_R1iQyE7Vg90H21EOLACvtfcHk0lgex-dY1gQjIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltbvP&md5=de315a1527f3a2e271f8a07ab9c64f2d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm900526h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900526h%26sid%3Dliteratum%253Aachs%26aulast%3DIgel%26aufirst%3DP.%26aulast%3DGeyer%26aufirst%3DR.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DDove%26aufirst%3DS.%26aulast%3DSeifert%26aufirst%3DR.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520cyanoguanidine-type%2520and%2520structurally%2520related%2520histamine%2520H4%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6297%26epage%3D6313%26doi%3D10.1021%2Fjm900526h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Striegl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, R.</span><span> </span><span class="NLM_article-title">Pharmacological profile of histaprodifens at four recombinant H1-receptor species isoforms</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.1124/jpet.107.129601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1124%2Fjpet.107.129601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=17928567" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2007&pages=60-71&author=A.+Strasserauthor=B.+Strieglauthor=H.-J.+Wittmannauthor=R.+Seifert&title=Pharmacological+profile+of+histaprodifens+at+four+recombinant+H1-receptor+species+isoforms&doi=10.1124%2Fjpet.107.129601"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.129601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.129601%26sid%3Dliteratum%253Aachs%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DStriegl%26aufirst%3DB.%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DSeifert%26aufirst%3DR.%26atitle%3DPharmacological%2520profile%2520of%2520histaprodifens%2520at%2520four%2520recombinant%2520H1-receptor%2520species%2520isoforms%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D324%26spage%3D60%26epage%3D71%26doi%3D10.1124%2Fjpet.107.129601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Wittmann, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span> </span><span class="NLM_article-title">Sodium binding to hH3R and hH4R - a molecular modeling study</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2394</span><span class="NLM_x">–</span> <span class="NLM_lpage">2404</span><span class="refDoi"> DOI: 10.1007/s00894-014-2394-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1007%2Fs00894-014-2394-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=25098339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADC%252BC2cbps1emuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=2394-2404&author=H.-J.+Wittmannauthor=R.+Seifertauthor=A.+Strasser&title=Sodium+binding+to+hH3R+and+hH4R+-+a+molecular+modeling+study&doi=10.1007%2Fs00894-014-2394-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium binding to hH3R and hH 4R--a molecular modeling study</span></div><div class="casAuthors">Wittmann Hans-Joachim; Seifert Roland; Strasser Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2394</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Several aminergic GPCRs, e.g., the human histamine H3-receptor (hH3R) are sensitive to sodium ions.  Based on these experimental results, including site directed mutagenesis studies, a sodium binding pocket near to the highly conserved Asp2.50 was suggested.  Recently, in the crystallized adenosine A2A receptor (4EIY), a sodium ion was found in a pocket, coordinated by Asp52, Ser91, and three water molecules.  Despite high homology in amino acid sequence between hH3R and hH4R, pharmacological studies revealed that the hH4R is--in contrast to hH3R--not sensitive to sodium ions.  In order to obtain a deeper insight onto the differences in sodium sensitivity between hH3R and hH4R, we performed molecular modelling studies, including molecular dynamic simulations and calculation of Gibbs energy of solvation.  The results of the modeling studies suggested that the amino acid at position 7.42 influences sodium binding to aminergic GPCRs in different ways.  A comparison of the amino acids forming the sodium binding channel between the ligand binding pocket and the sodium binding pocket of all human aminergic GPCRs showed an 80% occurrence of glycine--in contrast to hH3R and hH4R.  The Gln7.42 at hH4R disrupts a water chain, connecting the Asp3.32 of the orthosteric binding site and the Asp2.50 of the allosteric binding site.  Besides, the oxygen of the glutamine side chain stabilizes the interaction of the sodium ion with the Asp3.32.  Thus, the binding of the sodium into the allosteric binding site might be hindered kinetically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDm_Hf0VLBp8rRqEXsZufAfW6udTcc2eYc9l-jbsQ05bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbps1emuw%253D%253D&md5=ed8fa2f97559093c4215ec9796275021</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs00894-014-2394-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-014-2394-2%26sid%3Dliteratum%253Aachs%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DSeifert%26aufirst%3DR.%26aulast%3DStrasser%26aufirst%3DA.%26atitle%3DSodium%2520binding%2520to%2520hH3R%2520and%2520hH4R%2520-%2520a%2520molecular%2520modeling%2520study%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2014%26volume%3D20%26spage%3D2394%26epage%3D2404%26doi%3D10.1007%2Fs00894-014-2394-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, R.</span><span> </span><span class="NLM_article-title">Modulation of GPCRs by monovalent cations and anions</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span><span class="refDoi"> DOI: 10.1007/s00210-014-1073-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1007%2Fs00210-014-1073-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=25432095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSitLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2015&pages=363-380&author=A.+Strasserauthor=H.-J.+Wittmannauthor=E.+H.+Schneiderauthor=R.+Seifert&title=Modulation+of+GPCRs+by+monovalent+cations+and+anions&doi=10.1007%2Fs00210-014-1073-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of GPCRs by monovalent cations and anions</span></div><div class="casAuthors">Strasser, Andrea; Wittmann, Hans-Joachim; Schneider, Erich H.; Seifert, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-380</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The recent resoln. of G-protein-coupled receptor (GPCR) structures in complex with Na+ bound to an allosteric modulatory site has renewed interest of the regulation of GPCRs by ions.  Here, we summarise key data on ion modulation of GPCRs, obtained in pharmacol., crystallog., mutagenesis and mol. modeling studies.  We show that ion modulation is a highly complex process, involving not only cations but also, rather neglected until now, anions.  Pharmacotherapeutic and toxicol. aspects are discussed.  We provide a math. framework for the anal. of ion effects.  Finally, we discuss open questions in the field and future research directions.  Most importantly, the in vivo relevance of the modulation of GPCR function by monovalent ions must be clarified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDmk3TO24ZO7Vg90H21EOLACvtfcHk0liTOg4eeH55ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSitLzF&md5=74281aba85e6e810d49d08f89980fb01</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2Fs00210-014-1073-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-014-1073-2%26sid%3Dliteratum%253Aachs%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DSchneider%26aufirst%3DE.%2BH.%26aulast%3DSeifert%26aufirst%3DR.%26atitle%3DModulation%2520of%2520GPCRs%2520by%2520monovalent%2520cations%2520and%2520anions%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2015%26volume%3D388%26spage%3D363%26epage%3D380%26doi%3D10.1007%2Fs00210-014-1073-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Howlett, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabral, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casellas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devane, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herkenham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXVII. Classification of cannabinoid receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1124/pr.54.2.161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1124%2Fpr.54.2.161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=12037135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVOiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=161-202&author=A.+C.+Howlettauthor=F.+Barthauthor=T.+I.+Bonnerauthor=G.+Cabralauthor=P.+Casellasauthor=W.+A.+Devaneauthor=C.+C.+Felderauthor=M.+Herkenhamauthor=K.+Mackieauthor=B.+R.+Martinauthor=R.+Mechoulamauthor=R.+G.+Pertwee&title=International+Union+of+Pharmacology.+XXVII.+Classification+of+cannabinoid+receptors&doi=10.1124%2Fpr.54.2.161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Pharmacology. XXVII. Classification of cannabinoid receptors</span></div><div class="casAuthors">Howlett, A. C.; Barth, F.; Bonner, T. I.; Cabral, G.; Casellas, P.; Devane, W. A.; Felder, C. C.; Herkenham, M.; Mackie, K.; Martin, B. R.; Mechoulam, R.; Pertwee, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-202</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Two types of cannabinoid receptor have been discovered so far, CB1 (2.1: CBD:1:CB1:), cloned in 1990, and CB2 (2.1:CBD:2:CB2:), cloned in 1993.  Distinction between these receptors is based on differences in their predicted amino acid sequence, signaling mechanisms, tissue distribution, and sensitivity to certain potent agonists and antagonists that show marked selectivity for one or the other receptor type.  Cannabinoid receptors CB1 and CB2 exhibit 48% amino acid sequence identity.  Both receptor types are coupled through G proteins to adenylyl cyclase and mitogen-activated protein kinase.  CB1 receptors are also coupled through G proteins to several types of calcium and potassium channels.  These receptors exist primarily on central and peripheral neurons, one of their functions being to inhibit neurotransmitter release.  Indeed, endogenous CB1 agonists probably serve as retrograde synaptic messengers.  CB2 receptors are present mainly on immune cells.  Such cells also express CB1 receptors, albeit to a lesser extent, with both receptor types exerting a broad spectrum of immune effects that includes modulation of cytokine release.  Of several endogenous agonists for cannabinoid receptors identified thus far, the most notable are arachidonoylethanolamide, 2-arachidonoylglycerol, and 2-arachidonylglyceryl ether.  It is unclear whether these eicosanoid mols. are the only, or primary, endogenous agonists.  Hence, the authors consider it premature to rename cannabinoid receptors after an endogenous agonist as is recommended by the International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification.  Although pharmacol. evidence for the existence of addnl. types of cannabinoid receptor is emerging, other kinds of supporting evidence are still lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeoe-6izzgsrVg90H21EOLACvtfcHk0liTOg4eeH55ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVOiuro%253D&md5=4a8345d34b5724ee3cd999b71956ab54</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fpr.54.2.161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.54.2.161%26sid%3Dliteratum%253Aachs%26aulast%3DHowlett%26aufirst%3DA.%2BC.%26aulast%3DBarth%26aufirst%3DF.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26aulast%3DCabral%26aufirst%3DG.%26aulast%3DCasellas%26aufirst%3DP.%26aulast%3DDevane%26aufirst%3DW.%2BA.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DHerkenham%26aufirst%3DM.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXVII.%2520Classification%2520of%2520cannabinoid%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D161%26epage%3D202%26doi%3D10.1124%2Fpr.54.2.161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Ross, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockie, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Templeton, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">Agonist-inverse agonist characterization at CB<sub>1</sub> and CB<sub>2</sub> cannabinoid receptors of L759633, L759656 and AM630</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0702351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fsj.bjp.0702351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10188977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK1MXhslWit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1999&pages=665-672&author=R.+A.+Rossauthor=H.+C.+Brockieauthor=L.+A.+Stevensonauthor=V.+L.+Murphyauthor=F.+Templetonauthor=A.+Makriyannisauthor=R.+G.+Pertwee&title=Agonist-inverse+agonist+characterization+at+CB1+and+CB2+cannabinoid+receptors+of+L759633%2C+L759656+and+AM630&doi=10.1038%2Fsj.bjp.0702351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630</span></div><div class="casAuthors">Ross, Ruth A.; Brockie, Heather C.; Stevenson, Lesley A.; Murphy, Vicki L.; Templeton, Fiona; Makriyannis, Alexandros; Pertwee, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">665-672</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">We have tested our prediction that AM630 is a CB2 cannabinoid receptor ligand and also investigated whether L759633 and L759656, are CB2 receptor agonists.  Binding assays with membranes from CHO cells stably transfected with human CB1 or CB2 receptors using [3H]-CP55940, confirmed the CB2-selectivity of L759633 and L759656 (CB2/CB1 affinity ratios = 163 and 414 resp.) and showed AM630 to have a Ki at CB2 receptors of 31.2 nM and a CB2/CB1 affinity ratio of 165.  In CB2-transfected cells, L759633 and L759656 were potent inhibitors of forskolin-stimulated cAMP prodn., with EC50 values of 8.1 and 3.1 nM resp. and CB1/CB2 EC50 ratios of > 1000 and > 3000 resp.  AM630 inhibited [35S]-GTPγS binding to CB2 receptor membranes (EC50 = 76.6 nM), enhanced forskolin-stimulated cAMP prodn. in CB2-transfected cells (5.2 fold by 1 μM), and antagonized the inhibition of forskolin-stimulated cAMP prodn. in this cell line induced by CP55940.  In CB1-transfected cells, forskolin-stimulated cAMP prodn. was significantly inhibited by AM630 (22.6% at 1 μM and 45.9% at 10 μM) and by L759633 at 10 μM (48%) but not 1 μM.  L759656 (10 μM) was not inhibitory.  AM630 also produced a slight decrease in the mean inhibitory effect of CP55940 on cAMP prodn. which was not statistically significant.  We conclude that AM630 is a CB2-selective ligand that behaves as an inverse agonist at CB2 receptors and as a weak partial agonist at CB1 receptors.  L759633 and L759656 are both potent CB2-selective agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSFP_3NFRGm7Vg90H21EOLACvtfcHk0liTOg4eeH55ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhslWit78%253D&md5=6d0f811a461a91ebef93f45605fd3b11</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702351%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DR.%2BA.%26aulast%3DBrockie%26aufirst%3DH.%2BC.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DMurphy%26aufirst%3DV.%2BL.%26aulast%3DTempleton%26aufirst%3DF.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DAgonist-inverse%2520agonist%2520characterization%2520at%2520CB1%2520and%2520CB2%2520cannabinoid%2520receptors%2520of%2520L759633%252C%2520L759656%2520and%2520AM630%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D126%26spage%3D665%26epage%3D672%26doi%3D10.1038%2Fsj.bjp.0702351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Williams, C.</span><span> </span><span class="NLM_article-title">cAMP detection methods in HTS: selecting the best from the rest</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span><span class="refDoi"> DOI: 10.1038/nrd1306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnrd1306" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=125-135&author=C.+Williams&title=cAMP+detection+methods+in+HTS%3A+selecting+the+best+from+the+rest&doi=10.1038%2Fnrd1306"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnrd1306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1306%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DC.%26atitle%3DcAMP%2520detection%2520methods%2520in%2520HTS%253A%2520selecting%2520the%2520best%2520from%2520the%2520rest%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D125%26epage%3D135%26doi%3D10.1038%2Fnrd1306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drazba, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, Q.</span><span> </span><span class="NLM_article-title">Role of myeloma-derived MIF in myeloma cell adhesion to bone marrow and chemotherapy response</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">djw131</span><span class="refDoi"> DOI: 10.1093/jnci/djw131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1093%2Fjnci%2Fdjw131" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=djw131&issue=11&author=Y.+Zhengauthor=Q.+Wangauthor=T.+Liauthor=J.+Qianauthor=Y.+Luauthor=Y.+Liauthor=E.+Biauthor=F.+Reuauthor=Y.+Qinauthor=J.+Drazbaauthor=E.+Hsiauthor=J.+Yangauthor=Z.+Caiauthor=Q.+Yi&title=Role+of+myeloma-derived+MIF+in+myeloma+cell+adhesion+to+bone+marrow+and+chemotherapy+response&doi=10.1093%2Fjnci%2Fdjw131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjw131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjw131%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBi%26aufirst%3DE.%26aulast%3DReu%26aufirst%3DF.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DDrazba%26aufirst%3DJ.%26aulast%3DHsi%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DYi%26aufirst%3DQ.%26atitle%3DRole%2520of%2520myeloma-derived%2520MIF%2520in%2520myeloma%2520cell%2520adhesion%2520to%2520bone%2520marrow%2520and%2520chemotherapy%2520response%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2016%26volume%3D108%26issue%3D11%26spage%3Ddjw131%26doi%3D10.1093%2Fjnci%2Fdjw131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Waeber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chautard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicod, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pralong, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, R. C.</span><span> </span><span class="NLM_article-title">Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3′,5′-monophosphate responsive element-binding protein CREB in pituitary cells</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span><span class="refDoi"> DOI: 10.1210/mend.12.5.0109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1210%2Fmend.12.5.0109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=9605932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK1cXivVSgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=698-705&author=G.+Waeberauthor=N.+Thompsonauthor=T.+Chautardauthor=M.+Steinmannauthor=P.+Nicodauthor=F.+P.+Pralongauthor=T.+Calandraauthor=R.+C.+Gaillard&title=Transcriptional+activation+of+the+macrophage+migration-inhibitory+factor+gene+by+the+corticotropin-releasing+factor+is+mediated+by+the+cyclic+adenosine+3%E2%80%B2%2C5%E2%80%B2-monophosphate+responsive+element-binding+protein+CREB+in+pituitary+cells&doi=10.1210%2Fmend.12.5.0109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3',5'-monophosphate responsive element-binding protein CREB in pituitary cells</span></div><div class="casAuthors">Waeber, Gerard; Thompson, Nancy; Chautard, Thierry; Steinmann, Myriam; Nicod, Pascal; Pralong, Francois P.; Calandra, Thierry; Gaillard, Rolf C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">698-705</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Macrophage migration-inhibitory factor (MIF) has recently been identified as a pituitary hormone that functions as a counterregulatory modulator of glucocorticoid action within the immune system.  In the anterior pituitary gland, MIF is expressed in TSH- and ACTH-producing cells, and its secretion is induced by CRF.  To investigate MIF function and regulation within pituitary cells, we initiated the characterization of the MIF 5'-regulatory region of the gene.  The -1033 to +63 bp of the murine MIF promoter was cloned 5' to a luciferase reporter gene and transiently transfected into freshly isolated rat anterior pituitary cells.  This construct drove high basal transcriptional activity that was further enhanced after stimulation with CRF or with an activator of adenylate cyclase.  These transcriptional effects were assocd. with a concomitant rise in ACTH secretion in the transfected cells and by an increase in MIF gene expression as assessed by Northern blot anal.  A cAMP-responsive element (CRE) was identified within the MIF promoter region which, once mutated, abolished the cAMP responsiveness of the gene.  Using this newly identified CRE, DNA-binding activity was detected by gel retardation assay in nuclear exts. prepd. from isolated anterior pituitary cells and AtT-20 corticotroph tumor cells.  Supershift expts. using antibodies against the CRE-binding protein CREB, together with competition assays and the use of recombinant CREB, allowed the detection of CREB-binding activity with the identified MIF CRE.  These data demonstrate that CREB is the mediator of the CRF-induced MIF gene transcription in pituitary cells through an identified CRE in the proximal region of the MIF promoter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4ctiJbpNnCrVg90H21EOLACvtfcHk0lipCscN8DAH0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVSgs78%253D&md5=770f5d527647a365076307134c26dd73</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1210%2Fmend.12.5.0109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.12.5.0109%26sid%3Dliteratum%253Aachs%26aulast%3DWaeber%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DN.%26aulast%3DChautard%26aufirst%3DT.%26aulast%3DSteinmann%26aufirst%3DM.%26aulast%3DNicod%26aufirst%3DP.%26aulast%3DPralong%26aufirst%3DF.%2BP.%26aulast%3DCalandra%26aufirst%3DT.%26aulast%3DGaillard%26aufirst%3DR.%2BC.%26atitle%3DTranscriptional%2520activation%2520of%2520the%2520macrophage%2520migration-inhibitory%2520factor%2520gene%2520by%2520the%2520corticotropin-releasing%2520factor%2520is%2520mediated%2520by%2520the%2520cyclic%2520adenosine%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-monophosphate%2520responsive%2520element-binding%2520protein%2520CREB%2520in%2520pituitary%2520cells%26jtitle%3DMol.%2520Endocrinol.%26date%3D1998%26volume%3D12%26spage%3D698%26epage%3D705%26doi%3D10.1210%2Fmend.12.5.0109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Alas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonavida, B.</span><span> </span><span class="NLM_article-title">Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin’s lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=12538484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Ortw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=316-326&author=S.+Alasauthor=B.+Bonavida&title=Inhibition+of+constitutive+STAT3+activity+sensitizes+resistant+non-Hodgkin%E2%80%99s+lymphoma+and+multiple+myeloma+to+chemotherapeutic+drug-mediated+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis</span></div><div class="casAuthors">Alas, Steve; Bonavida, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">316-326</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hematopoietic malignancies have been shown to depend on cytokine growth factor autocrine/paracrine loops for growth and differentiation.  This results in the constitutive activation of cytokine-mediated transcription factors like signal transducer and activators of transcription (STAT) 3 in non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM).  Recent evidence demonstrates that cytokines also contribute to a drug-resistant phenotype in many tumor cell types.  We hypothesized that inhibitors of the STAT3 pathway would sensitize drug-resistant and endogenous cytokine-dependent NHL and MM tumor cells to the cytotoxic effects of chemotherapeutic drugs.  We examd. an AIDS-related NHL cell line, 2F7, known to be dependent on interleukin (IL)-10 for survival and an MM cell line, U266, known to be dependent on IL-6 for survival.  IL-10 and IL-6 signal the cells through the activation of Janus kinase (JAK)1 and JAK2, resp.  Thus, we investigated the effect of two chem. STAT3 pathway inhibitors, namely, piceatannol (JAK1/STAT3 inhibitor) and tyrphostin AG490 (JAK2/STAT3 inhibitor), on the tumor cells for sensitization to therapeutic drugs.  We demonstrate by phosphoprotein immunoblotting anal. and electrophoretic mobility shift anal. that piceatannol and AG490 inhibit the constitutive activity of STAT3 in 2F7 and U266, resp.  Furthermore, piceatannol and AG490 sensitize 2F7 and U266 cells, resp., to apoptosis by a range of therapeutic drugs including cisplatin, fludarabine, Adriamycin, and vinblastine.  The specificity of the inhibitors was corroborated in expts. showing that piceatannol had no effect on U266 and, likewise, AG490 has no effect on 2F7.  The sensitization obsd. by these inhibitors correlated with the inhibition of Bcl-2 expression in 2F7 and Bcl-xL expression in U266.  Altogether, these results demonstrate that STAT3 pathway inhibitors are a novel class of chemotherapeutic sensitizing agents capable of reversing the drug-resistant phenotype of cytokine-dependent tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8FrtRMRcL7Vg90H21EOLACvtfcHk0lipCscN8DAH0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Ortw%253D%253D&md5=a8429459592fc28b78075df1baff89bf</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlas%26aufirst%3DS.%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520constitutive%2520STAT3%2520activity%2520sensitizes%2520resistant%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%2520and%2520multiple%2520myeloma%2520to%2520chemotherapeutic%2520drug-mediated%2520apoptosis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D316%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ise, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, K.</span><span> </span><span class="NLM_article-title">Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gene Struct. Expression</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1493</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1016/S0167-4781(00)00168-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS0167-4781%2800%2900168-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10978511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1Sns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1493&publication_year=2000&pages=91-100&author=K.+Katoauthor=M.+Nomotoauthor=H.+Izumiauthor=T.+Iseauthor=S.+Nakanoauthor=Y.+Nihoauthor=K.+Kohno&title=Structure+and+functional+analysis+of+the+human+STAT3+gene+promoter%3A+alteration+of+chromatin+structure+as+a+possible+mechanism+for+the+upregulation+in+cisplatin-resistant+cells&doi=10.1016%2FS0167-4781%2800%2900168-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells</span></div><div class="casAuthors">Kato, K.; Nomoto, M.; Izumi, H.; Ise, T.; Nakano, S.; Niho, Y.; Kohno, K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Gene Structure and Expression</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1493</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">BBGSD5</span>;
        ISSN:<span class="NLM_cas:issn">0167-4781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">STAT3 is involved in the signal transduction activated by various cytokines and growth factors.  We found that the STAT3 gene is overexpressed in cisplatin-resistant cells.  We isolated a genomic fragment contg. the 5'-portion of the human STAT3 gene using a bubble PCR method.  Using the bubble PCR product as a probe, one genomic clone was isolated.  The nucleotide sequence of the first exon and the 1800 base pairs (bps) preceding it was detd.  The promoter region of the human STAT3 gene is highly homologous to the corresponding region of the mouse STAT3 gene; several potential factor binding sites such as CRE/ATF, SBE, and GC boxes are also well conserved between human and mouse.  A transient expression assay using the luciferase reporter gene showed that the sequence from -403 to +102 possesses maximal promoter activity, and transcription of the STAT3 gene was significantly higher in cisplatin-resistant cells than in parental cisplatin-sensitive cells.  Deletion of the region between -261 and -167 resulted in significant loss of promoter activity in both parental and cisplatin-resistant cells.  In vivo footprint anal. revealed several protein bindings; however, no significant differences were obsd. between drug-sensitive and drug-resistant cells.  MNase digestion revealed that several open or active nucleosomes were only detected in cisplatin-resistant cells.  These results suggest that STAT3 promoter function in a highly structured chromatin environment requires a complex interaction of several transcriptional factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUvgaeUQnDp7Vg90H21EOLACvtfcHk0liZ_O0peWWSkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1Sns7g%253D&md5=211aad8e6a379cb222e310918699f7a0</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS0167-4781%2800%2900168-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4781%252800%252900168-8%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNomoto%26aufirst%3DM.%26aulast%3DIzumi%26aufirst%3DH.%26aulast%3DIse%26aufirst%3DT.%26aulast%3DNakano%26aufirst%3DS.%26aulast%3DNiho%26aufirst%3DY.%26aulast%3DKohno%26aufirst%3DK.%26atitle%3DStructure%2520and%2520functional%2520analysis%2520of%2520the%2520human%2520STAT3%2520gene%2520promoter%253A%2520alteration%2520of%2520chromatin%2520structure%2520as%2520a%2520possible%2520mechanism%2520for%2520the%2520upregulation%2520in%2520cisplatin-resistant%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gene%2520Struct.%2520Expression%26date%3D2000%26volume%3D1493%26spage%3D91%26epage%3D100%26doi%3D10.1016%2FS0167-4781%2800%2900168-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Hill, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, S.</span><span> </span><span class="NLM_article-title">Reporter-gene systems for the study of G-protein-coupled receptors</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span><span class="refDoi"> DOI: 10.1016/S1471-4892(01)00091-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS1471-4892%2801%2900091-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=11764780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFOisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=526-532&author=S.+J.+Hillauthor=J.+G.+Bakerauthor=S.+Rees&title=Reporter-gene+systems+for+the+study+of+G-protein-coupled+receptors&doi=10.1016%2FS1471-4892%2801%2900091-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Reporter-gene systems for the study of G-protein-coupled receptors</span></div><div class="casAuthors">Hill, Stephen J.; Baker, Jillian G.; Rees, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">526-532</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Reporter-gene assays offer an alternative to biochem. assays for following signal transduction pathways from receptors at the cell surface to nuclear gene transcription in living cells.  Specific reporter-gene systems are now available for the study of ligand activity at Gαi/o, Gαs and Gαq G-protein-coupled receptors.  In recent years reporter genes have been applied in academia and industry to the study of ligand efficacy and affinity in recombinant and primary cell lines using a variety of color, fluorescent or luminescent read-outs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozKOKQCcaFu7Vg90H21EOLACvtfcHk0liZ_O0peWWSkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFOisr8%253D&md5=9f401de8554092238db94e108dcf88ca</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2801%2900091-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252801%252900091-1%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DS.%2BJ.%26aulast%3DBaker%26aufirst%3DJ.%2BG.%26aulast%3DRees%26aufirst%3DS.%26atitle%3DReporter-gene%2520systems%2520for%2520the%2520study%2520of%2520G-protein-coupled%2520receptors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2001%26volume%3D1%26spage%3D526%26epage%3D532%26doi%3D10.1016%2FS1471-4892%2801%2900091-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Wood, K. V.</span><span> </span><span class="NLM_article-title">Marker proteins for gene expression</span> <span class="citation_source-journal">Curr. Opin. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1016/0958-1669(95)80009-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2F0958-1669%2895%2980009-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=7894082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK2MXjsl2ks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=50-58&author=K.+V.+Wood&title=Marker+proteins+for+gene+expression&doi=10.1016%2F0958-1669%2895%2980009-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Marker proteins for gene expression</span></div><div class="casAuthors">Wood, Keith V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-8</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 50 refs.  Reporter genes are widely used as rapid and convenient means of measuring mol. genetic events.  Their role in exptl. strategies has expanded from anal. of the DNA sequences mediating RNA transcription to the broader ensemble of mol. events that define phenotype expression.  The several genetic reporters available today impart a range of performance criteria to choose from, including assay convenience and reliability, sensitivity, linearity, simplicity and dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmEvDr-4wzXLVg90H21EOLACvtfcHk0liZ_O0peWWSkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsl2ks78%253D&md5=fc816b081601a5020a209b44e827d619</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0958-1669%2895%2980009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0958-1669%252895%252980009-3%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DMarker%2520proteins%2520for%2520gene%2520expression%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D1995%26volume%3D6%26spage%3D50%26epage%3D58%26doi%3D10.1016%2F0958-1669%2895%2980009-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Renton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddaford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakhit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J. S.</span><span> </span><span class="NLM_article-title">NOpiates: Novel dual action neuronal nitric oxide synthase inhibitors with μ-opioid agonist activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1021/ml200268w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200268w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlyls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=227-231&author=P.+Rentonauthor=B.+Greenauthor=S.+Maddafordauthor=S.+Rakhitauthor=J.+S.+Andrews&title=NOpiates%3A+Novel+dual+action+neuronal+nitric+oxide+synthase+inhibitors+with+%CE%BC-opioid+agonist+activity&doi=10.1021%2Fml200268w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity</span></div><div class="casAuthors">Renton, Paul; Green, Brenda; Maddaford, Shawn; Rakhit, Suman; Andrews, John S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-231</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of benzimidazole designed multiple ligands (DMLs) with activity at the neuronal nitric oxide synthase (nNOS) enzyme and the μ-opioid receptor was developed.  Targeting of the structurally dissimilar heme-contg. enzyme and the μ-opioid GPCR was predicated on the modulatory role of nitric oxide on μ-opioid receptor function.  Structure-activity relationship studies yielded lead compd. 24 (I) with excellent nNOS inhibitory activity (IC50 = 0.44 μM), selectivity over both endothelial nitric oxide synthase (10-fold) and inducible nitric oxide synthase (125-fold), and potent μ-opioid binding affinity, Ki = 5.4 nM.  The functional activity as measured in the cyclic adenosine monosphospate secondary messenger assay resulted in full agonist activity (EC50 = 0.34 μM).  This work represents a novel approach in the development of new analgesics for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo12qBIKTlmjrVg90H21EOLACvtfcHk0liOxNLEvRPjuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlyls7g%253D&md5=6de1fce2b5543f611a2ed156c6d65260</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fml200268w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200268w%26sid%3Dliteratum%253Aachs%26aulast%3DRenton%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DB.%26aulast%3DMaddaford%26aufirst%3DS.%26aulast%3DRakhit%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DJ.%2BS.%26atitle%3DNOpiates%253A%2520Novel%2520dual%2520action%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%2520with%2520%25CE%25BC-opioid%2520agonist%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D227%26epage%3D231%26doi%3D10.1021%2Fml200268w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Hunger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kebrle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, K.</span><span> </span><span class="NLM_article-title">Benzimidazol-Derivate und verwandte Heterocyclen III. Synthese von 1-Aminoalkyl-2-benzyl-nitro-benzimidazolen</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span><span class="refDoi"> DOI: 10.1002/hlca.19600430412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fhlca.19600430412" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1960&pages=1032-1046&author=A.+Hungerauthor=J.+Kebrleauthor=A.+Rossiauthor=K.+Hoffmann&title=Benzimidazol-Derivate+und+verwandte+Heterocyclen+III.+Synthese+von+1-Aminoalkyl-2-benzyl-nitro-benzimidazolen&doi=10.1002%2Fhlca.19600430412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fhlca.19600430412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.19600430412%26sid%3Dliteratum%253Aachs%26aulast%3DHunger%26aufirst%3DA.%26aulast%3DKebrle%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DHoffmann%26aufirst%3DK.%26atitle%3DBenzimidazol-Derivate%2520und%2520verwandte%2520Heterocyclen%2520III.%2520Synthese%2520von%25201-Aminoalkyl-2-benzyl-nitro-benzimidazolen%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1960%26volume%3D43%26spage%3D1032%26epage%3D1046%26doi%3D10.1002%2Fhlca.19600430412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Privat, A.</span><span> </span><span class="NLM_article-title">Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">706</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span><span class="refDoi"> DOI: 10.1016/0006-8993(95)01032-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2F0006-8993%2895%2901032-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=8822355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK28Xns1yitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=706&publication_year=1996&pages=181-193&author=T.+Mauriceauthor=B.+P.+Lockhartauthor=A.+Privat&title=Amnesia+induced+in+mice+by+centrally+administered+%CE%B2-amyloid+peptides+involves+cholinergic+dysfunction&doi=10.1016%2F0006-8993%2895%2901032-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction</span></div><div class="casAuthors">Maurice, Tangui; Lockhart, Brian P.; Privat, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">706</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-93</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Substantial evidences suggest that the increased cerebral deposition, and neurotoxic action of the β-amyloid peptide, the major constituent of senile plaques, may represent the underlying cause of the cognitive deficits obsd. in Alzheimer's disease.  Herein, the authors attempted to verify this hypothesis by inducing a potential Alzheimer's-type amnesia after direct intracerebroventricular administration of aggregated β25-35-amyloid peptide in mice.  In this aim, amnesic capacities were evaluated after 6 to 13 days, using spontaneous alternation in the Y-maze, step-down type passive avoidance and place learning in a water-maze.  Pre-training administration of aggregated β25-35 peptide induced dose-dependent decreases in both alternation behavior and passive avoidance, at doses of 3 and 9 nmol/mouse.  A reduced but still significant impairment was obsd. when the peptide was not aggregated, or 'aged', by preincubation for 4 days at 37°.  The β1-28 peptide, at 3 nmol/mouse, also induced a marked decrease in step-down latency.  Post-training, but not pre-retention, administration of β25-35 peptide also significantly impaired learning.  The beneficial effects of cholinergic agents on β25-35-induced amnesia was examd. using the cholinesterase inhibitor tacrine (THA, 1.3 and 4.3 μmol/kg i.p.) and the nicotinic receptor agonist (-)-nicotine (NIC, 0.06 and 0.2 μmol/kg i.p.).  Both drugs induced a dose-dependent abrogation of the β25-35-induced decreases in alternation behavior and passive avoidance.  Furthermore, THA, at 1.3 μmol/kg, and NIC, at 0.2 μmol/kg, also reversed the β25-35-induced impairment of place learning and retention in the water-maze.  Histol. examn. of Cresyl violet-stained brain sections indicated a moderate but significant cell loss within the frontoparietal cortex and the hippocampal formation of mice treated with aged β25-35 peptide (9 nmol).  Examn. of Congo red-stained sections in the same animals demonstrated the presence of numerous amyloid deposits throughout these brain areas.  These results confirm that the deposition of β-amyloid peptide in the brain is in some way related to impairment of learning and cholinergic degeneration and suggest that the [25-35] fragment of the β-amyloid protein, sufficient to induce neuronal death in cultures, also induces an Alzheimer's-type amnesia in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCsjUgNl1iVLVg90H21EOLACvtfcHk0liOxNLEvRPjuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xns1yitQ%253D%253D&md5=5a0465719e2a405fcc1c6aae31ad0367</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2895%2901032-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252895%252901032-7%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DLockhart%26aufirst%3DB.%2BP.%26aulast%3DPrivat%26aufirst%3DA.%26atitle%3DAmnesia%2520induced%2520in%2520mice%2520by%2520centrally%2520administered%2520%25CE%25B2-amyloid%2520peptides%2520involves%2520cholinergic%2520dysfunction%26jtitle%3DBrain%2520Res.%26date%3D1996%26volume%3D706%26spage%3D181%26epage%3D193%26doi%3D10.1016%2F0006-8993%2895%2901032-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Lahmy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Givalois, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vamvakides, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span> </span><span class="NLM_article-title">Blockade of Tau hyperphosphorylation and Aβ1–42 generation by the aminotetrahydrofuran derivative ANAVEX2–73, a mixed muscarinic and σ1 receptor agonist, in a nontransgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1706</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span><span class="refDoi"> DOI: 10.1038/npp.2013.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnpp.2013.70" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=1706-1723&author=V.+Lahmyauthor=J.+Meunierauthor=S.+Malmstr%C3%B6mauthor=G.+Naertauthor=L.+Givaloisauthor=S.+H.+Kimauthor=V.+Villardauthor=A.+Vamvakidesauthor=T.+Maurice&title=Blockade+of+Tau+hyperphosphorylation+and+A%CE%B21%E2%80%9342+generation+by+the+aminotetrahydrofuran+derivative+ANAVEX2%E2%80%9373%2C+a+mixed+muscarinic+and+%CF%831+receptor+agonist%2C+in+a+nontransgenic+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnpp.2013.70"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2013.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2013.70%26sid%3Dliteratum%253Aachs%26aulast%3DLahmy%26aufirst%3DV.%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DMalmstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DNaert%26aufirst%3DG.%26aulast%3DGivalois%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DVillard%26aufirst%3DV.%26aulast%3DVamvakides%26aufirst%3DA.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DBlockade%2520of%2520Tau%2520hyperphosphorylation%2520and%2520A%25CE%25B21%25E2%2580%259342%2520generation%2520by%2520the%2520aminotetrahydrofuran%2520derivative%2520ANAVEX2%25E2%2580%259373%252C%2520a%2520mixed%2520muscarinic%2520and%2520%25CF%25831%2520receptor%2520agonist%252C%2520in%2520a%2520nontransgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D1706%26epage%3D1723%26doi%3D10.1038%2Fnpp.2013.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saedtler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Cytotoxic properties of the alkaloid rutaecarpine and its oligocyclic derivatives and chemical modifications to enhance water-solubility</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4937</span><span class="NLM_x">–</span> <span class="NLM_lpage">4941</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bmcl.2017.08.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4937-4941&author=G.+Huangauthor=A.+Drakopoulosauthor=M.+Saedtlerauthor=H.+Zouauthor=L.+Meinelauthor=J.+Heilmannauthor=M.+Decker&title=Cytotoxic+properties+of+the+alkaloid+rutaecarpine+and+its+oligocyclic+derivatives+and+chemical+modifications+to+enhance+water-solubility&doi=10.1016%2Fj.bmcl.2017.08.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DDrakopoulos%26aufirst%3DA.%26aulast%3DSaedtler%26aufirst%3DM.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DMeinel%26aufirst%3DL.%26aulast%3DHeilmann%26aufirst%3DJ.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DCytotoxic%2520properties%2520of%2520the%2520alkaloid%2520rutaecarpine%2520and%2520its%2520oligocyclic%2520derivatives%2520and%2520chemical%2520modifications%2520to%2520enhance%2520water-solubility%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4937%26epage%3D4941%26doi%3D10.1016%2Fj.bmcl.2017.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Gottlieb, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span> </span><span class="NLM_article-title">NMR chemical shifts of common laboratory solvents as trace impurities</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">7512</span><span class="NLM_x">–</span> <span class="NLM_lpage">7515</span><span class="refDoi"> DOI: 10.1021/jo971176v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+chemical+shifts+of+common+laboratory+solvents+as+trace+impurities&doi=10.1021%2Fjo971176v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0lig1XdbvyMFYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520chemical%2520shifts%2520of%2520common%2520laboratory%2520solvents%2520as%2520trace%2520impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7512%26epage%3D7515%26doi%3D10.1021%2Fjo971176v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b','cit27c'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b','cit33c'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43a','cit43b','cit43c'],'ref44':['cit44a','cit44b'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Qi Li, Ying Chen, Shuaishuai Xing, Qinghong Liao, Baichen Xiong, Yuanyuan Wang, Weixuan Lu, Siyu He, Feng Feng, Wenyuan Liu, Yao Chen, <span class="NLM_string-name hlFld-ContribAuthor">Haopeng Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6856-6876. <a href="https://doi.org/10.1021/acs.jmedchem.1c00167" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00167%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BPotent%252Band%252BSelective%252BButyrylcholinesterase%252BInhibitors%252Bfor%252BCognitive%252BImprovement%252Band%252BNeuroprotection%26aulast%3DLi%26aufirst%3DQi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D29012021%26date%3D11052021%26volume%3D64%26issue%3D10%26spage%3D6856%26epage%3D6876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">István Ujváry, Rachel Christie, Michael Evans-Brown, Ana Gallegos, Rita Jorge, Joanna de Morais, <span class="NLM_string-name hlFld-ContribAuthor">Roumen Sedefov</span>. </span><span class="cited-content_cbyCitation_article-title">DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1072-1092. <a href="https://doi.org/10.1021/acschemneuro.1c00037" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00037%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDARK%252BClassics%252Bin%252BChemical%252BNeuroscience%25253A%252BEtonitazene%252Band%252BRelated%252BBenzimidazoles%26aulast%3DUjv%25C3%25A1ry%26aufirst%3DIstv%25C3%25A1n%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19012021%26date%3D15032021%26date%3D24032021%26volume%3D12%26issue%3D7%26spage%3D1072%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Giuseppe Felice Mangiatordi, Francesca Intranuovo, Pietro Delre, Francesca Serena Abatematteo, Carmen Abate, Mauro Niso, Teresa Maria Creanza, Nicola Ancona, Angela Stefanachi, <span class="NLM_string-name hlFld-ContribAuthor">Marialessandra Contino</span>. </span><span class="cited-content_cbyCitation_article-title">Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14448-14469. <a href="https://doi.org/10.1021/acs.jmedchem.0c01357" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01357%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCannabinoid%252BReceptor%252BSubtype%252B2%252B%252528CB2R%252529%252Bin%252Ba%252BMultitarget%252BApproach%25253A%252BPerspective%252Bof%252Ban%252BInnovative%252BStrategy%252Bin%252BCancer%252Band%252BNeurodegeneration%26aulast%3DMangiatordi%26aufirst%3DGiuseppe%2BFelice%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03082020%26date%3D23102020%26volume%3D63%26issue%3D23%26spage%3D14448%26epage%3D14469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guiyan Han, Na Liu, Chenglan Li, Jie Tu, Zhuang Li, <span class="NLM_string-name hlFld-ContribAuthor">Chunquan Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5341-5359. <a href="https://doi.org/10.1021/acs.jmedchem.0c00102" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00102%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BFungal%252BLanosterol%252B14%2525CE%2525B1-Demethylase%252B%252528CYP51%252529%25252FHistone%252BDeacetylase%252BDual%252BInhibitors%252Bto%252BTreat%252BAzole-Resistant%252BCandidiasis%26aulast%3DHan%26aufirst%3DGuiyan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D04022020%26date%3D09052020%26date%3D29042020%26volume%3D63%26issue%3D10%26spage%3D5341%26epage%3D5359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthias Scheiner, Dominik Dolles, Sandra Gunesch, Matthias Hoffmann, Massimo Nabissi, Oliviero Marinelli, Marina Naldi, Manuela Bartolini, Sabrina Petralla, Eleonora Poeta, Barbara Monti, Christina Falkeis, Michael Vieth, Harald Hübner, Peter Gmeiner, Rangan Maitra, Tangui Maurice, <span class="NLM_string-name hlFld-ContribAuthor">Michael Decker</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9078-9102. <a href="https://doi.org/10.1021/acs.jmedchem.9b00623" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00623%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-Acting%252BCholinesterase%2525E2%252580%252593Human%252BCannabinoid%252BReceptor%252B2%252BLigands%252BShow%252BPronounced%252BNeuroprotection%252Bin%252BVitro%252Band%252BOveradditive%252Band%252BDisease-Modifying%252BNeuroprotective%252BEffects%252Bin%252BVivo%26aulast%3DScheiner%26aufirst%3DMatthias%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30042019%26date%3D14102019%26volume%3D62%26issue%3D20%26spage%3D9078%26epage%3D9102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthias Hoffmann, Carina Stiller, Erik Endres, Matthias Scheiner, Sandra Gunesch, Christoph Sotriffer, Tangui Maurice, <span class="NLM_string-name hlFld-ContribAuthor">Michael Decker</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer’s Disease Mouse Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9116-9140. <a href="https://doi.org/10.1021/acs.jmedchem.9b01012" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSelective%252BButyrylcholinesterase%252BInhibitors%252Bwith%252BTunable%252BDuration%252Bof%252BAction%252Bby%252BChemical%252BModification%252Bof%252BTransferable%252BCarbamate%252BUnits%252BExhibit%252BPronounced%252BNeuroprotective%252BEffect%252Bin%252Ban%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BMouse%252BModel%26aulast%3DHoffmann%26aufirst%3DMatthias%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26062019%26date%3D14102019%26volume%3D62%26issue%3D20%26spage%3D9116%26epage%3D9140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Srinivasa
Rao Manne, Jyoti Chandra, <span class="NLM_string-name hlFld-ContribAuthor">Bhubaneswar Mandal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of o-Nitroarylamines via Ipso Nucleophilic Substitution of Sulfonic Acids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (3)
                                     , 636-639. <a href="https://doi.org/10.1021/acs.orglett.8b03730" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b03730</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b03730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b03730%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252Bo-Nitroarylamines%252Bvia%252BIpso%252BNucleophilic%252BSubstitution%252Bof%252BSulfonic%252BAcids%26aulast%3DManne%26aufirst%3DSrinivasa%2BRao%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21112018%26date%3D11012019%26volume%3D21%26issue%3D3%26spage%3D636%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ewgenij Proschak, Holger Stark, <span class="NLM_string-name hlFld-ContribAuthor">Daniel Merk</span>. </span><span class="cited-content_cbyCitation_article-title">Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 420-444. <a href="https://doi.org/10.1021/acs.jmedchem.8b00760" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00760%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPolypharmacology%252Bby%252BDesign%25253A%252BA%252BMedicinal%252BChemist%2525E2%252580%252599s%252BPerspective%252Bon%252BMultitargeting%252BCompounds%26aulast%3DProschak%26aufirst%3DEwgenij%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D11052018%26date%3D03082018%26date%3D23072018%26volume%3D62%26issue%3D2%26spage%3D420%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Yi  Liu</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Chengang  Han</span>, <span class="hlFld-ContribAuthor ">Xiaoye  Feng</span>, <span class="hlFld-ContribAuthor ">Hui  Zhou</span>, <span class="hlFld-ContribAuthor ">Yanfang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, biological evaluation and molecular dynamic simulations of butyrylcholinesterase inhibitors through structure-based pharmacophore virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (9)
                                     , 769-784. <a href="https://doi.org/10.4155/fmc-2020-0325" title="DOI URL">https://doi.org/10.4155/fmc-2020-0325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0325%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdynamic%252Bsimulations%252Bof%252Bbutyrylcholinesterase%252Binhibitors%252Bthrough%252Bstructure-based%252Bpharmacophore%252Bvirtual%252Bscreening%26aulast%3DLu%26aufirst%3DTao%26date%3D2021%26volume%3D13%26issue%3D9%26spage%3D769%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danna  De Boer</span>, <span class="hlFld-ContribAuthor ">Nguyet  Nguyen</span>, <span class="hlFld-ContribAuthor ">Jia  Mao</span>, <span class="hlFld-ContribAuthor ">Jessica  Moore</span>, <span class="hlFld-ContribAuthor ">Eric J.  Sorin</span>. </span><span class="cited-content_cbyCitation_article-title">A Comprehensive Review of Cholinesterase Modeling and Simulation. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (4)
                                     , 580. <a href="https://doi.org/10.3390/biom11040580" title="DOI URL">https://doi.org/10.3390/biom11040580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11040580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11040580%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DA%252BComprehensive%252BReview%252Bof%252BCholinesterase%252BModeling%252Band%252BSimulation%26aulast%3DDe%2BBoer%26aufirst%3DDanna%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D4%26spage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuaishuai  Xing</span>, <span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Baichen  Xiong</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (2)
                                     , 858-901. <a href="https://doi.org/10.1002/med.21745" title="DOI URL">https://doi.org/10.1002/med.21745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21745%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DStructure%252Band%252Btherapeutic%252Buses%252Bof%252Bbutyrylcholinesterase%25253A%252BApplication%252Bin%252Bdetoxification%25252C%252BAlzheimer%252527s%252Bdisease%25252C%252Band%252Bfat%252Bmetabolism%26aulast%3DXing%26aufirst%3DShuaishuai%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D2%26spage%3D858%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, , <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, , <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>, . </span><span class="cited-content_cbyCitation_article-title">Multifunctional Ligand Approach: Search for Effective Therapy Against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 181-203. <a href="https://doi.org/10.36255/exonpublications.alzheimersdisease.2020.ch11" title="DOI URL">https://doi.org/10.36255/exonpublications.alzheimersdisease.2020.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.36255/exonpublications.alzheimersdisease.2020.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.36255%2Fexonpublications.alzheimersdisease.2020.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DMultifunctional%252BLigand%252BApproach%25253A%252BSearch%252Bfor%252BEffective%252BTherapy%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPasieka%26aufirst%3DAnna%26date%3D2020%26date%3D2020%26spage%3D181%26epage%3D203%26pub%3DExon%2520Publications%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDrug%252BDiscovery%26aulast%3DHuang%26aufirst%3DXudong%26date%3D2020%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hajar  Karimi Askarani</span>, <span class="hlFld-ContribAuthor ">Aida  Iraji</span>, <span class="hlFld-ContribAuthor ">Arezoo  Rastegari</span>, <span class="hlFld-ContribAuthor ">Syed Nasir  Abbas Bukhari</span>, <span class="hlFld-ContribAuthor ">Omidreza  Firuzi</span>, <span class="hlFld-ContribAuthor ">Tahmineh  Akbarzadeh</span>, <span class="hlFld-ContribAuthor ">Mina  Saeedi</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">BMC Chemistry</span><span> <strong>2020,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13065-020-00715-0" title="DOI URL">https://doi.org/10.1186/s13065-020-00715-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13065-020-00715-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13065-020-00715-0%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bmulti-target%252Bdirected%252B1%25252C2%25252C3-triazole-dimethylaminoacryloyl-chromenone%252Bderivatives%252Bwith%252Bpotential%252Buse%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DKarimi%2BAskarani%26aufirst%3DHajar%26date%3D2020%26date%3D2020%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongguang  Ma</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 1682-1692. <a href="https://doi.org/10.1016/j.drudis.2020.07.004" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DRecent%252Badvances%252Bin%252Bmultitarget-directed%252Bligands%252Btargeting%252BG-protein-coupled%252Breceptors%26aulast%3DMa%26aufirst%3DHongguang%26date%3D2020%26volume%3D25%26issue%3D9%26spage%3D1682%26epage%3D1692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fred  Shahbazi</span>, <span class="hlFld-ContribAuthor ">Victoria  Grandi</span>, <span class="hlFld-ContribAuthor ">Abhinandan  Banerjee</span>, <span class="hlFld-ContribAuthor ">John F.  Trant</span>. </span><span class="cited-content_cbyCitation_article-title">Cannabinoids and Cannabinoid Receptors: The Story so Far. </span><span class="cited-content_cbyCitation_journal-name">iScience</span><span> <strong>2020,</strong> <em>23 </em>
                                    (7)
                                     , 101301. <a href="https://doi.org/10.1016/j.isci.2020.101301" title="DOI URL">https://doi.org/10.1016/j.isci.2020.101301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.isci.2020.101301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.isci.2020.101301%26sid%3Dliteratum%253Aachs%26jtitle%3DiScience%26atitle%3DCannabinoids%252Band%252BCannabinoid%252BReceptors%25253A%252BThe%252BStory%252Bso%252BFar%26aulast%3DShahbazi%26aufirst%3DFred%26date%3D2020%26volume%3D23%26issue%3D7%26spage%3D101301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongchen  An</span>, <span class="hlFld-ContribAuthor ">Steve  Peigneur</span>, <span class="hlFld-ContribAuthor ">Louise Antonia  Hendrickx</span>, <span class="hlFld-ContribAuthor ">Jan  Tytgat</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (14)
                                     , 5064. <a href="https://doi.org/10.3390/ijms21145064" title="DOI URL">https://doi.org/10.3390/ijms21145064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21145064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21145064%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTargeting%252BCannabinoid%252BReceptors%25253A%252BCurrent%252BStatus%252Band%252BProspects%252Bof%252BNatural%252BProducts%26aulast%3DAn%26aufirst%3DDongchen%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D14%26spage%3D5064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Albertini</span>, <span class="hlFld-ContribAuthor ">Alessandra  Salerno</span>, <span class="hlFld-ContribAuthor ">Pedro  Sena Murteira Pinheiro</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.1002/med.21699" title="DOI URL">https://doi.org/10.1002/med.21699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21699%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DFrom%252Bcombinations%252Bto%252Bmultitarget%2525E2%252580%252590directed%252Bligands%25253A%252BA%252Bcontinuum%252Bin%252BAlzheimer%252527s%252Bdisease%252Bpolypharmacology%26aulast%3DAlbertini%26aufirst%3DClaudia%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinghong  Liao</span>, <span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Yifan  Zhao</span>, <span class="hlFld-ContribAuthor ">Pan  Jiang</span>, <span class="hlFld-ContribAuthor ">Yuhui  Yan</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103844. <a href="https://doi.org/10.1016/j.bioorg.2020.103844" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103844%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bcarboline-cinnamic%252Bacid%252Bhybrids%252Bas%252Bmultifunctional%252Bagents%252Bfor%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DLiao%26aufirst%3DQinghong%26date%3D2020%26volume%3D99%26spage%3D103844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe Ying  Ha</span>, <span class="hlFld-ContribAuthor ">Shintu  Mathew</span>, <span class="hlFld-ContribAuthor ">Keng Yoon  Yeong</span>. </span><span class="cited-content_cbyCitation_article-title">Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool. </span><span class="cited-content_cbyCitation_journal-name">Current Protein & Peptide Science</span><span> <strong>2020,</strong> <em>21 </em>
                                    (1)
                                     , 99-109. <a href="https://doi.org/10.2174/1389203720666191107094949" title="DOI URL">https://doi.org/10.2174/1389203720666191107094949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389203720666191107094949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389203720666191107094949%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Protein%2520%2526%2520Peptide%2520Science%26atitle%3DButyrylcholinesterase%25253A%252BA%252BMultifaceted%252BPharmacological%252BTarget%252Band%252BTool%26aulast%3DHa%26aufirst%3DZhe%2BYing%26date%3D2020%26volume%3D21%26issue%3D1%26spage%3D99%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eman M.E.  Dokla</span>, <span class="hlFld-ContribAuthor ">Nader S.  Abutaleb</span>, <span class="hlFld-ContribAuthor ">Sandra N.  Milik</span>, <span class="hlFld-ContribAuthor ">Daoyi  Li</span>, <span class="hlFld-ContribAuthor ">Karim  El-Baz</span>, <span class="hlFld-ContribAuthor ">Menna-Allah W.  Shalaby</span>, <span class="hlFld-ContribAuthor ">Rawan  Al-Karaki</span>, <span class="hlFld-ContribAuthor ">Maha  Nasr</span>, <span class="hlFld-ContribAuthor ">Christian D.  Klein</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>, <span class="hlFld-ContribAuthor ">Mohamed N.  Seleem</span>. </span><span class="cited-content_cbyCitation_article-title">Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111850. <a href="https://doi.org/10.1016/j.ejmech.2019.111850" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111850%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bbenzimidazole-based%252Bderivatives%252Bas%252Bantimicrobial%252Bagents%252Band%252Btheir%252Bsynergistic%252Beffect%252Bwith%252Bcolistin%252Bagainst%252Bgram-negative%252Bbacteria%26aulast%3DDokla%26aufirst%3DEman%2BM.E.%26date%3D2020%26volume%3D186%26spage%3D111850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Shuaishuai  Xing</span>, <span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Qinghong  Liao</span>, <span class="hlFld-ContribAuthor ">Qihang  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Siyu  He</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Qinglong  Guo</span>, <span class="hlFld-ContribAuthor ">Yuan  Sun</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111862. <a href="https://doi.org/10.1016/j.ejmech.2019.111862" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111862%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DReasonably%252Bactivating%252BNrf2%25253A%252BA%252Blong-term%25252C%252Beffective%252Band%252Bcontrollable%252Bstrategy%252Bfor%252Bneurodegenerative%252Bdiseases%26aulast%3DLi%26aufirst%3DQi%26date%3D2020%26volume%3D185%26spage%3D111862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Gunesch</span>, <span class="hlFld-ContribAuthor ">Matthias  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Carolina  Kiermeier</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Fischer</span>, <span class="hlFld-ContribAuthor ">Antonio F.M.  Pinto</span>, <span class="hlFld-ContribAuthor ">Tangui  Maurice</span>, <span class="hlFld-ContribAuthor ">Pamela  Maher</span>, <span class="hlFld-ContribAuthor ">Michael  Decker</span>. </span><span class="cited-content_cbyCitation_article-title">7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo. </span><span class="cited-content_cbyCitation_journal-name">Redox Biology</span><span> <strong>2020,</strong> <em>29 </em>, 101378. <a href="https://doi.org/10.1016/j.redox.2019.101378" title="DOI URL">https://doi.org/10.1016/j.redox.2019.101378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.redox.2019.101378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.redox.2019.101378%26sid%3Dliteratum%253Aachs%26jtitle%3DRedox%2520Biology%26atitle%3D7-O-Esters%252Bof%252Btaxifolin%252Bwith%252Bpronounced%252Band%252Boveradditive%252Beffects%252Bin%252Bneuroprotection%25252C%252Banti-neuroinflammation%25252C%252Band%252Bamelioration%252Bof%252Bshort-term%252Bmemory%252Bimpairment%252Bin%252Bvivo%26aulast%3DGunesch%26aufirst%3DSandra%26date%3D2020%26volume%3D29%26spage%3D101378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diego Alejandro  Rodríguez-Soacha</span>, <span class="hlFld-ContribAuthor ">Matthias  Scheiner</span>, <span class="hlFld-ContribAuthor ">Michael  Decker</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>180 </em>, 690-706. <a href="https://doi.org/10.1016/j.ejmech.2019.07.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.07.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.07.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMulti-target-directed-ligands%252Bacting%252Bas%252Benzyme%252Binhibitors%252Band%252Breceptor%252Bligands%26aulast%3DRodr%25C3%25ADguez-Soacha%26aufirst%3DDiego%2BAlejandro%26date%3D2019%26volume%3D180%26spage%3D690%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Javier  Pérez-Areales</span>, <span class="hlFld-ContribAuthor ">Andreea L.  Turcu</span>, <span class="hlFld-ContribAuthor ">Marta  Barniol-Xicota</span>, <span class="hlFld-ContribAuthor ">Caterina  Pont</span>, <span class="hlFld-ContribAuthor ">Deborah  Pivetta</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>, <span class="hlFld-ContribAuthor ">Francesc X.  Sureda</span>, <span class="hlFld-ContribAuthor ">Santiago  Vázquez</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>180 </em>, 613-626. <a href="https://doi.org/10.1016/j.ejmech.2019.07.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.07.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.07.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnovel%252Bclass%252Bof%252Bmultitarget%252Banti-Alzheimer%252Bbenzohomoadamantane%2525E2%252580%252592chlorotacrine%252Bhybrids%252Bmodulating%252Bcholinesterases%252Band%252Bglutamate%252BNMDA%252Breceptors%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJavier%26date%3D2019%26volume%3D180%26spage%3D613%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavan  Srivastava</span>, <span class="hlFld-ContribAuthor ">Prabhash Nath  Tripathi</span>, <span class="hlFld-ContribAuthor ">Piyoosh  Sharma</span>, <span class="hlFld-ContribAuthor ">Sushant Kumar  Shrivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of novel N-(4-phenoxybenzyl)aniline derivatives targeting acetylcholinesterase, β-amyloid aggregation and oxidative stress to treat Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (16)
                                     , 3650-3662. <a href="https://doi.org/10.1016/j.bmc.2019.07.001" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.07.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bnovel%252BN-%2525284-phenoxybenzyl%252529aniline%252Bderivatives%252Btargeting%252Bacetylcholinesterase%25252C%252B%2525CE%2525B2-amyloid%252Baggregation%252Band%252Boxidative%252Bstress%252Bto%252Btreat%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSrivastava%26aufirst%3DPavan%26date%3D2019%26volume%3D27%26issue%3D16%26spage%3D3650%26epage%3D3662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bérénice  Hatat</span>, <span class="hlFld-ContribAuthor ">Samir  Yahiaoui</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2019,</strong> <em>11 </em><a href="https://doi.org/10.3389/fnagi.2019.00148" title="DOI URL">https://doi.org/10.3389/fnagi.2019.00148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2019.00148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2019.00148%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DA%252BNovel%252Bin%252Bvivo%252BAnti-amnesic%252BAgent%25252C%252BSpecially%252BDesigned%252Bto%252BExpress%252BBoth%252BAcetylcholinesterase%252B%252528AChE%252529%252BInhibitory%25252C%252BSerotonergic%252BSubtype%252B4%252BReceptor%252B%2525285-HT4R%252529%252BAgonist%252Band%252BSerotonergic%252BSubtype%252B6%252BReceptor%252B%2525285-HT6R%252529%252BInverse%252BAgonist%252BActivities%25252C%252BWith%252Ba%252BPotential%252BInterest%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHatat%26aufirst%3DB%25C3%25A9r%25C3%25A9nice%26date%3D2019%26date%3D2019%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. F.  Makhaeva</span>, <span class="hlFld-ContribAuthor ">E. V.  Rudakova</span>, <span class="hlFld-ContribAuthor ">N. V.  Kovaleva</span>, <span class="hlFld-ContribAuthor ">S. V.  Lushchekina</span>, <span class="hlFld-ContribAuthor ">N. P.  Boltneva</span>, <span class="hlFld-ContribAuthor ">A. N.  Proshin</span>, <span class="hlFld-ContribAuthor ">E. V.  Shchegolkov</span>, <span class="hlFld-ContribAuthor ">Ya. V.  Burgart</span>, <span class="hlFld-ContribAuthor ">V. I.  Saloutin</span>. </span><span class="cited-content_cbyCitation_article-title">Cholinesterase and carboxylesterase inhibitors as pharmacological agents. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2019,</strong> <em>68 </em>
                                    (5)
                                     , 967-984. <a href="https://doi.org/10.1007/s11172-019-2507-2" title="DOI URL">https://doi.org/10.1007/s11172-019-2507-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-019-2507-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-019-2507-2%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DCholinesterase%252Band%252Bcarboxylesterase%252Binhibitors%252Bas%252Bpharmacological%252Bagents%26aulast%3DMakhaeva%26aufirst%3DG.%2BF.%26date%3D2019%26date%3D2019%26volume%3D68%26issue%3D5%26spage%3D967%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lanlan  Jing</span>, <span class="hlFld-ContribAuthor ">Gaochan  Wu</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (2)
                                     , 629-635. <a href="https://doi.org/10.1016/j.drudis.2018.11.012" title="DOI URL">https://doi.org/10.1016/j.drudis.2018.11.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2018.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2018.11.012%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DContemporary%252Bmedicinal-chemistry%252Bstrategies%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bbutyrylcholinesterase%252Binhibitors%26aulast%3DJing%26aufirst%3DLanlan%26date%3D2019%26volume%3D24%26issue%3D2%26spage%3D629%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng-Zhi  Gao</span>, <span class="hlFld-ContribAuthor ">Wei  Dong</span>, <span class="hlFld-ContribAuthor ">Zhi-Wen  Cui</span>, <span class="hlFld-ContribAuthor ">Qiong  Yuan</span>, <span class="hlFld-ContribAuthor ">Xia-Min  Hu</span>, <span class="hlFld-ContribAuthor ">Qing-Ming  Wu</span>, <span class="hlFld-ContribAuthor ">Xianlin  Han</span>, <span class="hlFld-ContribAuthor ">Yao  Xu</span>, <span class="hlFld-ContribAuthor ">Zhen-Li  Min</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 150-162. <a href="https://doi.org/10.1080/14756366.2018.1530224" title="DOI URL">https://doi.org/10.1080/14756366.2018.1530224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1530224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1530224%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bpreliminarily%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdocking%252Bstudy%252Bof%252Bnew%252BOlaparib%252Banalogues%252Bas%252Bmultifunctional%252BPARP-1%252Band%252Bcholinesterase%252Binhibitors%26aulast%3DGao%26aufirst%3DCheng-Zhi%26date%3D2019%26date%3D2018%26volume%3D34%26issue%3D1%26spage%3D150%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Siyu  He</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 463-477. <a href="https://doi.org/10.1016/j.ejmech.2018.09.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDonepezil-based%252Bmulti-functional%252Bcholinesterase%252Binhibitors%252Bfor%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLi%26aufirst%3DQi%26date%3D2018%26volume%3D158%26spage%3D463%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Nicolas  Coquelle</span>, <span class="hlFld-ContribAuthor ">Anja  Pišlar</span>, <span class="hlFld-ContribAuthor ">Simon  Žakelj</span>, <span class="hlFld-ContribAuthor ">Marko  Jukič</span>, <span class="hlFld-ContribAuthor ">Matej  Sova</span>, <span class="hlFld-ContribAuthor ">Janez  Mravljak</span>, <span class="hlFld-ContribAuthor ">Florian  Nachon</span>, <span class="hlFld-ContribAuthor ">Xavier  Brazzolotto</span>, <span class="hlFld-ContribAuthor ">Janko  Kos</span>, <span class="hlFld-ContribAuthor ">Jacques-Philippe  Colletier</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 598-617. <a href="https://doi.org/10.1016/j.ejmech.2018.07.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMulti-target-directed%252Bligands%252Bfor%252Btreating%252BAlzheimer%252527s%252Bdisease%25253A%252BButyrylcholinesterase%252Binhibitors%252Bdisplaying%252Bantioxidant%252Band%252Bneuroprotective%252Bactivities%26aulast%3DKnez%26aufirst%3DDamijan%26date%3D2018%26volume%3D156%26spage%3D598%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Development of the second generation lead structures <b>B</b>, <b>C</b>, and <b>D</b> starting from AstraZeneca’s selective <i>h</i>CB<sub>2</sub>R agonist <b>A</b>, the first generation lead.<a onclick="showRef(event, 'ref36 ref44'); return false;" href="javascript:void(0);" class="ref ref36 ref44">(36, 44)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural compound design approaches carried out starting from lead compounds <b>A</b>–<b>D</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>o</i>-Phenylene Diamine Precursors <b>9</b>–<b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (i) H<sub>2</sub>SO<sub>4</sub>, EtOH, reflux, 24 h; (ii) HNEt<sub>2</sub>, (COCl)<sub>2</sub>, NEt<sub>3</sub>, DMF, 0 °C to rt, 5 h; (iii) NHR<sup>2</sup>, NEt<sub>3</sub>, EtOH, rt, 3 h; (iv) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, reflux, 6 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Benzimidazoles with Different Amide Moieties or Spacer Lengths<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (v) <i>o</i>-phenylene diamine <b>9</b>, <b>12</b>, or <b>13</b>, HBTU, NEt<sub>3</sub>, DMF, rt, 24 h; (vi) AcOH, reflux, 2 h; (vii) LiOH, THF/H<sub>2</sub>O, rt, 24 h; (viii) primary and secondary amines <b>a</b>–<b>e</b>, HBTU, NEt<sub>3</sub>, DMF, rt, 24 h; (ix) PBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 12 h; (x) piperidine, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, 12 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2-Amino Benzimidazoles<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (i) CS<sub>2</sub>, NEt<sub>3</sub>, Boc<sub>2</sub>O, THF, 0 °C to rt, 12 h; (ii) <i>o</i>-phenylene diamine <b>10</b> or <b>11</b>, THF, rt, 6 h; (iii) EDCI·HCl, NEt<sub>3</sub>, THF, reflux, 5 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Benzimidazoles with Electron-Withdrawing/Donating Substituents at Position 5<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (i) isopentylamine, NEt<sub>3</sub>, EtOH, rt, 24 h; (ii) Na<sub>2</sub>S·H<sub>2</sub>O, NaHCO<sub>3</sub>, MeOH/H<sub>2</sub>O, reflux, 4 h; (iii) 2-(4-ethoxyphenyl)acetic, HBTU, NEt<sub>3</sub>, DMF, rt, 12 h; (iv) AcOH, reflux, 6 h; (v) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, reflux, 6 h; (vi) benzoic acid, HBTU, NEt<sub>3</sub>, DMF, rt, 6 h.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plot of IC<sub>50</sub> values for <i>h</i>BChE inhibition against p<i>K</i><sub>i</sub> values of <i>h</i>CB<sub>2</sub>R affinity. Compounds with no significant affinity for one of the targets are placed on the black lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Amino acid sequence alignment of the <i>h</i>CB<sub>1</sub>R (UniProtKB accession code: P21554) and the <i>h</i>CB<sub>2</sub>R (UniProtKB accession code: P34972). Asterisk: highly conserved amino acids, according to the Ballesteros and Weinstein nomenclature. Yellow boxes: amino acids, different between <i>h</i>CB<sub>1</sub>R and <i>h</i>CB<sub>2</sub>R. Gray boxes: amino acids of the <i>h</i>CB<sub>2</sub>R, not included in the homology model within the present work. Cyan boxes: part of the E2-loop, deleted in the <i>h</i>CB<sub>1</sub>R template and inserted by “LoopSearch” according to the amino acid sequence of the <i>h</i>CB<sub>2</sub>R. Green boxes: part of the I3-loop of the <i>h</i>CB<sub>2</sub>R, inserted by “LoopSearch”.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking poses (mode 1 and mode 2) of <b>20a</b> compared to the pose of compound AM11542 in the <i>h</i>CB<sub>1</sub>R-crystal structure (5XRA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0006.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Orthosteric binding pocket of the <i>h</i>CB<sub>2</sub>R with compound <b>20a</b> as well as internal water molecules and the allosteric binding site, as obtained by MD simulations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Interaction sites of the <i>h</i>CB<sub>2</sub>R with (a) the benzimidazole core, (b) the isopentyl side chain (R<sup>2</sup>), (c) the 4-ethoxy phenyl moiety (R<sup>3</sup>), and (d) the carbonyl moiety (mediated by water molecules) of compound <b>20a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Interaction network between the <i>h</i>CB<sub>2</sub>R and internal water molecules between the orthosteric (Val<sup>3.32</sup>) and allosteric (Asp<sup>2.50</sup>) binding site, obtained by MD simulations in the presence of <b>20a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (a) Overlay of <b>20a</b> and <b>20d</b> in the binding pocket of the <i>h</i>CB<sub>2</sub>R, obtained by MD simulations. (b) Differences in H-bond interactions between the <i>h</i>CB<sub>2</sub>R and <b>20a</b> or <b>20d</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Test compounds (<b>A</b>–<b>D</b>, <b>20a</b>–<b>c</b>, <b>20e</b>, and <b>23</b>) reduce MIF and STAT-3 gene expression. U266 cells were treated with test compounds (50 μM), forskolin (10 μM), or AM630 (25 μM) for 2 h. In combination experiment (AM630 plus test compounds), U266 cells were preincubated with AM630 for 30 min before adding the test compounds. MIF and STAT-3 mRNA levels were determined by qRT-PCR. GAPDH was used for normalization. Data are expressed as relative fold with respect to vehicle-treated cells used as the control. Data are expressed as mean ± SD *<i>p</i> < 0.01 vs untreated; # vs AM630.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structural similarities between etonitazene<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and (exemplary) lead compound <b>D</b>: an electron-withdrawing substituent at position 5 of the benzimidazole (red), a 4-ethoxybenzyl moiety at position 2 (green), and a basic amine linked with an ethylene bridge to <i>N</i><sup>1</sup> (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Protocol followed. Abbreviations key: Cpd, compound; ICV, intracerebroventricular injection; YMT, spontaneous alternation test in the Y-maze; ST-PA, step-through passive avoidance test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Effect of test compounds <b>A</b>, <b>B</b>, and <b>20a</b> on Aβ<sub>25–35</sub>-induced spontaneous alternation deficits in mice. Animals received Aβ<sub>25–35</sub> or Sc.Aβ peptide (9 nmol ICV) on day 1 and the test compounds (0.3 mg/kg ip) or vehicle solution (V, DMSO 20% in saline or DMSO 20%, Tween-80 2% in saline) od between days 1–7. Alternation performance was tested on day 8. Data shown mean ± SEM. ANOVA: F<sub>(4,54)</sub> = 6.55, <i>p</i> < 0.001, <i>n</i> = 9–14 per group in part a; F<sub>(4,54)</sub> = 5.43, <i>p</i> < 0.001, <i>n</i> = 8–14 per group in part b; F<sub>(4,57)</sub> = 4.05, <i>p</i> < 0.01, <i>n</i> = 9–14 per group in part c; F<sub>(4,54)</sub> = 2.72, <i>p</i> < 0.05 in part d; F<sub>(4,54)</sub> = 4.70, <i>p</i> < 0.01 in part e; F<sub>(4,57)</sub> = 0.59, <i>p</i> > 0.05 in part f. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 vs (Sc.Aβ+V)-treated group; ## <i>p</i> < 0.01, ### <i>p</i> < 0.001 vs (Aβ<sub>25–35</sub>+V)-treated group; Dunnett’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/medium/jm-2017-017608_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Effect of test compounds <b>A</b>, <b>B</b>, and <b>20a</b> on Aβ<sub>25–35</sub>-induced passive avoidance deficits in mice. Animals received Aβ<sub>25–35</sub> or Sc.Aβ peptide (9 nmol ICV) on day 1 and the test compounds (0.3 mg/kg ip) or vehicle solution (V, DMSO 20% in saline or DMSO 20%, Tween-80 2% in saline) od between days 1–7. Training was performed on day 9 and retention measured on day 10. Data show median and interquartile range. Kruskal–Wallis ANOVA: H = 19.0, <i>p</i> < 0.001, <i>n</i> = 9–14 per group in part a; H = 15.0, <i>p</i> < 0.01, <i>n</i> = 8–14 per group in part b; H = 21.1, <i>p</i> < 0.001, <i>n</i> = 11–14 in part c; H = 6.89, <i>p</i> > 0.05 in part d; H = 6.34, <i>p</i> > 0.05 in part e; H = 19.7, <i>p</i> < 0.001 in part f. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 vs (Sc.Aβ+V)-treated group; # <i>p</i> < 0.05, ## <i>p</i> < 0.01 vs (Aβ<sub>25–35</sub>+V)-treated group; Dunn’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-4/acs.jmedchem.7b01760/20180215/images/large/jm-2017-017608_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01760&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 72 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Prince, M.; Comas-Herrera, A.; Knapp, M.; Guerchet, M., Karagiannidou, M.</span> <span class="citation_source-book">World Alzheimer Report 2016; Improving healthcare for people living with dementia; Coverage, quality and costs now and in the future</span>; <span class="NLM_publisher-name">Alzheimer’s Disease International (ADI)</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+Prince&author=A.+Comas-Herrera&author=M.+Knapp&author=M.+Guerchet&author=M.+Karagiannidou&title=World+Alzheimer+Report+2016%3B+Improving+healthcare+for+people+living+with+dementia%3B+Coverage%2C+quality+and+costs+now+and+in+the+future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26btitle%3DWorld%2520Alzheimer%2520Report%25202016%253B%2520Improving%2520healthcare%2520for%2520people%2520living%2520with%2520dementia%253B%2520Coverage%252C%2520quality%2520and%2520costs%2520now%2520and%2520in%2520the%2520future%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%2520%2528ADI%2529%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Zemek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drtinova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepsova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span> </span><span class="NLM_article-title">Outcomes of Alzheimer’s disease therapy with acetylcholinesterase inhibitors and memantine</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=759-774&author=F.+Zemekauthor=L.+Drtinovaauthor=E.+Nepovimovaauthor=V.+Sepsovaauthor=J.+Korabecnyauthor=J.+Klimesauthor=K.+Kuca&title=Outcomes+of+Alzheimer%E2%80%99s+disease+therapy+with+acetylcholinesterase+inhibitors+and+memantine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZemek%26aufirst%3DF.%26aulast%3DDrtinova%26aufirst%3DL.%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DKlimes%26aufirst%3DJ.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DOutcomes%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%2520with%2520acetylcholinesterase%2520inhibitors%2520and%2520memantine%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2014%26volume%3D6%26spage%3D759%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ballard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aarsland, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span><span class="refDoi"> DOI: 10.1016/S0140-6736(10)61349-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS0140-6736%2810%2961349-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=21371747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADC%252BC3M3otlCqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=1019-1031&author=C.+Ballardauthor=S.+Gauthierauthor=A.+Corbettauthor=C.+Brayneauthor=D.+Aarslandauthor=E.+Jones&title=Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2810%2961349-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Ballard Clive; Gauthier Serge; Corbett Anne; Brayne Carol; Aarsland Dag; Jones Emma</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">9770</span>),
    <span class="NLM_cas:pages">1019-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">An estimated 24 million people worldwide have dementia, the majority of whom are thought to have Alzheimer's disease.  Thus, Alzheimer's disease represents a major public health concern and has been identified as a research priority.  Although there are licensed treatments that can alleviate symptoms of Alzheimer's disease, there is a pressing need to improve our understanding of pathogenesis to enable development of disease-modifying treatments.  Methods for improving diagnosis are also moving forward, but a better consensus is needed for development of a panel of biological and neuroimaging biomarkers that support clinical diagnosis.  There is now strong evidence of potential risk and protective factors for Alzheimer's disease, dementia, and cognitive decline, but further work is needed to understand these better and to establish whether interventions can substantially lower these risks.  In this Seminar, we provide an overview of recent evidence regarding the epidemiology, pathogenesis, diagnosis, and treatment of Alzheimer's disease, and discuss potential ways to reduce the risk of developing the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPHrxmEUcI2DdblLE_E9PWfW6udTcc2eZ-6gkwX-oE8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3otlCqtQ%253D%253D&md5=e37ee3fb78a85dfc774b372d0a9af0c5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2961349-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252961349-9%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DC.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DCorbett%26aufirst%3DA.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DAarsland%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DE.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26spage%3D1019%26epage%3D1031%26doi%3D10.1016%2FS0140-6736%2810%2961349-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Duyckaerts, C.; Dickson, D.</span><span> </span><span class="NLM_article-title">Neuropathology of Alzheimer’s disease and its variants</span>. In  <span class="citation_source-book">Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders</span>; <span class="NLM_contrib-group">Dickson, D.; Weller, R.</span>, Eds.; <span class="NLM_publisher-name">Wiley-Blackwell</span>: <span class="NLM_publisher-loc">Oxford</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">2</span>, pp  <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2F9781444341256.ch10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=62-91&author=C.+Duyckaerts&author=D.+Dicksonauthor=D.+Dickson&author=R.+Weller&title=Neurodegeneration%3A+The+Molecular+Pathology+of+Dementia+and+Movement+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2F9781444341256.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781444341256.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DDuyckaerts%26aufirst%3DC.%26atitle%3DNeuropathology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520its%2520variants%26btitle%3DNeurodegeneration%253A%2520The%2520Molecular%2520Pathology%2520of%2520Dementia%2520and%2520Movement%2520Disorders%26aulast%3DDickson%26aufirst%3DD.%26pub%3DWiley-Blackwell%26date%3D2011%26volume%3D2%26spage%3D62%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ferrer, I.</span><span> </span><span class="NLM_article-title">Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2012.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.pneurobio.2012.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=22459297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADC%252BC38rgs1GgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2012&pages=38-51&author=I.+Ferrer&title=Defining+Alzheimer+as+a+common+age-related+neurodegenerative+process+not+inevitably+leading+to+dementia&doi=10.1016%2Fj.pneurobio.2012.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia</span></div><div class="casAuthors">Ferrer Isidro</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since the description by Alois Alzheimer, more than 50 years have passed during which senile dementia and pre-senile dementia have been considered Alzheimer disease (AD) on the basis of their common neuropathological and clinical manifestations.  AD now covers pre-senile dementia, senile dementia, mild cognitive impairment and pre-clinical AD, all of them within the context of AD-related pathology.  However, there is still a gray area between normal aging with AD-related pathology and AD.  Here it is proposed that Alzheimer (or alzheimer) is an age-related neurodegenerative process distinguished from normal aging by the presence of senile plaques and neurofibrillary tangles.  Alzheimer affects about 80% of individuals aged 65 years but dementia only occurs in a small percentage of individuals at this age; prevalence of dementia in Alzheimer increases to 25% in individuals aged 80 years.  The concepts derived from the β-amyloid hypothesis support β-amyloid as a conductor in the pathogenesis of familial AD and as a prodding factor in sporadic AD.  Moreover, seeding of β-amyloid and truncated tau explains incorporation, enhancement and perpetuation of AD-related changes.  Therefore, the earliest Alzheimer changes confined to selected regions are the first grounds and the main risk factor for developing dementia.  The term Alzheimer embraces this assumption and likens its meaning to other degenerative biological processes, such as atherosclerosis, that may eventually progress to disease.  In this context, the first stages of Alzheimer should be considered as primary targets of therapeutic intervention in order to prevent progression to diseased states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8RZSMq5h6HMAKB7Fa-xrUfW6udTcc2eYwltLdmxKfALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rgs1GgtA%253D%253D&md5=60276ba23f11747b14a35ea1e18c45bf</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2012.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2012.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DFerrer%26aufirst%3DI.%26atitle%3DDefining%2520Alzheimer%2520as%2520a%2520common%2520age-related%2520neurodegenerative%2520process%2520not%2520inevitably%2520leading%2520to%2520dementia%26jtitle%3DProg.%2520Neurobiol.%26date%3D2012%26volume%3D97%26spage%3D38%26epage%3D51%26doi%3D10.1016%2Fj.pneurobio.2012.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wyss-Coray, T.</span><span> </span><span class="NLM_article-title">Inflammation in Alzheimer disease: driving force, bystander or beneficial response?</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=16960575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFClurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1005-1015&author=T.+Wyss-Coray&title=Inflammation+in+Alzheimer+disease%3A+driving+force%2C+bystander+or+beneficial+response%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation in Alzheimer disease: driving force, bystander or beneficial response?</span></div><div class="casAuthors">Wyss-Coray, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1005-1015</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease is a progressive dementia with unknown etiol. that affects a growing no. of the aging population.  Increased expression of inflammatory mediators in postmortem brains of people with Alzheimer disease has been reported, and epidemiol. studies link the use of anti-inflammatory drugs with reduced risk for the disorder.  On the initial basis of this kind of evidence, inflammation has been proposed as a possible cause or driving force of Alzheimer disease.  If true, this could have important implications for the development of new treatments.  Alternatively, inflammation could simply be a byproduct of the disease process and may not substantially alter its course.  Or components of the inflammatory response might even be beneficial and slow the disease.  To address these possibilities, we need to det. whether inflammation in Alzheimer disease is an early event, whether it is genetically linked with the disease and whether manipulation of inflammatory pathways changes the course of the pathol.  Although there is still little evidence that inflammation triggers or promotes Alzheimer disease, increasing evidence from mouse models suggests that certain inflammatory mediators are potent drivers of the disease.  Related factors, on the other hand, elicit beneficial responses and can reduce disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYCLID8AGyfLVg90H21EOLACvtfcHk0lhMt9zIdhGoSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFClurs%253D&md5=5d9aace20aebc0af42f7d7cafe877e19</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyss-Coray%26aufirst%3DT.%26atitle%3DInflammation%2520in%2520Alzheimer%2520disease%253A%2520driving%2520force%252C%2520bystander%2520or%2520beneficial%2520response%253F%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D1005%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Perry, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, J. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, C.</span><span> </span><span class="NLM_article-title">Microglia in neurodegenerative disease</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1038/nrneurol.2010.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnrneurol.2010.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=20234358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADC%252BC3c3kslyntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=193-201&author=V.+H.+Perryauthor=J.+A.+R.+Nicollauthor=C.+Holmes&title=Microglia+in+neurodegenerative+disease&doi=10.1038%2Fnrneurol.2010.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia in neurodegenerative disease</span></div><div class="casAuthors">Perry V Hugh; Nicoll James A R; Holmes Clive</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">193-201</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Microglia, the resident macrophages of the CNS, are exquisitely sensitive to brain injury and disease, altering their morphology and phenotype to adopt a so-called activated state in response to pathophysiological brain insults.  Morphologically activated microglia, like other tissue macrophages, exist as many different phenotypes, depending on the nature of the tissue injury.  Microglial responsiveness to injury suggests that these cells have the potential to act as diagnostic markers of disease onset or progression, and could contribute to the outcome of neurodegenerative diseases.  The persistence of activated microglia long after acute injury and in chronic disease suggests that these cells have an innate immune memory of tissue injury and degeneration.  Microglial phenotype is also modified by systemic infection or inflammation.  Evidence from some preclinical models shows that systemic manipulations can ameliorate disease progression, although data from other models indicates that systemic inflammation exacerbates disease progression.  Systemic inflammation is associated with a decline in function in patients with chronic neurodegenerative disease, both acutely and in the long term.  The fact that diseases with a chronic systemic inflammatory component are risk factors for Alzheimer disease implies that crosstalk occurs between systemic inflammation and microglia in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQICI_RTJIiGzC850By6mxpfW6udTcc2ebjs0YFTsCsDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3kslyntw%253D%253D&md5=efb215a8a737c924905e7aa04a5b6706</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2010.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2010.17%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DV.%2BH.%26aulast%3DNicoll%26aufirst%3DJ.%2BA.%2BR.%26aulast%3DHolmes%26aufirst%3DC.%26atitle%3DMicroglia%2520in%2520neurodegenerative%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D193%26epage%3D201%26doi%3D10.1038%2Fnrneurol.2010.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Matsuda, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lolait, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownstein, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, T. I.</span><span> </span><span class="NLM_article-title">Structure of cannabinoid receptor and functional expression of the cloned cDNA</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1038/346561a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2F346561a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=561-564&author=L.+A.+Matsudaauthor=S.+J.+Lolaitauthor=M.+J.+Brownsteinauthor=A.+C.+Youngauthor=T.+I.+Bonner&title=Structure+of+cannabinoid+receptor+and+functional+expression+of+the+cloned+cDNA&doi=10.1038%2F346561a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F346561a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F346561a0%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DL.%2BA.%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DBrownstein%26aufirst%3DM.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BC.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26atitle%3DStructure%2520of%2520cannabinoid%2520receptor%2520and%2520functional%2520expression%2520of%2520the%2520cloned%2520cDNA%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D561%26epage%3D564%26doi%3D10.1038%2F346561a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chiurchiù, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span> </span><span class="NLM_article-title">Endocannabinoid signaling in innate and adaptive immunity</span> <span class="citation_source-journal">Immunology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1111/imm.12441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1111%2Fimm.12441" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2015&pages=352-364&author=V.+Chiurchi%C3%B9author=L.+Battistiniauthor=M.+Maccarrone&title=Endocannabinoid+signaling+in+innate+and+adaptive+immunity&doi=10.1111%2Fimm.12441"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fimm.12441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimm.12441%26sid%3Dliteratum%253Aachs%26aulast%3DChiurchi%25C3%25B9%26aufirst%3DV.%26aulast%3DBattistini%26aufirst%3DL.%26aulast%3DMaccarrone%26aufirst%3DM.%26atitle%3DEndocannabinoid%2520signaling%2520in%2520innate%2520and%2520adaptive%2520immunity%26jtitle%3DImmunology%26date%3D2015%26volume%3D144%26spage%3D352%26epage%3D364%26doi%3D10.1111%2Fimm.12441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Van Sickle, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouihate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittmann, Q. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharkey, K. A.</span><span> </span><span class="NLM_article-title">Identification and functional characterization of brainstem cannabinoid CB2 receptors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1126/science.1115740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1126%2Fscience.1115740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=16224028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2hurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=329-332&author=M.+D.+Van+Sickleauthor=M.+Duncanauthor=P.+J.+Kingsleyauthor=A.+Mouihateauthor=P.+Urbaniauthor=K.+Mackieauthor=N.+Stellaauthor=A.+Makriyannisauthor=D.+Piomelliauthor=J.+S.+Davisonauthor=L.+J.+Marnettauthor=V.+Di+Marzoauthor=Q.+J.+Pittmannauthor=K.+D.+Patelauthor=K.+A.+Sharkey&title=Identification+and+functional+characterization+of+brainstem+cannabinoid+CB2+receptors&doi=10.1126%2Fscience.1115740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and functional characterization of brainstem cannabinoid CB2 receptors</span></div><div class="casAuthors">Van Sickle, Marja D.; Duncan, Marnie; Kingsley, Philip J.; Mouihate, Abdeslam; Urbani, Paolo; Mackie, Ken; Stella, Nephi; Makriyannis, Alexandros; Piomelli, Daniele; Davison, Joseph S.; Marnett, Lawrence J.; Di Marzo, Vincenzo; Pittman, Quentin J.; Patel, Kamala D.; Sharkey, Keith A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">5746</span>),
    <span class="NLM_cas:pages">329-332</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The presence and function of CB2 receptors in central nervous system (CNS) neurons are controversial.  The authors report the expression of CB2 receptor mRNA and protein localization on brainstem neurons.  These functional CB2 receptors in the brainstem were activated by a CB2 receptor agonist, 2-arachidonoylglycerol, and by elevated endogenous levels of endocannabinoids, which also act at CB1 receptors.  CB2 receptors represent an alternative site of action of endocannabinoids that opens the possibility of nonpsychotropic therapeutic interventions using enhanced endocannabinoid levels in localized brain areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriWgg6LDIT0bVg90H21EOLACvtfcHk0lh-IKOdbmQ1uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2hurvL&md5=ab457ab0bd1b8e30ea927a1e61366323</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.1115740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1115740%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BSickle%26aufirst%3DM.%2BD.%26aulast%3DDuncan%26aufirst%3DM.%26aulast%3DKingsley%26aufirst%3DP.%2BJ.%26aulast%3DMouihate%26aufirst%3DA.%26aulast%3DUrbani%26aufirst%3DP.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DStella%26aufirst%3DN.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DDavison%26aufirst%3DJ.%2BS.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DPittmann%26aufirst%3DQ.%2BJ.%26aulast%3DPatel%26aufirst%3DK.%2BD.%26aulast%3DSharkey%26aufirst%3DK.%2BA.%26atitle%3DIdentification%2520and%2520functional%2520characterization%2520of%2520brainstem%2520cannabinoid%2520CB2%2520receptors%26jtitle%3DScience%26date%3D2005%26volume%3D310%26spage%3D329%26epage%3D332%26doi%3D10.1126%2Fscience.1115740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Núnez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazos, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbachano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fajardo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolón, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span> </span><span class="NLM_article-title">Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1002/syn.20050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fsyn.20050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=208-213&author=E.+N%C3%BAnezauthor=C.+Benitoauthor=M.+R.+Pazosauthor=A.+Barbachanoauthor=O.+Fajardoauthor=S.+Gonz%C3%A1lezauthor=R.+M.+Tol%C3%B3nauthor=J.+Romero&title=Cannabinoid+CB2+receptors+are+expressed+by+perivascular+microglial+cells+in+the+human+brain%3A+an+immunohistochemical+study&doi=10.1002%2Fsyn.20050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fsyn.20050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.20050%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25BAnez%26aufirst%3DE.%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DPazos%26aufirst%3DM.%2BR.%26aulast%3DBarbachano%26aufirst%3DA.%26aulast%3DFajardo%26aufirst%3DO.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DS.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB2%2520receptors%2520are%2520expressed%2520by%2520perivascular%2520microglial%2520cells%2520in%2520the%2520human%2520brain%253A%2520an%2520immunohistochemical%2520study%26jtitle%3DSynapse%26date%3D2004%26volume%3D53%26spage%3D208%26epage%3D213%26doi%3D10.1002%2Fsyn.20050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Grünblatt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zander, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monoranu, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arzberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roggendorf, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span> </span><span class="NLM_article-title">Comparison analysis of gene expression patterns between sporadic Alzheimer’s and Parkinson’s disease</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span><span class="refDoi"> DOI: 10.3233/JAD-2007-12402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.3233%2FJAD-2007-12402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=18198416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFKjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=291-311&author=E.+Gr%C3%BCnblattauthor=N.+Zanderauthor=J.+Bartlauthor=L.+Jieauthor=C.+M.+Monoranuauthor=T.+Arzbergerauthor=R.+Ravidauthor=W.+Roggendorfauthor=M.+Gerlachauthor=P.+Riederer&title=Comparison+analysis+of+gene+expression+patterns+between+sporadic+Alzheimer%E2%80%99s+and+Parkinson%E2%80%99s+disease&doi=10.3233%2FJAD-2007-12402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison Analysis of Gene Expression Patterns between Sporadic Alzheimer's and Parkinson's Disease</span></div><div class="casAuthors">Gruenblatt, Edna; Zander, Nicole; Bartl, Jasmin; Jie, Li; Monoranu, Camelia-Maria; Arzberger, Thomas; Ravid, Rivka; Roggendorf, Wolfgang; Gerlach, Manfred; Riederer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">291-311</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Sporadic Alzheimer's (AD) and Parkinson's disease (PD) are late-onset neurodegenerative diseases with tremendous impact on lives of affected individuals.  There is a great probability of developing concurrent Parkinsonism in AD and vice-versa than would be predicted by independent prevalence of each disease.  We hypothesize that in sporadic AD as well as PD a combination of environmental effects and gene expression may affect specific brain areas leading to neurodegeneration.  We profiled gene expression of AD compared to PD and age matched controls post-mortem in the hippocampus, the gyrus-frontalis-medius (Gfm) and the cerebellum using Gene-Chip microarray (Affymetrix) and quant.-real-time-RT-PCR.  Twelve genes altered in similar manner in AD and PD, while four genes showed differential expression profiles between AD and PD in different brain regions (cannabinoid-receptor-2, Histone-cluster-1-H3e, nicotinic-cholinergic-receptor-α6 and β-site-APP-cleaving enzyme-1).  Knowledge of selective gene expression profile can lead to better understanding of disease pathol. and development of specific diagnosis and effective therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt2Fj086--37Vg90H21EOLACvtfcHk0lhx-R5lb2V_QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFKjtA%253D%253D&md5=ca706394d8bc3649b7d316e42abd33f1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3233%2FJAD-2007-12402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2007-12402%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnblatt%26aufirst%3DE.%26aulast%3DZander%26aufirst%3DN.%26aulast%3DBartl%26aufirst%3DJ.%26aulast%3DJie%26aufirst%3DL.%26aulast%3DMonoranu%26aufirst%3DC.%2BM.%26aulast%3DArzberger%26aufirst%3DT.%26aulast%3DRavid%26aufirst%3DR.%26aulast%3DRoggendorf%26aufirst%3DW.%26aulast%3DGerlach%26aufirst%3DM.%26aulast%3DRiederer%26aufirst%3DP.%26atitle%3DComparison%2520analysis%2520of%2520gene%2520expression%2520patterns%2520between%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2007%26volume%3D12%26spage%3D291%26epage%3D311%26doi%3D10.3233%2FJAD-2007-12402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Solas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, M. J.</span><span> </span><span class="NLM_article-title">CB<sub>2</sub> receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span><span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2012.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.neurobiolaging.2012.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=22763024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSgtb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=805-808&author=M.+Solasauthor=P.+T.+Francisauthor=R.+Francoauthor=M.+J.+Ramirez&title=CB2+receptor+and+amyloid+pathology+in+frontal+cortex+of+Alzheimer%E2%80%99s+disease+patients&doi=10.1016%2Fj.neurobiolaging.2012.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients</span></div><div class="casAuthors">Solas, Maite; Francis, Paul T.; Franco, Rafael; Ramirez, Maria J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">805-808</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The cannabinoid system seems to play an important role in various neurodegenerative diseases including Alzheimer's disease (AD).  The relationship of cannabinoid receptors (CB1R and CB2R) to cognitive function and neuropathol. markers in AD remains unclear.  In the present study, postmortem cortical brain tissues (Brodmann area 10) from a cohort of neuropathol. confirmed AD patients and age-matched controls were used to measure CB1R and CB2R by immunoblotting.  Correlational analyses were performed for the neurochem. and cognitive data.  CB1R expression was significantly decreased in AD.  Levels of CB1R correlated with hypophagia, but not with any AD mol. marker or cognitive status (Mini Mental State Examn. score).  The level of CB2R was significantly higher (40%) in AD.  Increases in the expression of the glial marker glial fibrillar acidic protein were also found.  CB2R expression did not correlate with cognitive status.  Interestingly, expression levels of CB2R correlated with two relevant AD mol. markers, Aβ42 levels and senile plaque score.  These results may constitute the basis of CB2R-based therapies and/or diagnostic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK3Am3IXxWvbVg90H21EOLACvtfcHk0lhx-R5lb2V_QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSgtb3M&md5=e7605adc118eb1782772c686a49efebc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DSolas%26aufirst%3DM.%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DRamirez%26aufirst%3DM.%2BJ.%26atitle%3DCB2%2520receptor%2520and%2520amyloid%2520pathology%2520in%2520frontal%2520cortex%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D805%26epage%3D808%26doi%3D10.1016%2Fj.neurobiolaging.2012.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Fernández-Ruiz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolón, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzmán, M.</span><span> </span><span class="NLM_article-title">Cannabinoid CB<sub>2</sub> receptor: a new target for controlling neural cell survival?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1016/j.tips.2006.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.tips.2006.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=17141334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlOmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=39-45&author=J.+Fern%C3%A1ndez-Ruizauthor=J.+Romeroauthor=G.+Velascoauthor=R.+M.+Tol%C3%B3nauthor=J.+A.+Ramosauthor=M.+Guzm%C3%A1n&title=Cannabinoid+CB2+receptor%3A+a+new+target+for+controlling+neural+cell+survival%3F&doi=10.1016%2Fj.tips.2006.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptor: a new target for controlling neural cell survival?</span></div><div class="casAuthors">Fernandez-Ruiz, Javier; Romero, Julian; Velasco, Guillermo; Tolon, Rosa M.; Ramos, Jose A.; Guzman, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-45</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Two types of cannabinoid receptor have been cloned and characterized.  Whereas CB1 receptors are ubiquitously expressed in neurons of the CNS, CB2 receptors have been thought to be absent from the CNS.  Recent data now question this notion and support the expression of CB2 receptors in microglial cells, astrocytes and even some neuron subpopulations.  This discrete distribution makes CB2 receptors interesting targets for treating neurol. disorders because CB2-selective agonists lack psychoactivity.  Here, we review evidence supporting the idea that CB2 receptors are implicated in the control of fundamental neural cell processes, such as proliferation and survival, and that their pharmacol. manipulation might be useful for both delaying the progression of neurodegenerative disorders and inhibiting the growth of glial tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpNrWrT5XU9bVg90H21EOLACvtfcHk0lhyCHluk_U44Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlOmsw%253D%253D&md5=8f809e0332df14885c66df7e891294f2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Ruiz%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DVelasco%26aufirst%3DG.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DRamos%26aufirst%3DJ.%2BA.%26aulast%3DGuzm%25C3%25A1n%26aufirst%3DM.%26atitle%3DCannabinoid%2520CB2%2520receptor%253A%2520a%2520new%2520target%2520for%2520controlling%2520neural%2520cell%2520survival%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D39%26epage%3D45%26doi%3D10.1016%2Fj.tips.2006.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Molina-Holgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina-Holgado, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guaza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothwell, N. J.</span><span> </span><span class="NLM_article-title">Role of CB<sub>1</sub> and CB<sub>2</sub> receptors in the inhibitory effects of cannabinoids on liposaccharide-induced nitric oxide release in astrocyte cultures</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span><span class="refDoi"> DOI: 10.1002/jnr.10165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fjnr.10165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=11891798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFCgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=829-836&author=F.+Molina-Holgadoauthor=E.+Molina-Holgadoauthor=C.+Guazaauthor=N.+J.+Rothwell&title=Role+of+CB1+and+CB2+receptors+in+the+inhibitory+effects+of+cannabinoids+on+liposaccharide-induced+nitric+oxide+release+in+astrocyte+cultures&doi=10.1002%2Fjnr.10165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures</span></div><div class="casAuthors">Molina-Holgado, Francisco; Molina-Holgado, Eduardo; Guaza, Carmen; Rothwell, Nancy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">829-836</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate the role of the central cannabinoid receptor (CB1) in mediating the actions of the endogenous cannabinoid agonist anandamide and the synthetic cannabinoid CP-55940.  Activation of primary mouse astrocyte cultures by exposure to bacterial lipopolysaccharide (LPS) caused a marked (approx. tenfold) increase in nitric oxide (NO) release.  Coincubation with the cannabinoid agonists anandamide or CP-55940 markedly inhibited release of NO (-12% to -55%).  This effect was abolished by SR-141716A (1 μM), a CB1 receptor antagonist.  SR-141716A alone also significantly increased NO release in response to LPS, suggesting that endogenous cannabinoids modify inflammatory responses.  In contrast, coincubation with the CB2 receptor antagonist SR-144528 (1 μM) abolished the inhibitory effects of the endogenous cannabinoid anandamide on LPS-induced NO release, although this may reflect nonspecific effects of this ligand or cannabinoid actions through atypical receptors of anandamide.  We also showed that endogenous or synthetic cannabinoids inhibit LPS-induced inducible NO synthase expression (mRNA and protein) in astrocyte cultures.  These results indicate that CB1 receptors may promote antiinflammatory responses in astrocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob_NRvXnWJg7Vg90H21EOLACvtfcHk0lhyCHluk_U44Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFCgtLo%253D&md5=4a2e3e4f6d36a78359f79549e6ee4214</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjnr.10165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.10165%26sid%3Dliteratum%253Aachs%26aulast%3DMolina-Holgado%26aufirst%3DF.%26aulast%3DMolina-Holgado%26aufirst%3DE.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DRothwell%26aufirst%3DN.%2BJ.%26atitle%3DRole%2520of%2520CB1%2520and%2520CB2%2520receptors%2520in%2520the%2520inhibitory%2520effects%2520of%2520cannabinoids%2520on%2520liposaccharide-induced%2520nitric%2520oxide%2520release%2520in%2520astrocyte%2520cultures%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2002%26volume%3D67%26spage%3D829%26epage%3D836%26doi%3D10.1002%2Fjnr.10165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sheng, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabral, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokensgard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, P. K.</span><span> </span><span class="NLM_article-title">Synthetic cannabinoid WIN55,212–2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1002/glia.20108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fglia.20108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=211-219&author=W.+S.+Shengauthor=S.+Huauthor=X.+Minauthor=G.+A.+Cabralauthor=J.+R.+Lokensgardauthor=P.+K.+Peterson&title=Synthetic+cannabinoid+WIN55%2C212%E2%80%932+inhibits+generation+of+inflammatory+mediators+by+IL-1beta-stimulated+human+astrocytes&doi=10.1002%2Fglia.20108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fglia.20108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20108%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DW.%2BS.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DCabral%26aufirst%3DG.%2BA.%26aulast%3DLokensgard%26aufirst%3DJ.%2BR.%26aulast%3DPeterson%26aufirst%3DP.%2BK.%26atitle%3DSynthetic%2520cannabinoid%2520WIN55%252C212%25E2%2580%25932%2520inhibits%2520generation%2520of%2520inflammatory%2520mediators%2520by%2520IL-1beta-stimulated%2520human%2520astrocytes%26jtitle%3DGlia%26date%3D2005%26volume%3D49%26spage%3D211%26epage%3D219%26doi%3D10.1002%2Fglia.20108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ehrhart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obregon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shytle, R. D.</span><span> </span><span class="NLM_article-title">Stimulation of cannabinoid receptor 2 (CB<sub>2</sub>) suppresses microglial activation</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="refDoi"> DOI: 10.1186/1742-2094-2-29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1186%2F1742-2094-2-29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=16343349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FlvFWnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=29&author=J.+Ehrhartauthor=D.+Obregonauthor=T.+Moriauthor=H.+Houauthor=N.+Sunauthor=Y.+Baiauthor=T.+Kleinauthor=F.+Fernandezauthor=J.+Tanauthor=R.+D.+Shytle&title=Stimulation+of+cannabinoid+receptor+2+%28CB2%29+suppresses+microglial+activation&doi=10.1186%2F1742-2094-2-29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation</span></div><div class="casAuthors">Ehrhart Jared; Obregon Demian; Mori Takashi; Hou Huayan; Sun Nan; Bai Yun; Klein Thomas; Fernandez Francisco; Tan Jun; Shytle R Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Activated microglial cells have been implicated in a number of neurodegenerative disorders, including Alzheimer's disease (AD), multiple sclerosis (MS), and HIV dementia.  It is well known that inflammatory mediators such as nitric oxide (NO), cytokines, and chemokines play an important role in microglial cell-associated neuron cell damage.  Our previous studies have shown that CD40 signaling is involved in pathological activation of microglial cells.  Many data reveal that cannabinoids mediate suppression of inflammation in vitro and in vivo through stimulation of cannabinoid receptor 2 (CB2).  METHODS:  In this study, we investigated the effects of a cannabinoid agonist on CD40 expression and function by cultured microglial cells activated by IFN-gamma using RT-PCR, Western immunoblotting, flow cytometry, and anti-CB2 small interfering RNA (siRNA) analyses.  Furthermore, we examined if the stimulation of CB2 could modulate the capacity of microglial cells to phagocytise Abeta1-42 peptide using a phagocytosis assay.  RESULTS:  We found that the selective stimulation of cannabinoid receptor CB2 by JWH-015 suppressed IFN-gamma-induced CD40 expression.  In addition, this CB2 agonist markedly inhibited IFN-gamma-induced phosphorylation of JAK/STAT1.  Further, this stimulation was also able to suppress microglial TNF-alpha and nitric oxide production induced either by IFN-gamma or Abeta peptide challenge in the presence of CD40 ligation.  Finally, we showed that CB2 activation by JWH-015 markedly attenuated CD40-mediated inhibition of microglial phagocytosis of Abeta1-42 peptide.  Taken together, these results provide mechanistic insight into beneficial effects provided by cannabinoid receptor CB2 modulation in neurodegenerative diseases, particularly AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwpZCNS5cmhmhHGZei4OW9fW6udTcc2eaALLu1raXh4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FlvFWnsA%253D%253D&md5=516f5264a60d5aa11675107dbd0e8879</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-2-29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-2-29%26sid%3Dliteratum%253Aachs%26aulast%3DEhrhart%26aufirst%3DJ.%26aulast%3DObregon%26aufirst%3DD.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DN.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DKlein%26aufirst%3DT.%26aulast%3DFernandez%26aufirst%3DF.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DShytle%26aufirst%3DR.%2BD.%26atitle%3DStimulation%2520of%2520cannabinoid%2520receptor%25202%2520%2528CB2%2529%2520suppresses%2520microglial%2520activation%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2005%26volume%3D2%26spage%3D29%26doi%3D10.1186%2F1742-2094-2-29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naguib, M.</span><span> </span><span class="NLM_article-title">Activation of the CB<sub>2</sub> receptor system reverses amyloid-induced memory deficiency</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span><span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2012.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.neurobiolaging.2012.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=22795792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVektLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=791-804&author=J.+Wuauthor=B.+Bieauthor=H.+Yangauthor=J.+J.+Xuauthor=D.+L.+Brownauthor=M.+Naguib&title=Activation+of+the+CB2+receptor+system+reverses+amyloid-induced+memory+deficiency&doi=10.1016%2Fj.neurobiolaging.2012.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the CB2 receptor system reverses amyloid-induced memory deficiency</span></div><div class="casAuthors">Wu, Jiang; Bie, Bihua; Yang, Hui; Xu, Jijun J.; Brown, David L.; Naguib, Mohamed</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">791-804</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Cannabinoid type 2 (CB2) agonists are neuroprotective and appear to play modulatory roles in neurodegenerative processes in Alzheimer's disease.  We have studied the effect of 1-((3-benzyl-3-methyl-2,3-dihydro-1-benzofuran-6-yl) carbonyl) piperidine (MDA7)-a novel selective CB2 agonist that lacks psychoactivity-on ameliorating the neuroinflammatory process, synaptic dysfunction, and cognitive impairment induced by bilateral microinjection of amyloid-β (Aβ)1-40 fibrils into the hippocampal CA1 area of rats.  In rats injected with Aβ1-40 fibrils, compared with the administration of i.p. saline for 14 days, treatment with 15 mg/kg of i.p. MDA7 daily for 14 days (1) ameliorated the expression of CD11b (microglia marker) and glial fibrillary acidic protein (astrocyte marker), (2) decreased the secretion of interleukin-1β, (3) decreased the upsurge of CB2 receptors, (4) promoted Aβ clearance, and (5) restored synaptic plasticity, cognition, and memory.  Our findings suggest that MDA7 is an innovative therapeutic approach for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqekBBhIM0ej7Vg90H21EOLACvtfcHk0ljPtQ4XHy0uXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVektLnO&md5=ee0c45a830bc6f4d2236ccfcee75b2ad</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DBie%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DJ.%2BJ.%26aulast%3DBrown%26aufirst%3DD.%2BL.%26aulast%3DNaguib%26aufirst%3DM.%26atitle%3DActivation%2520of%2520the%2520CB2%2520receptor%2520system%2520reverses%2520amyloid-induced%2520memory%2520deficiency%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D791%26epage%3D804%26doi%3D10.1016%2Fj.neurobiolaging.2012.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Martin-Moreno, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brera, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spuch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Garcia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innamorato, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuadrado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Ceballos, M. L.</span><span> </span><span class="NLM_article-title">Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1186/1742-2094-9-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1186%2F1742-2094-9-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=22248049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC38XksFGnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=8-12&author=A.+M.+Martin-Morenoauthor=B.+Breraauthor=C.+Spuchauthor=E.+Carroauthor=L.+Garcia-Garciaauthor=M.+Delgadoauthor=M.+A.+Pozoauthor=N.+G.+Innamoratoauthor=A.+Cuadradoauthor=M.+L.+de+Ceballos&title=Prolonged+oral+cannabinoid+administration+prevents+neuroinflammation%2C+lowers+%CE%B2-amyloid+levels+and+improves+cognitive+performance+in+Tg+APP+2576+mice&doi=10.1186%2F1742-2094-9-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice</span></div><div class="casAuthors">Martin-Moreno, Ana Maria; Brera, Begona; Spuch, Carlos; Carro, Eva; Garcia-Garcia, Luis; Delgado, Mercedes; Pozo, Miguel A.; Innamorato, Nadia G.; Cuadrado, Antonio; de Ceballos, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease (AD) brain shows an ongoing inflammatory condition and non-steroidal anti-inflammatories diminish the risk of suffering the neurol. disease.  Cannabinoids are neuroprotective and anti-inflammatory agents with therapeutic potential.  Methods: We have studied the effects of prolonged oral administration of transgenic amyloid precursor protein (APP) mice with two pharmacol. different cannabinoids (WIN 55,212-2 and JWH-133, 0.2 mg/kg/day in the drinking water during 4 mo) on inflammatory and cognitive parameters, and on 18F-fluoro-deoxyglucose (18FDG) uptake by positron emission tomog. (PET).  Results: Novel object recognition was significantly reduced in 11 mo old Tg APP mice and 4 mo administration of JWH was able to normalize this cognitive deficit, although WIN was ineffective.  Wild type mice cognitive performance was unaltered by cannabinoid administration.  Tg APP mice showed decreased 18FDG uptake in hippocampus and cortical regions, which was counteracted by oral JWH treatment.  Hippocampal GFAP immunoreactivity and cortical protein expression was unaffected by genotype or treatment.  In contrast, the d. of Iba1 pos. microglia was increased in Tg APP mice, and normalized following JWH chronic treatment.  Both cannabinoids were effective at reducing the enhancement of COX-2 protein levels and TNF-α mRNA expression found in the AD model.  Increased cortical β-amyloid (Aβ) levels were significantly reduced in the mouse model by both cannabinoids.  Noteworthy both cannabinoids enhanced Aβ transport across choroid plexus cells in vitro.  Conclusions: In summary we have shown that chronically administered cannabinoid showed marked beneficial effects concomitant with inflammation redn. and increased Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovz80RwKqgHbVg90H21EOLACvtfcHk0lgpYCNo2sVaVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksFGnt7k%253D&md5=f180a238cf921e7e18b87a9804219be1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-9-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-9-8%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Moreno%26aufirst%3DA.%2BM.%26aulast%3DBrera%26aufirst%3DB.%26aulast%3DSpuch%26aufirst%3DC.%26aulast%3DCarro%26aufirst%3DE.%26aulast%3DGarcia-Garcia%26aufirst%3DL.%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DPozo%26aufirst%3DM.%2BA.%26aulast%3DInnamorato%26aufirst%3DN.%2BG.%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3Dde%2BCeballos%26aufirst%3DM.%2BL.%26atitle%3DProlonged%2520oral%2520cannabinoid%2520administration%2520prevents%2520neuroinflammation%252C%2520lowers%2520%25CE%25B2-amyloid%2520levels%2520and%2520improves%2520cognitive%2520performance%2520in%2520Tg%2520APP%25202576%2520mice%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2012%26volume%3D9%26spage%3D8%26epage%3D12%26doi%3D10.1186%2F1742-2094-9-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Koppel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vingtdeux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marambaud, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">d’Abramo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span> </span><span class="NLM_article-title">CB<sub>2</sub> receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=357-364&author=J.+Koppelauthor=V.+Vingtdeuxauthor=P.+Marambaudauthor=C.+d%E2%80%99Abramoauthor=H.+Jimenezauthor=M.+Stauberauthor=R.+Friedmanauthor=P.+Davies&title=CB2+receptor+deficiency+increases+amyloid+pathology+and+alters+tau+processing+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoppel%26aufirst%3DJ.%26aulast%3DVingtdeux%26aufirst%3DV.%26aulast%3DMarambaud%26aufirst%3DP.%26aulast%3Dd%25E2%2580%2599Abramo%26aufirst%3DC.%26aulast%3DJimenez%26aufirst%3DH.%26aulast%3DStauber%26aufirst%3DM.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DDavies%26aufirst%3DP.%26atitle%3DCB2%2520receptor%2520deficiency%2520increases%2520amyloid%2520pathology%2520and%2520alters%2520tau%2520processing%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Med.%26date%3D2014%26volume%3D19%26spage%3D357%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Bisogno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccarrone, M.</span><span> </span><span class="NLM_article-title">Type-2 cannabinoid receptors in neurodegeneration</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1016/j.phrs.2016.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.phrs.2016.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=27450295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWnsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=721-730&author=T.+Bisognoauthor=S.+Oddiauthor=A.+Piccoliauthor=D.+Fazioauthor=M.+Maccarrone&title=Type-2+cannabinoid+receptors+in+neurodegeneration&doi=10.1016%2Fj.phrs.2016.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Type-2 cannabinoid receptors in neurodegeneration</span></div><div class="casAuthors">Bisogno, Tiziana; Oddi, Sergio; Piccoli, Alessandra; Fazio, Domenico; Maccarrone, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">721-730</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Based on its wide expression in immune cells, type-2 cannabinoid (CB2) receptors were traditionally thought to act as "peripheral receptors" with an almost exclusively immunomodulatory function.  However, their recent identification in mammalian brain areas, as well as in distinct neuronal cells, has opened the way to a re-consideration of CB2 signaling in the context of brain pathophysiol., synaptic plasticity and neuroprotection.  To date, accumulated evidence from several independent preclin. studies has offered new perspectives on the possible involvement of CB2 signaling in brain and spinal cord traumatic injury, as well as in the most relevant neurodegenerative disorders like Alzheimer's disease, Parkinson's disease and Huntington's chorea.  Here, we will review available information on CB2 in these disease conditions, along with data that support also its therapeutic potential to treat them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDLv1Yh2dX27Vg90H21EOLACvtfcHk0lgpYCNo2sVaVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWnsr7F&md5=b880502073163ef08a7af918544a7dd1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2016.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2016.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DOddi%26aufirst%3DS.%26aulast%3DPiccoli%26aufirst%3DA.%26aulast%3DFazio%26aufirst%3DD.%26aulast%3DMaccarrone%26aufirst%3DM.%26atitle%3DType-2%2520cannabinoid%2520receptors%2520in%2520neurodegeneration%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D111%26spage%3D721%26epage%3D730%26doi%3D10.1016%2Fj.phrs.2016.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A. J.</span><span> </span><span class="NLM_article-title">Selective loss of central cholinergic neurons in Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span><span class="refDoi"> DOI: 10.1016/S0140-6736(76)91936-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS0140-6736%2876%2991936-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=1976&pages=1403&author=P.+Daviesauthor=A.+J.+Maloney&title=Selective+loss+of+central+cholinergic+neurons+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0140-6736%2876%2991936-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2876%2991936-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252876%252991936-X%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMaloney%26aufirst%3DA.%2BJ.%26atitle%3DSelective%2520loss%2520of%2520central%2520cholinergic%2520neurons%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D1976%26volume%3D308%26spage%3D1403%26doi%3D10.1016%2FS0140-6736%2876%2991936-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Nordberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darreh-Shori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somogyi, M.</span><span> </span><span class="NLM_article-title">A Review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Prim. Care Companion CNS Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="refDoi"> DOI: 10.4088/PCC.12r01412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.4088%2FPCC.12r01412" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=2&author=A.+Nordbergauthor=C.+Ballardauthor=R.+Bullockauthor=T.+Darreh-Shoriauthor=M.+Somogyi&title=A+Review+of+butyrylcholinesterase+as+a+therapeutic+target+in+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.4088%2FPCC.12r01412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4088%2FPCC.12r01412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FPCC.12r01412%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26aulast%3DBallard%26aufirst%3DC.%26aulast%3DBullock%26aufirst%3DR.%26aulast%3DDarreh-Shori%26aufirst%3DT.%26aulast%3DSomogyi%26aufirst%3DM.%26atitle%3DA%2520Review%2520of%2520butyrylcholinesterase%2520as%2520a%2520therapeutic%2520target%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPrim.%2520Care%2520Companion%2520CNS%2520Disord.%26date%3D2013%26volume%3D15%26spage%3D2%26doi%3D10.4088%2FPCC.12r01412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Darvesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span> </span><span class="NLM_article-title">Neurobiology of butyrylcholinesterase</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1038/nrn1035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnrn1035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=12563284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=131-138&author=S.+Darveshauthor=D.+A.+Hopkinsauthor=C.+Geula&title=Neurobiology+of+butyrylcholinesterase&doi=10.1038%2Fnrn1035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Neurobiology of butyrylcholinesterase</span></div><div class="casAuthors">Darvesh, Sultan; Hopkins, David A.; Geula, Changiz</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-138</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Butyrylcholinesterase is a serine hydrolase related to acetylcholinesterase that catalyzes the hydrolysis of esters of choline, including acetylcholine.  Butyrylcholinesterase has unique enzymic properties and is widely distributed in the nervous system, pointing to its possible involvement in neural function.  Here, we summarize the biochem. properties of butyrylcholinesterase and review the evidence that this enzyme has important roles in cholinergic neurotransmission and could be involved in other nervous system functions and in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf8WbhaQUqP7Vg90H21EOLACvtfcHk0liDFOlwUPJUzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12hsg%253D%253D&md5=aeb5008a2c61e5feb48506f835899519</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnrn1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1035%26sid%3Dliteratum%253Aachs%26aulast%3DDarvesh%26aufirst%3DS.%26aulast%3DHopkins%26aufirst%3DD.%2BA.%26aulast%3DGeula%26aufirst%3DC.%26atitle%3DNeurobiology%2520of%2520butyrylcholinesterase%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D4%26spage%3D131%26epage%3D138%26doi%3D10.1038%2Fnrn1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Mesulam, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span> </span><span class="NLM_article-title">Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">722</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.1002/ana.410360506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fana.410360506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=7979218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADyaK2M%252FmvF2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1994&pages=722-727&author=M.+M.+Mesulamauthor=C.+Geula&title=Butyrylcholinesterase+reactivity+differentiates+the+amyloid+plaques+of+aging+from+those+of+dementia&doi=10.1002%2Fana.410360506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia</span></div><div class="casAuthors">Mesulam M M; Geula C</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">722-7</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">In a sample of consecutively received, 4 demented and 4 age-matched nondemented brains, the total cortical area covered by plaque-like A beta amyloid and butyrylcholinesterase deposits was measured at two regions of the temporal cortex with the help of computed densitometry.  Demented as well as age-matched nondemented brains contained A beta and butyrylcholinesterase-positive plaques.  The total cortical area covered by the A beta precipitates was higher in demented individuals but there was overlap with the values seen in the specimens from nondemented individuals.  The proportional plaque area displaying butyrylcholinesterase reactivity was very significantly and five fold to sixfold higher in the demented than in the nondemented group and there was no overlap between the two populations.  Diffuse A beta deposits in nondemented elderly brains may represent a benign or preclinical stage of plaque deposition with relatively little pathological effect on brain tissue and mental function.  Our results suggest that the progressively more extensive butyrylcholinesterase reactivity of plaques may participate in their transformation from a relatively benign form to pathogenic structures associated with neuritic degeneration and dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIhMoEIAbG5O-MdeMhXAHkfW6udTcc2eZqIwtkEFHmELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FmvF2gug%253D%253D&md5=85364c013028b9b0ccf028555d62c305</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fana.410360506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410360506%26sid%3Dliteratum%253Aachs%26aulast%3DMesulam%26aufirst%3DM.%2BM.%26aulast%3DGeula%26aufirst%3DC.%26atitle%3DButyrylcholinesterase%2520reactivity%2520differentiates%2520the%2520amyloid%2520plaques%2520of%2520aging%2520from%2520those%2520of%2520dementia%26jtitle%3DAnn.%2520Neurol.%26date%3D1994%26volume%3D36%26spage%3D722%26epage%3D727%26doi%3D10.1002%2Fana.410360506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Guillozet, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiley, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mash, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesulam, M. M.</span><span> </span><span class="NLM_article-title">Butyrylcholinesterase in the life cycle of amyloid plaques</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span><span class="refDoi"> DOI: 10.1002/ana.410420613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fana.410420613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=9403484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADyaK1c%252FmsFOnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1997&pages=909-918&author=A.+L.+Guillozetauthor=J.+F.+Smileyauthor=D.+C.+Mashauthor=M.+M.+Mesulam&title=Butyrylcholinesterase+in+the+life+cycle+of+amyloid+plaques&doi=10.1002%2Fana.410420613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase in the life cycle of amyloid plaques</span></div><div class="casAuthors">Guillozet A L; Smiley J F; Mash D C; Mesulam M M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">909-18</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">Deposits of diffuse beta-amyloid (Abeta) may exist in the brain for many years before leading to neuritic degeneration and dementia.  The factors that contribute to the putative transformation of the Abeta amyloid from a relatively inert to a pathogenic state remain unknown and may involve interactions with additional plaque constituents.  Matching brain sections from 2 demented and 4 nondemented subjects were processed for the demonstration of Abeta immunoreactivity, butyrylcholinesterase (BChE) enzyme activity, and thioflavine S binding.  Additional sections were processed for the concurrent demonstration of two or three of these markers.  A comparative analysis of multiple cytoarchitectonic areas processed with each of these markers indicated that Abeta plaque deposits are likely to undergo three stages of maturation, ie, a "diffuse" thioflavine S-negative stage, a thioflavine S-positive (ie, compact) but nonneuritic stage, and a compact neuritic stage.  A multiregional analysis showed that BChE-positive plaques were not found in cytoarchitectonic areas or cortical layers that contained only the thioflavine S-negative, diffuse type of Abeta plaques.  The BChE-positive plaques were found only in areas containing thioflavine S-positive compact plaques, both neuritic and nonneuritic.  Within such areas, almost all (>98%) BChE-containing plaques bound thioflavine S, and almost all (93%) thioflavine S plaques contained BChE.  These results suggest that BChE becomes associated with amyloid plaques at approximately the same time that the Abeta deposit assumes a compact beta-pleated conformation.  BChE may therefore participate in the transformation of Abeta from an initially benign form to an eventually malignant form associated with neuritic tissue degeneration and clinical dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2szOfqK4uRcvLc4ARHEmzfW6udTcc2eYaTKo-Tl3onbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c%252FmsFOnsA%253D%253D&md5=fc12e41d78b02a2fc06a65bd612aa13f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fana.410420613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410420613%26sid%3Dliteratum%253Aachs%26aulast%3DGuillozet%26aufirst%3DA.%2BL.%26aulast%3DSmiley%26aufirst%3DJ.%2BF.%26aulast%3DMash%26aufirst%3DD.%2BC.%26aulast%3DMesulam%26aufirst%3DM.%2BM.%26atitle%3DButyrylcholinesterase%2520in%2520the%2520life%2520cycle%2520of%2520amyloid%2520plaques%26jtitle%3DAnn.%2520Neurol.%26date%3D1997%26volume%3D42%26spage%3D909%26epage%3D918%26doi%3D10.1002%2Fana.410420613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Greig, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepeu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamczarz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambamurti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, D. K.</span><span> </span><span class="NLM_article-title">Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">17213</span><span class="NLM_x">–</span> <span class="NLM_lpage">17218</span><span class="refDoi"> DOI: 10.1073/pnas.0508575102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1073%2Fpnas.0508575102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=16275899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yksLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17213-17218&author=N.+H.+Greigauthor=T.+Utsukiauthor=D.+K.+Ingramauthor=Y.+Wangauthor=G.+Pepeuauthor=C.+Scaliauthor=Q.-S.+Yuauthor=J.+Mamczarzauthor=H.+W.+Hollowayauthor=T.+Giordanoauthor=D.+Chenauthor=K.+Furukawaauthor=K.+Sambamurtiauthor=A.+Brossiauthor=D.+K.+Lahiri&title=Selective+butyrylcholinesterase+inhibition+elevates+brain+acetylcholine%2C+augments+learning+and+lowers+Alzheimer+%CE%B2-amyloid+peptide+in+rodent&doi=10.1073%2Fpnas.0508575102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent</span></div><div class="casAuthors">Greig, Nigel H.; Utsuki, Tadanobu; Ingram, Donald K.; Wang, Yue; Pepeu, Giancarlo; Scali, Carla; Yu, Qian-Sheng; Mamczarz, Jacek; Holloway, Harold W.; Giordano, Tony; Chen, DeMao; Furukawa, Katsutoshi; Sambamurti, Kumar; Brossi, Arnold; Lahiri, Debomoy K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">17213-17218</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Like acetylcholinesterase, butyrylcholinesterase (BChE) inactivates the neurotransmitter acetylcholine (ACh) and is hence a viable therapeutic target in Alzheimer's disease, which is characterized by a cholinergic deficit.  Potent, reversible, and brain-targeted BChE inhibitors (cymserine analogs) were developed based on binding domain structures to help elucidate the role of this enzyme in the central nervous system.  In rats, cymserine analogs caused long-term inhibition of brain BChE and elevated extracellular ACh levels, without inhibitory effects on acetylcholinesterase.  In rat brain slices, selective BChE inhibition augmented long-term potentiation.  These compds. also improved the cognitive performance (maze navigation) of aged rats.  In cultured human SK-N-SH neuroblastoma cells, intra- and extracellular β-amyloid precursor protein, and secreted β-amyloid peptide levels were reduced without affecting cell viability.  Treatment of transgenic mice that overexpressed human mutant amyloid precursor protein also resulted in lower β-amyloid peptide brain levels than controls.  Selective, reversible inhibition of brain BChE may represent a treatment for Alzheimer's disease, improving cognition and modulating neuropathol. markers of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI6ACIUUc5wrVg90H21EOLACvtfcHk0lgtFEKneR3Kkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yksLfE&md5=a4ac89f6186f77125545c667f9efbe21</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0508575102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0508575102%26sid%3Dliteratum%253Aachs%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DUtsuki%26aufirst%3DT.%26aulast%3DIngram%26aufirst%3DD.%2BK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DQ.-S.%26aulast%3DMamczarz%26aufirst%3DJ.%26aulast%3DHolloway%26aufirst%3DH.%2BW.%26aulast%3DGiordano%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DSambamurti%26aufirst%3DK.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DLahiri%26aufirst%3DD.%2BK.%26atitle%3DSelective%2520butyrylcholinesterase%2520inhibition%2520elevates%2520brain%2520acetylcholine%252C%2520augments%2520learning%2520and%2520lowers%2520Alzheimer%2520%25CE%25B2-amyloid%2520peptide%2520in%2520rodent%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D17213%26epage%3D17218%26doi%3D10.1073%2Fpnas.0508575102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span> </span><span class="NLM_article-title">Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.ejmech.2017.03.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=28371641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1Kgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2017&pages=294-309&author=Q.+Liauthor=H.+Yangauthor=Y.+Chenauthor=H.+Sun&title=Recent+progress+in+the+identification+of+selective+butyrylcholinesterase+inhibitors+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2017.03.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Li, Qi; Yang, Hongyu; Chen, Yao; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">294-309</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders with notable factor of dysfunction in cholinergic system.  Low ACh level can be obsd. in the pathogenesis of AD.  Several AChE inhibitors have already been used for clin. treatments.  However, other than normal conditions, ACh is mostly hydrolyzed by BuChE in progressed AD.  Account for an increased level of BuChE and decreased level of AChE in the late stage of AD, development of selective BuChE inhibitor is of vital importance.  Up till now, compds. with various scaffolds have been discovered to selectively inhibit BuChE.  Different effective anti-BuChE mols. are concluded in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDt6Tt3Xrt4rVg90H21EOLACvtfcHk0lgtFEKneR3Kkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1Kgs78%253D&md5=75d8199f06da3d1b2b27d43510067720</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.062%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DRecent%2520progress%2520in%2520the%2520identification%2520of%2520selective%2520butyrylcholinesterase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D132%26spage%3D294%26epage%3D309%26doi%3D10.1016%2Fj.ejmech.2017.03.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sawatzky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bringmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Discovery of highly selective and nanomolar carbamate-based butyrylcholinesterase inhibitors by rational investigation into their inhibition mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2067</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01674</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01674" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis1Gks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2067-2082&author=E.+Sawatzkyauthor=S.+Wehleauthor=B.+Klingauthor=J.+Wendrichauthor=G.+Bringmannauthor=C.+A.+Sotrifferauthor=J.+Heilmannauthor=M.+Decker&title=Discovery+of+highly+selective+and+nanomolar+carbamate-based+butyrylcholinesterase+inhibitors+by+rational+investigation+into+their+inhibition+mode&doi=10.1021%2Facs.jmedchem.5b01674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27cR"><div class="casContent"><span class="casTitleNuber">27c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode</span></div><div class="casAuthors">Sawatzky, Edgar; Wehle, Sarah; Kling, Beata; Wendrich, Jan; Bringmann, Gerhard; Sotriffer, Christoph A.; Heilmann, Joerg; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2067-2082</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Butyrylcholinesterase (BChE) is a promising target for the treatment of later stage cognitive decline in Alzheimer's disease.  A set of pseudo-irreversible BChE inhibitors with high selectivity over hAChE was synthesized based on carbamates attached to tetrahydroquinazoline scaffolds with the 2-thiophenyl compd. I (R = n-heptyl) as the most potent inhibitor of eqBChE (KC = 14.3 nM) and also of hBChE (KC = 19.7 nM).  The inhibitors transfer the carbamate moiety onto the active site under release of the phenolic tetrahydroquinazoline scaffolds that themselves act as neuroprotectants.  By combination of kinetic data with mol. docking studies, a plausible binding model was probed describing how the tetrahydroquinazoline scaffold guides the carbamate into a close position to the active site.  The model explains the influence of the carrier scaffold onto the affinity of an inhibitor just before carbamate transfer.  This strategy can be used to utilize the binding mode of other carbamate-based inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrU8IRPStxUbVg90H21EOLACvtfcHk0lh73ItZ0N6rlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis1Gks7Y%253D&md5=3498d21d7e134df2ad55505fdc22c313</span></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01674%26sid%3Dliteratum%253Aachs%26aulast%3DSawatzky%26aufirst%3DE.%26aulast%3DWehle%26aufirst%3DS.%26aulast%3DKling%26aufirst%3DB.%26aulast%3DWendrich%26aufirst%3DJ.%26aulast%3DBringmann%26aufirst%3DG.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DHeilmann%26aufirst%3DJ.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520highly%2520selective%2520and%2520nanomolar%2520carbamate-based%2520butyrylcholinesterase%2520inhibitors%2520by%2520rational%2520investigation%2520into%2520their%2520inhibition%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2067%26epage%3D2082%26doi%3D10.1021%2Facs.jmedchem.5b01674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strehaiano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siméon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatonnet, A.</span><span> </span><span class="NLM_article-title">Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/j.bbr.2015.08.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bbr.2015.08.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=26306824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVOqt7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2016&pages=351-360&author=T.+Mauriceauthor=M.+Strehaianoauthor=N.+Sim%C3%A9onauthor=C.+Bertrandauthor=A.+Chatonnet&title=Learning+performances+and+vulnerability+to+amyloid+toxicity+in+the+butyrylcholinesterase+knockout+mouse&doi=10.1016%2Fj.bbr.2015.08.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse</span></div><div class="casAuthors">Maurice, Tangui; Strehaiano, Manon; Simeon, Nathalie; Bertrand, Christelle; Chatonnet, Arnaud</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">351-360</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Butyrylcholinesterase (BChE) is an important enzyme for detoxication and metab. of ester compds.  It also hydrolyzes the neurotransmitter acetylcholine (ACh) in pathol. conditions and may play a role in Alzheimer's disease (AD).  We here compared the learning ability and vulnerability to Aβ toxicity in male and female BChE knockout (KO) mice and their 129 Sv wild-type (Wt) controls.  Animals tested for place learning in the water-maze showed increased acquisition slopes and presence in the training quadrant during the probe test.  An increased passive avoidance response was also obsd. for males.  BChE KO mice therefore showed enhanced learning ability in spatial and non-spatial memory tests.  Intracerebroventricular (ICV) injection of increasing doses of amyloid-β[25-35] (Aβ25-35) peptide oligomers resulted, in Wt mice, in learning and memory deficits, oxidative stress and decrease in ACh hippocampal content.  In BChE KO mice, the Aβ25-35-induced deficit in place learning was attenuated in males and blocked in females.  No change in lipid peroxidn. or ACh levels was obsd. after Aβ25-35 treatment in male or female BChE KO mice.  These data showed that the genetic invalidation of BChE in mice augmented learning capacities and lowered the vulnerability to Aβ toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV3M4M6LenzrVg90H21EOLACvtfcHk0lh73ItZ0N6rlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOqt7bP&md5=1b8f7885ee358acacce167f61ea2599c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2015.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2015.08.026%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DStrehaiano%26aufirst%3DM.%26aulast%3DSim%25C3%25A9on%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DC.%26aulast%3DChatonnet%26aufirst%3DA.%26atitle%3DLearning%2520performances%2520and%2520vulnerability%2520to%2520amyloid%2520toxicity%2520in%2520the%2520butyrylcholinesterase%2520knockout%2520mouse%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D296%26spage%3D351%26epage%3D360%26doi%3D10.1016%2Fj.bbr.2015.08.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kosak, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakelj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trontelj, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pislar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slenc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zivin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tratnjek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podkowa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nachon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazzolotto, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieckowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malawska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mlinaric Rascan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coquelle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletier, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span> </span><span class="NLM_article-title">Development of an <i>in-vivo</i> active reversible butyrylcholinesterase inhibitor</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">39495</span><span class="NLM_x">–</span> <span class="NLM_lpage">39510</span><span class="refDoi"> DOI: 10.1038/srep39495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fsrep39495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=28000737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGju7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=39495-39510&author=U.+Kosakauthor=B.+Brusauthor=D.+Knezauthor=R.+Sinkauthor=S.+Zakeljauthor=J.+Tronteljauthor=A.+Pislarauthor=J.+Slencauthor=M.+Gobecauthor=M.+Zivinauthor=L.+Tratnjekauthor=M.+Perseauthor=K.+Salatauthor=A.+Podkowaauthor=B.+Filipekauthor=F.+Nachonauthor=X.+Brazzolottoauthor=A.+Wieckowskaauthor=B.+Malawskaauthor=J.+Stojanauthor=I.+Mlinaric+Rascanauthor=J.+Kosauthor=N.+Coquelleauthor=J.-P.+Colletierauthor=S.+Gobec&title=Development+of+an+in-vivo+active+reversible+butyrylcholinesterase+inhibitor&doi=10.1038%2Fsrep39495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Development of an in-vivo active reversible butyrylcholinesterase inhibitor</span></div><div class="casAuthors">Kosak, Urban; Brus, Boris; Knez, Damijan; Sink, Roman; Zakelj, Simon; Trontelj, Jurij; Pislar, Anja; Slenc, Jasna; Gobec, Martina; Zivin, Marko; Tratnjek, Larisa; Perse, Martina; Salat, Kinga; Podkowa, Adrian; Filipek, Barbara; Nachon, Florian; Brazzolotto, Xavier; Wieckowska, Anna; Malawska, Barbara; Stojan, Jure; Rascan, Irena Mlinaric; Kos, Janko; Coquelle, Nicolas; Colletier, Jacques-Philippe; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39495</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by severe basal forebrain cholinergic deficit, which results in progressive and chronic deterioration of memory and cognitive functions.  Similar to acetylcholinesterase, butyrylcholinesterase (BChE) contributes to the termination of cholinergic neurotransmission.  Its enzymic activity increases with the disease progression, thus classifying BChE as a viable therapeutic target in advanced AD.  Potent, selective and reversible human BChE inhibitors were developed.  The solved crystal structure of human BChE in complex with the most potent inhibitor reveals its binding mode and provides the mol. basis of its low nanomolar potency.  Addnl., this compd. is noncytotoxic and has neuroprotective properties.  Furthermore, this inhibitor moderately crosses the blood-brain barrier and improves memory, cognitive functions and learning abilities of mice in a model of the cholinergic deficit that characterizes AD, without producing acute cholinergic adverse effects.  Our study provides an advanced lead compd. for developing drugs for alleviating symptoms caused by cholinergic hypofunction in advanced AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0VM7BEyEMGbVg90H21EOLACvtfcHk0lh73ItZ0N6rlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGju7nJ&md5=fdec90109df9052d9b7340e45c7e7feb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep39495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep39495%26sid%3Dliteratum%253Aachs%26aulast%3DKosak%26aufirst%3DU.%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DKnez%26aufirst%3DD.%26aulast%3DSink%26aufirst%3DR.%26aulast%3DZakelj%26aufirst%3DS.%26aulast%3DTrontelj%26aufirst%3DJ.%26aulast%3DPislar%26aufirst%3DA.%26aulast%3DSlenc%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DZivin%26aufirst%3DM.%26aulast%3DTratnjek%26aufirst%3DL.%26aulast%3DPerse%26aufirst%3DM.%26aulast%3DSalat%26aufirst%3DK.%26aulast%3DPodkowa%26aufirst%3DA.%26aulast%3DFilipek%26aufirst%3DB.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DBrazzolotto%26aufirst%3DX.%26aulast%3DWieckowska%26aufirst%3DA.%26aulast%3DMalawska%26aufirst%3DB.%26aulast%3DStojan%26aufirst%3DJ.%26aulast%3DMlinaric%2BRascan%26aufirst%3DI.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DCoquelle%26aufirst%3DN.%26aulast%3DColletier%26aufirst%3DJ.-P.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520an%2520in-vivo%2520active%2520reversible%2520butyrylcholinesterase%2520inhibitor%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D39495%26epage%3D39510%26doi%3D10.1038%2Fsrep39495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Darvesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span> </span><span class="NLM_article-title">Neurobiology of butyrylcholinesterase</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1038/nrn1035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnrn1035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=12563284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=131-138&author=S.+Darveshauthor=D.+A.+Hopkinsauthor=C.+Geula&title=Neurobiology+of+butyrylcholinesterase&doi=10.1038%2Fnrn1035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Neurobiology of butyrylcholinesterase</span></div><div class="casAuthors">Darvesh, Sultan; Hopkins, David A.; Geula, Changiz</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-138</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Butyrylcholinesterase is a serine hydrolase related to acetylcholinesterase that catalyzes the hydrolysis of esters of choline, including acetylcholine.  Butyrylcholinesterase has unique enzymic properties and is widely distributed in the nervous system, pointing to its possible involvement in neural function.  Here, we summarize the biochem. properties of butyrylcholinesterase and review the evidence that this enzyme has important roles in cholinergic neurotransmission and could be involved in other nervous system functions and in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf8WbhaQUqP7Vg90H21EOLACvtfcHk0lgRM-zKxWBHIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12hsg%253D%253D&md5=aeb5008a2c61e5feb48506f835899519</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrn1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1035%26sid%3Dliteratum%253Aachs%26aulast%3DDarvesh%26aufirst%3DS.%26aulast%3DHopkins%26aufirst%3DD.%2BA.%26aulast%3DGeula%26aufirst%3DC.%26atitle%3DNeurobiology%2520of%2520butyrylcholinesterase%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D4%26spage%3D131%26epage%3D138%26doi%3D10.1038%2Fnrn1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Wright, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesulam, M.-M.</span><span> </span><span class="NLM_article-title">Neurological cholinesterases in the normal brain and in Alzheimer’s disease: relationship to plaques, tangles, and patterns of selective vulnerability</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span><span class="refDoi"> DOI: 10.1002/ana.410340312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fana.410340312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=8363355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADyaK3szntFSisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=373-384&author=C.+I.+Wrightauthor=C.+Geulaauthor=M.-M.+Mesulam&title=Neurological+cholinesterases+in+the+normal+brain+and+in+Alzheimer%E2%80%99s+disease%3A+relationship+to+plaques%2C+tangles%2C+and+patterns+of+selective+vulnerability&doi=10.1002%2Fana.410340312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability</span></div><div class="casAuthors">Wright C I; Geula C; Mesulam M M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-84</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">Butyrylcholinesterase (BChE) and an altered form of acetylcholinesterase (AChE) accumulate in the plaques and tangles of Alzheimer's disease (AD).  The sources for these plaque- and tangle-bound cholinesterases have not been identified.  We now report that AChE and BChE activities with pH preferences and inhibitor selectivities identical to those of plaque- and tangle-bound cholinesterases are found in the astrocytes and oligodendrocytes of control and AD brains.  These glial-type cholinesterases are selectively inhibited by indolamines and protease inhibitors.  In control brains glial-type cholinesterases appear confined to the intracellular space, whereas in patients with AD they decorate plaques and tangles as well.  In control and AD brains AChE-positive glia are distributed throughout the cortical layers and subcortical white matter, whereas BChE-positive glia reach high densities only in the deep cortical layers and white matter.  In non-AD control brains, the ratio of BChE to AChE glia was higher in entorhinal and inferotemporal cortex, two regions with a high susceptibility to the pathology of AD, than in primary somatosensory and visual cortex, two areas with a relatively lower susceptibility to the disease process.  There was no age-related differences in the density or distribution of cholinesterase-positive glia.  In comparison with age-matched control specimens, AD brains had a significantly higher density of BChE glia and a lower density of AChE glia in entorhinal and inferotemporal regions but not in the primary somatosensory or visual areas.  These results suggest that glia constitute a likely source for the cholinesterase activity of plaques and tangles and that a high ratio of BChE- to AChE-positive glia may play a permissive or causative role in the neuropathology of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPUmjxU3wJE02yPDyEFiigfW6udTcc2ebX0tm53YExMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szntFSisw%253D%253D&md5=024c8bf904699ff4a3002c4d0801ceb3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fana.410340312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410340312%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DC.%2BI.%26aulast%3DGeula%26aufirst%3DC.%26aulast%3DMesulam%26aufirst%3DM.-M.%26atitle%3DNeurological%2520cholinesterases%2520in%2520the%2520normal%2520brain%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520relationship%2520to%2520plaques%252C%2520tangles%252C%2520and%2520patterns%2520of%2520selective%2520vulnerability%26jtitle%3DAnn.%2520Neurol.%26date%3D1993%26volume%3D34%26spage%3D373%26epage%3D384%26doi%3D10.1002%2Fana.410340312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span><span class="refDoi"> DOI: 10.1021/jm058225d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm&doi=10.1021%2Fjm058225d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lgRM-zKxWBHIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543%26doi%3D10.1021%2Fjm058225d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uliassi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena-Altamira, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesaresi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Multitarget drug design strategy: quinone–tacrine hybrids designed To block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8576</span><span class="NLM_x">–</span> <span class="NLM_lpage">8589</span><span class="refDoi"> DOI: 10.1021/jm5010804</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010804" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8576-8589&author=E.+Nepovimovaauthor=E.+Uliassiauthor=J.+Korabecnyauthor=L.+E.+Pena-Altamiraauthor=S.+Samezauthor=A.+Pesaresiauthor=G.+E.+Garciaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=C.+Bergaminiauthor=R.+Fatoauthor=D.+Lambaauthor=M.+Robertiauthor=K.+Kucaauthor=B.+Montiauthor=M.+L.+Bolognesi&title=Multitarget+drug+design+strategy%3A+quinone%E2%80%93tacrine+hybrids+designed+To+block+amyloid-%CE%B2+aggregation+and+to+exert+anticholinesterase+and+antioxidant+effects&doi=10.1021%2Fjm5010804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1021%2Fjm5010804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010804%26sid%3Dliteratum%253Aachs%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DPena-Altamira%26aufirst%3DL.%2BE.%26aulast%3DSamez%26aufirst%3DS.%26aulast%3DPesaresi%26aufirst%3DA.%26aulast%3DGarcia%26aufirst%3DG.%2BE.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBergamini%26aufirst%3DC.%26aulast%3DFato%26aufirst%3DR.%26aulast%3DLamba%26aufirst%3DD.%26aulast%3DRoberti%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DMultitarget%2520drug%2520design%2520strategy%253A%2520quinone%25E2%2580%2593tacrine%2520hybrids%2520designed%2520To%2520block%2520amyloid-%25CE%25B2%2520aggregation%2520and%2520to%2520exert%2520anticholinesterase%2520and%2520antioxidant%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8576%26epage%3D8589%26doi%3D10.1021%2Fjm5010804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolezal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babkova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondrejicek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepsova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrabinova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soukup, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muckova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span> </span><span class="NLM_article-title">Tacrine–Trolox Hybrids: A novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8985</span><span class="NLM_x">–</span> <span class="NLM_lpage">9003</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01325</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01325" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8985-9003&author=E.+Nepovimovaauthor=J.+Korabecnyauthor=R.+Dolezalauthor=K.+Babkovaauthor=A.+Ondrejicekauthor=D.+Junauthor=V.+Sepsovaauthor=A.+Horovaauthor=M.+Hrabinovaauthor=O.+Soukupauthor=N.+Bukumauthor=P.+Jostauthor=L.+Muckovaauthor=J.+Kassaauthor=D.+Malinakauthor=M.+Andrsauthor=K.+Kuca&title=Tacrine%E2%80%93Trolox+Hybrids%3A+A+novel+class+of+centrally+active%2C+nonhepatotoxic+multi-target-directed+ligands+exerting+anticholinesterase+and+antioxidant+activities+with+low+in+vivo+toxicity&doi=10.1021%2Facs.jmedchem.5b01325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span></div><div class="casAuthors">Nepovimova, Eugenie; Korabecny, Jan; Dolezal, Rafael; Babkova, Katerina; Ondrejicek, Ales; Jun, Daniel; Sepsova, Vendula; Horova, Anna; Hrabinova, Martina; Soukup, Ondrej; Bukum, Neslihan; Jost, Petr; Muckova, Lubica; Kassa, Jiri; Malinak, David; Andrs, Martin; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8985-9003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coupling of two distinct pharmacophores, tacrine and trolox, endowed with different biol. properties, afforded 21 hybrid compds. as novel multifunctional candidates against Alzheimer's disease.  Several of them showed improved inhibitory properties toward acetylcholinesterase (AChE) in relation to tacrine.  These hybrids also scavenged free radicals.  Mol. modeling studies in tandem with kinetic anal. exhibited that these hybrids target both catalytic active site as well as peripheral anionic site of AChE.  In addn., incorporation of the moiety bearing antioxidant abilities displayed negligible toxicity on human hepatic cells.  This striking effect was explained by formation of nontoxic metabolites after 1 h incubation in human liver microsomes system.  Finally, tacrine-trolox hybrids exhibited low in vivo toxicity after i.m. administration in rats and potential to penetrate across blood-brain barrier.  All of these outstanding in vitro results in combination with promising in vivo outcomes highlighted deriv. I as the lead structure worthy of further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWjX4tC8Sy17Vg90H21EOLACvtfcHk0lijiUz5yC2JqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI&md5=550bddcd59b5bbb90d77e67faca28839</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01325%26sid%3Dliteratum%253Aachs%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DBabkova%26aufirst%3DK.%26aulast%3DOndrejicek%26aufirst%3DA.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DHorova%26aufirst%3DA.%26aulast%3DHrabinova%26aufirst%3DM.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DBukum%26aufirst%3DN.%26aulast%3DJost%26aufirst%3DP.%26aulast%3DMuckova%26aufirst%3DL.%26aulast%3DKassa%26aufirst%3DJ.%26aulast%3DMalinak%26aufirst%3DD.%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DTacrine%25E2%2580%2593Trolox%2520Hybrids%253A%2520A%2520novel%2520class%2520of%2520centrally%2520active%252C%2520nonhepatotoxic%2520multi-target-directed%2520ligands%2520exerting%2520anticholinesterase%2520and%2520antioxidant%2520activities%2520with%2520low%2520in%2520vivo%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8985%26epage%3D9003%26doi%3D10.1021%2Facs.jmedchem.5b01325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Spilovska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolezal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezeiova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soukup, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span> </span><span class="NLM_article-title">Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1006</span><span class="NLM_x">–</span> <span class="NLM_lpage">1026</span><span class="refDoi"> DOI: 10.2174/1568026605666160927152728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.2174%2F1568026605666160927152728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=27697055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVOrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=1006-1026&author=K.+Spilovskaauthor=J.+Korabecnyauthor=E.+Nepovimovaauthor=R.+Dolezalauthor=E.+Mezeiovaauthor=O.+Soukupauthor=K.+Kuca&title=Multitarget+tacrine+hybrids+with+neuroprotective+properties+to+confront+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1568026605666160927152728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease</span></div><div class="casAuthors">Spilovska, Katarina; Korabecny, Jan; Nepovimova, Eugenie; Dolezal, Rafael; Mezeiova, Eva; Soukup, Ondrej; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1006-1026</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder.  Several hallmarks such as β-amyloid (Aβ) aggregation underlying amyloid plaque formation, τ-hyperphosphorylation leading to prodn. of neurofibrillary tangles, and decline in the no. of cholinergic neurons appear to be fundamental in the pathophysiol. of the disease.  Other evidence points also to the involvement of oxidative stress, biometal dyshomeostasis, inflammation, and cell cycle regulatory failure.  Taking into account such premises, many attractive targets for the development of anti-AD drugs have emerged.  Specifically, the multifactorial nature of AD calls for multi-target-directed ligands (MTDLs) which can be beneficial by providing interactions with multiple targets.  Tacrine (THA), the first clin. effective acetylcholinesterase inhibitor, was approved for the treatment of mild to moderate AD.  Unfortunately, frequent adverse effects including peripheral cholinergic effects and hepatotoxicity limited its therapeutic potential.  Based on the numerous biol. systems involved in AD progression, this review covers THA-incorporated hybrids possessing a neuroprotective profile.  In particular, it focuses on THA hybrids capable of scavenging reactive oxygen species (ROS), and derivs. which reduce the formation of Aβ-plaques either directly by confronting the Aβ1-42 selfaggregation process or indirectly by inhibiting the BACE-1 enzyme or AChE-induced Aβ1-40 aggregation.  Particular interest is also addressed to THA hybrids with suppressed hepatotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp91WDdPABL1bVg90H21EOLACvtfcHk0lijiUz5yC2JqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVOrurc%253D&md5=395db30019a8773fc2915161d2dae231</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.2174%2F1568026605666160927152728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026605666160927152728%26sid%3Dliteratum%253Aachs%26aulast%3DSpilovska%26aufirst%3DK.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DMezeiova%26aufirst%3DE.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DMultitarget%2520tacrine%2520hybrids%2520with%2520neuroprotective%2520properties%2520to%2520confront%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D1006%26epage%3D1026%26doi%3D10.2174%2F1568026605666160927152728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Nimczick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span><span class="refDoi"> DOI: 10.1002/cmdc.201500041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fcmdc.201500041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=25820617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlt1alu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=773-786&author=M.+Nimczickauthor=M.+Decker&title=New+approaches+in+the+design+and+development+of+cannabinoid+receptor+ligands%3A+multifunctional+and+bivalent+compounds&doi=10.1002%2Fcmdc.201500041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds</span></div><div class="casAuthors">Nimczick, Martin; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">773-786</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Since the identification of the endocannabinoid system, two G protein-coupled receptors (GPCRs) of this complex system were identified and characterized: cannabinoid receptors type 1 (CB1R) and type 2 (CB2R).  In addn. to orthosteric and subsequently allosteric ligands, new strategies have been used to target CBRs.  Bivalent ligands and multifunctional ligands acting at diverse biol. targets have been designed, synthesized, and characterized for both CBRs.  Due to their altered receptor binding and pharmacol. profiles, they are interesting tools to explore CBR functions and their interactions with other physiol. systems.  Moreover, this approach may bear therapeutic advantages in the therapy of CBR-related disorders, esp. multifactorial diseases.  Promising prospects include anorectics with fewer side effects, analgesics with decreased tolerance, and therapeutics with multiple pharmacol. activities for the treatment of cancer, inflammation, multiple sclerosis, Huntington's and Alzheimer's diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO0S1iWc8qP7Vg90H21EOLACvtfcHk0lijiUz5yC2JqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlt1alu7s%253D&md5=48866ef33207c0dcb703225d1e2e577e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500041%26sid%3Dliteratum%253Aachs%26aulast%3DNimczick%26aufirst%3DM.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DNew%2520approaches%2520in%2520the%2520design%2520and%2520development%2520of%2520cannabinoid%2520receptor%2520ligands%253A%2520multifunctional%2520and%2520bivalent%2520compounds%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D773%26epage%3D786%26doi%3D10.1002%2Fcmdc.201500041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Dolles, D.; Decker, M.</span><span> </span><span class="NLM_article-title">Dual-acting compounds acting as receptor ligands and enzyme inhibitors</span>. In  <span class="citation_source-book">Design of Hybrid Molecules for Drug Development</span>; <span class="NLM_contrib-group">Decker, M.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FB978-0-08-101011-2.00005-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=137-165&author=D.+Dolles&author=M.+Deckerauthor=M.+Decker&title=Design+of+Hybrid+Molecules+for+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FB978-0-08-101011-2.00005-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-08-101011-2.00005-2%26sid%3Dliteratum%253Aachs%26aulast%3DDolles%26aufirst%3DD.%26atitle%3DDual-acting%2520compounds%2520acting%2520as%2520receptor%2520ligands%2520and%2520enzyme%2520inhibitors%26btitle%3DDesign%2520of%2520Hybrid%2520Molecules%2520for%2520Drug%2520Development%26aulast%3DDecker%26aufirst%3DM.%26pub%3DElsevier%26date%3D2017%26spage%3D137%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Dolles, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimczick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadtmüller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawatzky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Aminobenzimidazoles and structural isomers as templates for dual-acting butyrylcholinesterase inhibitors and <i>h</i>CB<sub>2</sub>R ligands to combat neurodegenerative disorders</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span><span class="refDoi"> DOI: 10.1002/cmdc.201500418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fcmdc.201500418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=26548365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyms7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1270-1283&author=D.+Dollesauthor=M.+Nimczickauthor=M.+Scheinerauthor=J.+Ramlerauthor=P.+Stadtm%C3%BCllerauthor=E.+Sawatzkyauthor=A.+Drakopoulosauthor=C.+Sotrifferauthor=H.-J.+Wittmannauthor=A.+Strasserauthor=M.+Decker&title=Aminobenzimidazoles+and+structural+isomers+as+templates+for+dual-acting+butyrylcholinesterase+inhibitors+and+hCB2R+ligands+to+combat+neurodegenerative+disorders&doi=10.1002%2Fcmdc.201500418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Aminobenzimidazoles and Structural Isomers as Templates for Dual-Acting Butyrylcholinesterase Inhibitors and hCB2R Ligands To Combat Neurodegenerative Disorders</span></div><div class="casAuthors">Dolles, Dominik; Nimczick, Martin; Scheiner, Matthias; Ramler, Jacqueline; Stadtmueller, Patricia; Sawatzky, Edgar; Drakopoulos, Antonios; Sotriffer, Christoph; Wittmann, Hans-Joachim; Strasser, Andrea; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1270-1283</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A pharmacophore model for butyrylcholinesterase (BChE) inhibitors was applied to a human cannabinoid subtype 2 receptor (hCB2R) agonist and verified it as a first-generation lead for resp. dual-acting compds.  The design, synthesis, and pharmacol. evaluation of various derivs. led to the identification of aminobenzimidazoles as second-generation leads with micro- or sub-micromolar activities at both targets and excellent selectivity over hCB1 and AChE, resp.  Computational studies of the first- and second-generation lead structures by applying mol. dynamics (MD) on the active hCB2R model, along with docking and MD on hBChE, has enabled an explanation of their binding profiles at the protein levels and opened the way for further optimization.  Dual-acting compds. with "balanced" affinities and excellent selectivities could be obtained that represent leads for treatment of both cognitive and pathophysiol. impairment occurring in neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP2lcUsRAXJ7Vg90H21EOLACvtfcHk0ljTrzEX-CbLYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyms7%252FI&md5=dcd6f52f38134002413bd3d975ee9da3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500418%26sid%3Dliteratum%253Aachs%26aulast%3DDolles%26aufirst%3DD.%26aulast%3DNimczick%26aufirst%3DM.%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DRamler%26aufirst%3DJ.%26aulast%3DStadtm%25C3%25BCller%26aufirst%3DP.%26aulast%3DSawatzky%26aufirst%3DE.%26aulast%3DDrakopoulos%26aufirst%3DA.%26aulast%3DSotriffer%26aufirst%3DC.%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DAminobenzimidazoles%2520and%2520structural%2520isomers%2520as%2520templates%2520for%2520dual-acting%2520butyrylcholinesterase%2520inhibitors%2520and%2520hCB2R%2520ligands%2520to%2520combat%2520neurodegenerative%2520disorders%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1270%26epage%3D1283%26doi%3D10.1002%2Fcmdc.201500418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Le Naour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akgün, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yekkirala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunzer, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalyuzhny, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portoghese, P. S.</span><span> </span><span class="NLM_article-title">Bivalent ligands that target μ opioid (MOP) and cannabinoid 1 (CB<sub>1</sub>) receptors are potent analgesics devoid of tolerance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5505</span><span class="NLM_x">–</span> <span class="NLM_lpage">5513</span><span class="refDoi"> DOI: 10.1021/jm4005219</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005219" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5505-5513&author=M.+Le+Naourauthor=E.+Akg%C3%BCnauthor=A.+Yekkiralaauthor=M.+M.+Lunzerauthor=M.+D.+Powersauthor=A.+E.+Kalyuzhnyauthor=P.+S.+Portoghese&title=Bivalent+ligands+that+target+%CE%BC+opioid+%28MOP%29+and+cannabinoid+1+%28CB1%29+receptors+are+potent+analgesics+devoid+of+tolerance&doi=10.1021%2Fjm4005219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm4005219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005219%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BNaour%26aufirst%3DM.%26aulast%3DAkg%25C3%25BCn%26aufirst%3DE.%26aulast%3DYekkirala%26aufirst%3DA.%26aulast%3DLunzer%26aufirst%3DM.%2BM.%26aulast%3DPowers%26aufirst%3DM.%2BD.%26aulast%3DKalyuzhny%26aufirst%3DA.%2BE.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DBivalent%2520ligands%2520that%2520target%2520%25CE%25BC%2520opioid%2520%2528MOP%2529%2520and%2520cannabinoid%25201%2520%2528CB1%2529%2520receptors%2520are%2520potent%2520analgesics%2520devoid%2520of%2520tolerance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5505%26epage%3D5513%26doi%3D10.1021%2Fjm4005219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Perrey, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Toward the development of bivalent ligand probes of cannabinoid CB1 and orexin OX1 receptor heterodimers</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">634</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span><span class="refDoi"> DOI: 10.1021/ml4004759</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4004759" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVCku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=634-638&author=D.+A.+Perreyauthor=B.+P.+Gilmourauthor=B.+F.+Thomasauthor=Y.+Zhang&title=Toward+the+development+of+bivalent+ligand+probes+of+cannabinoid+CB1+and+orexin+OX1+receptor+heterodimers&doi=10.1021%2Fml4004759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers</span></div><div class="casAuthors">Perrey, David A.; Gilmour, Brian P.; Thomas, Brian F.; Zhang, Yanan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">634-638</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cannabinoid CB1 and orexin OX1 receptors have been suggested to form heterodimers and oligomers.  Aimed at studying these complexes, a series of bivalent CB1 and OX1 ligands combining SR141716 and ACT-078573 pharmacophores were designed, synthesized, and tested for activity against CB1 and OX1 individually and in cell lines that coexpress both receptors.  Compd. I showed a robust enhancement in potency at both receptors when coexpressed as compared to individually expressed, suggesting possible interaction with CB1-OX1 dimers.  Bivalent ligands targeting CB1-OX1 receptor dimers could be potentially useful as a tool for further exploring the roles of such heterodimers in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBpUEo2iDgJLVg90H21EOLACvtfcHk0ljTrzEX-CbLYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVCku7c%253D&md5=6c863e7a9a205cbcb330853f37bdcbeb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fml4004759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4004759%26sid%3Dliteratum%253Aachs%26aulast%3DPerrey%26aufirst%3DD.%2BA.%26aulast%3DGilmour%26aufirst%3DB.%2BP.%26aulast%3DThomas%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DToward%2520the%2520development%2520of%2520bivalent%2520ligand%2520probes%2520of%2520cannabinoid%2520CB1%2520and%2520orexin%2520OX1%2520receptor%2520heterodimers%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D634%26epage%3D638%26doi%3D10.1021%2Fml4004759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Lange, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coolen, H. K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Neut, M. A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, A. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stork, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verveer, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span> </span><span class="NLM_article-title">Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1338</span><span class="NLM_x">–</span> <span class="NLM_lpage">1346</span><span class="refDoi"> DOI: 10.1021/jm901614b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901614b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1338-1346&author=J.+H.+M.+Langeauthor=H.+K.+A.+Coolenauthor=M.+A.+W.+Van+der+Neutauthor=A.+J.+M.+Borstauthor=B.+Storkauthor=P.+C.+Verveerauthor=C.+G.+Kruse&title=Design%2C+synthesis%2C+biological+properties%2C+and+molecular+modeling+investigations+of+novel+tacrine+derivatives+with+a+combination+of+acetylcholinesterase+inhibition+and+cannabinoid+CB1+receptor+antagonism&doi=10.1021%2Fjm901614b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm901614b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901614b%26sid%3Dliteratum%253Aachs%26aulast%3DLange%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DCoolen%26aufirst%3DH.%2BK.%2BA.%26aulast%3DVan%2Bder%2BNeut%26aufirst%3DM.%2BA.%2BW.%26aulast%3DBorst%26aufirst%3DA.%2BJ.%2BM.%26aulast%3DStork%26aufirst%3DB.%26aulast%3DVerveer%26aufirst%3DP.%2BC.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26atitle%3DDesign%252C%2520synthesis%252C%2520biological%2520properties%252C%2520and%2520molecular%2520modeling%2520investigations%2520of%2520novel%2520tacrine%2520derivatives%2520with%2520a%2520combination%2520of%2520acetylcholinesterase%2520inhibition%2520and%2520cannabinoid%2520CB1%2520receptor%2520antagonism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1338%26epage%3D1346%26doi%3D10.1021%2Fjm901614b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Montanari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalvini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligresti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Fatty acid amide hydrolase (FAAH), acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE): networked targets for the development of carbamates as potential anti-Alzheimer’s disease agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">6387</span><span class="NLM_x">–</span> <span class="NLM_lpage">6406</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00609</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFylsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6387-6406&author=S.+Montanariauthor=L.+Scalviniauthor=M.+Bartoliniauthor=F.+Bellutiauthor=S.+Gobbiauthor=V.+Andrisanoauthor=A.+Ligrestiauthor=V.+Di+Marzoauthor=S.+Rivaraauthor=M.+Morauthor=A.+Bisiauthor=A.+Rampa&title=Fatty+acid+amide+hydrolase+%28FAAH%29%2C+acetylcholinesterase+%28AChE%29%2C+and+butyrylcholinesterase+%28BuChE%29%3A+networked+targets+for+the+development+of+carbamates+as+potential+anti-Alzheimer%E2%80%99s+disease+agents&doi=10.1021%2Facs.jmedchem.6b00609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents</span></div><div class="casAuthors">Montanari, Serena; Scalvini, Laura; Bartolini, Manuela; Belluti, Federica; Gobbi, Silvia; Andrisano, Vincenza; Ligresti, Alessia; Di Marzo, Vincenzo; Rivara, Silvia; Mor, Marco; Bisi, Alessandra; Rampa, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6387-6406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The modulation of the endocannabinoid system is emerging as a viable avenue for the treatment of neurodegeneration, being involved in neuroprotective and anti-inflammatory processes.  In particular, indirectly enhancing endocannabinoid signaling to therapeutic levels through FAAH inhibition might be beneficial for neurodegenerative disorders such as Alzheimer's disease, effectively preventing or slowing the progression of the disease.  Hence, in the search for a more effective treatment for Alzheimer's disease, in this paper, the multitarget-directed ligand paradigm was applied to the design of carbamates able to simultaneously target the recently proposed endocannabinoid system and the classic cholinesterase system, and achieve effective dual FAAH/cholinesterase inhibitors.  Among the two series of synthesized compds., while some derivs. proved to be extremely potent on a single target, compds. 9 and 19 were identified as effective dual FAAH/ChE inhibitors, with well-balanced nanomolar activities.  Thus, 9 and 19 might be considered as new promising candidates for Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKiL1QuQosRrVg90H21EOLACvtfcHk0ljw1YG0kdVDjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFylsL4%253D&md5=b1dcd2958856cf5bfc9d77c451186b5b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00609%26sid%3Dliteratum%253Aachs%26aulast%3DMontanari%26aufirst%3DS.%26aulast%3DScalvini%26aufirst%3DL.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DFatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%252C%2520acetylcholinesterase%2520%2528AChE%2529%252C%2520and%2520butyrylcholinesterase%2520%2528BuChE%2529%253A%2520networked%2520targets%2520for%2520the%2520development%2520of%2520carbamates%2520as%2520potential%2520anti-Alzheimer%25E2%2580%2599s%2520disease%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6387%26epage%3D6406%26doi%3D10.1021%2Facs.jmedchem.6b00609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and compoutational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+compoutational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520compoutational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Stößel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlenk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Küppers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span> </span><span class="NLM_article-title">Dual Targeting of adenosine A<sub>2A</sub> receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4580</span><span class="NLM_x">–</span> <span class="NLM_lpage">4596</span><span class="refDoi"> DOI: 10.1021/jm400336x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400336x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4580-4596&author=A.+St%C3%B6%C3%9Felauthor=M.+Schlenkauthor=S.+Hinzauthor=P.+K%C3%BCppersauthor=J.+Heerauthor=M.+G%C3%BCtschowauthor=C.+E.+M%C3%BCller&title=Dual+Targeting+of+adenosine+A2A+receptors+and+monoamine+oxidase+B+by+4H-3%2C1-benzothiazin-4-ones&doi=10.1021%2Fjm400336x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm400336x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400336x%26sid%3Dliteratum%253Aachs%26aulast%3DSt%25C3%25B6%25C3%259Fel%26aufirst%3DA.%26aulast%3DSchlenk%26aufirst%3DM.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DK%25C3%25BCppers%26aufirst%3DP.%26aulast%3DHeer%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDual%2520Targeting%2520of%2520adenosine%2520A2A%2520receptors%2520and%2520monoamine%2520oxidase%2520B%2520by%25204H-3%252C1-benzothiazin-4-ones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4580%26epage%3D4596%26doi%3D10.1021%2Fjm400336x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Darras, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pockes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimczick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and computational studies of tri- and tetracyclic nitrogen-bridgehead compounds as potent dual-acting AChE inhibitors and <i>h</i>H<sub>3</sub> receptor antagonists</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1021/cn4002126</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn4002126" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVSntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=225-242&author=F.+H.+Darrasauthor=S.+Pockesauthor=G.+Huangauthor=S.+Wehleauthor=A.+Strasserauthor=H.-J.+Wittmannauthor=M.+Nimczickauthor=C.+A.+Sotrifferauthor=M.+Decker&title=Synthesis%2C+biological+evaluation%2C+and+computational+studies+of+tri-+and+tetracyclic+nitrogen-bridgehead+compounds+as+potent+dual-acting+AChE+inhibitors+and+hH3+receptor+antagonists&doi=10.1021%2Fcn4002126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43aR"><div class="casContent"><span class="casTitleNuber">43a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Biological Evaluation, and Computational Studies of Tri- and Tetracyclic Nitrogen-Bridgehead Compounds as Potent Dual-Acting AChE Inhibitors and hH3 Receptor Antagonists</span></div><div class="casAuthors">Darras, Fouad H.; Pockes, Steffen; Huang, Guozheng; Wehle, Sarah; Strasser, Andrea; Wittmann, Hans-Joachim; Nimczick, Martin; Sotriffer, Christoph A.; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-242</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Combination of AChE inhibiting and histamine H3 receptor antagonizing properties in a single mol. might show synergistic effects to improve cognitive deficits in Alzheimer's disease, since both pharmacol. actions are able to enhance cholinergic neurotransmission in the cortex.  However, whereas AChE inhibitors prevent hydrolysis of acetylcholine also peripherally, histamine H3 antagonists will raise acetylcholine levels mostly in the brain due to predominant occurrence of the receptor in the central nervous system.  In this work, we designed and synthesized two novel classes of tri- and tetracyclic nitrogen-bridgehead compds. acting as dual AChE inhibitors and histamine H3 antagonists by combining the nitrogen-bridgehead moiety of novel AChE inhibitors with a second N-basic fragment based on the piperidinylpropoxy pharmacophore with different spacer lengths.  Intensive structure-activity relationships (SARs) with regard to both biol. targets led to compd. (I) which showed balanced affinities as hAChE inhibitor with IC50 = 33.9 nM, and hH3R antagonism with Ki = 76.2 nM with greater than 200-fold selectivity over the other histamine receptor subtypes.  Mol. docking studies were performed to explain the potent AChE inhibition of the target compds. and mol. dynamics studies to explain high affinity at the hH3R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrUrSATqvWOLVg90H21EOLACvtfcHk0ljw1YG0kdVDjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVSntw%253D%253D&md5=c2853a155748d5748989b59e5c17b2e9</span></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=10.1021%2Fcn4002126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn4002126%26sid%3Dliteratum%253Aachs%26aulast%3DDarras%26aufirst%3DF.%2BH.%26aulast%3DPockes%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DWehle%26aufirst%3DS.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DNimczick%26aufirst%3DM.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520computational%2520studies%2520of%2520tri-%2520and%2520tetracyclic%2520nitrogen-bridgehead%2520compounds%2520as%2520potent%2520dual-acting%2520AChE%2520inhibitors%2520and%2520hH3%2520receptor%2520antagonists%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D225%26epage%3D242%26doi%3D10.1021%2Fcn4002126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurulain, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darras, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadek, B.</span><span> </span><span class="NLM_article-title">The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairments in Rats</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span><span class="refDoi"> DOI: 10.1016/j.bbr.2015.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bbr.2015.10.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2016&pages=155-164&author=N.+Khanauthor=A.+Saadauthor=S.+M.+Nurulainauthor=F.+H.+Darrasauthor=M.+Deckerauthor=B.+Sadek&title=The+dual-acting+H3+receptor+antagonist+and+AChE+inhibitor+UW-MD-71+dose-dependently+enhances+memory+retrieval+and+reverses+dizocilpine-induced+memory+impairments+in+Rats&doi=10.1016%2Fj.bbr.2015.10.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2015.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2015.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DSaad%26aufirst%3DA.%26aulast%3DNurulain%26aufirst%3DS.%2BM.%26aulast%3DDarras%26aufirst%3DF.%2BH.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DSadek%26aufirst%3DB.%26atitle%3DThe%2520dual-acting%2520H3%2520receptor%2520antagonist%2520and%2520AChE%2520inhibitor%2520UW-MD-71%2520dose-dependently%2520enhances%2520memory%2520retrieval%2520and%2520reverses%2520dizocilpine-induced%2520memory%2520impairments%2520in%2520Rats%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D297%26spage%3D155%26epage%3D164%26doi%3D10.1016%2Fj.bbr.2015.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit43c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sadek, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darras, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pockes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">The dual-acting AChE inhibitor and H<sub>3</sub> receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats</span> <span class="citation_source-journal">Physiol. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1016/j.physbeh.2016.08.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.physbeh.2016.08.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=27568232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFaru7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2016&pages=383-391&author=B.+Sadekauthor=N.+Khanauthor=F.+H.+Darrasauthor=S.+Pockesauthor=M.+Decker&title=The+dual-acting+AChE+inhibitor+and+H3+receptor+antagonist+UW-MD-72+reverses+amnesia+induced+by+scopolamine+or+dizocilpine+in+passive+avoidance+paradigm+in+rats&doi=10.1016%2Fj.physbeh.2016.08.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43cR"><div class="casContent"><span class="casTitleNuber">43c</span><div class="casTitle"><span class="NLM_cas:atitle">The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats</span></div><div class="casAuthors">Sadek, Bassem; Khan, Nadia; Darras, Fouad H.; Pockes, Steffen; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Physiology & Behavior</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">383-391</span>CODEN:
                <span class="NLM_cas:coden">PHBHA4</span>;
        ISSN:<span class="NLM_cas:issn">0031-9384</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Both the acetylcholine esterase (AChE) and the histamine H3 receptor (H3R) are involved in the metab. and modulation of acetylcholine release and numerous other centrally acting neurotransmitters.  Hence, dual-active AChE inhibitors (AChEIs) and H3R antagonists hold potential to treat cognitive disorders like Alzheimer's disease (AD).  The novel dual-acting AChEI and H3R antagonist 7-(3-(piperidin-1-yl)propoxy)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one (UW-MD-72) shows excellent selectivity profiles over the AChE's isoenzyme butyrylcholinesterase (BChE) as well as high and balanced in-vitro affinities at both AChE and hH3R with IC50 of 5.4 μM on hAChE and hH3R antagonism with Ki of 2.54 μM, resp.  In the current study, the effects of UW-MD-72 (1.25, 2.5, and 5 mg/kg, i.p.) on memory deficits induced by the muscarinic cholinergic antagonist scopolamine (SCO) and the non-competitive N-methyl-D-aspartate (NMDA) antagonist dizocilpine (DIZ) were investigated in a step-through type passive avoidance paradigm in adult male rats applying donepezil (DOZ) and pitolisant (PIT) as ref. drugs.  The results obsd. show that SCO (2 mg/kg, i.p.) and DIZ (0.1 mg/kg, i.p.) significantly impaired learning and memory in rats.  However, acute systemic administration of UW-MD-72 significantly ameliorated the SCO- and DIZ-induced amnesic effects.  Furthermore, the ameliorating activity of UW-MD-72 (1.25 mg/kg, i.p.) in DIZ-induced amnesia was partly reversed when rats were pretreated with the centrally-acting H2R antagonist zolantidine (ZOL, 10 mg/kg, i.p.), but not with the CNS penetrant H1R antagonist pyrilamine (PYR, 10 mg/kg, i.p.).  Moreover, ameliorative effect of UW-MD-72 (1.25 mg/kg, i.p.) in DIZ-induced amnesia was strongly reversed when rats were pretreated with a combination of ZOL (10 mg/kg, i.p.) and SCO (1.0 mg/kg, i.p.), indicating that these memory enhancing effects were, in addn. to other neural circuits, obsd. through histaminergic H2R as well as muscarinic cholinergic neurotransmission.  These results demonstrate the ameliorative effects of UW-MD-72 in two in-vivo memory models and provide evidence for the potential of dual-acting AChEI and H3R antagonists to treat cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBRc7BhsE5YrVg90H21EOLACvtfcHk0lgtL_gXXqZ5MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFaru7vJ&md5=59b884447a8de8426d8107282498bb30</span></div><a href="/servlet/linkout?suffix=cit43c&amp;dbid=16384&amp;doi=10.1016%2Fj.physbeh.2016.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.physbeh.2016.08.022%26sid%3Dliteratum%253Aachs%26aulast%3DSadek%26aufirst%3DB.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DDarras%26aufirst%3DF.%2BH.%26aulast%3DPockes%26aufirst%3DS.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DThe%2520dual-acting%2520AChE%2520inhibitor%2520and%2520H3%2520receptor%2520antagonist%2520UW-MD-72%2520reverses%2520amnesia%2520induced%2520by%2520scopolamine%2520or%2520dizocilpine%2520in%2520passive%2520avoidance%2520paradigm%2520in%2520rats%26jtitle%3DPhysiol.%2520Behav.%26date%3D2016%26volume%3D165%26spage%3D383%26epage%3D391%26doi%3D10.1016%2Fj.physbeh.2016.08.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pagé, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisvert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodzic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Onge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salois, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payza, K.</span><span> </span><span class="NLM_article-title">Novel benzimidazole derivatives as selective CB2 agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3695</span><span class="NLM_x">–</span> <span class="NLM_lpage">3700</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.05.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bmcl.2008.05.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=18522867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1Ohurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3695-3700&author=D.+Pag%C3%A9author=E.+Balauxauthor=L.+Boisvertauthor=Z.+Liuauthor=C.+Milburnauthor=M.+Tremblayauthor=Z.+Weiauthor=S.+Wooauthor=X.+Luoauthor=Y.-X.+Chengauthor=H.+Yangauthor=S.+Srivastavaauthor=F.+Zhouauthor=W.+Brownauthor=M.+Tomaszewskiauthor=C.+Walpoleauthor=L.+Hodzicauthor=S.+St-Ongeauthor=C.+Godboutauthor=D.+Saloisauthor=K.+Payza&title=Novel+benzimidazole+derivatives+as+selective+CB2+agonists&doi=10.1016%2Fj.bmcl.2008.05.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44aR"><div class="casContent"><span class="casTitleNuber">44a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel benzimidazole derivatives as selective CB2 agonists</span></div><div class="casAuthors">Page, Daniel; Balaux, Elise; Boisvert, Luc; Liu, Ziping; Milburn, Claire; Tremblay, Maxime; Wei, Zhongyong; Woo, Simon; Luo, Xuehong; Cheng, Yun-Xing; Yang, Hua; Srivastava, Sanjay; Zhou, Fei; Brown, William; Tomaszewski, Miroslaw; Walpole, Christopher; Hodzic, Leila; St-Onge, Stephane; Godbout, Claude; Salois, Dominic; Payza, Keymal</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3695-3700</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The prepn. and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety, e.g., I, are reported.  They showed binding affinities up to 1 nM towards the CB2 receptor with partial to full agonist potencies.  They also demonstrated good to excellent selectivity (>1000-fold) over the CB1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbeiXe1I0Yg7Vg90H21EOLACvtfcHk0lgtL_gXXqZ5MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1Ohurs%253D&md5=fa9e0921054b0d9f26044a1feb82a604</span></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.073%26sid%3Dliteratum%253Aachs%26aulast%3DPag%25C3%25A9%26aufirst%3DD.%26aulast%3DBalaux%26aufirst%3DE.%26aulast%3DBoisvert%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMilburn%26aufirst%3DC.%26aulast%3DTremblay%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DWoo%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DY.-X.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DBrown%26aufirst%3DW.%26aulast%3DTomaszewski%26aufirst%3DM.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DHodzic%26aufirst%3DL.%26aulast%3DSt-Onge%26aufirst%3DS.%26aulast%3DGodbout%26aufirst%3DC.%26aulast%3DSalois%26aufirst%3DD.%26aulast%3DPayza%26aufirst%3DK.%26atitle%3DNovel%2520benzimidazole%2520derivatives%2520as%2520selective%2520CB2%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3695%26epage%3D3700%26doi%3D10.1016%2Fj.bmcl.2008.05.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cheng, Y.-X.; Tomaszewski, M.; Walpole, C.; Yang, H.</span><span> </span><span class="NLM_article-title">Novel Compounds</span>. WO 02/085866 A1, October 31,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=Y.-X.+Cheng&author=M.+Tomaszewski&author=C.+Walpole&author=H.+Yang&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-X.%26atitle%3DNovel%2520Compounds%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">González-Naranjo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Macias, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arán, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girón, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Robles, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Canas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Arencibia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Ruiz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Páez, J. A.</span><span> </span><span class="NLM_article-title">Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.ejmech.2013.11.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=56-72&author=P.+Gonz%C3%A1lez-Naranjoauthor=N.+P%C3%A9rez-Maciasauthor=N.+E.+Campilloauthor=C.+P%C3%A9rezauthor=V.+J.+Ar%C3%A1nauthor=R.+Gir%C3%B3nauthor=E.+S%C3%A1nchez-Roblesauthor=M.+I.+Mart%C3%ADnauthor=M.+G%C3%B3mez-Canasauthor=M.+Garc%C3%ADa-Arencibiaauthor=J.+Fern%C3%A1ndez-Ruizauthor=J.+A.+P%C3%A1ez&title=Cannabinoid+agonists+showing+BuChE+inhibition+as+potential+therapeutic+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2013.11.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DGonz%25C3%25A1lez-Naranjo%26aufirst%3DP.%26aulast%3DP%25C3%25A9rez-Macias%26aufirst%3DN.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DGir%25C3%25B3n%26aufirst%3DR.%26aulast%3DS%25C3%25A1nchez-Robles%26aufirst%3DE.%26aulast%3DMart%25C3%25ADn%26aufirst%3DM.%2BI.%26aulast%3DG%25C3%25B3mez-Canas%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Arencibia%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez-Ruiz%26aufirst%3DJ.%26aulast%3DP%25C3%25A1ez%26aufirst%3DJ.%2BA.%26atitle%3DCannabinoid%2520agonists%2520showing%2520BuChE%2520inhibition%2520as%2520potential%2520therapeutic%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D73%26spage%3D56%26epage%3D72%26doi%3D10.1016%2Fj.ejmech.2013.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Munch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittelkow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boas, U.</span><span> </span><span class="NLM_article-title">A new efficient synthesis of isothiocyanates from amines using di-<i>tert</i>-butyl dicarbonate</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3117</span><span class="NLM_x">–</span> <span class="NLM_lpage">3119</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2008.03.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.tetlet.2008.03.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=3117-3119&author=H.+Munchauthor=J.+S.+Hansenauthor=M.+Pittelkowauthor=J.+B.+Christensenauthor=U.+Boas&title=A+new+efficient+synthesis+of+isothiocyanates+from+amines+using+di-tert-butyl+dicarbonate&doi=10.1016%2Fj.tetlet.2008.03.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2008.03.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2008.03.045%26sid%3Dliteratum%253Aachs%26aulast%3DMunch%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DJ.%2BS.%26aulast%3DPittelkow%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DJ.%2BB.%26aulast%3DBoas%26aufirst%3DU.%26atitle%3DA%2520new%2520efficient%2520synthesis%2520of%2520isothiocyanates%2520from%2520amines%2520using%2520di-tert-butyl%2520dicarbonate%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D3117%26epage%3D3119%26doi%3D10.1016%2Fj.tetlet.2008.03.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Freitag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemies, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Gaghlab, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumpf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, A.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of splitomicin analogs targeted at human NAD<sup>+</sup>-dependent histone deacetylases (sirtuins)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3669</span><span class="NLM_x">–</span> <span class="NLM_lpage">3677</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.01.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bmc.2011.01.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3669-3677&author=M.+Freitagauthor=J.+Schemiesauthor=T.+Larsenauthor=K.+El+Gaghlabauthor=F.+Schulzauthor=T.+Rumpfauthor=M.+Jungauthor=A.+Link&title=Synthesis+and+biological+activity+of+splitomicin+analogs+targeted+at+human+NAD%2B-dependent+histone+deacetylases+%28sirtuins%29&doi=10.1016%2Fj.bmc.2011.01.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.01.026%26sid%3Dliteratum%253Aachs%26aulast%3DFreitag%26aufirst%3DM.%26aulast%3DSchemies%26aufirst%3DJ.%26aulast%3DLarsen%26aufirst%3DT.%26aulast%3DEl%2BGaghlab%26aufirst%3DK.%26aulast%3DSchulz%26aufirst%3DF.%26aulast%3DRumpf%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DLink%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520splitomicin%2520analogs%2520targeted%2520at%2520human%2520NAD%252B-dependent%2520histone%2520deacetylases%2520%2528sirtuins%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3669%26epage%3D3677%26doi%3D10.1016%2Fj.bmc.2011.01.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Darras, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with ’inverted’ binding mode</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4867</span><span class="NLM_x">–</span> <span class="NLM_lpage">4881</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.06.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bmc.2014.06.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4867-4881&author=F.+H.+Darrasauthor=S.+Wehleauthor=G.+Huangauthor=C.+A.+Sotrifferauthor=M.+Decker&title=Amine+substitution+of+quinazolinones+leads+to+selective+nanomolar+AChE+inhibitors+with+%E2%80%99inverted%E2%80%99+binding+mode&doi=10.1016%2Fj.bmc.2014.06.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.06.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.06.045%26sid%3Dliteratum%253Aachs%26aulast%3DDarras%26aufirst%3DF.%2BH.%26aulast%3DWehle%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DAmine%2520substitution%2520of%2520quinazolinones%2520leads%2520to%2520selective%2520nanomolar%2520AChE%2520inhibitors%2520with%2520%25E2%2580%2599inverted%25E2%2580%2599%2520binding%2520mode%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4867%26epage%3D4881%26doi%3D10.1016%2Fj.bmc.2014.06.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Lange, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Stuivenberg, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coolen, H. K. A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolfs, T. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCreary, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keizer, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wals, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veerman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, A. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Looff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verveer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span> </span><span class="NLM_article-title">Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1823</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span><span class="refDoi"> DOI: 10.1021/jm040843r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040843r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFSrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1823-1838&author=J.+H.+M.+Langeauthor=H.+H.+van+Stuivenbergauthor=H.+K.+A.+C.+Coolenauthor=T.+J.+P.+Adolfsauthor=A.+C.+McCrearyauthor=H.+G.+Keizerauthor=H.+C.+Walsauthor=W.+Veermanauthor=A.+J.+M.+Borstauthor=W.+de+Looffauthor=C.+Verveerauthor=C.+G.+Kruse&title=Bioisosteric+replacements+of+the+pyrazole+moiety+of+rimonabant%3A+synthesis%2C+biological+properties%2C+and+molecular+modeling+investigations+of+thiazoles%2C+triazoles%2C+and+imidazoles+as+potent+and+selective+CB1+cannabinoid+receptor+antagonists&doi=10.1021%2Fjm040843r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosteric Replacements of the Pyrazole Moiety of Rimonabant: Synthesis, Biological Properties, and Molecular Modeling Investigations of Thiazoles, Triazoles, and Imidazoles as Potent and Selective CB1 Cannabinoid Receptor Antagonists</span></div><div class="casAuthors">Lange, Jos H. M.; van Stuivenberg, Herman H.; Coolen, Hein K. A. C.; Adolfs, Tiny J. P.; McCreary, Andrew C.; Keizer, Hiskias G.; Wals, Henri C.; Veerman, Willem; Borst, Alice J. M.; de Looff, Wouter; Verveer, Peter C.; Kruse, Chris G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1823-1838</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Series of thiazoles, triazoles, and imidazoles were designed as bioisosteres, based on the 1,5-diarylpyrazole motif that is present in the potent CB1 receptor antagonist rimonabant.  A no. of target compds. were synthesized and evaluated in cannabinoid (hCB1 and hCB2) receptor assays.  The thiazoles, triazoles, and imidazoles elicited in vitro CB1 antagonistic activities and in general exhibited considerable CB1 vs CB2 receptor subtype selectivities, thereby demonstrating to be cannabinoid bioisosteres of the original diarylpyrazole class.  Some key representatives in the imidazole series showed potent pharmacol. in vivo activities after oral administration in both a CB agonist-induced hypotension model and a CB agonist-induced hypothermia model.  Mol. modeling studies showed a close three-dimensional structural overlap between the imidazole I and rimonabant.  A structure-activity relationship (SAR) study revealed a close correlation between the biol. results in the imidazole and pyrazole series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp16SsR1EEEVbVg90H21EOLACvtfcHk0li9hEjDRQl3Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFSrsLg%253D&md5=c3b80380a273d7f69a33c812a45e0154</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm040843r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040843r%26sid%3Dliteratum%253Aachs%26aulast%3DLange%26aufirst%3DJ.%2BH.%2BM.%26aulast%3Dvan%2BStuivenberg%26aufirst%3DH.%2BH.%26aulast%3DCoolen%26aufirst%3DH.%2BK.%2BA.%2BC.%26aulast%3DAdolfs%26aufirst%3DT.%2BJ.%2BP.%26aulast%3DMcCreary%26aufirst%3DA.%2BC.%26aulast%3DKeizer%26aufirst%3DH.%2BG.%26aulast%3DWals%26aufirst%3DH.%2BC.%26aulast%3DVeerman%26aufirst%3DW.%26aulast%3DBorst%26aufirst%3DA.%2BJ.%2BM.%26aulast%3Dde%2BLooff%26aufirst%3DW.%26aulast%3DVerveer%26aufirst%3DC.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26atitle%3DBioisosteric%2520replacements%2520of%2520the%2520pyrazole%2520moiety%2520of%2520rimonabant%253A%2520synthesis%252C%2520biological%2520properties%252C%2520and%2520molecular%2520modeling%2520investigations%2520of%2520thiazoles%252C%2520triazoles%252C%2520and%2520imidazoles%2520as%2520potent%2520and%2520selective%2520CB1%2520cannabinoid%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1823%26epage%3D1838%26doi%3D10.1021%2Fjm040843r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrison, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daza, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayson, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wensink, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> and in vivo characterization of A-796260: a selective cannabinoid CB<sub>2</sub> receptor agonist exhibiting analgesic activity in rodent pain models</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fsj.bjp.0707568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=17994110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlajsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=390-401&author=B.+B.+Yaoauthor=G.+C.+Hsiehauthor=J.+M.+Frostauthor=Y.+Fanauthor=T.+R.+Garrisonauthor=A.+V.+Dazaauthor=G.+K.+Graysonauthor=C.+Z.+Zhuauthor=M.+Paiauthor=P.+Chandranauthor=A.+K.+Salyersauthor=E.+J.+Wensinkauthor=P.+Honoreauthor=J.+P.+Sullivanauthor=M.+J.+Dartauthor=M.+D.+Meyer&title=In+vitro+and+in+vivo+characterization+of+A-796260%3A+a+selective+cannabinoid+CB2+receptor+agonist+exhibiting+analgesic+activity+in+rodent+pain+models&doi=10.1038%2Fsj.bjp.0707568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models</span></div><div class="casAuthors">Yao, B. B.; Hsieh, G. C.; Frost, J. M.; Fan, Y.; Garrison, T. R.; Daza, A. V.; Grayson, G. K.; Zhu, C. Z.; Pai, M.; Chandran, P.; Salyers, A. K.; Wensink, E. J.; Honore, P.; Sullivan, J. P.; Dart, M. J.; Meyer, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">390-401</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Selective cannabinoid CB2 receptor agonists have demonstrated analgesic activity across multiple preclin. pain models.  AM1241 is an indole deriv. that exhibits high affinity and selectivity for the CB2 binding site and broad spectrum analgesic activity in rodent models, but is not an antagonist of CB2 in vitro functional assays.  Addnl., its analgesic effects are -opioid receptor-dependent.  Herein, we describe the in vitro and in vivo pharmacol. properties of A-796260, a novel CB2 agonist.  Exptl. approach: A-796260 was characterized in radioligand binding and in vitro functional assays at rat and human CB1 and CB2 receptors.  The behavioral profile of A-796260 was assessed in models of inflammatory, post-operative, neuropathic, and osteoarthritic (OA) pain, as well as its effects on motor activity.  The receptor specificity was confirmed using selective CB1, CB2, and -opioid receptor antagonists.  A-796260 exhibited high affinity and agonist efficacy at human and rat CB2 receptors, and was selective for the CB2 vs CB1 subtype.  Efficacy in models of inflammatory, post-operative, neuropathic and OA pain was demonstrated, and these activities were selectively blocked by CB2, but not CB1, or -opioid receptor-selective antagonists.  Efficacy was achieved at doses that had no significant effects on motor activity.  These results further confirm the therapeutic potential of CB2 receptor-selective agonists for the treatment of pain.  In addn., they demonstrate that A-796260 may be a useful new pharmacol. compd. for further studying CB2 receptor pharmacol. and for evaluating its role in the modulation of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRpbBOoGZg27Vg90H21EOLACvtfcHk0liHdLiLK24ckQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlajsbs%253D&md5=c4d06d34da40f688a17aa15fffe03c64</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707568%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DDaza%26aufirst%3DA.%2BV.%26aulast%3DGrayson%26aufirst%3DG.%2BK.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DWensink%26aufirst%3DE.%2BJ.%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520characterization%2520of%2520A-796260%253A%2520a%2520selective%2520cannabinoid%2520CB2%2520receptor%2520agonist%2520exhibiting%2520analgesic%2520activity%2520in%2520rodent%2520pain%2520models%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D390%26epage%3D401%26doi%3D10.1038%2Fsj.bjp.0707568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Bottegoni, G.; Cavalli, A.</span><span> </span><span class="NLM_article-title">Computational Methods in Multitarget Drug Discovery</span>. In  <span class="citation_source-book">Design of Hybrid Molecules for Drug Development</span>; <span class="NLM_contrib-group">Decker, M.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FB978-0-08-101011-2.00009-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=239-258&author=G.+Bottegoni&author=A.+Cavalliauthor=M.+Decker&title=Design+of+Hybrid+Molecules+for+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FB978-0-08-101011-2.00009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-08-101011-2.00009-X%26sid%3Dliteratum%253Aachs%26aulast%3DBottegoni%26aufirst%3DG.%26atitle%3DComputational%2520Methods%2520in%2520Multitarget%2520Drug%2520Discovery%26btitle%3DDesign%2520of%2520Hybrid%2520Molecules%2520for%2520Drug%2520Development%26aulast%3DDecker%26aufirst%3DM.%26pub%3DElsevier%26date%3D2017%26spage%3D239%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Hua, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vemuri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikas, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laprairie, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z. J.</span><span> </span><span class="NLM_article-title">Crystal structures of agonist-bound human cannabinoid receptor CB1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">547</span><span class="NLM_x">, </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1038/nature23272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnature23272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=28678776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=547&publication_year=2017&pages=468-471&author=T.+Huaauthor=K.+Vemuriauthor=S.+P.+Nikasauthor=R.+B.+Laprairieauthor=Y.+Wuauthor=L.+Quauthor=M.+Puauthor=A.+Kordeauthor=S.+Jiangauthor=J.+H.+Hoauthor=G.+W.+Hanauthor=K.+Dingauthor=X.+Liauthor=H.+Liuauthor=M.+A.+Hansonauthor=S.+Zhaoauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=R.+C.+Stevensauthor=Z.+J.+Liu&title=Crystal+structures+of+agonist-bound+human+cannabinoid+receptor+CB1&doi=10.1038%2Fnature23272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of agonist-bound human cannabinoid receptor CB1</span></div><div class="casAuthors">Hua, Tian; Vemuri, Kiran; Nikas, Spyros P.; Laprairie, Robert B.; Wu, Yiran; Qu, Lu; Pu, Mengchen; Korde, Anisha; Jiang, Shan; Ho, Jo-Hao; Han, Gye Won; Ding, Kang; Li, Xuanxuan; Liu, Haiguang; Hanson, Michael A.; Zhao, Suwen; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">547</span>
        (<span class="NLM_cas:issue">7664</span>),
    <span class="NLM_cas:pages">468-471</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC).  Here the authors report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841) at 2.80 Å and 2.95 Å resoln., resp.  The two CB1-agonist complexes reveal important conformational changes in the overall structure, relative to the antagonist-bound state, including a 53% redn. in the vol. of the ligand-binding pocket and an increase in the surface area of the G-protein-binding region.  In addn., a 'twin toggle switch' of Phe 2003.36 and Trp 3566.48 (superscripts denote Ballesteros-Weinstein numbering) is exptl. obsd. and appears to be essential for receptor activation.  The structures reveal important insights into the activation mechanism of CB1 and provide a mol. basis for predicting the binding modes of Δ9-THC, and endogenous and synthetic cannabinoids.  The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G-protein-coupled receptors.  These findings should inspire the design of chem. diverse ligands with distinct pharmacol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw6XE4Hx5gDrVg90H21EOLACvtfcHk0liHdLiLK24ckQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73E&md5=f77fcc823e5856ece0bb5730ac00ea07</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnature23272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature23272%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DLaprairie%26aufirst%3DR.%2BB.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DKorde%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DJ.%2BH.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%2BJ.%26atitle%3DCrystal%2520structures%2520of%2520agonist-bound%2520human%2520cannabinoid%2520receptor%2520CB1%26jtitle%3DNature%26date%3D2017%26volume%3D547%26spage%3D468%26epage%3D471%26doi%3D10.1038%2Fnature23272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1016/S1043-9471(05)80049-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=366-428&author=J.+A.+Ballesterosauthor=H.+Weinstein&title=Integrated+methods+for+the+construction+of+three-dimensional+models+and+computational+probing+of+structure-function+relations+in+G+protein-coupled+receptors&doi=10.1016%2FS1043-9471%2805%2980049-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span></div><div class="casAuthors">Ballesteros, Juan A.; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">366-428</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review, with 135 refs., on approaches that can be used to resolve the apparent ambiguities that burden the pharmacol. testing of G protein-coupled receptor (GPCR) models, based on the integration of structural information about the receptor, about mutants, and about the changes induced by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfENoRspqa7LVg90H21EOLACvtfcHk0liamzzd_xsp5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D&md5=d3f99e9d07cea245a770f3f099bc8cc7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three-dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure-function%2520relations%2520in%2520G%2520protein-coupled%2520receptors%26jtitle%3DMethods%2520Neurosci.%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428%26doi%3D10.1016%2FS1043-9471%2805%2980049-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Igel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dove, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschauer, A.</span><span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6297</span><span class="NLM_x">–</span> <span class="NLM_lpage">6313</span><span class="refDoi"> DOI: 10.1021/jm900526h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900526h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6297-6313&author=P.+Igelauthor=R.+Geyerauthor=A.+Strasserauthor=S.+Doveauthor=R.+Seifertauthor=A.+Buschauer&title=Synthesis+and+structure-activity+relationships+of+cyanoguanidine-type+and+structurally+related+histamine+H4+receptor+agonists&doi=10.1021%2Fjm900526h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of Cyanoguanidine-Type and Structurally Related Histamine H4 Receptor Agonists</span></div><div class="casAuthors">Igel, Patrick; Geyer, Roland; Strasser, Andrea; Dove, Stefan; Seifert, Roland; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6297-6313</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, we identified high-affinity human histamine H3 (hH3R) and H4 receptor (hH4R) ligands among a series of NG-acylated imidazolylpropylguanidines, which were originally designed as histamine H2 receptor (H2R) agonists.  Aiming at selectivity for hH4R, the acylguanidine group was replaced with related moieties.  Within a series of cyanoguanidines, 2-cyano-1-[4-(1H-imidazol-4-yl)butyl]-3-[(2-phenylthio)ethyl]guanidine (UR-PI376, I) was identified as the most potent hH4R agonist (pEC50 = 7.47, α = 0.93) showing negligible hH1R and hH2R activities and significant selectivity over the hH3R (pKB = 6.00, α = -0.28), as detd. in steady-state GTPase assays using membrane prepns. of hHxR-expressing Sf9 cells.  In contrast to previously described selective H4R agonists, this compd. and other 3-substituted derivs. are devoid of agonistic activity at the other HR subtypes.  Modeling of the binding mode of I suggests that the cyanoguanidine moiety forms charge-assisted hydrogen bonds not only with the conserved Asp-94 but also with the hH4R-specific Arg-341 residue.  2-Carbamoyl-1-[2-(1H-imidazol-4-yl)ethyl]-3-(3-phenylpropyl)guanidine (UR-PI97, II) was unexpectedly identified as a highly potent and selective hH3R inverse agonist (pKB = 8.42, >300-fold selectivity over the other HR subtypes).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8F_R1iQyE7Vg90H21EOLACvtfcHk0liamzzd_xsp5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltbvP&md5=de315a1527f3a2e271f8a07ab9c64f2d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm900526h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900526h%26sid%3Dliteratum%253Aachs%26aulast%3DIgel%26aufirst%3DP.%26aulast%3DGeyer%26aufirst%3DR.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DDove%26aufirst%3DS.%26aulast%3DSeifert%26aufirst%3DR.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520cyanoguanidine-type%2520and%2520structurally%2520related%2520histamine%2520H4%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6297%26epage%3D6313%26doi%3D10.1021%2Fjm900526h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Striegl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, R.</span><span> </span><span class="NLM_article-title">Pharmacological profile of histaprodifens at four recombinant H1-receptor species isoforms</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.1124/jpet.107.129601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1124%2Fjpet.107.129601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=17928567" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2007&pages=60-71&author=A.+Strasserauthor=B.+Strieglauthor=H.-J.+Wittmannauthor=R.+Seifert&title=Pharmacological+profile+of+histaprodifens+at+four+recombinant+H1-receptor+species+isoforms&doi=10.1124%2Fjpet.107.129601"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.129601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.129601%26sid%3Dliteratum%253Aachs%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DStriegl%26aufirst%3DB.%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DSeifert%26aufirst%3DR.%26atitle%3DPharmacological%2520profile%2520of%2520histaprodifens%2520at%2520four%2520recombinant%2520H1-receptor%2520species%2520isoforms%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D324%26spage%3D60%26epage%3D71%26doi%3D10.1124%2Fjpet.107.129601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Wittmann, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span> </span><span class="NLM_article-title">Sodium binding to hH3R and hH4R - a molecular modeling study</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2394</span><span class="NLM_x">–</span> <span class="NLM_lpage">2404</span><span class="refDoi"> DOI: 10.1007/s00894-014-2394-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1007%2Fs00894-014-2394-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=25098339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A280%3ADC%252BC2cbps1emuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=2394-2404&author=H.-J.+Wittmannauthor=R.+Seifertauthor=A.+Strasser&title=Sodium+binding+to+hH3R+and+hH4R+-+a+molecular+modeling+study&doi=10.1007%2Fs00894-014-2394-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium binding to hH3R and hH 4R--a molecular modeling study</span></div><div class="casAuthors">Wittmann Hans-Joachim; Seifert Roland; Strasser Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2394</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Several aminergic GPCRs, e.g., the human histamine H3-receptor (hH3R) are sensitive to sodium ions.  Based on these experimental results, including site directed mutagenesis studies, a sodium binding pocket near to the highly conserved Asp2.50 was suggested.  Recently, in the crystallized adenosine A2A receptor (4EIY), a sodium ion was found in a pocket, coordinated by Asp52, Ser91, and three water molecules.  Despite high homology in amino acid sequence between hH3R and hH4R, pharmacological studies revealed that the hH4R is--in contrast to hH3R--not sensitive to sodium ions.  In order to obtain a deeper insight onto the differences in sodium sensitivity between hH3R and hH4R, we performed molecular modelling studies, including molecular dynamic simulations and calculation of Gibbs energy of solvation.  The results of the modeling studies suggested that the amino acid at position 7.42 influences sodium binding to aminergic GPCRs in different ways.  A comparison of the amino acids forming the sodium binding channel between the ligand binding pocket and the sodium binding pocket of all human aminergic GPCRs showed an 80% occurrence of glycine--in contrast to hH3R and hH4R.  The Gln7.42 at hH4R disrupts a water chain, connecting the Asp3.32 of the orthosteric binding site and the Asp2.50 of the allosteric binding site.  Besides, the oxygen of the glutamine side chain stabilizes the interaction of the sodium ion with the Asp3.32.  Thus, the binding of the sodium into the allosteric binding site might be hindered kinetically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDm_Hf0VLBp8rRqEXsZufAfW6udTcc2ea9xqDVtWH6tbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbps1emuw%253D%253D&md5=ed8fa2f97559093c4215ec9796275021</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs00894-014-2394-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-014-2394-2%26sid%3Dliteratum%253Aachs%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DSeifert%26aufirst%3DR.%26aulast%3DStrasser%26aufirst%3DA.%26atitle%3DSodium%2520binding%2520to%2520hH3R%2520and%2520hH4R%2520-%2520a%2520molecular%2520modeling%2520study%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2014%26volume%3D20%26spage%3D2394%26epage%3D2404%26doi%3D10.1007%2Fs00894-014-2394-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, R.</span><span> </span><span class="NLM_article-title">Modulation of GPCRs by monovalent cations and anions</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span><span class="refDoi"> DOI: 10.1007/s00210-014-1073-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1007%2Fs00210-014-1073-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=25432095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSitLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2015&pages=363-380&author=A.+Strasserauthor=H.-J.+Wittmannauthor=E.+H.+Schneiderauthor=R.+Seifert&title=Modulation+of+GPCRs+by+monovalent+cations+and+anions&doi=10.1007%2Fs00210-014-1073-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of GPCRs by monovalent cations and anions</span></div><div class="casAuthors">Strasser, Andrea; Wittmann, Hans-Joachim; Schneider, Erich H.; Seifert, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-380</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The recent resoln. of G-protein-coupled receptor (GPCR) structures in complex with Na+ bound to an allosteric modulatory site has renewed interest of the regulation of GPCRs by ions.  Here, we summarise key data on ion modulation of GPCRs, obtained in pharmacol., crystallog., mutagenesis and mol. modeling studies.  We show that ion modulation is a highly complex process, involving not only cations but also, rather neglected until now, anions.  Pharmacotherapeutic and toxicol. aspects are discussed.  We provide a math. framework for the anal. of ion effects.  Finally, we discuss open questions in the field and future research directions.  Most importantly, the in vivo relevance of the modulation of GPCR function by monovalent ions must be clarified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDmk3TO24ZO7Vg90H21EOLACvtfcHk0ljNDGQK_2HgOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSitLzF&md5=74281aba85e6e810d49d08f89980fb01</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2Fs00210-014-1073-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-014-1073-2%26sid%3Dliteratum%253Aachs%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DSchneider%26aufirst%3DE.%2BH.%26aulast%3DSeifert%26aufirst%3DR.%26atitle%3DModulation%2520of%2520GPCRs%2520by%2520monovalent%2520cations%2520and%2520anions%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2015%26volume%3D388%26spage%3D363%26epage%3D380%26doi%3D10.1007%2Fs00210-014-1073-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Howlett, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabral, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casellas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devane, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herkenham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXVII. Classification of cannabinoid receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1124/pr.54.2.161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1124%2Fpr.54.2.161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=12037135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVOiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=161-202&author=A.+C.+Howlettauthor=F.+Barthauthor=T.+I.+Bonnerauthor=G.+Cabralauthor=P.+Casellasauthor=W.+A.+Devaneauthor=C.+C.+Felderauthor=M.+Herkenhamauthor=K.+Mackieauthor=B.+R.+Martinauthor=R.+Mechoulamauthor=R.+G.+Pertwee&title=International+Union+of+Pharmacology.+XXVII.+Classification+of+cannabinoid+receptors&doi=10.1124%2Fpr.54.2.161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Pharmacology. XXVII. Classification of cannabinoid receptors</span></div><div class="casAuthors">Howlett, A. C.; Barth, F.; Bonner, T. I.; Cabral, G.; Casellas, P.; Devane, W. A.; Felder, C. C.; Herkenham, M.; Mackie, K.; Martin, B. R.; Mechoulam, R.; Pertwee, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-202</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Two types of cannabinoid receptor have been discovered so far, CB1 (2.1: CBD:1:CB1:), cloned in 1990, and CB2 (2.1:CBD:2:CB2:), cloned in 1993.  Distinction between these receptors is based on differences in their predicted amino acid sequence, signaling mechanisms, tissue distribution, and sensitivity to certain potent agonists and antagonists that show marked selectivity for one or the other receptor type.  Cannabinoid receptors CB1 and CB2 exhibit 48% amino acid sequence identity.  Both receptor types are coupled through G proteins to adenylyl cyclase and mitogen-activated protein kinase.  CB1 receptors are also coupled through G proteins to several types of calcium and potassium channels.  These receptors exist primarily on central and peripheral neurons, one of their functions being to inhibit neurotransmitter release.  Indeed, endogenous CB1 agonists probably serve as retrograde synaptic messengers.  CB2 receptors are present mainly on immune cells.  Such cells also express CB1 receptors, albeit to a lesser extent, with both receptor types exerting a broad spectrum of immune effects that includes modulation of cytokine release.  Of several endogenous agonists for cannabinoid receptors identified thus far, the most notable are arachidonoylethanolamide, 2-arachidonoylglycerol, and 2-arachidonylglyceryl ether.  It is unclear whether these eicosanoid mols. are the only, or primary, endogenous agonists.  Hence, the authors consider it premature to rename cannabinoid receptors after an endogenous agonist as is recommended by the International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification.  Although pharmacol. evidence for the existence of addnl. types of cannabinoid receptor is emerging, other kinds of supporting evidence are still lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeoe-6izzgsrVg90H21EOLACvtfcHk0ljNDGQK_2HgOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVOiuro%253D&md5=4a8345d34b5724ee3cd999b71956ab54</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fpr.54.2.161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.54.2.161%26sid%3Dliteratum%253Aachs%26aulast%3DHowlett%26aufirst%3DA.%2BC.%26aulast%3DBarth%26aufirst%3DF.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26aulast%3DCabral%26aufirst%3DG.%26aulast%3DCasellas%26aufirst%3DP.%26aulast%3DDevane%26aufirst%3DW.%2BA.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DHerkenham%26aufirst%3DM.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXVII.%2520Classification%2520of%2520cannabinoid%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D161%26epage%3D202%26doi%3D10.1124%2Fpr.54.2.161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Ross, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockie, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Templeton, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">Agonist-inverse agonist characterization at CB<sub>1</sub> and CB<sub>2</sub> cannabinoid receptors of L759633, L759656 and AM630</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0702351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fsj.bjp.0702351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10188977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK1MXhslWit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1999&pages=665-672&author=R.+A.+Rossauthor=H.+C.+Brockieauthor=L.+A.+Stevensonauthor=V.+L.+Murphyauthor=F.+Templetonauthor=A.+Makriyannisauthor=R.+G.+Pertwee&title=Agonist-inverse+agonist+characterization+at+CB1+and+CB2+cannabinoid+receptors+of+L759633%2C+L759656+and+AM630&doi=10.1038%2Fsj.bjp.0702351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630</span></div><div class="casAuthors">Ross, Ruth A.; Brockie, Heather C.; Stevenson, Lesley A.; Murphy, Vicki L.; Templeton, Fiona; Makriyannis, Alexandros; Pertwee, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">665-672</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">We have tested our prediction that AM630 is a CB2 cannabinoid receptor ligand and also investigated whether L759633 and L759656, are CB2 receptor agonists.  Binding assays with membranes from CHO cells stably transfected with human CB1 or CB2 receptors using [3H]-CP55940, confirmed the CB2-selectivity of L759633 and L759656 (CB2/CB1 affinity ratios = 163 and 414 resp.) and showed AM630 to have a Ki at CB2 receptors of 31.2 nM and a CB2/CB1 affinity ratio of 165.  In CB2-transfected cells, L759633 and L759656 were potent inhibitors of forskolin-stimulated cAMP prodn., with EC50 values of 8.1 and 3.1 nM resp. and CB1/CB2 EC50 ratios of > 1000 and > 3000 resp.  AM630 inhibited [35S]-GTPγS binding to CB2 receptor membranes (EC50 = 76.6 nM), enhanced forskolin-stimulated cAMP prodn. in CB2-transfected cells (5.2 fold by 1 μM), and antagonized the inhibition of forskolin-stimulated cAMP prodn. in this cell line induced by CP55940.  In CB1-transfected cells, forskolin-stimulated cAMP prodn. was significantly inhibited by AM630 (22.6% at 1 μM and 45.9% at 10 μM) and by L759633 at 10 μM (48%) but not 1 μM.  L759656 (10 μM) was not inhibitory.  AM630 also produced a slight decrease in the mean inhibitory effect of CP55940 on cAMP prodn. which was not statistically significant.  We conclude that AM630 is a CB2-selective ligand that behaves as an inverse agonist at CB2 receptors and as a weak partial agonist at CB1 receptors.  L759633 and L759656 are both potent CB2-selective agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSFP_3NFRGm7Vg90H21EOLACvtfcHk0ljNDGQK_2HgOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhslWit78%253D&md5=6d0f811a461a91ebef93f45605fd3b11</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702351%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DR.%2BA.%26aulast%3DBrockie%26aufirst%3DH.%2BC.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DMurphy%26aufirst%3DV.%2BL.%26aulast%3DTempleton%26aufirst%3DF.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DAgonist-inverse%2520agonist%2520characterization%2520at%2520CB1%2520and%2520CB2%2520cannabinoid%2520receptors%2520of%2520L759633%252C%2520L759656%2520and%2520AM630%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D126%26spage%3D665%26epage%3D672%26doi%3D10.1038%2Fsj.bjp.0702351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Williams, C.</span><span> </span><span class="NLM_article-title">cAMP detection methods in HTS: selecting the best from the rest</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span><span class="refDoi"> DOI: 10.1038/nrd1306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnrd1306" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=125-135&author=C.+Williams&title=cAMP+detection+methods+in+HTS%3A+selecting+the+best+from+the+rest&doi=10.1038%2Fnrd1306"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnrd1306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1306%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DC.%26atitle%3DcAMP%2520detection%2520methods%2520in%2520HTS%253A%2520selecting%2520the%2520best%2520from%2520the%2520rest%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D125%26epage%3D135%26doi%3D10.1038%2Fnrd1306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drazba, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, Q.</span><span> </span><span class="NLM_article-title">Role of myeloma-derived MIF in myeloma cell adhesion to bone marrow and chemotherapy response</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">djw131</span><span class="refDoi"> DOI: 10.1093/jnci/djw131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1093%2Fjnci%2Fdjw131" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=djw131&issue=11&author=Y.+Zhengauthor=Q.+Wangauthor=T.+Liauthor=J.+Qianauthor=Y.+Luauthor=Y.+Liauthor=E.+Biauthor=F.+Reuauthor=Y.+Qinauthor=J.+Drazbaauthor=E.+Hsiauthor=J.+Yangauthor=Z.+Caiauthor=Q.+Yi&title=Role+of+myeloma-derived+MIF+in+myeloma+cell+adhesion+to+bone+marrow+and+chemotherapy+response&doi=10.1093%2Fjnci%2Fdjw131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjw131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjw131%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DBi%26aufirst%3DE.%26aulast%3DReu%26aufirst%3DF.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DDrazba%26aufirst%3DJ.%26aulast%3DHsi%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DYi%26aufirst%3DQ.%26atitle%3DRole%2520of%2520myeloma-derived%2520MIF%2520in%2520myeloma%2520cell%2520adhesion%2520to%2520bone%2520marrow%2520and%2520chemotherapy%2520response%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2016%26volume%3D108%26issue%3D11%26spage%3Ddjw131%26doi%3D10.1093%2Fjnci%2Fdjw131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Waeber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chautard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicod, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pralong, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, R. C.</span><span> </span><span class="NLM_article-title">Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3′,5′-monophosphate responsive element-binding protein CREB in pituitary cells</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span><span class="refDoi"> DOI: 10.1210/mend.12.5.0109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1210%2Fmend.12.5.0109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=9605932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK1cXivVSgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=698-705&author=G.+Waeberauthor=N.+Thompsonauthor=T.+Chautardauthor=M.+Steinmannauthor=P.+Nicodauthor=F.+P.+Pralongauthor=T.+Calandraauthor=R.+C.+Gaillard&title=Transcriptional+activation+of+the+macrophage+migration-inhibitory+factor+gene+by+the+corticotropin-releasing+factor+is+mediated+by+the+cyclic+adenosine+3%E2%80%B2%2C5%E2%80%B2-monophosphate+responsive+element-binding+protein+CREB+in+pituitary+cells&doi=10.1210%2Fmend.12.5.0109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3',5'-monophosphate responsive element-binding protein CREB in pituitary cells</span></div><div class="casAuthors">Waeber, Gerard; Thompson, Nancy; Chautard, Thierry; Steinmann, Myriam; Nicod, Pascal; Pralong, Francois P.; Calandra, Thierry; Gaillard, Rolf C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">698-705</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Macrophage migration-inhibitory factor (MIF) has recently been identified as a pituitary hormone that functions as a counterregulatory modulator of glucocorticoid action within the immune system.  In the anterior pituitary gland, MIF is expressed in TSH- and ACTH-producing cells, and its secretion is induced by CRF.  To investigate MIF function and regulation within pituitary cells, we initiated the characterization of the MIF 5'-regulatory region of the gene.  The -1033 to +63 bp of the murine MIF promoter was cloned 5' to a luciferase reporter gene and transiently transfected into freshly isolated rat anterior pituitary cells.  This construct drove high basal transcriptional activity that was further enhanced after stimulation with CRF or with an activator of adenylate cyclase.  These transcriptional effects were assocd. with a concomitant rise in ACTH secretion in the transfected cells and by an increase in MIF gene expression as assessed by Northern blot anal.  A cAMP-responsive element (CRE) was identified within the MIF promoter region which, once mutated, abolished the cAMP responsiveness of the gene.  Using this newly identified CRE, DNA-binding activity was detected by gel retardation assay in nuclear exts. prepd. from isolated anterior pituitary cells and AtT-20 corticotroph tumor cells.  Supershift expts. using antibodies against the CRE-binding protein CREB, together with competition assays and the use of recombinant CREB, allowed the detection of CREB-binding activity with the identified MIF CRE.  These data demonstrate that CREB is the mediator of the CRF-induced MIF gene transcription in pituitary cells through an identified CRE in the proximal region of the MIF promoter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4ctiJbpNnCrVg90H21EOLACvtfcHk0lgGvKngC0uC5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVSgs78%253D&md5=770f5d527647a365076307134c26dd73</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1210%2Fmend.12.5.0109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.12.5.0109%26sid%3Dliteratum%253Aachs%26aulast%3DWaeber%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DN.%26aulast%3DChautard%26aufirst%3DT.%26aulast%3DSteinmann%26aufirst%3DM.%26aulast%3DNicod%26aufirst%3DP.%26aulast%3DPralong%26aufirst%3DF.%2BP.%26aulast%3DCalandra%26aufirst%3DT.%26aulast%3DGaillard%26aufirst%3DR.%2BC.%26atitle%3DTranscriptional%2520activation%2520of%2520the%2520macrophage%2520migration-inhibitory%2520factor%2520gene%2520by%2520the%2520corticotropin-releasing%2520factor%2520is%2520mediated%2520by%2520the%2520cyclic%2520adenosine%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-monophosphate%2520responsive%2520element-binding%2520protein%2520CREB%2520in%2520pituitary%2520cells%26jtitle%3DMol.%2520Endocrinol.%26date%3D1998%26volume%3D12%26spage%3D698%26epage%3D705%26doi%3D10.1210%2Fmend.12.5.0109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Alas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonavida, B.</span><span> </span><span class="NLM_article-title">Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin’s lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=12538484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Ortw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=316-326&author=S.+Alasauthor=B.+Bonavida&title=Inhibition+of+constitutive+STAT3+activity+sensitizes+resistant+non-Hodgkin%E2%80%99s+lymphoma+and+multiple+myeloma+to+chemotherapeutic+drug-mediated+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis</span></div><div class="casAuthors">Alas, Steve; Bonavida, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">316-326</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hematopoietic malignancies have been shown to depend on cytokine growth factor autocrine/paracrine loops for growth and differentiation.  This results in the constitutive activation of cytokine-mediated transcription factors like signal transducer and activators of transcription (STAT) 3 in non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM).  Recent evidence demonstrates that cytokines also contribute to a drug-resistant phenotype in many tumor cell types.  We hypothesized that inhibitors of the STAT3 pathway would sensitize drug-resistant and endogenous cytokine-dependent NHL and MM tumor cells to the cytotoxic effects of chemotherapeutic drugs.  We examd. an AIDS-related NHL cell line, 2F7, known to be dependent on interleukin (IL)-10 for survival and an MM cell line, U266, known to be dependent on IL-6 for survival.  IL-10 and IL-6 signal the cells through the activation of Janus kinase (JAK)1 and JAK2, resp.  Thus, we investigated the effect of two chem. STAT3 pathway inhibitors, namely, piceatannol (JAK1/STAT3 inhibitor) and tyrphostin AG490 (JAK2/STAT3 inhibitor), on the tumor cells for sensitization to therapeutic drugs.  We demonstrate by phosphoprotein immunoblotting anal. and electrophoretic mobility shift anal. that piceatannol and AG490 inhibit the constitutive activity of STAT3 in 2F7 and U266, resp.  Furthermore, piceatannol and AG490 sensitize 2F7 and U266 cells, resp., to apoptosis by a range of therapeutic drugs including cisplatin, fludarabine, Adriamycin, and vinblastine.  The specificity of the inhibitors was corroborated in expts. showing that piceatannol had no effect on U266 and, likewise, AG490 has no effect on 2F7.  The sensitization obsd. by these inhibitors correlated with the inhibition of Bcl-2 expression in 2F7 and Bcl-xL expression in U266.  Altogether, these results demonstrate that STAT3 pathway inhibitors are a novel class of chemotherapeutic sensitizing agents capable of reversing the drug-resistant phenotype of cytokine-dependent tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8FrtRMRcL7Vg90H21EOLACvtfcHk0lgGvKngC0uC5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Ortw%253D%253D&md5=a8429459592fc28b78075df1baff89bf</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlas%26aufirst%3DS.%26aulast%3DBonavida%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520constitutive%2520STAT3%2520activity%2520sensitizes%2520resistant%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%2520and%2520multiple%2520myeloma%2520to%2520chemotherapeutic%2520drug-mediated%2520apoptosis%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D316%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ise, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, K.</span><span> </span><span class="NLM_article-title">Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Gene Struct. Expression</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1493</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1016/S0167-4781(00)00168-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS0167-4781%2800%2900168-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10978511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1Sns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1493&publication_year=2000&pages=91-100&author=K.+Katoauthor=M.+Nomotoauthor=H.+Izumiauthor=T.+Iseauthor=S.+Nakanoauthor=Y.+Nihoauthor=K.+Kohno&title=Structure+and+functional+analysis+of+the+human+STAT3+gene+promoter%3A+alteration+of+chromatin+structure+as+a+possible+mechanism+for+the+upregulation+in+cisplatin-resistant+cells&doi=10.1016%2FS0167-4781%2800%2900168-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells</span></div><div class="casAuthors">Kato, K.; Nomoto, M.; Izumi, H.; Ise, T.; Nakano, S.; Niho, Y.; Kohno, K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Gene Structure and Expression</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1493</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">BBGSD5</span>;
        ISSN:<span class="NLM_cas:issn">0167-4781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">STAT3 is involved in the signal transduction activated by various cytokines and growth factors.  We found that the STAT3 gene is overexpressed in cisplatin-resistant cells.  We isolated a genomic fragment contg. the 5'-portion of the human STAT3 gene using a bubble PCR method.  Using the bubble PCR product as a probe, one genomic clone was isolated.  The nucleotide sequence of the first exon and the 1800 base pairs (bps) preceding it was detd.  The promoter region of the human STAT3 gene is highly homologous to the corresponding region of the mouse STAT3 gene; several potential factor binding sites such as CRE/ATF, SBE, and GC boxes are also well conserved between human and mouse.  A transient expression assay using the luciferase reporter gene showed that the sequence from -403 to +102 possesses maximal promoter activity, and transcription of the STAT3 gene was significantly higher in cisplatin-resistant cells than in parental cisplatin-sensitive cells.  Deletion of the region between -261 and -167 resulted in significant loss of promoter activity in both parental and cisplatin-resistant cells.  In vivo footprint anal. revealed several protein bindings; however, no significant differences were obsd. between drug-sensitive and drug-resistant cells.  MNase digestion revealed that several open or active nucleosomes were only detected in cisplatin-resistant cells.  These results suggest that STAT3 promoter function in a highly structured chromatin environment requires a complex interaction of several transcriptional factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUvgaeUQnDp7Vg90H21EOLACvtfcHk0lgGvKngC0uC5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1Sns7g%253D&md5=211aad8e6a379cb222e310918699f7a0</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS0167-4781%2800%2900168-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4781%252800%252900168-8%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNomoto%26aufirst%3DM.%26aulast%3DIzumi%26aufirst%3DH.%26aulast%3DIse%26aufirst%3DT.%26aulast%3DNakano%26aufirst%3DS.%26aulast%3DNiho%26aufirst%3DY.%26aulast%3DKohno%26aufirst%3DK.%26atitle%3DStructure%2520and%2520functional%2520analysis%2520of%2520the%2520human%2520STAT3%2520gene%2520promoter%253A%2520alteration%2520of%2520chromatin%2520structure%2520as%2520a%2520possible%2520mechanism%2520for%2520the%2520upregulation%2520in%2520cisplatin-resistant%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gene%2520Struct.%2520Expression%26date%3D2000%26volume%3D1493%26spage%3D91%26epage%3D100%26doi%3D10.1016%2FS0167-4781%2800%2900168-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Hill, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, S.</span><span> </span><span class="NLM_article-title">Reporter-gene systems for the study of G-protein-coupled receptors</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span><span class="refDoi"> DOI: 10.1016/S1471-4892(01)00091-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2FS1471-4892%2801%2900091-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=11764780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFOisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=526-532&author=S.+J.+Hillauthor=J.+G.+Bakerauthor=S.+Rees&title=Reporter-gene+systems+for+the+study+of+G-protein-coupled+receptors&doi=10.1016%2FS1471-4892%2801%2900091-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Reporter-gene systems for the study of G-protein-coupled receptors</span></div><div class="casAuthors">Hill, Stephen J.; Baker, Jillian G.; Rees, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">526-532</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Reporter-gene assays offer an alternative to biochem. assays for following signal transduction pathways from receptors at the cell surface to nuclear gene transcription in living cells.  Specific reporter-gene systems are now available for the study of ligand activity at Gαi/o, Gαs and Gαq G-protein-coupled receptors.  In recent years reporter genes have been applied in academia and industry to the study of ligand efficacy and affinity in recombinant and primary cell lines using a variety of color, fluorescent or luminescent read-outs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozKOKQCcaFu7Vg90H21EOLACvtfcHk0lhCQs69yT5q5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFOisr8%253D&md5=9f401de8554092238db94e108dcf88ca</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2801%2900091-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252801%252900091-1%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DS.%2BJ.%26aulast%3DBaker%26aufirst%3DJ.%2BG.%26aulast%3DRees%26aufirst%3DS.%26atitle%3DReporter-gene%2520systems%2520for%2520the%2520study%2520of%2520G-protein-coupled%2520receptors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2001%26volume%3D1%26spage%3D526%26epage%3D532%26doi%3D10.1016%2FS1471-4892%2801%2900091-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Wood, K. V.</span><span> </span><span class="NLM_article-title">Marker proteins for gene expression</span> <span class="citation_source-journal">Curr. Opin. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1016/0958-1669(95)80009-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2F0958-1669%2895%2980009-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=7894082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK2MXjsl2ks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1995&pages=50-58&author=K.+V.+Wood&title=Marker+proteins+for+gene+expression&doi=10.1016%2F0958-1669%2895%2980009-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Marker proteins for gene expression</span></div><div class="casAuthors">Wood, Keith V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-8</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 50 refs.  Reporter genes are widely used as rapid and convenient means of measuring mol. genetic events.  Their role in exptl. strategies has expanded from anal. of the DNA sequences mediating RNA transcription to the broader ensemble of mol. events that define phenotype expression.  The several genetic reporters available today impart a range of performance criteria to choose from, including assay convenience and reliability, sensitivity, linearity, simplicity and dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmEvDr-4wzXLVg90H21EOLACvtfcHk0lhCQs69yT5q5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsl2ks78%253D&md5=fc816b081601a5020a209b44e827d619</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0958-1669%2895%2980009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0958-1669%252895%252980009-3%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DMarker%2520proteins%2520for%2520gene%2520expression%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D1995%26volume%3D6%26spage%3D50%26epage%3D58%26doi%3D10.1016%2F0958-1669%2895%2980009-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Renton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddaford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakhit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J. S.</span><span> </span><span class="NLM_article-title">NOpiates: Novel dual action neuronal nitric oxide synthase inhibitors with μ-opioid agonist activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1021/ml200268w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200268w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlyls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=227-231&author=P.+Rentonauthor=B.+Greenauthor=S.+Maddafordauthor=S.+Rakhitauthor=J.+S.+Andrews&title=NOpiates%3A+Novel+dual+action+neuronal+nitric+oxide+synthase+inhibitors+with+%CE%BC-opioid+agonist+activity&doi=10.1021%2Fml200268w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity</span></div><div class="casAuthors">Renton, Paul; Green, Brenda; Maddaford, Shawn; Rakhit, Suman; Andrews, John S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-231</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of benzimidazole designed multiple ligands (DMLs) with activity at the neuronal nitric oxide synthase (nNOS) enzyme and the μ-opioid receptor was developed.  Targeting of the structurally dissimilar heme-contg. enzyme and the μ-opioid GPCR was predicated on the modulatory role of nitric oxide on μ-opioid receptor function.  Structure-activity relationship studies yielded lead compd. 24 (I) with excellent nNOS inhibitory activity (IC50 = 0.44 μM), selectivity over both endothelial nitric oxide synthase (10-fold) and inducible nitric oxide synthase (125-fold), and potent μ-opioid binding affinity, Ki = 5.4 nM.  The functional activity as measured in the cyclic adenosine monosphospate secondary messenger assay resulted in full agonist activity (EC50 = 0.34 μM).  This work represents a novel approach in the development of new analgesics for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo12qBIKTlmjrVg90H21EOLACvtfcHk0lhCQs69yT5q5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlyls7g%253D&md5=6de1fce2b5543f611a2ed156c6d65260</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fml200268w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200268w%26sid%3Dliteratum%253Aachs%26aulast%3DRenton%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DB.%26aulast%3DMaddaford%26aufirst%3DS.%26aulast%3DRakhit%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DJ.%2BS.%26atitle%3DNOpiates%253A%2520Novel%2520dual%2520action%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%2520with%2520%25CE%25BC-opioid%2520agonist%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D227%26epage%3D231%26doi%3D10.1021%2Fml200268w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Hunger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kebrle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, K.</span><span> </span><span class="NLM_article-title">Benzimidazol-Derivate und verwandte Heterocyclen III. Synthese von 1-Aminoalkyl-2-benzyl-nitro-benzimidazolen</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1032</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span><span class="refDoi"> DOI: 10.1002/hlca.19600430412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1002%2Fhlca.19600430412" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1960&pages=1032-1046&author=A.+Hungerauthor=J.+Kebrleauthor=A.+Rossiauthor=K.+Hoffmann&title=Benzimidazol-Derivate+und+verwandte+Heterocyclen+III.+Synthese+von+1-Aminoalkyl-2-benzyl-nitro-benzimidazolen&doi=10.1002%2Fhlca.19600430412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fhlca.19600430412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.19600430412%26sid%3Dliteratum%253Aachs%26aulast%3DHunger%26aufirst%3DA.%26aulast%3DKebrle%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DHoffmann%26aufirst%3DK.%26atitle%3DBenzimidazol-Derivate%2520und%2520verwandte%2520Heterocyclen%2520III.%2520Synthese%2520von%25201-Aminoalkyl-2-benzyl-nitro-benzimidazolen%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1960%26volume%3D43%26spage%3D1032%26epage%3D1046%26doi%3D10.1002%2Fhlca.19600430412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Privat, A.</span><span> </span><span class="NLM_article-title">Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">706</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span><span class="refDoi"> DOI: 10.1016/0006-8993(95)01032-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2F0006-8993%2895%2901032-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=8822355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK28Xns1yitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=706&publication_year=1996&pages=181-193&author=T.+Mauriceauthor=B.+P.+Lockhartauthor=A.+Privat&title=Amnesia+induced+in+mice+by+centrally+administered+%CE%B2-amyloid+peptides+involves+cholinergic+dysfunction&doi=10.1016%2F0006-8993%2895%2901032-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction</span></div><div class="casAuthors">Maurice, Tangui; Lockhart, Brian P.; Privat, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">706</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-93</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Substantial evidences suggest that the increased cerebral deposition, and neurotoxic action of the β-amyloid peptide, the major constituent of senile plaques, may represent the underlying cause of the cognitive deficits obsd. in Alzheimer's disease.  Herein, the authors attempted to verify this hypothesis by inducing a potential Alzheimer's-type amnesia after direct intracerebroventricular administration of aggregated β25-35-amyloid peptide in mice.  In this aim, amnesic capacities were evaluated after 6 to 13 days, using spontaneous alternation in the Y-maze, step-down type passive avoidance and place learning in a water-maze.  Pre-training administration of aggregated β25-35 peptide induced dose-dependent decreases in both alternation behavior and passive avoidance, at doses of 3 and 9 nmol/mouse.  A reduced but still significant impairment was obsd. when the peptide was not aggregated, or 'aged', by preincubation for 4 days at 37°.  The β1-28 peptide, at 3 nmol/mouse, also induced a marked decrease in step-down latency.  Post-training, but not pre-retention, administration of β25-35 peptide also significantly impaired learning.  The beneficial effects of cholinergic agents on β25-35-induced amnesia was examd. using the cholinesterase inhibitor tacrine (THA, 1.3 and 4.3 μmol/kg i.p.) and the nicotinic receptor agonist (-)-nicotine (NIC, 0.06 and 0.2 μmol/kg i.p.).  Both drugs induced a dose-dependent abrogation of the β25-35-induced decreases in alternation behavior and passive avoidance.  Furthermore, THA, at 1.3 μmol/kg, and NIC, at 0.2 μmol/kg, also reversed the β25-35-induced impairment of place learning and retention in the water-maze.  Histol. examn. of Cresyl violet-stained brain sections indicated a moderate but significant cell loss within the frontoparietal cortex and the hippocampal formation of mice treated with aged β25-35 peptide (9 nmol).  Examn. of Congo red-stained sections in the same animals demonstrated the presence of numerous amyloid deposits throughout these brain areas.  These results confirm that the deposition of β-amyloid peptide in the brain is in some way related to impairment of learning and cholinergic degeneration and suggest that the [25-35] fragment of the β-amyloid protein, sufficient to induce neuronal death in cultures, also induces an Alzheimer's-type amnesia in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCsjUgNl1iVLVg90H21EOLACvtfcHk0ljWjp80LCYA-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xns1yitQ%253D%253D&md5=5a0465719e2a405fcc1c6aae31ad0367</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2895%2901032-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252895%252901032-7%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DLockhart%26aufirst%3DB.%2BP.%26aulast%3DPrivat%26aufirst%3DA.%26atitle%3DAmnesia%2520induced%2520in%2520mice%2520by%2520centrally%2520administered%2520%25CE%25B2-amyloid%2520peptides%2520involves%2520cholinergic%2520dysfunction%26jtitle%3DBrain%2520Res.%26date%3D1996%26volume%3D706%26spage%3D181%26epage%3D193%26doi%3D10.1016%2F0006-8993%2895%2901032-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Lahmy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Givalois, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vamvakides, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span> </span><span class="NLM_article-title">Blockade of Tau hyperphosphorylation and Aβ1–42 generation by the aminotetrahydrofuran derivative ANAVEX2–73, a mixed muscarinic and σ1 receptor agonist, in a nontransgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1706</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span><span class="refDoi"> DOI: 10.1038/npp.2013.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1038%2Fnpp.2013.70" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=1706-1723&author=V.+Lahmyauthor=J.+Meunierauthor=S.+Malmstr%C3%B6mauthor=G.+Naertauthor=L.+Givaloisauthor=S.+H.+Kimauthor=V.+Villardauthor=A.+Vamvakidesauthor=T.+Maurice&title=Blockade+of+Tau+hyperphosphorylation+and+A%CE%B21%E2%80%9342+generation+by+the+aminotetrahydrofuran+derivative+ANAVEX2%E2%80%9373%2C+a+mixed+muscarinic+and+%CF%831+receptor+agonist%2C+in+a+nontransgenic+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnpp.2013.70"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2013.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2013.70%26sid%3Dliteratum%253Aachs%26aulast%3DLahmy%26aufirst%3DV.%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DMalmstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DNaert%26aufirst%3DG.%26aulast%3DGivalois%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DVillard%26aufirst%3DV.%26aulast%3DVamvakides%26aufirst%3DA.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DBlockade%2520of%2520Tau%2520hyperphosphorylation%2520and%2520A%25CE%25B21%25E2%2580%259342%2520generation%2520by%2520the%2520aminotetrahydrofuran%2520derivative%2520ANAVEX2%25E2%2580%259373%252C%2520a%2520mixed%2520muscarinic%2520and%2520%25CF%25831%2520receptor%2520agonist%252C%2520in%2520a%2520nontransgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D1706%26epage%3D1723%26doi%3D10.1038%2Fnpp.2013.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saedtler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Cytotoxic properties of the alkaloid rutaecarpine and its oligocyclic derivatives and chemical modifications to enhance water-solubility</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4937</span><span class="NLM_x">–</span> <span class="NLM_lpage">4941</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=10.1016%2Fj.bmcl.2017.08.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4937-4941&author=G.+Huangauthor=A.+Drakopoulosauthor=M.+Saedtlerauthor=H.+Zouauthor=L.+Meinelauthor=J.+Heilmannauthor=M.+Decker&title=Cytotoxic+properties+of+the+alkaloid+rutaecarpine+and+its+oligocyclic+derivatives+and+chemical+modifications+to+enhance+water-solubility&doi=10.1016%2Fj.bmcl.2017.08.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DDrakopoulos%26aufirst%3DA.%26aulast%3DSaedtler%26aufirst%3DM.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DMeinel%26aufirst%3DL.%26aulast%3DHeilmann%26aufirst%3DJ.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DCytotoxic%2520properties%2520of%2520the%2520alkaloid%2520rutaecarpine%2520and%2520its%2520oligocyclic%2520derivatives%2520and%2520chemical%2520modifications%2520to%2520enhance%2520water-solubility%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4937%26epage%3D4941%26doi%3D10.1016%2Fj.bmcl.2017.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Gottlieb, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span> </span><span class="NLM_article-title">NMR chemical shifts of common laboratory solvents as trace impurities</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">7512</span><span class="NLM_x">–</span> <span class="NLM_lpage">7515</span><span class="refDoi"> DOI: 10.1021/jo971176v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+chemical+shifts+of+common+laboratory+solvents+as+trace+impurities&doi=10.1021%2Fjo971176v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0ljWjp80LCYA-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520chemical%2520shifts%2520of%2520common%2520laboratory%2520solvents%2520as%2520trace%2520impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7512%26epage%3D7515%26doi%3D10.1021%2Fjo971176v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XRA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XRA','PDB','5XRA'); return false;">PDB: 5XRA</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i37"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01760">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50425"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01760">10.1021/acs.jmedchem.7b01760</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental and spectral data of compounds, detailed information about the measurement of inhibition of AChE and BChE, radioligand binding studies on the <i>h</i>CB<sub>1</sub>R, <i>h</i>CB<sub>2</sub>R, and <i>h</i>MOP receptors, efficacy on <i>h</i>CB<sub>2</sub>R, information on cell culture and cell lines, statistics, animals, biochemical and histological procedures, and statistics of behavioral studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_002.csv">CSV</a>)</p></li><li><p class="inline">Crystal structure of the human CB1 receptor (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_003.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_001.pdf">jm7b01760_si_001.pdf (723.49 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_002.csv">jm7b01760_si_002.csv (2.53 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01760/suppl_file/jm7b01760_si_003.pdb">jm7b01760_si_003.pdb (376.6 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code for the crystal structure of the human CB1 receptor in complex with agonist AM11542 is 5XRA.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> This crystal structure was used for the generation of the homology model for computational studies of the human CB2 receptor in complex with compound <b>20a</b> or <b>20d</b>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-4%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01760%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01760" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799719cf8aa3c8e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
